1	The	DT	O	the	det	3	SENT_1	[p1l459t88r503b110],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_1	[p1l512t88r741b117],
3	Joumal	NNP	O	Joumal	nsubj	5	SENT_1	[p1l750t88r834b115],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l844t88r920b116],
5	2006	CD	DATE	2006	_	0	SENT_1	[p1l844t88r920b116],
6	)	NN	O	)	nsubj	17	SENT_1	[p1l844t88r920b116],
7	6	CD	NUMBER	6	num	6	SENT_1	[p1l930t88r950b114],
8	,	,	O	,	_	0	SENT_1	[p1l930t88r950b114],
9	174-178	CD	NUMBER	174-178	num	16	SENT_1	[p1l961t88r1054b110],
10	©	CD	NUMBER	©	number	11	SENT_1	[p1l349t120r365b139],
11	2006	CD	DATE	2006	num	16	SENT_1	[p1l373t120r420b139],
12	Nature	NNP	ORGANIZATION	Nature	nn	16	SENT_1	[p1l429t120r491b139],
13	Publishing	NNP	ORGANIZATION	Publishing	nn	16	SENT_1	[p1l501t119r594b145],
14	Group	NNP	ORGANIZATION	Group	nn	16	SENT_1	[p1l603t120r661b145],
15	All	NNP	ORGANIZATION	All	nn	16	SENT_1	[p1l669t119r691b139],
16	rights	NNS	O	rights	appos	6	SENT_1	[p1l700t119r751b145],
17	reserved	VBD	O	reserve	rcmod	5	SENT_1	[p1l760t119r835b139],
18	1470-269X	NN	O	1470-269x	dobj	17	SENT_1	[p1l845t119r980b141],
19	/	:	O	/	punct	23	SENT_1	[p1l845t119r980b141],
20	06	CD	NUMBER	06	dep	23	SENT_1	[p1l845t119r980b141],
21	$	$	MONEY	$	dep	20	SENT_1	[p1l989t119r1054b140],
22	30.00	CD	MONEY	30.00	num	21	SENT_1	[p1l989t119r1054b140],
23	www.nature.com/tp]	NN	O	www.nature.com/tp]	parataxis	5	SENT_1	[p1l858t165r1053b190],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l1665t229r1919b268],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l1939t229r2149b268],

1	Influence	NN	O	influence	_	0	SENT_3	[p1l16t362r406b437],
2	of	IN	O	of	_	0	SENT_3	[p1l439t362r522b437],
3	phenotype	NN	O	phenotype	prep_of	1	SENT_3	[p1l553t362r1019b461],
4	and	CC	O	and	_	0	SENT_3	[p1l1052t362r1209b437],
5	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	1	SENT_3	[p1l1248t362r2007b461],
6	on	IN	O	on	_	0	SENT_3	[p1l2039t384r2144b437],
7	ﬂ-blocker	NN	O	ﬂ-blocker	nn	10	SENT_3	[p1l11t487r418b582],
8	drug	NN	O	drug	nn	10	SENT_3	[p1l454t487r653b586],
9	target	NN	O	target	nn	10	SENT_3	[p1l695t496r956b586],
10	pharmacogenetics	NNS	O	pharmacogenetic	prep_on	1	SENT_3	[p1l996t487r1793b586],

1	AL	NNP	PERSON	AL	nn	2	SENT_4	[p1l8t674r60b708],
2	Beitelsheesl	NNP	PERSON	Beitelsheesl	nsubj	5	SENT_4	[p1l80t668r336b716],
3	,	,	O	,	_	0	SENT_4	[p1l80t668r336b716],
4	I	PRP	O	I	nsubj	5	SENT_4	[p1l359t674r365b708],
5	Zineh	VBP	O	zineh	_	0	SENT_4	[p1l385t668r535b716],
6	‘	NN	O	‘	nn	9	SENT_4	[p1l385t668r535b716],
7	,	,	O	,	_	0	SENT_4	[p1l385t668r535b716],
8	HN	NN	O	hn	dep	9	SENT_4	[p1l12t732r76b766],
9	Yarandi2	NN	O	yarandi2	dep	11	SENT_4	[p1l95t726r314b774],
10	'	''	O	'	_	0	SENT_4	[p1l95t726r314b774],
11	3	CD	NUMBER	3	dep	5	SENT_4	[p1l95t726r314b774],
12	,	,	O	,	_	0	SENT_4	[p1l95t726r314b774],
13	DF	NN	O	df	appos	11	SENT_4	[p1l338t732r390b766],
14	Pau	NNP	LOCATION	Pau	nn	16	SENT_4	[p1l412t726r540b778],
15	|	CD	NUMBER	|	num	16	SENT_4	[p1l412t726r540b778],
16	y4	NN	O	y4	dep	13	SENT_4	[p1l412t726r540b778],
17	and	CC	O	and	_	0	SENT_4	[p1l10t789r85b825],
18	JA	NNP	O	JA	nn	19	SENT_4	[p1l105t790r147b834],
19	Johnson	NNP	O	Johnson	dep	5	SENT_4	[p1l163t784r382b833],
20	”	IN	O	”	dep	19	SENT_4	[p1l163t784r382b833],

1	1	CD	NUMBER	1	_	0	SENT_5	[p1l10t880r17b894],
2	Department	NNP	ORGANIZATION	Department	dep	1	SENT_5	[p1l25t884r192b916],
3	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l204t883r232b908],
4	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	5	SENT_5	[p1l241t883r381b915],
5	Practice	NNP	ORGANIZATION	Practice	prep_of	2	SENT_5	[p1l392t883r499b908],
6	and	CC	ORGANIZATION	and	_	0	SENT_5	[p1l511t883r565b908],
7	Center	NNP	ORGANIZATION	Center	prep_of	2	SENT_5	[p1l577t883r668b908],
8	for	IN	ORGANIZATION	for	_	0	SENT_5	[p1l11t920r49b945],
9	Pharmacogenomics	NNP	ORGANIZATION	Pharmacogenomics	nn	11	SENT_5	[p1l59t920r335b953],
10	,	,	O	,	_	0	SENT_5	[p1l59t920r335b953],
11	University	NNP	ORGANIZATION	University	prep_for	2	SENT_5	[p1l352t921r488b953],
12	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l498t920r526b945],
13	Florida	NNP	ORGANIZATION	Florida	nn	14	SENT_5	[p1l536t920r628b945],
14	College	NNP	ORGANIZATION	College	prep_of	11	SENT_5	[p1l11t957r111b990],
15	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l122t957r151b982],
16	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	18	SENT_5	[p1l160t957r304b990],
17	,	,	O	,	_	0	SENT_5	[p1l160t957r304b990],
18	Gainesville	NNP	LOCATION	Gainesville	prep_of	14	SENT_5	[p1l320t957r473b988],
19	,	,	O	,	_	0	SENT_5	[p1l320t957r473b988],
20	FL	NN	LOCATION	fl	appos	18	SENT_5	[p1l489t958r522b988],
21	,	,	O	,	_	0	SENT_5	[p1l489t958r522b988],
22	USA	NNP	LOCATION	USA	appos	20	SENT_5	[p1l539t958r602b988],
23	;	:	O	;	_	0	SENT_5	[p1l539t958r602b988],
24	2University	NN	O	2university	dep	20	SENT_5	[p1l9t992r161b1027],
25	of	IN	O	of	_	0	SENT_5	[p1l171t995r200b1020],
26	Florida	NNP	LOCATION	Florida	nn	28	SENT_5	[p1l209t995r301b1020],
27	‘	NNP	O	‘	nn	28	SENT_5	[p1l306t995r414b1032],
28	College	NNP	O	College	prep_of	24	SENT_5	[p1l306t995r414b1032],
29	of	IN	O	of	_	0	SENT_5	[p1l426t995r455b1020],
30	Nursing	NNP	O	Nursing	prep_of	28	SENT_5	[p1l464t995r578b1028],
31	,	,	O	,	_	0	SENT_5	[p1l464t995r578b1028],

1	Gainesville	NNP	LOCATION	Gainesville	_	0	SENT_6	[p1l11t1107r163b1138],
2	,	,	O	,	_	0	SENT_6	[p1l11t1107r163b1138],
3	FL	NN	LOCATION	fl	appos	1	SENT_6	[p1l179t1108r213b1138],
4	,	,	O	,	_	0	SENT_6	[p1l179t1108r213b1138],
5	USA	NNP	LOCATION	USA	appos	1	SENT_6	[p1l230t1108r293b1138],
6	;	:	O	;	_	0	SENT_6	[p1l230t1108r293b1138],
7	‘	NNP	ORGANIZATION	‘	nn	8	SENT_6	[p1l306t1107r457b1140],
8	University	NNP	ORGANIZATION	University	dep	5	SENT_6	[p1l306t1107r457b1140],
9	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l467t1107r496b1132],
10	Florida	NNP	ORGANIZATION	Florida	nn	11	SENT_6	[p1l506t1107r597b1132],
11	Department	NNP	ORGANIZATION	Department	prep_of	8	SENT_6	[p1l11t1146r178b1178],
12	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l187t1145r216b1170],
13	Statistics	NNPS	ORGANIZATION	Statistics	prep_of	11	SENT_6	[p1l222t1145r349b1175],
14	,	,	O	,	_	0	SENT_6	[p1l222t1145r349b1175],
15	Gainesville	NNP	LOCATION	Gainesville	prep_of	11	SENT_6	[p1l363t1145r515b1175],
16	,	,	O	,	_	0	SENT_6	[p1l363t1145r515b1175],
17	FL	NN	LOCATION	fl	prep_of	11	SENT_6	[p1l529t1146r562b1175],
18	,	,	O	,	_	0	SENT_6	[p1l529t1146r562b1175],
19	USA	NNP	LOCATION	USA	prep_of	11	SENT_6	[p1l577t1145r630b1170],
20	and	CC	O	and	_	0	SENT_6	[p1l641t1145r695b1170],
21	4Division	NN	O	4division	conj_and	13	SENT_6	[p1l9t1179r132b1207],
22	of	IN	O	of	_	0	SENT_6	[p1l145t1182r174b1207],
23	Cardiology	NNP	O	Cardiology	prep_of	8	SENT_6	[p1l184t1182r337b1215],
24	,	,	O	,	_	0	SENT_6	[p1l184t1182r337b1215],
25	University	NNP	ORGANIZATION	University	appos	1	SENT_6	[p1l354t1183r490b1215],
26	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l500t1182r529b1207],
27	Florida	NNP	ORGANIZATION	Florida	nn	28	SENT_6	[p1l538t1182r630b1207],
28	College	NNP	ORGANIZATION	College	prep_of	25	SENT_6	[p1l11t1219r111b1253],
29	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l122t1219r151b1245],
30	Medicine	NNP	ORGANIZATION	Medicine	nn	32	SENT_6	[p1l160t1219r289b1250],
31	,	,	O	,	_	0	SENT_6	[p1l160t1219r289b1250],
32	Gainesville	NNP	LOCATION	Gainesville	prep_of	28	SENT_6	[p1l306t1219r458b1250],
33	,	,	O	,	_	0	SENT_6	[p1l306t1219r458b1250],
34	FL	NN	LOCATION	fl	dep	1	SENT_6	[p1l474t1221r508b1250],
35	,	,	O	,	_	0	SENT_6	[p1l474t1221r508b1250],
36	USA	NNP	LOCATION	USA	appos	34	SENT_6	[p1l525t1220r579b1245],

1	Correspondence	NN	O	correspondence	_	0	SENT_7	[p1l10t1302r271b1335],
2	:	:	O	:	_	0	SENT_7	[p1l10t1302r271b1335],
3	Dr	VB	O	dr	dep	17	SENT_7	[p1l11t1341r45b1364],
4	JA	NNP	PERSON	JA	nn	5	SENT_7	[p1l55t1341r85b1371],
5	Johnson	NNP	PERSON	Johnson	dobj	3	SENT_7	[p1l96t1340r220b1371],
6	,	,	O	,	_	0	SENT_7	[p1l96t1340r220b1371],
7	Department	NNP	ORGANIZATION	Department	conj_and	5	SENT_7	[p1l236t1341r412b1373],
8	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l424t1340r452b1365],
9	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	10	SENT_7	[p1l465t1340r606b1373],
10	Practice	NNP	ORGANIZATION	Practice	prep_of	7	SENT_7	[p1l11t1377r121b1402],
11	and	CC	ORGANIZATION	and	_	0	SENT_7	[p1l134t1377r187b1402],
12	Center	NNP	ORGANIZATION	Center	conj_and	5	SENT_7	[p1l201t1378r299b1402],
13	for	IN	ORGANIZATION	for	_	0	SENT_7	[p1l309t1377r350b1402],
14	Pharmacogenomics	NNP	ORGANIZATION	Pharmacogenomics	nn	16	SENT_7	[p1l363t1377r655b1410],
15	,	,	O	,	_	0	SENT_7	[p1l363t1377r655b1410],
16	University	NNP	ORGANIZATION	University	prep_for	12	SENT_7	[p1l11t1415r151b1447],
17	of	IN	ORGANIZATION	of	dep	1	SENT_7	[p1l164t1414r192b1439],
18	Florida	NNP	ORGANIZATION	Florida	nn	19	SENT_7	[p1l205t1414r299b1439],
19	College	NNP	ORGANIZATION	College	pobj	17	SENT_7	[p1l313t1414r422b1447],
20	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l435t1414r463b1439],
21	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	24	SENT_7	[p1l476t1414r624b1447],
22	,	,	O	,	_	0	SENT_7	[p1l476t1414r624b1447],
23	PO	NNP	O	PO	appos	24	SENT_7	[p1l640t1415r681b1439],
24	Box	NNP	O	Box	prep_of	19	SENT_7	[p1l11t1453r63b1477],
25	100486	CD	NUMBER	100486	num	24	SENT_7	[p1l76t1452r194b1482],
26	,	,	O	,	_	0	SENT_7	[p1l76t1452r194b1482],
27	Gainesville	NNP	LOCATION	Gainesville	appos	24	SENT_7	[p1l208t1452r368b1482],
28	,	,	O	,	_	0	SENT_7	[p1l208t1452r368b1482],
29	FL	NN	LOCATION	fl	appos	24	SENT_7	[p1l383t1453r413b1476],
30	32610-0486	CD	NUMBER	32610-0486	num	29	SENT_7	[p1l425t1452r611b1482],
31	,	,	O	,	_	0	SENT_7	[p1l425t1452r611b1482],
32	USA	NNP	LOCATION	USA	appos	24	SENT_7	[p1l625t1452r691b1477],
33	.	.	O	.	_	0	SENT_7	[p1l625t1452r691b1477],

1	E-mail	NN	O	e-mail	_	0	SENT_8	[p1l11t1489r105b1514],
2	:	:	O	:	_	0	SENT_8	[p1l11t1489r105b1514],
3	johnson@cop.uf	NN	O	johnson@cop.uf	nn	4	SENT_8	[p1l119t1489r425b1522],
4	|	NN	O	|	dep	1	SENT_8	[p1l119t1489r425b1522],
5	.	.	O	.	_	0	SENT_8	[p1l119t1489r425b1522],

1	edu	NN	O	edu	_	0	SENT_9	[p1l119t1489r425b1522],

1	Received	VBN	O	receive	_	0	SENT_10	[p1l11t2648r145b2673],
2	11	CD	DATE	11	dobj	1	SENT_10	[p1l161t2649r190b2673],
3	April	NNP	DATE	April	tmod	1	SENT_10	[p1l208t2648r279b2681],
4	2005	CD	DATE	2005	num	3	SENT_10	[p1l294t2649r376b2678],
5	;	:	O	;	_	0	SENT_10	[p1l294t2649r376b2678],
6	revised	VBN	O	revise	parataxis	1	SENT_10	[p1l392t2648r499b2673],
7	12	CD	DATE	12	dobj	6	SENT_10	[p1l516t2649r550b2673],
8	October	NNP	DATE	October	tmod	6	SENT_10	[p1l563t2648r690b2673],
9	2005	CD	DATE	2005	num	8	SENT_10	[p1l9t2686r92b2716],
10	;	:	O	;	_	0	SENT_10	[p1l9t2686r92b2716],
11	accepted	VBN	O	accept	parataxis	1	SENT_10	[p1l105t2685r243b2719],
12	26	CD	DATE	26	dobj	11	SENT_10	[p1l256t2686r292b2711],
13	October	NNP	DATE	October	tmod	11	SENT_10	[p1l305t2685r431b2711],
14	2005	CD	DATE	2005	num	13	SENT_10	[p1l442t2686r524b2716],
15	;	:	O	;	_	0	SENT_10	[p1l442t2686r524b2716],
16	published	VBN	O	publish	parataxis	1	SENT_10	[p1l539t2685r687b2719],
17	online	NN	O	online	prep	16	SENT_10	[p1l9t2723r104b2748],
18	10	CD	DATE	10	dep	17	SENT_10	[p1l119t2724r154b2748],
19	January	NNP	DATE	January	tmod	16	SENT_10	[p1l165t2724r282b2756],
20	2006	CD	DATE	2006	num	19	SENT_10	[p1l294t2724r368b2748],

1	Two	CD	NUMBER	two	num	3	SENT_11	[p1l747t664r825b694],
2	common	JJ	O	common	amod	3	SENT_11	[p1l841t672r1003b694],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	21	SENT_11	[p1l1023t663r1301b704],
4	in	IN	O	in	_	0	SENT_11	[p1l1319t663r1347b694],
5	the	DT	O	the	det	10	SENT_11	[p1l1364t663r1422b694],
6	[	CD	MONEY	[	number	7	SENT_11	[p1l1438t663r1686b704],
7	£	CD	MONEY	£	num	10	SENT_11	[p1l1438t663r1686b704],
8	1-adrenergic	JJ	O	1-adrenergic	amod	10	SENT_11	[p1l1438t663r1686b704],
9	receptor	NN	O	receptor	nn	10	SENT_11	[p1l1703t666r1854b704],
10	gene	NN	O	gene	prep_in	3	SENT_11	[p1l1869t672r1967b704],
11	,	,	O	,	_	0	SENT_11	[p1l1869t672r1967b704],
12	Ser49G	NN	O	ser49g	nn	14	SENT_11	[p1l1987t663r2150b704],
13	|	NN	O	|	nn	14	SENT_11	[p1l1987t663r2150b704],
14	y	NN	O	y	appos	3	SENT_11	[p1l1987t663r2150b704],
15	and	CC	O	and	_	0	SENT_11	[p1l749t709r814b741],
16	Arg389G	NN	O	arg389g	nn	18	SENT_11	[p1l836t709r1042b751],
17	|	CD	NUMBER	|	num	18	SENT_11	[p1l836t709r1042b751],
18	y	NN	O	y	appos	3	SENT_11	[p1l836t709r1042b751],
19	,	,	O	,	_	0	SENT_11	[p1l836t709r1042b751],
20	are	VBP	O	be	auxpass	21	SENT_11	[p1l1067t719r1120b741],
21	associated	VBN	O	associate	_	0	SENT_11	[p1l1143t709r1326b741],
22	with	IN	O	with	_	0	SENT_11	[p1l1348t709r1426b741],
23	variable	JJ	O	variable	amod	25	SENT_11	[p1l1449t709r1589b741],
24	antihypertensive	JJ	O	antihypertensive	amod	25	SENT_11	[p1l1612t709r1910b751],
25	response	NN	O	response	prep_with	21	SENT_11	[p1l1934t719r2092b751],
26	to	TO	O	to	_	0	SENT_11	[p1l2113t713r2149b741],
27	metoprolol	NN	O	metoprolol	prep_to	21	SENT_11	[p1l750t756r959b798],
28	.	.	O	.	_	0	SENT_11	[p1l750t756r959b798],

1	We	PRP	O	we	nsubj	2	SENT_12	[p1l989t757r1047b788],
2	sought	VBD	O	seek	_	0	SENT_12	[p1l1076t756r1202b798],
3	to	TO	O	to	aux	4	SENT_12	[p1l1229t760r1264b788],
4	determine	VB	O	determine	xcomp	2	SENT_12	[p1l1293t756r1479b788],
5	whether	IN	O	whether	complm	10	SENT_12	[p1l1507t756r1659b788],
6	similar	JJ	O	similar	amod	8	SENT_12	[p1l1686t756r1803b788],
7	pharmacogenetic	JJ	O	pharmacogenetic	amod	8	SENT_12	[p1l1832t756r2149b798],
8	associations	NNS	O	association	nsubj	10	SENT_12	[p1l749t804r962b835],
9	were	VBD	O	be	cop	10	SENT_12	[p1l980t812r1067b835],
10	present	JJ	DATE	present	ccomp	4	SENT_12	[p1l1089t807r1222b845],
11	with	IN	O	with	_	0	SENT_12	[p1l1239t803r1317b835],
12	the	DT	O	the	det	16	SENT_12	[p1l1337t803r1394b835],
13	negative	JJ	O	negative	amod	16	SENT_12	[p1l1415t804r1568b845],
14	chronotropic	JJ	O	chronotropic	amod	16	SENT_12	[p1l1588t803r1822b845],
15	response	NN	O	response	nn	16	SENT_12	[p1l1843t812r2000b845],
16	phenotype	NN	O	phenotype	prep_with	10	SENT_12	[p1l2021t803r2149b845, p1l748t854r827b891],
17	to	TO	O	to	_	0	SENT_12	[p1l848t854r883b881],
18	metoprolol	NN	O	metoprolol	prep_to	10	SENT_12	[p1l907t850r1116b891],
19	.	.	O	.	_	0	SENT_12	[p1l907t850r1116b891],

1	Metoprolol	NNP	O	Metoprolol	nsubjpass	3	SENT_13	[p1l1141t850r1339b891],
2	was	VBD	O	be	auxpass	3	SENT_13	[p1l1361t859r1429b881],
3	titrated	VBN	O	titrate	_	0	SENT_13	[p1l1450t850r1580b881],
4	in	IN	O	in	_	0	SENT_13	[p1l1604t851r1633b881],
5	54	CD	NUMBER	54	num	8	SENT_13	[p1l1656t852r1700b881],
6	untreated	JJ	O	untreated	amod	7	SENT_13	[p1l1723t850r1897b881],
7	hypertensive	JJ	O	hypertensive	amod	8	SENT_13	[p1l1921t850r2149b891],
8	patients	NNS	O	patient	prep_in	3	SENT_13	[p1l750t897r892b938],
9	to	TO	O	to	aux	10	SENT_13	[p1l904t900r940b928],
10	achieve	VB	O	achieve	xcomp	3	SENT_13	[p1l953t897r1088b928],
11	blood	NN	O	blood	nn	13	SENT_13	[p1l1103t897r1205b928],
12	pressure	NN	O	pressure	nn	13	SENT_13	[p1l1221t906r1368b938],
13	control	NN	O	control	dobj	10	SENT_13	[p1l1381t897r1519b928],
14	.	.	O	.	_	0	SENT_13	[p1l1381t897r1519b928],

1	We	PRP	O	we	nsubj	2	SENT_14	[p1l1533t898r1591b928],
2	found	VBD	O	find	_	0	SENT_14	[p1l1603t897r1709b928],
3	no	DT	O	no	det	4	SENT_14	[p1l1725t906r1769b928],
4	association	NN	O	association	dobj	2	SENT_14	[p1l1783t897r1978b928],
5	between	IN	O	between	_	0	SENT_14	[p1l1994t897r2148b928],
6	either	CC	O	either	advmod	7	SENT_14	[p1l749t943r853b975],
7	resting	VBG	O	rest	prepc_between	4	SENT_14	[p1l869t944r988b985],
8	or	CC	O	or	_	0	SENT_14	[p1l1006t953r1043b975],
9	exercise	NN	O	exercise	conj_or	9	SENT_14	[p1l1057t944r1200b975],
10	heart	NN	O	heart	nn	11	SENT_14	[p1l1217t943r1309b975],
11	rate	NN	O	rate	dobj	9	SENT_14	[p1l1326t947r1392b975],
12	at	IN	O	at	_	0	SENT_14	[p1l1408t947r1442b975],
13	baseline	NN	O	baseline	npadvmod	15	SENT_14	[p1l1458t943r1602b975],
14	(	CD	NUMBER	(	num	13	SENT_14	[p1l1618t943r1823b982],
15	untreated	JJ	O	untreated	amod	16	SENT_14	[p1l1618t943r1823b982],
16	)	NN	O	)	prep_at	9	SENT_14	[p1l1618t943r1823b982],
17	or	CC	O	or	_	0	SENT_14	[p1l1840t953r1877b975],
18	in	IN	O	in	_	0	SENT_14	[p1l1892t944r1921b974],
19	response	NN	O	response	prep_in	9	SENT_14	[p1l1940t953r2098b985],
20	to	TO	O	to	_	0	SENT_14	[p1l2113t947r2149b975],
21	metoprolol	NN	O	metoprolol	prep_to	19	SENT_14	[p1l750t990r947b1031],
22	by	IN	O	by	_	0	SENT_14	[p1l967t990r1009b1031],
23	codon	NN	O	codon	nn	25	SENT_14	[p1l1024t990r1136b1021],
24	389	CD	NUMBER	389	num	25	SENT_14	[p1l1156t991r1222b1021],
25	genotype	NN	O	genotype	prep_by	9	SENT_14	[p1l1239t994r1421b1031],
26	.	.	O	.	_	0	SENT_14	[p1l1239t994r1421b1031],

1	In	IN	O	in	_	0	SENT_15	[p1l1441t992r1470b1021],
2	contrast	NN	O	contrast	pobj	1	SENT_15	[p1l1488t994r1643b1028],
3	,	,	O	,	_	0	SENT_15	[p1l1488t994r1643b1028],
4	when	WRB	O	when	advmod	5	SENT_15	[p1l1660t990r1759b1021],
5	compared	VBN	O	compare	dep	2	SENT_15	[p1l1777t990r1959b1031],
6	by	IN	O	by	_	0	SENT_15	[p1l1978t990r2020b1031],
7	codon	NN	O	codon	prep_by	5	SENT_15	[p1l2036t990r2148b1021],

1	49	CD	NUMBER	49	num	2	SENT_16	[p1l748t1113r793b1143],
2	genotype	NN	O	genotype	_	0	SENT_16	[p1l808t1115r990b1153],
3	,	,	O	,	_	0	SENT_16	[p1l808t1115r990b1153],
4	Ser49	NN	O	ser49	nn	5	SENT_16	[p1l1007t1113r1108b1143],
5	homozygotes	NNS	O	homozygote	nsubj	6	SENT_16	[p1l1124t1112r1369b1153],
6	had	VBD	O	have	dep	2	SENT_16	[p1l1384t1112r1449b1143],
7	significantly	RB	O	significantly	advmod	8	SENT_16	[p1l1464t1112r1679b1153],
8	higher	JJR	O	higher	acomp	9	SENT_16	[p1l1694t1112r1810b1153],
9	resting	VBG	O	rest	ccomp	6	SENT_16	[p1l1824t1112r1944b1153],
10	heart	NN	O	heart	nn	11	SENT_16	[p1l1960t1112r2053b1143],
11	rates	NNS	O	rate	dobj	9	SENT_16	[p1l2067t1115r2149b1143],
12	at	IN	O	at	_	0	SENT_16	[p1l749t1162r783b1190],
13	baseline	NN	O	baseline	npadvmod	15	SENT_16	[p1l808t1158r952b1190],
14	(	CD	NUMBER	(	num	13	SENT_16	[p1l978t1158r1183b1198],
15	untreated	JJ	O	untreated	amod	16	SENT_16	[p1l978t1158r1183b1198],
16	)	NN	O	)	prep_at	9	SENT_16	[p1l978t1158r1183b1198],
17	than	IN	O	than	mark	22	SENT_16	[p1l1209t1158r1289b1190],
18	G	NN	O	g	nn	21	SENT_16	[p1l1316t1158r1421b1200],
19	|	NNS	O	|	nn	21	SENT_16	[p1l1316t1158r1421b1200],
20	y49	NN	O	y49	nn	21	SENT_16	[p1l1316t1158r1421b1200],
21	carriers	NNS	O	carrier	nsubj	22	SENT_16	[p1l1448t1159r1576b1190],
22	(	VBP	O	(	advcl	6	SENT_16	[p1l1602t1159r1750b1198],
23	82i10	NN	O	82i10	dobj	22	SENT_16	[p1l1602t1159r1750b1198],
24	versus	CC	O	versus	prep	23	SENT_16	[p1l1774t1168r1885b1190],
25	74i11bpm	NN	O	74i11bpm	dep	24	SENT_16	[p1l1912t1158r2147b1200],
26	,	,	O	,	_	0	SENT_16	[p1l1912t1158r2147b1200],
27	respectively	RB	O	respectively	advmod	22	SENT_16	[p1l750t1205r970b1247],
28	,	,	O	,	_	0	SENT_16	[p1l750t1205r970b1247],
29	P	NN	O	p	appos	2	SENT_16	[p1l987t1207r1043b1237],
30	:	:	O	:	_	0	SENT_16	[p1l987t1207r1043b1237],
31	0.016	CD	NUMBER	0.016	num	32	SENT_16	[p1l1053t1206r1182b1245],
32	)	NN	O	)	dep	29	SENT_16	[p1l1053t1206r1182b1245],
33	.	.	O	.	_	0	SENT_16	[p1l1053t1206r1182b1245],

1	When	WRB	O	when	advmod	2	SENT_17	[p1l1196t1205r1302b1237],
2	corrected	VBN	O	correct	advcl	8	SENT_17	[p1l1317t1205r1486b1237],
3	for	IN	O	for	_	0	SENT_17	[p1l1499t1205r1550b1237],
4	plasma	NN	O	plasma	nn	5	SENT_17	[p1l1563t1205r1687b1247],
5	concentration	NN	O	concentration	prep_for	2	SENT_17	[p1l1702t1206r1963b1244],
6	,	,	O	,	_	0	SENT_17	[p1l1702t1206r1963b1244],
7	we	PRP	O	we	nsubj	8	SENT_17	[p1l1978t1215r2030b1237],
8	found	VBD	O	find	dep	29	SENT_17	[p1l2042t1205r2148b1237],
9	no	DT	O	no	det	10	SENT_17	[p1l750t1261r794b1284],
10	difference	NN	O	difference	dobj	8	SENT_17	[p1l813t1252r992b1284],
11	in	IN	O	in	_	0	SENT_17	[p1l1012t1253r1041b1283],
12	reduction	NN	O	reduction	prep_in	8	SENT_17	[p1l1063t1252r1234b1284],
13	in	IN	O	in	_	0	SENT_17	[p1l1255t1253r1284b1283],
14	exercise	NN	O	exercise	nn	16	SENT_17	[p1l1305t1253r1448b1284],
15	heart	NN	O	heart	nn	16	SENT_17	[p1l1468t1252r1560b1284],
16	rate	NN	O	rate	prep_in	12	SENT_17	[p1l1580t1256r1646b1284],
17	in	IN	O	in	_	0	SENT_17	[p1l1667t1253r1696b1283],
18	response	NN	O	response	prep_in	16	SENT_17	[p1l1718t1261r1875b1293],
19	to	TO	O	to	_	0	SENT_17	[p1l1894t1256r1929b1284],
20	metoprolol	NN	O	metoprolol	prep_to	8	SENT_17	[p1l1950t1252r2148b1293],
21	between	IN	O	between	_	0	SENT_17	[p1l750t1299r904b1330],
22	Ser49	NN	O	ser49	nn	23	SENT_17	[p1l944t1300r1044b1330],
23	homozygotes	NNS	O	homozygote	prep_between	20	SENT_17	[p1l1085t1299r1329b1340],
24	and	CC	O	and	_	0	SENT_17	[p1l1367t1299r1433b1330],
25	G	NN	O	g	nn	28	SENT_17	[p1l1472t1299r1578b1340],
26	|	NNS	O	|	nn	28	SENT_17	[p1l1472t1299r1578b1340],
27	y49	NN	O	y49	nn	28	SENT_17	[p1l1472t1299r1578b1340],
28	carriers	NNS	O	carrier	conj_and	23	SENT_17	[p1l1616t1300r1745b1330],
29	(	VBP	O	(	_	0	SENT_17	[p1l1783t1299r1994b1338],
30	0.75	CD	NUMBER	0.75	num	32	SENT_17	[p1l1783t1299r1994b1338],
31	i0	JJ	O	i0	amod	32	SENT_17	[p1l1783t1299r1994b1338],
32	.11	CD	NUMBER	.11	dobj	29	SENT_17	[p1l1783t1299r1994b1338],
33	versus	CC	O	versus	prep	29	SENT_17	[p1l2039t1308r2150b1330],
34	0.57	CD	NUMBER	0.57	num	35	SENT_17	[p1l749t1346r1130b1387],
35	iO	NN	O	io	dep	33	SENT_17	[p1l749t1346r1130b1387],
36	.17	CD	PERCENT	.17	num	37	SENT_17	[p1l749t1346r1130b1387],
37	%	NN	PERCENT	%	nsubj	29	SENT_17	[p1l749t1346r1130b1387],
38	/	:	O	/	punct	39	SENT_17	[p1l749t1346r1130b1387],
39	ng/ml	NN	O	ng/ml	dep	37	SENT_17	[p1l749t1346r1130b1387],
40	,	,	O	,	_	0	SENT_17	[p1l749t1346r1130b1387],
41	respectively	RB	O	respectively	dep	39	SENT_17	[p1l1149t1346r1368b1387],
42	,	,	O	,	_	0	SENT_17	[p1l1149t1346r1368b1387],
43	P	NN	O	p	appos	37	SENT_17	[p1l1386t1347r1442b1377],
44	:	:	O	:	_	0	SENT_17	[p1l1386t1347r1442b1377],
45	0.37	CD	NUMBER	0.37	num	46	SENT_17	[p1l1453t1346r1558b1385],
46	)	NN	O	)	dep	43	SENT_17	[p1l1453t1346r1558b1385],
47	.	.	O	.	_	0	SENT_17	[p1l1453t1346r1558b1385],

1	However	RB	O	however	advmod	22	SENT_18	[p1l1576t1347r1744b1384],
2	,	,	O	,	_	0	SENT_18	[p1l1576t1347r1744b1384],
3	if	IN	O	if	mark	5	SENT_18	[p1l1762t1346r1782b1377],
4	one	CD	NUMBER	one	nsubj	5	SENT_18	[p1l1795t1355r1861b1377],
5	fails	VBZ	O	fail	advcl	22	SENT_18	[p1l1874t1346r1941b1377],
6	to	TO	O	to	aux	7	SENT_18	[p1l1955t1349r1991b1377],
7	account	VB	O	account	xcomp	5	SENT_18	[p1l2005t1349r2151b1377],
8	for	IN	O	for	_	0	SENT_18	[p1l747t1392r798b1424],
9	plasma	NN	O	plasma	nn	10	SENT_18	[p1l813t1392r938b1434],
10	concentration	NN	O	concentration	prep_for	7	SENT_18	[p1l953t1393r1215b1430],
11	,	,	O	,	_	0	SENT_18	[p1l953t1393r1215b1430],
12	trends	NNS	O	trend	nsubjpass	22	SENT_18	[p1l1232t1392r1345b1424],
13	toward	IN	O	toward	_	0	SENT_18	[p1l1359t1392r1486b1424],
14	a	DT	O	a	det	16	SENT_18	[p1l1503t1402r1520b1424],
15	significant	JJ	O	significant	amod	16	SENT_18	[p1l1535t1392r1721b1434],
16	difference	NN	O	difference	prep_toward	12	SENT_18	[p1l1734t1392r1912b1424],
17	in	IN	O	in	_	0	SENT_18	[p1l1929t1393r1958b1423],
18	heart	NN	O	heart	nn	20	SENT_18	[p1l1976t1392r2068b1424],
19	rate	NN	O	rate	nn	20	SENT_18	[p1l2083t1396r2149b1424],
20	reduction	NN	O	reduction	prep_in	16	SENT_18	[p1l750t1439r921b1470],
21	are	VBP	O	be	auxpass	22	SENT_18	[p1l943t1448r997b1470],
22	seen	VBN	O	see	_	0	SENT_18	[p1l1017t1448r1096b1470],
23	between	IN	O	between	_	0	SENT_18	[p1l1120t1439r1274b1470],
24	Ser49	NN	O	ser49	nn	25	SENT_18	[p1l1297t1440r1398b1470],
25	homozygotes	NNS	O	homozygote	prep_between	22	SENT_18	[p1l1421t1439r1665b1480],
26	and	CC	O	and	_	0	SENT_18	[p1l1687t1439r1752b1470],
27	G	NN	O	g	nn	28	SENT_18	[p1l1775t1439r1880b1480],
28	|	NNS	O	|	conj_and	25	SENT_18	[p1l1775t1439r1880b1480],
29	y49	NN	O	y49	nn	30	SENT_18	[p1l1775t1439r1880b1480],
30	carriers	NNS	O	carrier	nsubj	31	SENT_18	[p1l1902t1440r2030b1470],
31	(	VBP	O	(	rcmod	25	SENT_18	[p1l2052t1439r2149b1478],
32	31	CD	PERCENT	31	number	33	SENT_18	[p1l2052t1439r2149b1478],
33	%	NN	PERCENT	%	amod	34	SENT_18	[p1l2052t1439r2149b1478],
34	reduction	NN	O	reduction	dobj	31	SENT_18	[p1l750t1486r921b1517],
35	versus	CC	O	versus	prep	34	SENT_18	[p1l934t1495r1045b1517],
36	25	CD	PERCENT	25	number	37	SENT_18	[p1l1059t1487r1142b1517],
37	%	NN	PERCENT	%	amod	38	SENT_18	[p1l1059t1487r1142b1517],
38	reduction	NN	O	reduction	dep	35	SENT_18	[p1l1157t1486r1339b1524],
39	,	,	O	,	_	0	SENT_18	[p1l1157t1486r1339b1524],
40	P	NN	O	p	appos	38	SENT_18	[p1l1356t1487r1412b1517],
41	:	:	O	:	_	0	SENT_18	[p1l1356t1487r1412b1517],
42	0.05	CD	NUMBER	0.05	num	43	SENT_18	[p1l1422t1486r1527b1525],
43	)	NN	O	)	dep	40	SENT_18	[p1l1422t1486r1527b1525],
44	.	.	O	.	_	0	SENT_18	[p1l1422t1486r1527b1525],

1	Our	PRP$	O	we	poss	2	SENT_19	[p1l1544t1487r1613b1517],
2	data	NNS	O	datum	nsubj	3	SENT_19	[p1l1625t1486r1702b1517],
3	suggest	VBP	O	suggest	_	0	SENT_19	[p1l1716t1490r1856b1527],
4	that	IN	O	that	complm	21	SENT_19	[p1l1867t1486r1940b1517],
5	neither	CC	O	neither	preconj	10	SENT_19	[p1l1954t1486r2081b1517],
6	the	DT	O	the	det	10	SENT_19	[p1l2092t1486r2149b1517],
7	/	:	O	/	punct	8	SENT_19	[p1l748t1533r996b1574],
8	31-adrenergic	JJ	O	31-adrenergic	dep	10	SENT_19	[p1l748t1533r996b1574],
9	receptor	NN	O	receptor	nn	10	SENT_19	[p1l1023t1536r1175b1574],
10	Arg389G	NN	O	arg389g	nsubj	21	SENT_19	[p1l1197t1533r1403b1574],
11	|	CD	NUMBER	|	num	12	SENT_19	[p1l1197t1533r1403b1574],
12	y	NN	O	y	dep	10	SENT_19	[p1l1197t1533r1403b1574],
13	,	,	O	,	_	0	SENT_19	[p1l1197t1533r1403b1574],
14	nor	CC	O	nor	_	0	SENT_19	[p1l1433t1542r1493b1564],
15	the	DT	O	the	det	17	SENT_19	[p1l1517t1533r1574b1564],
16	Ser49G	NN	O	ser49g	nn	17	SENT_19	[p1l1601t1533r1765b1574],
17	|	NN	O	|	conj_nor	10	SENT_19	[p1l1601t1533r1765b1574],
18	y	NN	O	y	nn	19	SENT_19	[p1l1601t1533r1765b1574],
19	polymorphisms	NNS	O	polymorphism	nsubj	20	SENT_19	[p1l1791t1533r2070b1574],
20	are	VBP	O	be	rcmod	17	SENT_19	[p1l2096t1542r2149b1564],
21	associated	VBN	O	associate	ccomp	3	SENT_19	[p1l749t1581r932b1612],
22	with	IN	O	with	_	0	SENT_19	[p1l954t1581r1031b1612],
23	variable	JJ	O	variable	amod	26	SENT_19	[p1l1053t1581r1193b1612],
24	negative	JJ	O	negative	amod	26	SENT_19	[p1l1216t1581r1369b1622],
25	chronotropic	JJ	O	chronotropic	amod	26	SENT_19	[p1l1390t1581r1625b1622],
26	response	NN	O	response	prep_with	21	SENT_19	[p1l1648t1590r1805b1622],
27	to	TO	O	to	_	0	SENT_19	[p1l1826t1584r1862b1612],
28	metoprolol	NN	O	metoprolol	prep_to	21	SENT_19	[p1l1885t1581r2093b1622],
29	.	.	O	.	_	0	SENT_19	[p1l1885t1581r2093b1622],

1	In	IN	O	in	_	0	SENT_20	[p1l2119t1582r2148b1612],
2	addition	NN	O	addition	prep_in	6	SENT_20	[p1l749t1629r908b1667],
3	,	,	O	,	_	0	SENT_20	[p1l749t1629r908b1667],
4	our	PRP$	O	we	poss	5	SENT_20	[p1l942t1638r1003b1661],
5	data	NNS	O	datum	nsubj	6	SENT_20	[p1l1032t1629r1109b1661],
6	highlight	VBP	O	highlight	_	0	SENT_20	[p1l1143t1629r1306b1671],
7	the	DT	O	the	det	8	SENT_20	[p1l1336t1629r1393b1661],
8	importance	NN	O	importance	dobj	6	SENT_20	[p1l1426t1630r1632b1671],
9	of	IN	O	of	_	0	SENT_20	[p1l1663t1629r1698b1661],
10	measuring	VBG	O	measure	prepc_of	8	SENT_20	[p1l1729t1630r1916b1671],
11	metoprolol	NN	O	metoprolol	nn	12	SENT_20	[p1l1950t1629r2148b1671],
12	concentration	NN	O	concentration	dobj	10	SENT_20	[p1l749t1678r999b1709],
13	in	IN	O	in	mark	16	SENT_20	[p1l1021t1678r1050b1708],
14	order	NN	O	order	dep	16	SENT_20	[p1l1071t1677r1168b1709],
15	to	TO	O	to	aux	16	SENT_20	[p1l1185t1681r1221b1709],
16	account	VB	O	account	purpcl	10	SENT_20	[p1l1240t1681r1385b1709],
17	for	IN	O	for	_	0	SENT_20	[p1l1402t1677r1453b1709],
18	variable	JJ	O	variable	amod	19	SENT_20	[p1l1469t1677r1609b1709],
19	pharmacokinetics	NNS	O	pharmacokinetic	prep_for	16	SENT_20	[p1l1630t1677r1947b1718],
20	and	CC	O	and	_	0	SENT_20	[p1l1966t1677r2032b1709],
21	avoid	VB	O	avoid	purpcl	10	SENT_20	[p1l2052t1677r2148b1709],
22	misinterpretation	NN	O	misinterpretation	dobj	21	SENT_20	[p1l750t1726r1059b1767],
23	of	IN	O	of	_	0	SENT_20	[p1l1078t1725r1113b1757],
24	the	DT	O	the	det	25	SENT_20	[p1l1127t1725r1184b1757],
25	data	NNS	O	datum	prep_of	22	SENT_20	[p1l1201t1725r1289b1757],
26	.	.	O	.	_	0	SENT_20	[p1l1201t1725r1289b1757],

1	The	DT	O	the	det	3	SENT_21	[p1l753t1773r812b1804],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_21	[p1l823t1773r1152b1814],
3	journal	NN	O	journal	_	0	SENT_21	[p1l1160t1773r1284b1812],
4	(	CD	NUMBER	(	dep	3	SENT_21	[p1l1292t1773r1410b1812],
5	2006	CD	DATE	2006	num	6	SENT_21	[p1l1292t1773r1410b1812],
6	)	NN	O	)	dep	4	SENT_21	[p1l1292t1773r1410b1812],
7	6	CD	NUMBER	6	dep	3	SENT_21	[p1l1422t1774r1453b1811],
8	,	,	O	,	_	0	SENT_21	[p1l1422t1774r1453b1811],
9	1	CD	NUMBER	1	number	10	SENT_21	[p1l1470t1774r1481b1804],
10	74-1	CD	NUMBER	74-1	appos	7	SENT_21	[p1l1493t1774r1571b1804],
11	78	CD	NUMBER	78	dep	10	SENT_21	[p1l1583t1774r1635b1804],
12	.	.	O	.	_	0	SENT_21	[p1l1583t1774r1635b1804],

1	doi	FW	O	doi	_	0	SENT_22	[p1l1648t1773r2147b1814],
2	:10.1038	CD	NUMBER	:10.1038	dep	1	SENT_22	[p1l1648t1773r2147b1814],
3	/	:	O	/	punct	4	SENT_22	[p1l1648t1773r2147b1814],
4	sJ	NN	O	sj	dep	2	SENT_22	[p1l1648t1773r2147b1814],
5	.	.	O	.	_	0	SENT_22	[p1l1648t1773r2147b1814],

1	tpj	NN	O	tpj	_	0	SENT_23	[p1l1648t1773r2147b1814],
2	.6500354	CD	NUMBER	.6500354	num	1	SENT_23	[p1l1648t1773r2147b1814],
3	;	:	O	;	_	0	SENT_23	[p1l1648t1773r2147b1814],
4	published	VBN	O	publish	dep	1	SENT_23	[p1l750t1821r919b1863],
5	online	NN	O	online	prep	4	SENT_23	[p1l936t1821r1044b1853],
6	10	CD	DATE	10	dep	5	SENT_23	[p1l1062t1822r1104b1853],
7	January	NNP	DATE	January	tmod	4	SENT_23	[p1l1119t1822r1251b1863],
8	2006	CD	DATE	2006	num	7	SENT_23	[p1l1266t1822r1356b1853],

1	Keywords	NNPS	O	Keywords	_	0	SENT_24	[p1l749t1918r920b1951],
2	:	:	O	:	_	0	SENT_24	[p1l749t1918r920b1951],
3	heart	NN	O	heart	dep	4	SENT_24	[p1l940t1918r1014b1943],
4	rate	NN	O	rate	dep	1	SENT_24	[p1l1029t1921r1090b1948],
5	;	:	O	;	_	0	SENT_24	[p1l1029t1921r1090b1948],
6	metoprolol	NN	O	metoprolol	dep	17	SENT_24	[p1l1108t1918r1274b1951],
7	;	:	O	;	_	0	SENT_24	[p1l1108t1918r1274b1951],
8	/	:	O	/	punct	11	SENT_24	[p1l1290t1918r1489b1951],
9	31-adrenergic	JJ	O	31-adrenergic	amod	11	SENT_24	[p1l1290t1918r1489b1951],
10	receptor	NN	O	receptor	nn	11	SENT_24	[p1l1504t1921r1625b1951],
11	polymorphisms	NNS	O	polymorphism	dep	15	SENT_24	[p1l1639t1918r1870b1951],
12	;	:	O	;	_	0	SENT_24	[p1l1639t1918r1870b1951],
13	pharmacokinetics	NNS	O	pharmacokinetic	dep	11	SENT_24	[p1l1887t1918r2148b1951],
14	;	:	O	;	_	0	SENT_24	[p1l1887t1918r2148b1951],
15	pharmacogenetics	NNS	O	pharmacogenetic	dep	6	SENT_24	[p1l750t1955r1023b1989],
16	;	:	O	;	_	0	SENT_24	[p1l750t1955r1023b1989],
17	ADRBI	NNP	O	ADRBI	parataxis	4	SENT_24	[p1l1037t1956r1129b1980],

1	Introduction	NN	O	introduction	_	0	SENT_25	[p1l749t2139r987b2167],

1	Two	CD	NUMBER	two	num	3	SENT_26	[p1l747t2233r820b2260],
2	common	JJ	O	common	amod	3	SENT_26	[p1l836t2240r991b2260],
3	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_26	[p1l1007t2232r1279b2269],
4	exist	VBP	O	exist	_	0	SENT_26	[p1l1295t2233r1374b2260],
5	in	IN	O	in	_	0	SENT_26	[p1l1389t2233r1423b2260],
6	the	DT	O	the	det	9	SENT_26	[p1l1439t2232r1494b2260],
7	Byadrenergic	JJ	MISC	byadrenergic	amod	9	SENT_26	[p1l1510t2232r1740b2269],
8	receptor	NN	O	receptor	nn	9	SENT_26	[p1l1755t2235r1897b2269],
9	gene	NN	O	gene	prep_in	4	SENT_26	[p1l1912t2240r2001b2269],
10	,	,	O	,	_	0	SENT_26	[p1l1912t2240r2001b2269],
11	ADRB1	NN	O	adrb1	prep_in	4	SENT_26	[p1l2017t2233r2147b2266],
12	,	,	O	,	_	0	SENT_26	[p1l2017t2233r2147b2266],
13	Arg389Gly	NN	O	arg389gly	conj_and	9	SENT_26	[p1l748t2279r934b2316],
14	and	CC	O	and	_	0	SENT_26	[p1l956t2279r1020b2307],
15	Ser49Gly	NN	O	ser49gly	prep_in	4	SENT_26	[p1l1043t2279r1203b2316],
16	.	.	O	.	_	0	SENT_26	[p1l1043t2279r1203b2316],

1	In	FW	O	in	nn	2	SENT_27	[p1l1226t2280r1260b2307],
2	vitro	FW	O	vitro	amod	4	SENT_27	[p1l1282t2279r1354b2307],
3	mutagenesis	NN	O	mutagenesis	nn	4	SENT_27	[p1l1376t2280r1590b2316],
4	studies	NNS	O	study	nsubj	5	SENT_27	[p1l1614t2279r1731b2307],
5	suggest	VBP	O	suggest	_	0	SENT_27	[p1l1755t2282r1879b2316],
6	both	DT	O	both	nsubj	10	SENT_27	[p1l1900t2279r1982b2307],
7	of	IN	O	of	_	0	SENT_27	[p1l2005t2279r2040b2307],
8	these	DT	O	these	det	9	SENT_27	[p1l2060t2279r2149b2307],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_27	[p1l748t2326r1020b2363],
10	have	VBP	O	have	ccomp	5	SENT_27	[p1l1051t2326r1132b2354],
11	functional	JJ	O	functional	amod	12	SENT_27	[p1l1164t2325r1344b2354],
12	consequences	NNS	O	consequence	dobj	10	SENT_27	[p1l1375t2322r1664b2363],
13	.	.	O	.	_	0	SENT_27	[p1l1375t2322r1664b2363],

1	”	NN	O	”	nsubj	25	SENT_28	[p1l1375t2322r1664b2363],
2	We	PRP	O	we	nsubj	4	SENT_28	[p1l1695t2327r1748b2354],
3	have	VBP	O	have	aux	4	SENT_28	[p1l1780t2326r1861b2354],
4	found	VBN	O	find	rcmod	1	SENT_28	[p1l1892t2325r1996b2354],
5	Arg389	NN	O	arg389	nn	6	SENT_28	[p1l2026t2326r2149b2363],
6	homozygotes	NNS	O	homozygote	dobj	4	SENT_28	[p1l748t2378r979b2415],
7	to	TO	O	to	aux	8	SENT_28	[p1l995t2382r1029b2406],
8	have	VB	O	have	dep	4	SENT_28	[p1l1046t2378r1126b2406],
9	a	DT	O	a	det	11	SENT_28	[p1l1143t2386r1160b2406],
10	greater	JJR	O	greater	amod	11	SENT_28	[p1l1176t2382r1294b2415],
11	magnitude	NN	O	magnitude	dobj	8	SENT_28	[p1l1309t2378r1496b2415],
12	of	IN	O	of	_	0	SENT_28	[p1l1513t2378r1548b2406],
13	antihypertensive	JJ	O	antihypertensive	amod	14	SENT_28	[p1l1562t2378r1853b2415],
14	response	NN	O	response	prep_of	11	SENT_28	[p1l1869t2386r2018b2415],
15	and	CC	O	and	_	0	SENT_28	[p1l2035t2378r2100b2406],
16	to	TO	O	to	aux	19	SENT_28	[p1l2115t2382r2149b2406],
17	be	VB	O	be	cop	19	SENT_28	[p1l747t2432r786b2460],
18	more	RBR	O	more	advmod	19	SENT_28	[p1l798t2440r887b2460],
19	likely	JJ	O	likely	dep	4	SENT_28	[p1l898t2432r993b2469],
20	to	TO	O	to	aux	22	SENT_28	[p1l1003t2435r1037b2460],
21	be	VB	O	be	auxpass	22	SENT_28	[p1l1048t2432r1087b2460],
22	considered	VBN	O	consider	xcomp	19	SENT_28	[p1l1099t2432r1286b2460],
23	‘	JJ	O	‘	amod	24	SENT_28	[p1l1298t2432r1503b2469],
24	responders	NNS	O	responder	dobj	22	SENT_28	[p1l1298t2432r1503b2469],
25	’	VBP	O	’	_	0	SENT_28	[p1l1298t2432r1503b2469],
26	(	RB	O	(	advmod	25	SENT_28	[p1l1517t2432r1659b2467],
27	defined	VBN	O	define	dep	25	SENT_28	[p1l1517t2432r1659b2467],
28	as	IN	O	as	_	0	SENT_28	[p1l1670t2440r1702b2460],
29	a	DT	O	a	det	33	SENT_28	[p1l1714t2440r1731b2460],
30	2	CD	PERCENT	2	number	32	SENT_28	[p1l1748t2437r1772b2464],
31	10	CD	PERCENT	10	number	32	SENT_28	[p1l1782t2433r1853b2460],
32	%	NN	PERCENT	%	amod	33	SENT_28	[p1l1782t2433r1853b2460],
33	reduction	NN	O	reduction	prep_as	27	SENT_28	[p1l1865t2432r2032b2460],
34	in	IN	O	in	_	0	SENT_28	[p1l2043t2433r2078b2460],
35	day	NN	DURATION	day	nn	36	SENT_28	[p1l2090t2432r2151b2469],
36	time	NN	O	time	prep_in	33	SENT_28	[p1l748t2486r826b2513],
37	diastolic	JJ	O	diastolic	amod	43	SENT_28	[p1l841t2485r985b2513],
38	blood	NN	O	blood	nn	43	SENT_28	[p1l999t2485r1098b2513],
39	pressure	NN	O	pressure	nn	43	SENT_28	[p1l1112t2493r1253b2522],
40	(	CD	NUMBER	(	num	43	SENT_28	[p1l1269t2485r1377b2520],
41	DBP	NN	O	dbp	nn	43	SENT_28	[p1l1269t2485r1377b2520],
42	)	CD	NUMBER	)	num	43	SENT_28	[p1l1269t2485r1377b2520],
43	)	NN	O	)	dobj	27	SENT_28	[p1l1269t2485r1377b2520],
44	to	TO	O	to	_	0	SENT_28	[p1l1393t2488r1428b2513],
45	metoprolol	NN	O	metoprolol	prep_to	27	SENT_28	[p1l1442t2485r1635b2522],
46	than	IN	O	than	_	0	SENT_28	[p1l1650t2485r1730b2513],
47	Gly389	NN	O	gly389	nn	48	SENT_28	[p1l1746t2485r1868b2522],
48	carriers	NNS	O	carrier	prep_than	27	SENT_28	[p1l1884t2481r2034b2513],
49	.3	NN	NUMBER	.3	nn	51	SENT_28	[p1l1884t2481r2034b2513],
50	Other	JJ	O	other	amod	51	SENT_28	[p1l2050t2485r2150b2513],
51	investigators	NNS	O	investigator	nsubj	53	SENT_28	[p1l748t2533r967b2569],
52	have	VBP	O	have	aux	53	SENT_28	[p1l991t2532r1072b2560],
53	found	VBN	O	find	rcmod	48	SENT_28	[p1l1096t2532r1199b2560],
54	similar	JJ	O	similar	amod	55	SENT_28	[p1l1223t2532r1340b2560],
55	associations	NNS	O	association	dobj	53	SENT_28	[p1l1364t2533r1569b2560],
56	with	IN	O	with	_	0	SENT_28	[p1l1592t2532r1671b2560],
57	Arg389Gly	NN	O	arg389gly	nn	58	SENT_28	[p1l1694t2532r1880b2569],
58	genotype	NN	O	genotype	prep_with	55	SENT_28	[p1l1902t2535r2062b2569],
59	and	CC	O	and	_	0	SENT_28	[p1l2086t2532r2150b2560],
60	blood	NN	O	blood	nn	62	SENT_28	[p1l747t2579r847b2608],
61	pressure	NN	O	pressure	nn	62	SENT_28	[p1l867t2587r1007b2617],
62	response	NN	O	response	prep_with	55	SENT_28	[p1l1027t2587r1177b2617],
63	to	TO	O	to	_	0	SENT_28	[p1l1197t2583r1231b2608],
64	[	CD	NUMBER	[	num	65	SENT_28	[p1l1252t2579r1426b2615],
65	3-blockers	NNS	O	3-blocker	prep_to	53	SENT_28	[p1l1252t2579r1426b2615],
66	as	RB	O	as	_	0	SENT_28	[p1l1447t2587r1479b2608],
67	well	RB	O	well	_	0	SENT_28	[p1l1498t2579r1569b2608],
68	as	IN	O	as	_	0	SENT_28	[p1l1590t2587r1621b2608],
69	with	IN	O	with	_	0	SENT_28	[p1l1641t2579r1720b2608],
70	contractile	NN	O	contractile	nn	71	SENT_28	[p1l1741t2579r1925b2608],
71	response	NN	O	response	prep_with	53	SENT_28	[p1l1945t2587r2095b2617],
72	to	TO	O	to	_	0	SENT_28	[p1l2115t2583r2149b2608],
73	dobutamine	NN	O	dobutamine	prep_to	53	SENT_28	[p1l749t2623r1016b2655],
74	.	.	O	.	_	0	SENT_28	[p1l749t2623r1016b2655],

1	““	NN	O	““	nsubj	17	SENT_29	[p1l749t2623r1016b2655],
2	’	CD	NUMBER	’	num	1	SENT_29	[p1l749t2623r1016b2655],
3	We	PRP	O	we	nsubj	6	SENT_29	[p1l1040t2627r1094b2655],
4	have	VBP	O	have	aux	6	SENT_29	[p1l1119t2626r1199b2655],
5	also	RB	O	also	advmod	6	SENT_29	[p1l1225t2626r1290b2655],
6	shown	VBN	O	show	_	0	SENT_29	[p1l1316t2626r1430b2655],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_29	[p1l1455t2626r1636b2663],
8	associations	NNS	O	association	dobj	6	SENT_29	[p1l1661t2628r1867b2655],
9	between	IN	O	between	_	0	SENT_29	[p1l1891t2626r2036b2655],
10	these	DT	O	these	det	11	SENT_29	[p1l2060t2626r2149b2655],
11	polymorphisms	NNS	O	polymorphism	prep_between	8	SENT_29	[p1l748t2673r1020b2710],
12	and	CC	O	and	_	0	SENT_29	[p1l1044t2673r1108b2701],
13	both	DT	O	both	det	15	SENT_29	[p1l1130t2673r1211b2701],
14	initial	JJ	O	initial	amod	15	SENT_29	[p1l1235t2673r1337b2701],
15	tolerability	NN	O	tolerability	conj_and	11	SENT_29	[p1l1360t2673r1551b2710],
16	and	CC	O	and	_	0	SENT_29	[p1l1574t2673r1638b2701],
17	left	VBD	O	leave	conj_and	6	SENT_29	[p1l1661t2673r1717b2701],
18	ventricular	JJ	O	ventricular	amod	20	SENT_29	[p1l1739t2673r1929b2701],
19	remodeling	NN	O	remodeling	nn	20	SENT_29	[p1l1952t2673r2150b2710],
20	responses	NNS	O	response	dobj	17	SENT_29	[p1l748t2728r913b2757],
21	to	TO	O	to	aux	22	SENT_29	[p1l927t2724r961b2748],
22	ﬁ	VB	O	ﬁ	xcomp	17	SENT_29	[p1l976t2720r1162b2756],
23	.	.	O	.	_	0	SENT_29	[p1l976t2720r1162b2756],

1	—	NN	O	—	_	0	SENT_30	[p1l976t2720r1162b2756],
2	.	.	O	.	_	0	SENT_30	[p1l976t2720r1162b2756],

1	blockade	NN	O	blockade	_	0	SENT_31	[p1l976t2720r1162b2756],
2	in	IN	O	in	_	0	SENT_31	[p1l1176t2721r1211b2748],
3	heart	NN	O	heart	nn	5	SENT_31	[p1l1225t2720r1314b2748],
4	failure	NN	O	failure	nn	5	SENT_31	[p1l1328t2720r1437b2748],
5	patients	NNS	O	patient	prep_in	1	SENT_31	[p1l1452t2716r1641b2757],
6	.	.	O	.	_	0	SENT_31	[p1l1452t2716r1641b2757],

1	”	NN	O	”	_	0	SENT_32	[p1l1452t2716r1641b2757],

1	The	DT	O	the	det	2	SENT_33	[p1l84t2911r217b2969],
2	association	NN	O	association	_	0	SENT_33	[p1l251t2914r641b2969],
3	between	IN	O	between	_	0	SENT_33	[p1l671t2911r969b2969],
4	these	DT	O	these	det	5	SENT_33	[p1l1001t2911r1183b2969],
5	polymorphisms	NNS	O	polymorphism	prep_between	2	SENT_33	[p1l1214t2911r1771b2987],
6	and	CC	O	and	_	0	SENT_33	[p1l1805t2911r1936b2969],
7	heart	NN	O	heart	nn	8	SENT_33	[p1l1967t2911r2150b2969],
8	rate	NN	O	rate	prep_between	2	SENT_33	[p1l10t3014r159b3077],
9	,	,	O	,	_	0	SENT_33	[p1l10t3014r159b3077],
10	or	CC	O	or	_	0	SENT_33	[p1l196t3024r267b3065],
11	heart	NN	O	heart	nn	13	SENT_33	[p1l298t3007r480b3065],
12	rate	NN	O	rate	nn	13	SENT_33	[p1l512t3014r642b3065],
13	response	NN	O	response	prep_between	2	SENT_33	[p1l675t3024r980b3083],
14	to	TO	O	to	aux	15	SENT_33	[p1l1013t3014r1082b3065],
15	ﬁ	VB	O	ﬁ	infmod	2	SENT_33	[p1l1115t3007r1471b3079],
16	.	.	O	.	_	0	SENT_33	[p1l1115t3007r1471b3079],

1	—	NN	O	—	_	0	SENT_34	[p1l1115t3007r1471b3079],
2	.	.	O	.	_	0	SENT_34	[p1l1115t3007r1471b3079],

1	b1ocl	NN	O	b1ocl	nsubj	36	SENT_35	[p1l1115t3007r1471b3079],
2	<	JJR	O	<	amod	3	SENT_35	[p1l1115t3007r1471b3079],
3	ers	NNPS	O	ers	nsubj	6	SENT_35	[p1l1115t3007r1471b3079],
4	is	VBZ	O	be	cop	6	SENT_35	[p1l1503t3010r1554b3065],
5	less	RBR	O	less	advmod	6	SENT_35	[p1l1586t3007r1706b3065],
6	clear	JJ	O	clear	rcmod	1	SENT_35	[p1l1739t3007r1904b3065],
7	in	IN	O	in	_	0	SENT_35	[p1l1934t3010r2005b3064],
8	the	DT	O	the	det	9	SENT_35	[p1l2036t3007r2149b3065],
9	literature	NN	O	literature	prep_in	6	SENT_35	[p1l10t3103r350b3173],
10	,	,	O	,	_	0	SENT_35	[p1l10t3103r350b3173],
11	and	CC	O	and	_	0	SENT_35	[p1l380t3102r511b3160],
12	the	DT	O	the	det	15	SENT_35	[p1l535t3102r647b3160],
13	negative	JJ	O	negative	amod	15	SENT_35	[p1l672t3105r970b3178],
14	chronotropic	JJ	O	chronotropic	amod	15	SENT_35	[p1l996t3102r1461b3178],
15	effect	NN	O	effect	conj_and	9	SENT_35	[p1l1486t3102r1677b3160],
16	of	IN	O	of	_	0	SENT_35	[p1l1701t3102r1773b3160],
17	/	:	O	/	punct	20	SENT_35	[p1l1793t3102r2149b3175],
18	3-blockers	NNS	O	3-blocker	nsubj	20	SENT_35	[p1l1793t3102r2149b3175],
19	is	VBZ	O	be	cop	20	SENT_35	[p1l10t3201r60b3256],
20	relevant	JJ	O	relevant	dep	15	SENT_35	[p1l86t3198r390b3269],
21	,	,	O	,	_	0	SENT_35	[p1l86t3198r390b3269],
22	as	IN	O	as	mark	27	SENT_35	[p1l422t3215r486b3256],
23	this	DT	O	this	nsubj	27	SENT_35	[p1l513t3198r642b3256],
24	is	VBZ	O	be	cop	27	SENT_35	[p1l668t3201r718b3256],
25	the	DT	O	the	det	27	SENT_35	[p1l745t3198r858b3256],
26	primary	JJ	O	primary	amod	27	SENT_35	[p1l883t3201r1166b3274],
27	mechanism	NN	O	mechanism	advcl	20	SENT_35	[p1l1190t3199r1601b3256],
28	of	IN	O	of	_	0	SENT_35	[p1l1627t3198r1699b3256],
29	benefit	NN	O	benefit	prep_of	27	SENT_35	[p1l1718t3198r1967b3256],
30	of	IN	O	of	prep	29	SENT_35	[p1l1993t3198r2065b3256],
31	/	:	O	/	punct	20	SENT_35	[p1l2085t3200r2149b3271, p1l7t3295r297b3353],
32	3blockers	NNS	O	3blocker	prep_of	15	SENT_35	[p1l2085t3200r2149b3271, p1l7t3295r297b3353],
33	in	IN	O	in	_	0	SENT_35	[p1l324t3298r395b3352],
34	certain	JJ	O	certain	amod	35	SENT_35	[p1l421t3298r664b3353],
35	settings	NNS	O	setting	prep_in	32	SENT_35	[p1l691t3298r959b3371],
36	(	VBP	O	(	_	0	SENT_35	[p1l989t3295r1129b3371],
37	e.g.	FW	O	e.g.	nn	38	SENT_35	[p1l989t3295r1129b3371],
38	arrhythmias	FW	O	arrhythmias	dobj	36	SENT_35	[p1l1160t3295r1609b3371],
39	,	,	O	,	_	0	SENT_35	[p1l1160t3295r1609b3371],
40	angina	NN	O	angina	nn	41	SENT_35	[p1l1641t3295r1926b3371],
41	)	NN	O	)	appos	38	SENT_35	[p1l1641t3295r1926b3371],
42	.	.	O	.	_	0	SENT_35	[p1l1641t3295r1926b3371],

1	Thus	RB	O	thus	advmod	9	SENT_36	[p1l1954t3295r2145b3365],
2	,	,	O	,	_	0	SENT_36	[p1l1954t3295r2145b3365],
3	the	DT	O	the	det	4	SENT_36	[p1l9t3391r122b3448],
4	aim	NN	O	aim	nsubj	9	SENT_36	[p1l157t3394r288b3448],
5	of	IN	O	of	_	0	SENT_36	[p1l322t3390r394b3448],
6	the	DT	O	the	det	8	SENT_36	[p1l422t3391r535b3448],
7	present	JJ	DATE	present	amod	8	SENT_36	[p1l569t3398r828b3466],
8	study	NN	O	study	prep_of	4	SENT_36	[p1l863t3391r1055b3466],
9	was	VBD	O	be	_	0	SENT_36	[p1l1085t3407r1212b3448],
10	to	TO	O	to	aux	11	SENT_36	[p1l1247t3398r1316b3448],
11	compare	VB	O	compare	xcomp	9	SENT_36	[p1l1351t3407r1654b3466],
12	pharmacogenetic	JJ	O	pharmacogenetic	amod	13	SENT_36	[p1l1688t3391r2149b3466, p1l10t3490r185b3545],
13	associations	NNS	O	association	dobj	11	SENT_36	[p1l222t3490r644b3545],
14	with	IN	O	with	_	0	SENT_36	[p1l680t3487r842b3545],
15	metoprolol	NN	O	metoprolol	prep_with	11	SENT_36	[p1l879t3487r1274b3563],
16	across	IN	O	across	_	0	SENT_36	[p1l1313t3504r1521b3545],
17	various	JJ	O	various	amod	20	SENT_36	[p1l1557t3490r1813b3545],
18	negative	JJ	O	negative	amod	20	SENT_36	[p1l1851t3490r2149b3563],
19	chronotropic	JJ	O	chronotropic	amod	20	SENT_36	[p1l10t3583r476b3659],
20	phenotypes	NNS	O	phenotype	prep_across	15	SENT_36	[p1l504t3583r936b3659],
21	.	.	O	.	_	0	SENT_36	[p1l504t3583r936b3659],

1	Results	NNS	O	result	_	0	SENT_37	[p2l12t84r280b142],

1	Allele	NN	O	allele	nn	2	SENT_38	[p2l8t273r206b331],
2	frequencies	NNS	O	frequency	nsubj	4	SENT_38	[p2l239t273r641b349],
3	were	VBD	O	be	cop	4	SENT_38	[p2l672t290r835b331],
4	0.76	CD	NUMBER	0.76	_	0	SENT_38	[p2l868t275r1017b331],
5	for	IN	O	for	_	0	SENT_38	[p2l1050t273r1149b331],
6	Arg389	NN	O	arg389	prep_for	4	SENT_38	[p2l1178t275r1428b349],
7	and	CC	O	and	_	0	SENT_38	[p2l1463t274r1595b331],
8	0.85	CD	NUMBER	0.85	conj_and	4	SENT_38	[p2l1626t275r1772b331],
9	for	IN	O	for	_	0	SENT_38	[p2l1809t273r1907b331],
10	Ser49	NN	O	ser49	prep_for	8	SENT_38	[p2l1938t275r2145b331],
11	.	.	O	.	_	0	SENT_38	[p2l1938t275r2145b331],

1	The	DT	O	the	det	3	SENT_39	[p2l8t369r140b427],
2	54	CD	NUMBER	54	num	3	SENT_39	[p2l208t372r289b427],
3	patients	NNS	O	patient	nsubjpass	5	SENT_39	[p2l355t372r637b445],
4	were	VBD	O	be	auxpass	5	SENT_39	[p2l701t386r865b427],
5	made	VBN	O	make	_	0	SENT_39	[p2l931t369r1122b427],
6	up	IN	O	up	dep	7	SENT_39	[p2l1187t386r1278b445],
7	of	IN	O	of	quantmod	10	SENT_39	[p2l1344t369r1416b427],
8	29	CD	PERCENT	29	number	10	SENT_39	[p2l1478t371r1558b427],
9	(	CD	PERCENT	(	number	10	SENT_39	[p2l1629t369r1829b441],
10	54	CD	PERCENT	54	num	11	SENT_39	[p2l1629t369r1829b441],
11	%	NN	PERCENT	%	dobj	5	SENT_39	[p2l1629t369r1829b441],
12	)	CD	NUMBER	)	num	14	SENT_39	[p2l1629t369r1829b441],
13	Arg389	NN	O	arg389	nn	14	SENT_39	[p2l1897t371r2147b445],
14	homozygotes	NNS	O	homozygote	dep	11	SENT_39	[p2l10t464r500b540],
15	,	,	O	,	_	0	SENT_39	[p2l10t464r500b540],
16	24	CD	PERCENT	24	number	17	SENT_39	[p2l570t466r651b521],
17	(	CD	PERCENT	(	conj_and	11	SENT_39	[p2l720t464r920b536],
18	44	CD	PERCENT	44	num	19	SENT_39	[p2l720t464r920b536],
19	%	NN	PERCENT	%	dep	17	SENT_39	[p2l720t464r920b536],
20	)	CD	NUMBER	)	num	22	SENT_39	[p2l720t464r920b536],
21	Gly389	NN	O	gly389	nn	22	SENT_39	[p2l989t464r1240b540],
22	heterozygotes	NNS	O	heterozygote	dep	17	SENT_39	[p2l1306t464r1813b540],
23	,	,	O	,	_	0	SENT_39	[p2l1306t464r1813b540],
24	1	CD	NUMBER	1	num	25	SENT_39	[p2l1888t466r1917b521],
25	(	NN	O	(	conj_and	11	SENT_39	[p2l1990t464r2146b536],
26	2	CD	PERCENT	2	number	27	SENT_39	[p2l1990t464r2146b536],
27	%	NN	PERCENT	%	amod	25	SENT_39	[p2l1990t464r2146b536],
28	)	CD	NUMBER	)	num	30	SENT_39	[p2l1990t464r2146b536],
29	Gly389	NN	O	gly389	nn	30	SENT_39	[p2l11t559r262b634],
30	homozygote	NN	O	homozygote	dep	25	SENT_39	[p2l324t559r783b634],
31	,	,	O	,	_	0	SENT_39	[p2l324t559r783b634],
32	38	CD	PERCENT	38	number	33	SENT_39	[p2l850t560r931b616],
33	(	CD	PERCENT	(	dobj	5	SENT_39	[p2l996t559r1196b631],
34	70	CD	PERCENT	70	num	35	SENT_39	[p2l996t559r1196b631],
35	%	NN	PERCENT	%	dep	33	SENT_39	[p2l996t559r1196b631],
36	)	CD	NUMBER	)	num	38	SENT_39	[p2l996t559r1196b631],
37	Ser49	NN	O	ser49	nn	38	SENT_39	[p2l1261t560r1448b616],
38	homozygotes	NNS	O	homozygote	dep	33	SENT_39	[p2l1510t559r2000b634],
39	,	,	O	,	_	0	SENT_39	[p2l1510t559r2000b634],
40	16	CD	PERCENT	16	number	41	SENT_39	[p2l2072t560r2149b616],
41	(	CD	PERCENT	(	conj_and	11	SENT_39	[p2l13t654r213b726],
42	30	CD	PERCENT	30	num	43	SENT_39	[p2l13t654r213b726],
43	%	NN	PERCENT	%	dep	41	SENT_39	[p2l13t654r213b726],
44	)	CD	NUMBER	)	num	46	SENT_39	[p2l13t654r213b726],
45	Gly49	NN	O	gly49	nn	46	SENT_39	[p2l265t654r472b730],
46	heterozygotes	NNS	O	heterozygote	dep	41	SENT_39	[p2l521t654r1028b730],
47	,	,	O	,	_	0	SENT_39	[p2l521t654r1028b730],
48	and	CC	O	and	_	0	SENT_39	[p2l1081t654r1212b712],
49	no	DT	O	no	det	51	SENT_39	[p2l1258t671r1349b712],
50	Gly49	NN	O	gly49	nn	51	SENT_39	[p2l1398t654r1605b730],
51	homozygotes	NNS	O	homozygote	conj_and	11	SENT_39	[p2l1655t654r2145b730],
52	.	.	O	.	_	0	SENT_39	[p2l1655t654r2145b730],

1	Genotype	NN	O	genotype	nn	2	SENT_40	[p2l11t751r355b825],
2	frequencies	NNS	O	frequency	nsubj	3	SENT_40	[p2l381t749r783b825],
3	were	VBD	O	be	_	0	SENT_40	[p2l807t766r970b807],
4	in	IN	O	in	_	0	SENT_40	[p2l996t752r1066b806],
5	Hardy	NNP	O	Hardy	prep_in	3	SENT_40	[p2l1092t749r1687b825],
6	.	.	O	.	_	0	SENT_40	[p2l1092t749r1687b825],

1	—	NN	O	—	_	0	SENT_41	[p2l1092t749r1687b825],
2	.	.	O	.	_	0	SENT_41	[p2l1092t749r1687b825],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_42	[p2l1092t749r1687b825],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_42	[p2l1711t749r2145b825],
3	.	.	O	.	_	0	SENT_42	[p2l1711t749r2145b825],

1	The	DT	O	the	det	3	SENT_43	[p2l8t844r140b901],
2	mean	NN	O	mean	nn	3	SENT_43	[p2l167t860r363b901],
3	age	NN	O	age	nsubj	8	SENT_43	[p2l390t860r503b919],
4	of	IN	O	of	_	0	SENT_43	[p2l530t843r602b901],
5	the	DT	O	the	det	6	SENT_43	[p2l624t844r736b901],
6	subjects	NNS	O	subject	prep_of	3	SENT_43	[p2l764t844r1040b919],
7	was	VBD	O	be	cop	8	SENT_43	[p2l1065t860r1193b901],
8	49	CD	NUMBER	49	_	0	SENT_43	[p2l1220t845r1301b901],
9	i	FW	O	i	nsubj	16	SENT_43	[p2l1319t851r1367b910],
10	8	CD	DURATION	8	num	11	SENT_43	[p2l1384t845r1421b901],
11	years	NNS	NUMBER	year	dep	9	SENT_43	[p2l1446t860r1624b919],
12	and	CC	O	and	_	0	SENT_43	[p2l1651t844r1782b901],
13	61	CD	PERCENT	61	num	14	SENT_43	[p2l1810t845r1961b901],
14	%	NN	PERCENT	%	conj_and	9	SENT_43	[p2l1810t845r1961b901],
15	were	VBD	O	be	cop	16	SENT_43	[p2l1985t860r2149b901],
16	male	JJ	O	male	rcmod	8	SENT_43	[p2l10t939r198b997],
17	.	.	O	.	_	0	SENT_43	[p2l10t939r198b997],

1	Patients	NNS	O	patient	nsubj	4	SENT_44	[p2l228t942r507b997],
2	were	VBD	O	be	cop	4	SENT_44	[p2l531t956r695b997],
3	generally	RB	O	generally	advmod	4	SENT_44	[p2l721t939r1047b1015],
4	obese	JJ	O	obese	_	0	SENT_44	[p2l1071t939r1281b1009],
5	,	,	O	,	_	0	SENT_44	[p2l1071t939r1281b1009],
6	with	IN	O	with	_	0	SENT_44	[p2l1309t939r1471b997],
7	a	DT	O	a	det	11	SENT_44	[p2l1498t956r1532b997],
8	mean	JJ	O	mean	amod	11	SENT_44	[p2l1557t956r1754b997],
9	body	NN	O	body	nn	11	SENT_44	[p2l1777t939r1956b1015],
10	mass	NN	O	mass	nn	11	SENT_44	[p2l1980t956r2149b997],
11	index	NN	O	index	prep_with	4	SENT_44	[p2l10t1031r209b1089],
12	of	IN	O	of	_	0	SENT_44	[p2l245t1031r316b1089],
13	30.5	CD	NUMBER	30.5	num	14	SENT_44	[p2l349t1033r677b1098],
14	i5	NN	O	i5	prep_of	11	SENT_44	[p2l349t1033r677b1098],
15	.1	CD	NUMBER	.1	num	16	SENT_44	[p2l349t1033r677b1098],
16	kg/m2	NN	O	kg/m2	dep	14	SENT_44	[p2l700t1024r932b1107],
17	.	.	O	.	_	0	SENT_44	[p2l700t1024r932b1107],

1	Baseline	NN	O	baseline	nn	3	SENT_45	[p2l973t1032r1259b1089],
2	demographic	JJ	O	demographic	amod	3	SENT_45	[p2l1297t1031r1763b1107],
3	characteristics	NNS	O	characteristic	nsubj	6	SENT_45	[p2l1799t1032r2149b1089, p2l10t1131r181b1186],
4	did	VBD	O	do	aux	6	SENT_45	[p2l216t1128r328b1186],
5	not	RB	O	not	neg	6	SENT_45	[p2l360t1135r481b1186],
6	differ	VB	O	differ	_	0	SENT_45	[p2l514t1128r701b1186],
7	by	IN	O	by	_	0	SENT_45	[p2l731t1128r819b1204],
8	codon	NN	O	codon	prep_by	6	SENT_45	[p2l849t1128r1070b1186],
9	49	CD	NUMBER	49	num	12	SENT_45	[p2l1103t1129r1185b1186],
10	or	CC	O	or	_	0	SENT_45	[p2l1220t1145r1292b1186],
11	389	CD	NUMBER	389	num	12	SENT_45	[p2l1325t1129r1448b1186],
12	genotype	NN	O	genotype	dobj	6	SENT_45	[p2l1484t1135r1810b1204],
13	with	IN	O	with	_	0	SENT_45	[p2l1842t1128r2003b1186],
14	the	DT	O	the	det	15	SENT_45	[p2l2036t1128r2149b1186],
15	exception	NN	O	exception	prep_with	12	SENT_45	[p2l10t1225r358b1298],
16	of	IN	O	of	_	0	SENT_45	[p2l401t1222r473b1280],
17	race/ethnicity	NN	O	race/ethnicity	prep_of	15	SENT_45	[p2l512t1222r1008b1298],
18	(	CD	NUMBER	(	num	19	SENT_45	[p2l1052t1222r1225b1294],
19	data	NNS	O	datum	npadvmod	20	SENT_45	[p2l1052t1222r1225b1294],
20	not	RB	O	not	neg	21	SENT_45	[p2l1267t1230r1388b1280],
21	shown	VBN	O	show	partmod	17	SENT_45	[p2l1432t1223r1709b1295],
22	)	NN	O	)	dobj	21	SENT_45	[p2l1432t1223r1709b1295],
23	.	.	O	.	_	0	SENT_45	[p2l1432t1223r1709b1295],

1	The	DT	O	the	det	2	SENT_46	[p2l1754t1222r1887b1280],
2	racial	JJ	O	racial	nsubj	11	SENT_46	[p2l1931t1222r2149b1288],
3	/	:	O	/	punct	5	SENT_46	[p2l1931t1222r2149b1288],
4	ethnic	JJ	O	ethnic	amod	5	SENT_46	[p2l10t1317r235b1375],
5	breakdown	NN	O	breakdown	dep	2	SENT_46	[p2l265t1317r659b1375],
6	of	IN	O	of	_	0	SENT_46	[p2l693t1317r764b1375],
7	the	DT	O	the	det	9	SENT_46	[p2l792t1317r904b1375],
8	overall	JJ	O	overall	amod	9	SENT_46	[p2l938t1317r1176b1375],
9	population	NN	O	population	prep_of	5	SENT_46	[p2l1208t1317r1601b1393],
10	was	VBD	O	be	cop	11	SENT_46	[p2l1631t1334r1760b1375],
11	41	CD	NUMBER	41	_	0	SENT_46	[p2l1793t1319r1871b1374],
12	Caucasian	JJ	MISC	caucasian	dep	11	SENT_46	[p2l1910t1319r2148b1375, p2l11t1416r167b1483],
13	,	,	O	,	_	0	SENT_46	[p2l1910t1319r2148b1375, p2l11t1416r167b1483],
14	10	CD	NUMBER	10	conj_and	11	SENT_46	[p2l205t1415r283b1471],
15	African	JJ	MISC	african	amod	16	SENT_46	[p2l309t1413r565b1471],
16	American	JJ	MISC	american	amod	14	SENT_46	[p2l591t1415r949b1483],
17	,	,	O	,	_	0	SENT_46	[p2l591t1415r949b1483],
18	and	CC	O	and	_	0	SENT_46	[p2l982t1413r1113b1471],
19	three	CD	NUMBER	three	num	20	SENT_46	[p2l1139t1413r1320b1471],
20	Hispanic/Latino	NN	O	hispanic/latino	conj_and	11	SENT_46	[p2l1348t1413r1935b1489],
21	.	.	O	.	_	0	SENT_46	[p2l1348t1413r1935b1489],

1	More	RBR	MISC	more	advmod	2	SENT_47	[p2l1966t1415r2149b1471],
2	African	JJ	MISC	african	amod	4	SENT_47	[p2l8t1507r265b1565],
3	American	JJ	MISC	american	amod	4	SENT_47	[p2l298t1509r639b1565],
4	subjects	NNS	O	subject	nsubj	7	SENT_47	[p2l676t1508r951b1583],
5	were	VBD	O	be	cop	7	SENT_47	[p2l985t1524r1149b1565],
6	Gly389	NN	O	gly389	nn	7	SENT_47	[p2l1186t1508r1437b1583],
7	carriers	NNS	O	carrier	dep	18	SENT_47	[p2l1474t1511r1728b1565],
8	(	VBP	O	(	rcmod	7	SENT_47	[p2l1767t1508r1870b1580],
9	15	CD	NUMBER	15	num	14	SENT_47	[p2l1767t1508r1870b1580],
10	Caucasian/eight	JJ	O	caucasian/eight	amod	14	SENT_47	[p2l1910t1509r2148b1565, p2l11t1603r363b1679],
11	African	JJ	MISC	african	amod	14	SENT_47	[p2l427t1603r684b1661],
12	American/two	NN	O	american/two	nn	14	SENT_47	[p2l749t1603r1253b1668],
13	Hispanic/Latino	NN	O	hispanic/latino	nn	14	SENT_47	[p2l1322t1603r1914b1679],
14	)	NN	O	)	dobj	8	SENT_47	[p2l1322t1603r1914b1679],
15	than	IN	O	than	_	0	SENT_47	[p2l1985t1603r2150b1661],
16	Arg389	NN	O	arg389	nn	17	SENT_47	[p2l8t1700r258b1774],
17	homozygotes	NNS	O	homozygote	prep_than	14	SENT_47	[p2l292t1698r764b1774],
18	(	VBP	O	(	_	0	SENT_47	[p2l800t1698r907b1770],
19	26	CD	NUMBER	26	dobj	18	SENT_47	[p2l800t1698r907b1770],
20	Caucasian/two	NNP	O	Caucasian/two	nn	22	SENT_47	[p2l940t1698r1461b1763],
21	African	NNP	MISC	African	nn	22	SENT_47	[p2l1492t1698r1749b1756],
22	American	NNP	MISC	American	nsubj	18	SENT_47	[p2l1779t1698r2149b1763],
23	/	:	O	/	punct	25	SENT_47	[p2l1779t1698r2149b1763],
24	one	CD	NUMBER	one	num	25	SENT_47	[p2l10t1810r139b1851],
25	Hispanic/Latino	NN	O	hispanic/latino	dep	22	SENT_47	[p2l177t1793r770b1869],
26	)	CD	NUMBER	)	number	27	SENT_47	[p2l177t1793r770b1869],
27	(	CD	NUMBER	(	num	28	SENT_47	[p2l815t1793r1205b1865],
28	P	NN	O	p	dep	25	SENT_47	[p2l815t1793r1205b1865],
29	:0.041	CD	NUMBER	:0.041	num	30	SENT_47	[p2l815t1793r1205b1865],
30	)	NN	O	)	dep	28	SENT_47	[p2l815t1793r1205b1865],
31	,	,	O	,	_	0	SENT_47	[p2l815t1793r1205b1865],
32	which	WDT	O	which	nsubj	34	SENT_47	[p2l1245t1793r1466b1851],
33	is	VBZ	O	be	cop	34	SENT_47	[p2l1503t1796r1554b1851],
34	consistent	JJ	O	consistent	rcmod	22	SENT_47	[p2l1592t1796r1953b1851],
35	with	IN	O	with	_	0	SENT_47	[p2l1988t1793r2150b1851],
36	known	JJ	O	known	amod	38	SENT_47	[p2l10t1886r255b1944],
37	racial	JJ	O	racial	amod	38	SENT_47	[p2l295t1886r484b1944],
38	differences	NNS	O	difference	prep_with	34	SENT_47	[p2l526t1886r907b1944],
39	in	IN	O	in	_	0	SENT_47	[p2l948t1889r1019b1943],
40	codon	NN	O	codon	nn	43	SENT_47	[p2l1060t1886r1280b1944],
41	389	CD	NUMBER	389	num	43	SENT_47	[p2l1323t1888r1447b1944],
42	allele	NN	O	allele	nn	43	SENT_47	[p2l1491t1886r1672b1944],
43	frequencies9	NN	O	frequencies9	prep_in	38	SENT_47	[p2l1714t1879r2148b1962],
44	and	CC	O	and	_	0	SENT_47	[p2l10t1981r142b2039],
45	the	DT	O	the	det	48	SENT_47	[p2l168t1981r281b2039],
46	a	DT	O	a	det	47	SENT_47	[p2l309t1999r346b2039],
47	priori	FW	O	priori	nn	48	SENT_47	[p2l366t1982r548b2057],
48	rationale	NN	O	rationale	conj_and	38	SENT_47	[p2l574t1981r887b2039],
49	for	IN	O	for	_	0	SENT_47	[p2l916t1981r1014b2039],
50	including	VBG	O	include	prepc_for	48	SENT_47	[p2l1040t1981r1382b2057],
51	race	NN	O	race	dobj	50	SENT_47	[p2l1409t1998r1548b2039],
52	as	IN	O	as	mark	58	SENT_47	[p2l1577t1998r1642b2039],
53	a	DT	O	a	det	54	SENT_47	[p2l1671t1998r1705b2039],
54	covariate	NN	O	covariate	nsubj	58	SENT_47	[p2l1733t1984r2051b2039],
55	in	IN	O	in	_	0	SENT_47	[p2l2079t1984r2150b2038],
56	all	DT	O	all	det	57	SENT_47	[p2l10t2077r92b2135],
57	analyses	NNS	O	analysis	prep_in	54	SENT_47	[p2l139t2077r429b2153],
58	(	VBP	O	(	advcl	50	SENT_47	[p2l479t2077r606b2149],
59	see	VB	O	see	xcomp	58	SENT_47	[p2l479t2077r606b2149],
60	Materials	NNPS	O	Materials	dobj	59	SENT_47	[p2l651t2077r975b2135],
61	and	CC	O	and	_	0	SENT_47	[p2l1022t2077r1154b2135],
62	methods	NNS	O	method	conj_and	60	SENT_47	[p2l1199t2077r1553b2149],
63	)	CD	NUMBER	)	num	62	SENT_47	[p2l1199t2077r1553b2149],
64	.	.	O	.	_	0	SENT_47	[p2l1199t2077r1553b2149],

1	There	EX	O	there	expl	2	SENT_48	[p2l1602t2077r1802b2135],
2	were	VBD	O	be	_	0	SENT_48	[p2l1847t2094r2011b2135],
3	no	DT	O	no	det	5	SENT_48	[p2l2058t2094r2149b2135],
4	racial	JJ	O	racial	amod	5	SENT_48	[p2l10t2172r199b2229],
5	differences	NNS	O	difference	nsubj	2	SENT_48	[p2l229t2171r609b2229],
6	in	IN	O	in	_	0	SENT_48	[p2l640t2174r710b2228],
7	codon	NN	O	codon	nn	10	SENT_48	[p2l740t2171r960b2229],
8	49	CD	NUMBER	49	num	10	SENT_48	[p2l990t2173r1071b2229],
9	allele	NN	O	allele	nn	10	SENT_48	[p2l1104t2171r1285b2229],
10	frequencies	NNS	O	frequency	prep_in	5	SENT_48	[p2l1316t2171r1737b2247],
11	.	.	O	.	_	0	SENT_48	[p2l1316t2171r1737b2247],

1	Baseline	NN	O	baseline	npadvmod	3	SENT_49	[p2l87t2266r373b2324],
2	(	CD	NUMBER	(	num	1	SENT_49	[p2l401t2266r790b2339],
3	untreated	JJ	O	untreated	amod	7	SENT_49	[p2l401t2266r790b2339],
4	)	NN	O	)	nn	7	SENT_49	[p2l401t2266r790b2339],
5	heart	NN	O	heart	nn	7	SENT_49	[p2l818t2266r1000b2324],
6	rate	NN	O	rate	nn	7	SENT_49	[p2l1023t2274r1154b2324],
7	measurements	NNS	O	measurement	nsubjpass	13	SENT_49	[p2l1178t2274r1690b2324],
8	by	IN	O	by	_	0	SENT_49	[p2l1713t2266r1801b2342],
9	codon	NN	O	codon	nn	11	SENT_49	[p2l1822t2266r2042b2324],
10	49	CD	NUMBER	49	num	11	SENT_49	[p2l2067t2268r2147b2324],
11	genotype	NN	O	genotype	prep_by	7	SENT_49	[p2l10t2369r336b2438],
12	are	VBP	O	be	auxpass	13	SENT_49	[p2l383t2379r484b2420],
13	shown	VBN	O	show	_	0	SENT_49	[p2l532t2362r765b2420],
14	in	IN	O	in	_	0	SENT_49	[p2l810t2365r880b2419],
15	Table	NNP	O	Table	prep_in	13	SENT_49	[p2l924t2362r1109b2420],
16	1	CD	NUMBER	1	num	15	SENT_49	[p2l1162t2364r1214b2420],
17	.	.	O	.	_	0	SENT_49	[p2l1162t2364r1214b2420],

1	Ser49	NN	O	ser49	nn	2	SENT_50	[p2l1264t2364r1451b2420],
2	homozygotes	NNS	O	homozygote	nsubj	3	SENT_50	[p2l1499t2362r1972b2438],
3	had	VBD	O	have	_	0	SENT_50	[p2l2018t2362r2150b2420],
4	significantly	RB	O	significantly	advmod	5	SENT_50	[p2l11t2456r451b2532],
5	higher	JJR	O	higher	amod	8	SENT_50	[p2l476t2457r707b2532],
6	24-h	JJ	O	24-h	amod	8	SENT_50	[p2l734t2457r893b2514],
7	heart	NN	O	heart	nn	8	SENT_50	[p2l921t2457r1103b2514],
8	rate	NN	O	rate	dobj	3	SENT_50	[p2l1131t2464r1261b2514],
9	and	CC	O	and	_	0	SENT_50	[p2l1291t2457r1422b2514],
10	resting	VBG	O	rest	amod	12	SENT_50	[p2l1450t2460r1690b2532],
11	heart	NN	O	heart	nn	12	SENT_50	[p2l1717t2457r1899b2514],
12	rate	NN	O	rate	dobj	3	SENT_50	[p2l1926t2464r2057b2514],
13	at	IN	O	at	_	0	SENT_50	[p2l2086t2464r2150b2514],
14	1430	CD	DATE	1430	prep_at	12	SENT_50	[p2l15t2553r199b2609],
15	.	.	O	.	_	0	SENT_50	[p2l15t2553r199b2609],

1	Baseline	NN	O	baseline	nsubj	13	SENT_51	[p2l247t2552r533b2609],
2	resting	VBG	O	rest	dep	1	SENT_51	[p2l578t2555r818b2627],
3	and	CC	O	and	_	0	SENT_51	[p2l861t2552r992b2609],
4	exercise	NN	O	exercise	dep	1	SENT_51	[p2l1035t2555r1310b2609],
5	(	CD	NUMBER	(	num	10	SENT_51	[p2l1357t2552r1746b2624],
6	untreated	JJ	O	untreated	amod	10	SENT_51	[p2l1357t2552r1746b2624],
7	)	NN	O	)	nn	10	SENT_51	[p2l1357t2552r1746b2624],
8	heart	NN	O	heart	nn	10	SENT_51	[p2l1793t2552r1975b2609],
9	rate	NN	O	rate	nn	10	SENT_51	[p2l2018t2559r2149b2609],
10	measurements	NNS	O	measurement	dobj	4	SENT_51	[p2l10t2654r522b2705],
11	did	VBD	O	do	aux	13	SENT_51	[p2l557t2647r669b2705],
12	not	RB	O	not	neg	13	SENT_51	[p2l703t2654r824b2705],
13	differ	VB	O	differ	_	0	SENT_51	[p2l858t2647r1045b2705],
14	by	IN	O	by	_	0	SENT_51	[p2l1076t2647r1164b2723],
15	codon	NN	O	codon	nn	17	SENT_51	[p2l1196t2647r1416b2705],
16	389	CD	NUMBER	389	num	17	SENT_51	[p2l1452t2649r1576b2705],
17	genotype	NN	O	genotype	prep_by	13	SENT_51	[p2l1612t2654r1938b2723],
18	(	CD	NUMBER	(	num	19	SENT_51	[p2l1977t2647r2150b2719],
19	data	NNS	O	datum	npadvmod	20	SENT_51	[p2l1977t2647r2150b2719],
20	not	RB	O	not	neg	21	SENT_51	[p2l10t2748r130b2799],
21	shown	VBN	O	show	partmod	17	SENT_51	[p2l161t2741r438b2813],
22	)	NN	O	)	dobj	21	SENT_51	[p2l161t2741r438b2813],
23	.	.	O	.	_	0	SENT_51	[p2l161t2741r438b2813],

1	All	DT	O	all	det	3	SENT_52	[p2l85t2837r182b2894],
2	genotype	NN	O	genotype	nn	3	SENT_52	[p2l205t2844r531b2913],
3	groups	NNS	O	group	nsubjpass	5	SENT_52	[p2l555t2854r791b2913],
4	were	VBD	O	be	auxpass	5	SENT_52	[p2l812t2854r976b2895],
5	titrated	VBN	O	titrate	_	0	SENT_52	[p2l999t2837r1259b2895],
6	to	TO	O	to	_	0	SENT_52	[p2l1281t2844r1351b2895],
7	equivalent	JJ	O	equivalent	amod	8	SENT_52	[p2l1375t2837r1748b2913],
8	twice	JJ	O	twice	amod	11	SENT_52	[p2l1771t2840r1954b2895],
9	daily	JJ	SET	daily	amod	11	SENT_52	[p2l1979t2837r2152b2913],
10	metoprolol	NN	O	metoprolol	nn	11	SENT_52	[p2l10t2931r405b3007],
11	doses	NNS	O	dose	prep_to	5	SENT_52	[p2l478t2931r683b3002],
12	,	,	O	,	_	0	SENT_52	[p2l478t2931r683b3002],
13	120i65	CD	NUMBER	120i65	num	14	SENT_52	[p2l766t2933r1047b2998],
14	mg	NN	O	mg	appos	11	SENT_52	[p2l1067t2948r1179b3007],
15	in	IN	O	in	_	0	SENT_52	[p2l1250t2934r1320b2988],
16	Ser49	NN	O	ser49	nn	17	SENT_52	[p2l1393t2933r1579b2989],
17	homozygotes	NNS	O	homozygote	prep_in	14	SENT_52	[p2l1655t2931r2145b3007],
18	,	,	O	,	_	0	SENT_52	[p2l1655t2931r2145b3007],
19	120i68	CD	NUMBER	120i68	num	20	SENT_52	[p2l15t3028r298b3093],
20	mg	NN	O	mg	conj_and	11	SENT_52	[p2l316t3044r428b3103],
21	in	IN	O	in	_	0	SENT_52	[p2l454t3030r524b3084],
22	Gly49	NN	O	gly49	nn	23	SENT_52	[p2l553t3027r760b3103],
23	carriers	NNS	O	carrier	prep_in	20	SENT_52	[p2l790t3030r1062b3097],
24	,	,	O	,	_	0	SENT_52	[p2l790t3030r1062b3097],
25	121	CD	NUMBER	121	num	27	SENT_52	[p2l1099t3028r1216b3084],
26	i66	NN	O	i66	nn	27	SENT_52	[p2l1237t3028r1383b3093],
27	mg	NN	O	mg	conj_and	11	SENT_52	[p2l1401t3044r1512b3103],
28	in	IN	O	in	_	0	SENT_52	[p2l1538t3030r1608b3084],
29	Arg389	NN	O	arg389	nn	30	SENT_52	[p2l1634t3028r1885b3103],
30	homozygotes	NNS	O	homozygote	prep_in	27	SENT_52	[p2l1914t3027r2149b3085, p2l9t3129r286b3197],
31	,	,	O	,	_	0	SENT_52	[p2l1914t3027r2149b3085, p2l9t3129r286b3197],
32	and	CC	O	and	_	0	SENT_52	[p2l345t3121r476b3179],
33	1241-64	CD	NUMBER	1241-64	num	34	SENT_52	[p2l535t3123r819b3188],
34	mg	NN	O	mg	conj_and	11	SENT_52	[p2l837t3138r948b3197],
35	in	IN	O	in	_	0	SENT_52	[p2l1000t3124r1070b3178],
36	Gly389	NN	O	gly389	nn	37	SENT_52	[p2l1125t3121r1375b3197],
37	carriers	NNS	O	carrier	prep_in	34	SENT_52	[p2l1432t3124r1703b3179],
38	.	.	O	.	_	0	SENT_52	[p2l1432t3124r1703b3179],

1	Of	IN	O	of	_	0	SENT_53	[p2l1763t3121r1850b3179],
2	the	DT	O	the	det	4	SENT_53	[p2l1899t3122r2012b3179],
3	54	CD	NUMBER	54	num	4	SENT_53	[p2l2068t3124r2148b3179],
4	patients	NNS	O	patient	prep_of	7	SENT_53	[p2l9t3219r309b3292],
5	,	,	O	,	_	0	SENT_53	[p2l9t3219r309b3292],
6	53	CD	NUMBER	53	nsubj	7	SENT_53	[p2l354t3218r433b3274],
7	completed	VBN	O	complete	_	0	SENT_53	[p2l475t3216r848b3292],
8	treatment	NN	O	treatment	nn	10	SENT_53	[p2l885t3224r1236b3274],
9	phase	NN	O	phase	nn	10	SENT_53	[p2l1274t3216r1474b3292],
10	treadmill	NN	O	treadmill	nsubj	11	SENT_53	[p2l1513t3216r1835b3274],
11	exercise	NN	O	exercise	ccomp	7	SENT_53	[p2l1874t3219r2148b3274],
12	testing	NN	O	testing	dobj	11	SENT_53	[p2l9t3315r266b3388],
13	.	.	O	.	_	0	SENT_53	[p2l9t3315r266b3388],

1	One	CD	NUMBER	one	num	2	SENT_54	[p2l298t3314r443b3370],
2	patient	NN	O	patient	nsubj	4	SENT_54	[p2l469t3315r721b3388],
3	was	VBD	O	be	cop	4	SENT_54	[p2l746t3329r874b3370],
4	unable	JJ	O	unable	_	0	SENT_54	[p2l900t3312r1139b3370],
5	to	TO	O	to	aux	6	SENT_54	[p2l1167t3319r1236b3370],
6	complete	VB	O	complete	xcomp	4	SENT_54	[p2l1264t3312r1590b3388],
7	the	DT	O	the	det	8	SENT_54	[p2l1617t3312r1729b3370],
8	testing	NN	O	testing	nsubj	9	SENT_54	[p2l1757t3315r1997b3388],
9	due	JJ	O	due	xcomp	6	SENT_54	[p2l2023t3312r2148b3370],
10	to	TO	O	to	_	0	SENT_54	[p2l9t3414r79b3464],
11	elevated	JJ	O	elevated	amod	13	SENT_54	[p2l113t3407r404b3464],
12	blood	NN	O	blood	nn	13	SENT_54	[p2l434t3407r638b3464],
13	pressure	NN	O	pressure	prep_to	9	SENT_54	[p2l670t3423r957b3482],
14	on	IN	O	on	_	0	SENT_54	[p2l991t3423r1082b3464],
15	the	DT	O	the	det	17	SENT_54	[p2l1115t3407r1227b3464],
16	test	NN	O	test	nn	17	SENT_54	[p2l1261t3414r1385b3464],
17	day	NN	DURATION	day	prep_on	13	SENT_54	[p2l1417t3407r1553b3482],
18	.	.	O	.	_	0	SENT_54	[p2l1417t3407r1553b3482],

1	Neither	DT	O	neither	nsubj	2	SENT_55	[p2l1588t3407r1856b3464],
2	resting	VBG	O	rest	_	0	SENT_55	[p2l1888t3410r2145b3482],
3	,	,	O	,	_	0	SENT_55	[p2l1888t3410r2145b3482],
4	nor	CC	O	nor	_	0	SENT_55	[p2l10t3518r132b3559],
5	maximal	JJ	O	maximal	amod	9	SENT_55	[p2l180t3502r491b3559],
6	exercise	NN	O	exercise	nn	9	SENT_55	[p2l542t3505r816b3559],
7	heart	NN	O	heart	nn	9	SENT_55	[p2l866t3502r1048b3559],
8	rate	NN	O	rate	nn	9	SENT_55	[p2l1097t3509r1228b3559],
9	response	NN	O	response	nsubj	12	SENT_55	[p2l1279t3518r1584b3577],
10	to	TO	O	to	_	0	SENT_55	[p2l1634t3509r1704b3559],
11	metoprolol	NN	O	metoprolol	prep_to	9	SENT_55	[p2l1754t3502r2149b3577],
12	differed	VBN	O	differ	conj_nor	2	SENT_55	[p2l10t3597r281b3655],
13	by	IN	O	by	_	0	SENT_55	[p2l319t3597r407b3673],
14	codon	NN	O	codon	nn	16	SENT_55	[p2l445t3597r666b3655],
15	389	CD	NUMBER	389	num	16	SENT_55	[p2l708t3599r832b3655],
16	genotype	NN	O	genotype	prep_by	12	SENT_55	[p2l875t3604r1201b3673],
17	(	CD	NUMBER	(	num	18	SENT_55	[p2l1246t3597r1419b3669],
18	data	NNS	O	datum	npadvmod	19	SENT_55	[p2l1246t3597r1419b3669],
19	not	RB	O	not	neg	20	SENT_55	[p2l1460t3604r1580b3655],
20	shown	VBN	O	show	dep	16	SENT_55	[p2l1623t3597r1899b3669],
21	)	NN	O	)	dobj	20	SENT_55	[p2l1623t3597r1899b3669],
22	,	,	O	,	_	0	SENT_55	[p2l1623t3597r1899b3669],
23	either	CC	O	either	dep	20	SENT_55	[p2l1945t3597r2150b3655],
24	when	WRB	O	when	advmod	28	SENT_55	[p2l8t3692r205b3750],
25	all	DT	O	all	det	26	SENT_55	[p2l243t3692r324b3750],
26	subjects	NNS	O	subject	nsubjpass	28	SENT_55	[p2l363t3692r639b3768],
27	were	VBD	O	be	auxpass	28	SENT_55	[p2l675t3709r838b3750],
28	considered	VBN	O	consider	conj	20	SENT_55	[p2l877t3692r1277b3762],
29	,	,	O	,	_	0	SENT_55	[p2l877t3692r1277b3762],
30	or	CC	O	or	_	0	SENT_55	[p2l1319t3709r1391b3750],
31	when	WRB	O	when	advmod	34	SENT_55	[p2l1425t3692r1622b3750],
32	analyses	NNS	O	analysis	nsubjpass	34	SENT_55	[p2l1660t3692r1950b3768],
33	were	VBD	O	be	auxpass	34	SENT_55	[p2l1985t3709r2149b3750],
34	confined	VBN	O	confine	conj_or	28	SENT_55	[p3l10t16r324b74],
35	to	TO	O	to	_	0	SENT_55	[p3l353t23r423b74],
36	Caucasian	JJ	MISC	caucasian	amod	37	SENT_55	[p3l454t18r813b74],
37	subjects	NNS	O	subject	prep_to	34	SENT_55	[p3l844t16r1138b92],
38	.	.	O	.	_	0	SENT_55	[p3l844t16r1138b92],

1	/	:	O	/	punct	21	SENT_56	[p3l86t110r729b183],
2	3-Blocker-induced	JJ	O	3-blocker-induced	amod	3	SENT_56	[p3l86t110r729b183],
3	reduction	NN	O	reduction	dep	21	SENT_56	[p3l769t110r1112b168],
4	in	IN	O	in	_	0	SENT_56	[p3l1152t113r1222b167],
5	resting	VBG	O	rest	prep_in	3	SENT_56	[p3l1262t113r1502b186],
6	or	CC	O	or	_	0	SENT_56	[p3l1542t127r1613b168],
7	exercise	NN	O	exercise	nn	10	SENT_56	[p3l1653t113r1927b168],
8	heart	NN	O	heart	nn	10	SENT_56	[p3l1967t110r2150b168],
9	rate	NN	O	rate	nn	10	SENT_56	[p3l10t213r140b264],
10	Values	NNS	O	value	prep_in	3	SENT_56	[p3l181t206r418b276],
11	,	,	O	,	_	0	SENT_56	[p3l181t206r418b276],
12	corrected	VBN	O	correct	partmod	10	SENT_56	[p3l465t206r792b264],
13	for	IN	O	for	_	0	SENT_56	[p3l834t206r932b264],
14	S	NN	O	s	nn	17	SENT_56	[p3l971t206r1430b282],
15	—	CD	NUMBER	—	num	17	SENT_56	[p3l971t206r1430b282],
16	metopro1ol	NN	O	metopro1ol	nn	17	SENT_56	[p3l971t206r1430b282],
17	concentration	NN	O	concentration	prep_for	12	SENT_56	[p3l1473t209r1990b276],
18	,	,	O	,	_	0	SENT_56	[p3l1473t209r1990b276],
19	did	VBD	O	do	aux	21	SENT_56	[p3l2038t206r2150b264],
20	not	RB	O	not	neg	21	SENT_56	[p3l10t308r130b358],
21	differ	VB	O	differ	_	0	SENT_56	[p3l161t300r348b358],
22	by	IN	O	by	_	0	SENT_56	[p3l376t301r464b376],
23	codon	NN	O	codon	nn	25	SENT_56	[p3l493t300r713b358],
24	49	CD	NUMBER	49	num	25	SENT_56	[p3l745t302r826b358],
25	genotype	NN	O	genotype	prep_by	21	SENT_56	[p3l859t308r1185b376],
26	at	IN	O	at	_	0	SENT_56	[p3l1217t308r1281b358],
27	1030	CD	DATE	1030	prep_at	25	SENT_56	[p3l1318t302r1483b358],
28	or	CC	DATE	or	_	0	SENT_56	[p3l1515t317r1586b358],
29	1430	CD	DATE	1430	number	30	SENT_56	[p3l1622t302r1787b358],
30	(	CD	NUMBER	(	conj_or	25	SENT_56	[p3l1822t300r2028b372],
31	Table	NNP	O	Table	dep	30	SENT_56	[p3l1822t300r2028b372],
32	2	CD	NUMBER	2	number	33	SENT_56	[p3l2061t301r2145b373],
33	)	CD	NUMBER	)	dobj	21	SENT_56	[p3l2061t301r2145b373],
34	.	.	O	.	_	0	SENT_56	[p3l2061t301r2145b373],

1	To	TO	O	to	aux	3	SENT_57	[p3l8t398r92b453],
2	further	RB	O	further	advmod	3	SENT_57	[p3l125t395r372b453],
3	elucidate	VB	O	elucidate	purpcl	19	SENT_57	[p3l402t395r720b453],
4	whether	IN	O	whether	complm	6	SENT_57	[p3l751t395r1045b453],
5	there	EX	O	there	expl	6	SENT_57	[p3l1075t395r1255b453],
6	were	VBD	O	be	ccomp	3	SENT_57	[p3l1286t412r1450b453],
7	pharmacodynamic	JJ	O	pharmacodynamic	amod	8	SENT_57	[p3l1481t395r2150b471],
8	differences	NNS	O	difference	nsubj	6	SENT_57	[p3l10t491r391b549],
9	in	IN	O	in	_	0	SENT_57	[p3l432t494r502b548],
10	heart	NN	O	heart	nn	12	SENT_57	[p3l542t491r724b549],
11	rate	NN	O	rate	nn	12	SENT_57	[p3l764t498r895b549],
12	response	NN	O	response	prep_in	8	SENT_57	[p3l936t508r1242b567],
13	to	TO	O	to	_	0	SENT_57	[p3l1283t498r1353b549],
14	metoprolol	NN	O	metoprolol	prep_to	12	SENT_57	[p3l1393t491r1788b567],
15	by	IN	O	by	_	0	SENT_57	[p3l1827t491r1915b567],
16	genotype	NN	O	genotype	prep_by	6	SENT_57	[p3l1953t508r2149b567, p3l9t593r179b661],
17	,	,	O	,	_	0	SENT_57	[p3l1953t508r2149b567, p3l9t593r179b661],
18	We	PRP	O	we	nsubj	19	SENT_57	[p3l205t602r301b643],
19	plotted	VBD	O	plot	_	0	SENT_57	[p3l326t586r580b661],
20	the	DT	O	the	det	27	SENT_57	[p3l603t586r716b643],
21	negative	JJ	O	negative	amod	27	SENT_57	[p3l742t589r1038b661],
22	chronotropic	JJ	O	chronotropic	amod	27	SENT_57	[p3l1064t586r1529b661],
23	response	NN	O	response	nn	27	SENT_57	[p3l1553t586r2150b661],
24	—	CD	NUMBER	—	num	27	SENT_57	[p3l1553t586r2150b661],
25	p1asma	NN	O	p1asma	nn	27	SENT_57	[p3l1553t586r2150b661],
26	concentration	NN	O	concentration	nn	27	SENT_57	[p3l10t684r510b738],
27	relationship	NN	O	relationship	dobj	19	SENT_57	[p3l542t681r986b756],
28	,	,	O	,	_	0	SENT_57	[p3l542t681r986b756],
29	pooling	VBG	O	pool	partmod	19	SENT_57	[p3l1021t681r1296b756],
30	the	DT	O	the	det	31	SENT_57	[p3l1326t681r1438b738],
31	data	NNS	O	datum	dobj	29	SENT_57	[p3l1471t681r1620b738],
32	in	IN	O	in	_	0	SENT_57	[p3l1652t684r1722b738],
33	all	DT	O	all	det	34	SENT_57	[p3l1754t681r1836b738],
34	patients	NNS	O	patient	prep_in	29	SENT_57	[p3l1867t684r2149b756],
35	at	IN	O	at	_	0	SENT_57	[p3l10t783r74b834],
36	1030	CD	DATE	1030	prep_at	34	SENT_57	[p3l118t778r283b834],
37	and	CC	DATE	and	_	0	SENT_57	[p3l322t776r453b834],
38	1430	CD	DATE	1430	number	39	SENT_57	[p3l497t778r663b834],
39	(	CD	NUMBER	(	num	40	SENT_57	[p3l705t777r944b852],
40	Figure	NN	O	figure	prep_in	29	SENT_57	[p3l705t777r944b852],
41	1	CD	NUMBER	1	num	42	SENT_57	[p3l989t776r1068b848],
42	)	NN	O	)	dep	40	SENT_57	[p3l989t776r1068b848],
43	.	.	O	.	_	0	SENT_57	[p3l989t776r1068b848],

1	The	DT	O	the	det	4	SENT_58	[p3l1109t776r1241b834],
2	32	CD	NUMBER	32	num	4	SENT_58	[p3l1281t797r1309b849],
3	(	NN	O	(	nn	4	SENT_58	[p3l1352t776r1611b852],
4	slopes	NNS	O	slope	nsubj	5	SENT_58	[p3l1352t776r1611b852],
5	)	VBP	O	)	_	0	SENT_58	[p3l1352t776r1611b852],
6	did	VBD	O	do	aux	8	SENT_58	[p3l1654t776r1766b834],
7	not	RB	O	not	neg	8	SENT_58	[p3l1804t783r1925b834],
8	differ	VB	O	differ	ccomp	5	SENT_58	[p3l1963t776r2150b834],
9	ll-blocker	JJ	O	ll-blocker	amod	15	SENT_58	[p3l8t1017r232b1074],
10	drug	NN	O	drug	nn	15	SENT_58	[p3l248t1017r360b1076],
11	target	NN	O	target	nn	15	SENT_58	[p3l379t1022r531b1076],
12	pharmacogenetics	NNS	O	pharmacogenetic	nn	15	SENT_58	[p3l550t1017r992b1076],
13	mg	NN	O	mg	nn	15	SENT_58	[p3l2025t1005r2151b1129],
14	AL	NNP	O	AL	nn	15	SENT_58	[p3l6t1090r58b1129],
15	Beitelshees	NNP	O	Beitelshees	dobj	8	SENT_58	[p3l77t1088r297b1130],
16	et	FW	O	et	nn	17	SENT_58	[p3l317t1093r353b1130],
17	al	FW	O	al	dep	15	SENT_58	[p3l370t1088r406b1130],

1	Table	NNP	O	Table	_	0	SENT_59	[p3l7t1376r196b1433],
2	1	CD	NUMBER	1	num	1	SENT_59	[p3l230t1378r253b1432],
3	Baseline	NN	O	baseline	nn	5	SENT_59	[p3l346t1378r616b1433],
4	heart	NN	O	heart	nn	5	SENT_59	[p3l648t1378r823b1433],
5	rate	NN	O	rate	dep	1	SENT_59	[p3l852t1384r980b1433],
6	(	CD	NUMBER	(	num	8	SENT_59	[p3l1012t1378r1396b1447],
7	untreated	JJ	O	untreated	amod	8	SENT_59	[p3l1012t1378r1396b1447],
8	)	NN	O	)	dep	1	SENT_59	[p3l1012t1378r1396b1447],

1	Variable	JJ	O	variable	amod	3	SENT_60	[p3l16t1552r258b1606],
2	Ser49	NN	O	ser49	nn	3	SENT_60	[p3l1060t1553r1232b1606],
3	G/y49	NN	O	g/y49	dep	7	SENT_60	[p3l1551t1551r1728b1623],
4	P-value	JJ	O	p-value	amod	6	SENT_60	[p3l1932t1552r2153b1606],
5	homozygotes	NNS	O	homozygote	nn	6	SENT_60	[p3l946t1637r1347b1709],
6	carriers	NNS	O	carrier	dep	3	SENT_60	[p3l1531t1639r1747b1692],
7	(	VBP	O	(	_	0	SENT_60	[p3l1021t1724r1079b1792],
8	n	NN	O	n	dobj	7	SENT_60	[p3l1021t1724r1079b1792],
9	=	JJ	O	=	amod	8	SENT_60	[p3l1099t1750r1148b1768],
10	38	CD	NUMBER	38	number	11	SENT_60	[p3l1170t1724r1271b1792],
11	)	CD	NUMBER	)	num	13	SENT_60	[p3l1170t1724r1271b1792],
12	(	NN	O	(	nn	13	SENT_60	[p3l1513t1724r1571b1792],
13	n	NN	O	n	npadvmod	14	SENT_60	[p3l1513t1724r1571b1792],
14	=	JJ	O	=	amod	8	SENT_60	[p3l1591t1750r1640b1768],
15	76	CD	NUMBER	76	num	16	SENT_60	[p3l1669t1724r1763b1792],
16	)	NN	O	)	nsubj	7	SENT_60	[p3l1669t1724r1763b1792],

1	24-h	JJ	O	24-h	amod	4	SENT_61	[p3l9t1952r151b2006],
2	HR	NN	DURATION	hr	nn	4	SENT_61	[p3l185t1955r270b2007],
3	(	NN	O	(	nn	4	SENT_61	[p3l298t1952r493b2024],
4	bpm	NN	O	bpm	dep	17	SENT_61	[p3l298t1952r493b2024],
5	)	CD	NUMBER	)	number	6	SENT_61	[p3l298t1952r493b2024],
6	81	CD	NUMBER	81	num	11	SENT_61	[p3l1050t1954r1113b2007],
7	i10	NN	O	i10	nn	11	SENT_61	[p3l1141t1954r1280b2015],
8	75i10	NN	O	75i10	nn	11	SENT_61	[p3l1544t1954r1772b2015],
9	0.046	CD	NUMBER	0.046	number	10	SENT_61	[p3l1948t1954r2128b2007],
10	1030	CD	DATE	1030	num	11	SENT_61	[p3l12t2040r169b2093],
11	supine	NN	O	supine	dep	4	SENT_61	[p3l198t2039r402b2110],
12	HR	NN	DURATION	hr	nn	14	SENT_61	[p3l435t2041r520b2093],
13	(	NN	O	(	nn	14	SENT_61	[p3l547t2038r743b2110],
14	bpm	NN	O	bpm	dep	11	SENT_61	[p3l547t2038r743b2110],
15	)	CD	NUMBER	)	num	16	SENT_61	[p3l547t2038r743b2110],
16	73i10	NN	O	73i10	dep	17	SENT_61	[p3l1052t2040r1280b2101],
17	70i9	CD	NUMBER	70i9	dep	35	SENT_61	[p3l1544t2040r1730b2101],
18	0.34	CD	NUMBER	0.34	number	19	SENT_61	[p3l1948t2040r2087b2093],
19	1030	CD	DATE	1030	num	23	SENT_61	[p3l12t2126r169b2179],
20	exercise	NN	O	exercise	nn	23	SENT_61	[p3l199t2125r447b2179],
21	HR	NN	DURATION	hr	nn	23	SENT_61	[p3l479t2127r564b2179],
22	(	NN	O	(	nn	23	SENT_61	[p3l592t2124r787b2196],
23	bpm	NN	O	bpm	dep	17	SENT_61	[p3l592t2124r787b2196],
24	)	CD	NUMBER	)	num	26	SENT_61	[p3l592t2124r787b2196],
25	148i8	CD	NUMBER	148i8	num	26	SENT_61	[p3l1010t2126r1238b2187],
26	l49i6	NN	O	l49i6	dep	23	SENT_61	[p3l1503t2126r1731b2187],
27	0.647	CD	NUMBER	0.647	number	28	SENT_61	[p3l1948t2126r2128b2179],
28	1430	CD	DATE	1430	num	32	SENT_61	[p3l12t2211r169b2264],
29	supine	NN	O	supine	nn	32	SENT_61	[p3l198t2211r402b2281],
30	HR	NN	DURATION	hr	nn	32	SENT_61	[p3l435t2212r520b2264],
31	(	NN	O	(	nn	32	SENT_61	[p3l547t2209r743b2281],
32	bpm	NN	O	bpm	dep	26	SENT_61	[p3l547t2209r743b2281],
33	)	CD	NUMBER	)	num	35	SENT_61	[p3l547t2209r743b2281],
34	82J_r1O	NN	O	82j_r1o	nn	35	SENT_61	[p3l1050t2211r1280b2272],
35	74i11	NN	O	74i11	dep	46	SENT_61	[p3l1544t2211r1759b2272],
36	0.016	CD	NUMBER	0.016	number	37	SENT_61	[p3l1948t2211r2128b2264],
37	1430	CD	DATE	1430	num	41	SENT_61	[p3l12t2297r169b2350],
38	exercise	NN	O	exercise	nn	41	SENT_61	[p3l199t2297r446b2350],
39	HR	NN	DURATION	hr	nn	41	SENT_61	[p3l479t2298r564b2350],
40	(	NN	O	(	nn	41	SENT_61	[p3l592t2295r787b2367],
41	bpm	NN	O	bpm	dep	35	SENT_61	[p3l592t2295r787b2367],
42	)	CD	NUMBER	)	num	44	SENT_61	[p3l592t2295r787b2367],
43	148i8	CD	NUMBER	148i8	num	44	SENT_61	[p3l1011t2297r1238b2358],
44	147i	NNS	O	147us	dep	41	SENT_61	[p3l1503t2297r1680b2358],
45	7	CD	NUMBER	7	num	46	SENT_61	[p3l1699t2298r1731b2350],
46	0.738	CD	NUMBER	0.738	_	0	SENT_61	[p3l1948t2297r2128b2350],

1	Table	NNP	O	Table	_	0	SENT_62	[p3l7t2591r196b2648],
2	2	CD	NUMBER	2	num	1	SENT_62	[p3l228t2593r267b2647],
3	Negative	JJ	O	negative	amod	5	SENT_62	[p3l348t2593r646b2665],
4	chronotropic	JJ	O	chronotropic	amod	5	SENT_62	[p3l678t2593r1113b2665],
5	response	NN	O	response	dep	1	SENT_62	[p3l1146t2609r1442b2665],
6	to	TO	O	to	_	0	SENT_62	[p3l1472t2599r1540b2648],
7	metoprolol	NN	O	metoprolol	nn	10	SENT_62	[p3l1574t2593r1942b2665],
8	(	CD	NUMBER	(	num	7	SENT_62	[p3l1979t2593r2147b2662, p3l9t2678r728b2747],
9	concentration-corrected	JJ	O	concentration-corrected	amod	10	SENT_62	[p3l1979t2593r2147b2662, p3l9t2678r728b2747],
10	)	NN	O	)	prep_to	5	SENT_62	[p3l1979t2593r2147b2662, p3l9t2678r728b2747],
11	(	CD	NUMBER	(	number	12	SENT_62	[p3l762t2678r856b2747],
12	°	CD	NUMBER	°	amod	10	SENT_62	[p3l762t2678r856b2747],
13	/	:	O	/	punct	15	SENT_62	[p3l762t2678r856b2747],
14	o	NN	O	o	nn	15	SENT_62	[p3l762t2678r856b2747],
15	change	NN	O	change	dep	12	SENT_62	[p3l884t2678r1126b2749],
16	in	IN	O	in	_	0	SENT_62	[p3l1158t2678r1213b2732],
17	HR/ng/ml	NN	O	hr/ng/ml	prep_in	15	SENT_62	[p3l1248t2678r1606b2749],
18	)	CD	NUMBER	)	num	17	SENT_62	[p3l1248t2678r1606b2749],

1	Variable	JJ	O	variable	amod	2	SENT_63	[p3l16t2851r258b2906],
2	Ser49	NN	O	ser49	_	0	SENT_63	[p3l1038t2853r1210b2906],
3	Gly49	NN	O	gly49	nn	4	SENT_63	[p3l1524t2852r1701b2923],
4	P-vaIue	NN	O	p-vaiue	dep	2	SENT_63	[p3l1901t2852r2148b2906],
5	*	CD	NUMBER	*	dep	2	SENT_63	[p3l1901t2852r2148b2906],

1	homozygotes	NNS	O	homozygote	dep	3	SENT_64	[p3l924t2938r1324b3009],
2	carriers	NNS	O	carrier	dep	1	SENT_64	[p3l1504t2939r1720b2992],
3	(	VBP	O	(	_	0	SENT_64	[p3l999t3025r1057b3093],
4	n	NN	O	n	dobj	3	SENT_64	[p3l999t3025r1057b3093],
5	=	JJ	O	=	amod	4	SENT_64	[p3l1077t3051r1126b3069],
6	37	CD	NUMBER	37	number	7	SENT_64	[p3l1147t3025r1248b3093],
7	)	CD	NUMBER	)	num	9	SENT_64	[p3l1147t3025r1248b3093],
8	(	NN	O	(	nn	9	SENT_64	[p3l1487t3025r1544b3093],
9	n	NN	O	n	npadvmod	10	SENT_64	[p3l1487t3025r1544b3093],
10	=	JJ	O	=	amod	4	SENT_64	[p3l1565t3051r1614b3069],
11	16	CD	NUMBER	16	num	12	SENT_64	[p3l1643t3026r1713b3079],
12	)	NN	O	)	nsubj	3	SENT_64	[p3l1711t3025r1736b3093],

1	1030	CD	DATE	1030	num	2	SENT_65	[p3l12t3257r169b3310],
2	supine	NN	O	supine	_	0	SENT_65	[p3l198t3256r402b3327],
3	(	CD	PERCENT	(	num	4	SENT_65	[p3l432t3255r767b3327],
4	%	NN	PERCENT	%	dep	2	SENT_65	[p3l432t3255r767b3327],
5	/	:	O	/	punct	2	SENT_65	[p3l432t3255r767b3327],
6	ng/ml	NN	O	ng/ml	dep	12	SENT_65	[p3l432t3255r767b3327],
7	)	CD	NUMBER	)	num	8	SENT_65	[p3l432t3255r767b3327],
8	0.53	CD	NUMBER	0.53	dep	6	SENT_65	[p3l944t3257r1299b3318],
9	i0	NN	O	i0	dep	12	SENT_65	[p3l944t3257r1299b3318],
10	.09	CD	NUMBER	.09	num	9	SENT_65	[p3l944t3257r1299b3318],
11	0.54	CD	NUMBER	0.54	num	12	SENT_65	[p3l1432t3257r1785b3318],
12	i0	NN	O	i0	dep	16	SENT_65	[p3l1432t3257r1785b3318],
13	.15	CD	NUMBER	.15	num	14	SENT_65	[p3l1432t3257r1785b3318],
14	0.95	CD	NUMBER	0.95	dep	12	SENT_65	[p3l1953t3257r2090b3310],
15	1030	CD	DATE	1030	num	16	SENT_65	[p3l12t3343r169b3396],
16	exercise	NN	O	exercise	dep	18	SENT_65	[p3l199t3342r447b3396],
17	(	CD	PERCENT	(	num	18	SENT_65	[p3l477t3341r811b3413],
18	%	NN	PERCENT	%	dep	2	SENT_65	[p3l477t3341r811b3413],
19	/	:	O	/	punct	18	SENT_65	[p3l477t3341r811b3413],
20	ng/ml	NN	O	ng/ml	dep	26	SENT_65	[p3l477t3341r811b3413],
21	)	CD	NUMBER	)	num	22	SENT_65	[p3l477t3341r811b3413],
22	0.75	CD	NUMBER	0.75	dep	20	SENT_65	[p3l944t3343r1286b3404],
23	i0	NN	O	i0	dep	26	SENT_65	[p3l944t3343r1286b3404],
24	.11	CD	NUMBER	.11	num	23	SENT_65	[p3l944t3343r1286b3404],
25	0.57	CD	NUMBER	0.57	num	26	SENT_65	[p3l1432t3343r1787b3404],
26	i0	NN	O	i0	dep	30	SENT_65	[p3l1432t3343r1787b3404],
27	.17	CD	NUMBER	.17	num	28	SENT_65	[p3l1432t3343r1787b3404],
28	0.37	CD	NUMBER	0.37	dep	26	SENT_65	[p3l1953t3343r2092b3396],
29	1430	CD	DATE	1430	num	30	SENT_65	[p3l12t3429r169b3482],
30	supine	NN	O	supine	dep	32	SENT_65	[p3l198t3428r402b3499],
31	(	CD	PERCENT	(	num	32	SENT_65	[p3l432t3427r767b3499],
32	%	NN	PERCENT	%	dep	18	SENT_65	[p3l432t3427r767b3499],
33	/	:	O	/	punct	32	SENT_65	[p3l432t3427r767b3499],
34	ng/ml	NN	O	ng/ml	dep	42	SENT_65	[p3l432t3427r767b3499],
35	)	CD	NUMBER	)	number	36	SENT_65	[p3l432t3427r767b3499],
36	0.72	CD	NUMBER	0.72	dep	34	SENT_65	[p3l944t3429r1298b3490],
37	i0	NN	O	i0	dep	36	SENT_65	[p3l944t3429r1298b3490],
38	.13	CD	NUMBER	.13	num	37	SENT_65	[p3l944t3429r1298b3490],
39	0.76	CD	NUMBER	0.76	num	40	SENT_65	[p3l1432t3429r1787b3490],
40	i0	NN	O	i0	dep	42	SENT_65	[p3l1432t3429r1787b3490],
41	.20	CD	NUMBER	.20	num	42	SENT_65	[p3l1432t3429r1787b3490],
42	0.88	CD	NUMBER	0.88	dep	46	SENT_65	[p3l1953t3429r2092b3482],
43	1430	CD	DATE	1430	num	44	SENT_65	[p3l12t3515r169b3568],
44	exercise	NN	O	exercise	dep	42	SENT_65	[p3l199t3514r447b3568],
45	(	CD	PERCENT	(	num	46	SENT_65	[p3l477t3513r811b3585],
46	%	NN	PERCENT	%	dep	32	SENT_65	[p3l477t3513r811b3585],
47	/	:	O	/	punct	46	SENT_65	[p3l477t3513r811b3585],
48	ng/ml	NN	O	ng/ml	dep	52	SENT_65	[p3l477t3513r811b3585],
49	)	CD	NUMBER	)	dep	48	SENT_65	[p3l477t3513r811b3585],
50	0.66	CD	NUMBER	0.66	num	51	SENT_65	[p3l944t3515r1286b3576],
51	i0	NN	O	i0	dep	52	SENT_65	[p3l944t3515r1286b3576],
52	.11	CD	NUMBER	.11	dep	56	SENT_65	[p3l944t3515r1286b3576],
53	0.69	CD	NUMBER	0.69	num	54	SENT_65	[p3l1432t3515r1787b3576],
54	i0	NN	O	i0	dep	52	SENT_65	[p3l1432t3515r1787b3576],
55	.16	CD	NUMBER	.16	num	56	SENT_65	[p3l1432t3515r1787b3576],
56	0.89	CD	NUMBER	0.89	dep	46	SENT_65	[p3l1953t3515r2092b3568],

1	*	NN	O	*	nsubj	5	SENT_66	[p3l9t3715r315b3770],
2	Contro	NNP	O	Contro	nn	4	SENT_66	[p3l9t3715r315b3770],
3	|	NNP	O	|	nn	4	SENT_66	[p3l9t3715r315b3770],
4	|	NNP	O	|	dep	1	SENT_66	[p3l9t3715r315b3770],
5	ed	VBD	O	ed	_	0	SENT_66	[p3l9t3715r315b3770],
6	for	IN	O	for	_	0	SENT_66	[p3l338t3725r411b3770],
7	race	NN	O	race	prep_for	5	SENT_66	[p3l434t3738r552b3770],
8	.	.	O	.	_	0	SENT_66	[p3l434t3738r552b3770],

1	i	FW	O	i	nn	2	SENT_67	[p4l1355t334r1389b371],
2	Ear-Miser	FW	O	ear-miser	_	0	SENT_67	[p4l1458t334r1663b371],
3	Ca	MD	O	can	aux	4	SENT_67	[p4l1355t395r1389b433],
4	‘	VB	O	‘	rcmod	2	SENT_67	[p4l1454t395r1581b445],
5	EMS	NNP	O	EMS	nn	6	SENT_67	[p4l1454t395r1581b445],
6	carriers	NNS	O	carrier	dobj	4	SENT_67	[p4l1597t395r1762b433],

1	Percent	NN	O	percent	nn	2	SENT_68	[p4l67t1120r113b1321],
2	Pia	NN	PERSON	pium	_	0	SENT_68	[p4l67t1013r125b1100],
3	.	.	O	.	_	0	SENT_68	[p4l67t1013r125b1100],
4	)	SYM	O	)	dep	2	SENT_68	[p4l67t1013r125b1100],

1	ishaznge	NN	O	ishaznge	nn	2	SENT_69	[p4l67t797r125b993],
2	ins	NNS	O	in	nsubj	7	SENT_69	[p4l67t736r113b777],
3	er-ratrcisa	JJ	O	er-ratrcisa	amod	4	SENT_69	[p4l67t498r113b719],
4	heart	NN	O	heart	dep	2	SENT_69	[p4l67t346r113b478],
5	rate	NN	O	rate	dep	2	SENT_69	[p4l71t227r113b326],
6	a	DT	O	a	dep	5	SENT_69	[p4l297t1448r322b1489],
7	ran	VBD	O	run	_	0	SENT_69	[p4l707t1415r785b1489],
8	zen	NN	O	zen	dobj	7	SENT_69	[p4l1138t1417r1221b1489],
9	3	CD	NUMBER	3	num	8	SENT_69	[p4l1573t1415r1655b1489],
10	&	CC	O	&	_	0	SENT_69	[p4l1573t1415r1655b1489],
11	0	CD	NUMBER	0	num	12	SENT_69	[p4l1573t1415r1655b1489],
12	#oo	NN	O	#oo	dobj	7	SENT_69	[p4l2007t1448r2090b1489],

1	Sarnetnprnlnl	NN	O	sarnetnprnlnl	nn	2	SENT_70	[p4l715t1530r1049b1587],
2	eunnentratinn	NN	O	eunnentratinn	_	0	SENT_70	[p4l1069t1530r1425b1575],
3	:	:	O	:	_	0	SENT_70	[p4l1069t1530r1425b1575],
4	ingfml	NN	O	ingfml	nn	5	SENT_70	[p4l1446t1530r1626b1587],
5	}	NN	O	}	dep	2	SENT_70	[p4l1446t1530r1626b1587],

1	Figure	NNP	O	Figure	_	0	SENT_71	[p4l12t1659r204b1726],
2	1	CD	NUMBER	1	num	3	SENT_71	[p4l245t1659r266b1709],
3	Relationship	NN	O	relationship	dep	1	SENT_71	[p4l347t1658r702b1726],
4	between	IN	O	between	_	0	SENT_71	[p4l741t1658r993b1710],
5	reduction	NN	O	reduction	prep_between	3	SENT_71	[p4l1034t1658r1313b1710],
6	in	IN	O	in	_	0	SENT_71	[p4l1352t1659r1400b1709],
7	maximal	JJ	O	maximal	amod	9	SENT_71	[p4l1441t1658r1690b1710],
8	exercise	NN	O	exercise	nn	9	SENT_71	[p4l1729t1659r1962b1710],
9	heart	NN	O	heart	prep_in	5	SENT_71	[p4l2000t1658r2151b1710],
10	rate-S-metoprolol	JJ	O	rate-s-metoprolol	amod	11	SENT_71	[p4l11t1743r528b1811],
11	concentration	NN	O	concentration	dep	1	SENT_71	[p4l559t1744r969b1795],
12	by	IN	O	by	_	0	SENT_71	[p4l1002t1743r1071b1811],
13	ADRB1	NN	O	adrb1	nn	14	SENT_71	[p4l1097t1745r1285b1795],
14	codon	NN	O	codon	prep_by	11	SENT_71	[p4l1321t1743r1504b1795],
15	49	CD	NUMBER	49	num	16	SENT_71	[p4l1533t1745r1607b1795],
16	genotype	NN	O	genotype	dep	11	SENT_71	[p4l1637t1749r1935b1811],
17	.	.	O	.	_	0	SENT_71	[p4l1637t1749r1935b1811],

1	Figure	NN	O	figure	nsubj	2	SENT_72	[p4l1969t1744r2148b1811],
2	includes	VBZ	O	include	_	0	SENT_72	[p4l10t1828r249b1880],
3	1030	CD	DATE	1030	dobj	2	SENT_72	[p4l292t1830r440b1880],
4	and	CC	DATE	and	_	0	SENT_72	[p4l480t1828r587b1880],
5	1430	CD	DATE	1430	num	9	SENT_72	[p4l632t1830r780b1880],
6	maximal	JJ	O	maximal	amod	9	SENT_72	[p4l822t1828r1070b1880],
7	exercise	NN	O	exercise	nn	9	SENT_72	[p4l1113t1830r1346b1880],
8	heart-rate	JJ	O	heart-rate	amod	9	SENT_72	[p4l1388t1828r1674b1880],
9	responses	NNS	O	response	dobj	2	SENT_72	[p4l1716t1843r1999b1896],
10	and	CC	O	and	_	0	SENT_72	[p4l2039t1828r2146b1880],
11	metoprolol	NN	O	metoprolol	nn	13	SENT_72	[p4l11t1913r333b1981],
12	plasma	NN	O	plasma	nn	13	SENT_72	[p4l365t1913r569b1981],
13	concentrations	NNS	O	concentration	conj_and	3	SENT_72	[p4l597t1915r1035b1965],
14	for	IN	O	for	_	0	SENT_72	[p4l1059t1913r1143b1965],
15	all	DT	O	all	det	16	SENT_72	[p4l1167t1913r1226b1965],
16	subjects	NNS	O	subject	prep_for	13	SENT_72	[p4l1255t1913r1506b1981],
17	.	.	O	.	_	0	SENT_72	[p4l1255t1913r1506b1981],

1	between	IN	O	between	_	0	SENT_73	[p4l6t2135r303b2193],
2	Ser49	NN	O	ser49	nn	3	SENT_73	[p4l365t2136r552b2193],
3	homozygotes	NNS	O	homozygote	prep_between	7	SENT_73	[p4l616t2135r1088b2211],
4	and	CC	O	and	_	0	SENT_73	[p4l1151t2135r1282b2193],
5	G1y49	NN	O	g1y49	nn	6	SENT_73	[p4l1345t2135r1552b2211],
6	carriers	NNS	O	carrier	prep_between	7	SENT_73	[p4l1616t2138r1869b2193],
7	(	VBP	O	(	_	0	SENT_73	[p4l1935t2135r2146b2207],
8	Ser49	NN	O	ser49	nn	10	SENT_73	[p4l1935t2135r2146b2207],
9	homozygote	NN	O	homozygote	nn	10	SENT_73	[p4l8t2230r449b2305],
10	y	NN	O	y	nsubj	11	SENT_73	[p4l479t2250r507b2302],
11	=	JJ	O	=	xcomp	7	SENT_73	[p4l528t2258r579b2276],
12	-0.06	CD	NUMBER	-0.06	nsubj	7	SENT_73	[p4l601t2231r824b2300],
13	,	,	O	,	_	0	SENT_73	[p4l601t2231r824b2300],
14	G1y49	NN	O	g1y49	nn	15	SENT_73	[p4l860t2229r1067b2305],
15	carrier	NN	O	carrier	appos	12	SENT_73	[p4l1099t2232r1323b2287],
16	32	CD	NUMBER	32	dep	15	SENT_73	[p4l1351t2250r1379b2302],
17	=	JJ	O	=	amod	16	SENT_73	[p4l1400t2258r1451b2276],
18	-0.08	CD	NUMBER	-0.08	tmod	17	SENT_73	[p4l1474t2231r1696b2299],
19	;	:	O	;	_	0	SENT_73	[p4l1474t2231r1696b2299],
20	P	NN	O	p	dep	15	SENT_73	[p4l1727t2230r2053b2301],
21	=	JJ	O	=	amod	23	SENT_73	[p4l1727t2230r2053b2301],
22	0.71	CD	NUMBER	0.71	tmod	21	SENT_73	[p4l1727t2230r2053b2301],
23	)	NN	O	)	dep	20	SENT_73	[p4l1727t2230r2053b2301],
24	.	.	O	.	_	0	SENT_73	[p4l1727t2230r2053b2301],

1	Given	VBN	O	give	dep	20	SENT_74	[p4l86t2326r296b2383],
2	that	IN	O	that	complm	12	SENT_74	[p4l345t2325r488b2383],
3	many	JJ	O	many	amod	4	SENT_74	[p4l537t2342r739b2401],
4	investigators	NNS	O	investigator	nsubj	12	SENT_74	[p4l786t2328r1235b2401],
5	conducting	VBG	O	conduct	partmod	4	SENT_74	[p4l1285t2325r1690b2401],
6	drug	NN	O	drug	nn	9	SENT_74	[p4l1738t2325r1899b2401],
7	target	NN	O	target	nn	9	SENT_74	[p4l1946t2332r2149b2401],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	9	SENT_74	[p4l8t2420r622b2495],
9	studies	NNS	O	study	dobj	5	SENT_74	[p4l669t2419r909b2477],
10	do	VBP	O	do	aux	12	SENT_74	[p4l955t2419r1041b2477],
11	not	RB	O	not	neg	12	SENT_74	[p4l1086t2427r1207b2477],
12	control	VB	O	control	pcomp	1	SENT_74	[p4l1252t2419r1508b2477],
13	for	IN	O	for	_	0	SENT_74	[p4l1553t2419r1652b2477],
14	plasma	NN	O	plasma	nn	16	SENT_74	[p4l1694t2420r1943b2495],
15	drug	NN	O	drug	nn	16	SENT_74	[p4l1989t2419r2150b2495],
16	concentration	NN	O	concentration	prep_for	12	SENT_74	[p4l9t2516r526b2584],
17	,	,	O	,	_	0	SENT_74	[p4l9t2516r526b2584],
18	we	PRP	O	we	nsubj	20	SENT_74	[p4l593t2530r689b2571],
19	also	RB	O	also	advmod	20	SENT_74	[p4l753t2513r887b2571],
20	tested	VBD	O	test	_	0	SENT_74	[p4l951t2514r1159b2571],
21	the	DT	O	the	det	22	SENT_74	[p4l1222t2513r1334b2571],
22	association	NN	O	association	dobj	20	SENT_74	[p4l1399t2516r1790b2571],
23	between	IN	O	between	_	0	SENT_74	[p4l1851t2513r2148b2571],
24	negative	JJ	O	negative	amod	26	SENT_74	[p4l8t2613r305b2686],
25	chronotropic	JJ	O	chronotropic	amod	26	SENT_74	[p4l378t2610r844b2686],
26	response	NN	O	response	prep_between	22	SENT_74	[p4l915t2627r1220b2686],
27	by	IN	O	by	_	0	SENT_74	[p4l1291t2610r1378b2686],
28	genotype	NN	O	genotype	prep_by	20	SENT_74	[p4l1447t2617r1791b2686],
29	,	,	O	,	_	0	SENT_74	[p4l1447t2617r1791b2686],
30	without	IN	O	without	_	0	SENT_74	[p4l1866t2610r2148b2668],
31	correcting	VBG	O	correct	prepc_without	20	SENT_74	[p4l9t2708r368b2780],
32	for	IN	O	for	_	0	SENT_74	[p4l396t2704r495b2762],
33	plasma	NN	O	plasma	nn	34	SENT_74	[p4l523t2705r772b2780],
34	concentration	NN	O	concentration	prep_for	31	SENT_74	[p4l802t2708r1320b2762],
35	.	.	O	.	_	0	SENT_74	[p4l802t2708r1320b2762],

1	In	IN	O	in	_	0	SENT_75	[p4l1355t2707r1428b2762],
2	this	DT	O	this	det	3	SENT_75	[p4l1458t2705r1587b2762],
3	case	NN	O	case	prep_in	6	SENT_75	[p4l1619t2721r1778b2775],
4	,	,	O	,	_	0	SENT_75	[p4l1619t2721r1778b2775],
5	we	PRP	O	we	nsubj	6	SENT_75	[p4l1810t2721r1906b2762],
6	found	VBD	O	find	_	0	SENT_75	[p4l1937t2704r2149b2762],
7	Ser49	NN	O	ser49	nn	8	SENT_75	[p4l9t2801r196b2857],
8	homozygotes	NNS	O	homozygote	nsubj	9	SENT_75	[p4l249t2800r721b2875],
9	had	VBD	O	have	ccomp	6	SENT_75	[p4l773t2800r905b2857],
10	a	DT	O	a	det	14	SENT_75	[p4l956t2816r991b2857],
11	greater	JJR	O	greater	amod	14	SENT_75	[p4l1042t2807r1284b2875],
12	negative	JJ	O	negative	amod	14	SENT_75	[p4l1333t2803r1631b2875],
13	chronotropic	NN	O	chronotropic	nn	14	SENT_75	[p4l1683t2800r2148b2875],
14	response	NN	O	response	dobj	9	SENT_75	[p4l8t2912r314b2971],
15	than	IN	O	than	mark	18	SENT_75	[p4l359t2895r524b2953],
16	G1y49	NN	O	g1y49	nn	17	SENT_75	[p4l569t2895r776b2971],
17	carriers	NNS	O	carrier	nsubj	18	SENT_75	[p4l825t2898r1077b2953],
18	(	VBP	O	(	advcl	9	SENT_75	[p4l1126t2895r1303b2967],
19	31	CD	PERCENT	31	number	20	SENT_75	[p4l1126t2895r1303b2967],
20	%	NN	PERCENT	%	amod	22	SENT_75	[p4l1126t2895r1303b2967],
21	reduction	NN	O	reduction	nn	22	SENT_75	[p4l1347t2895r1690b2953],
22	Versus	NNP	O	Versus	nsubj	24	SENT_75	[p4l1733t2912r1950b2953],
23	25	CD	PERCENT	25	number	24	SENT_75	[p4l1996t2897r2148b2953],
24	%	NN	PERCENT	%	xcomp	18	SENT_75	[p4l1996t2897r2148b2953],

1	mg	NN	O	mg	nn	3	SENT_76	[p4l8t3324r135b3448],
2	ﬂ-blocker	NN	O	ﬂ-blocker	nn	3	SENT_76	[p4l1164t3336r1389b3393],
3	drug	NN	O	drug	_	0	SENT_76	[p4l1404t3336r1517b3395],
4	target	NN	O	target	nn	5	SENT_76	[p4l1536t3341r1687b3395],
5	pharmacogenetics	NNS	O	pharmacogenetic	dep	3	SENT_76	[p4l1707t3336r2149b3395],
6	AL	NNP	MISC	AL	nn	7	SENT_76	[p4l1753t3409r1805b3448],
7	Beitelshees	NNP	MISC	Beitelshees	dep	5	SENT_76	[p4l1825t3407r2045b3449],
8	et	FW	O	et	nn	10	SENT_76	[p4l2065t3412r2101b3449],
9	al	FW	O	al	nn	10	SENT_76	[p4l2117t3407r2153b3449],
10	reduction	NN	O	reduction	dep	3	SENT_76	[p4l9t3695r369b3765],
11	,	,	O	,	_	0	SENT_76	[p4l9t3695r369b3765],
12	P	NN	O	p	appos	10	SENT_76	[p4l411t3696r738b3767],
13	=	JJ	O	=	amod	15	SENT_76	[p4l411t3696r738b3767],
14	0.05	CD	NUMBER	0.05	tmod	13	SENT_76	[p4l411t3696r738b3767],
15	)	NN	O	)	dep	12	SENT_76	[p4l411t3696r738b3767],
16	.	.	O	.	_	0	SENT_76	[p4l411t3696r738b3767],

1	Such	JJ	O	such	amod	2	SENT_77	[p4l784t3695r952b3753],
2	differences	NNS	O	difference	nsubj	5	SENT_77	[p4l994t3695r1374b3753],
3	were	VBD	O	be	cop	5	SENT_77	[p4l1414t3712r1577b3753],
4	not	RB	O	not	neg	5	SENT_77	[p4l1619t3702r1740b3753],
5	evident	JJ	O	evident	_	0	SENT_77	[p4l1781t3695r2045b3753],
6	at	IN	O	at	prep	5	SENT_77	[p4l2085t3702r2149b3753],

1	1430	CD	DATE	1430	nsubj	17	SENT_78	[p5l14t20r197b89],
2	,	,	O	,	_	0	SENT_78	[p5l14t20r197b89],
3	even	RB	O	even	advmod	8	SENT_78	[p5l255t36r420b77],
4	when	WRB	O	when	advmod	5	SENT_78	[p5l470t19r668b77],
5	uncorrected	JJ	O	uncorrected	advmod	8	SENT_78	[p5l719t19r1145b77],
6	for	IN	O	for	_	0	SENT_78	[p5l1197t19r1296b77],
7	plasma	NN	O	plasma	prep_for	5	SENT_78	[p5l1347t19r1596b95],
8	concentration	NN	O	concentration	appos	1	SENT_78	[p5l1648t22r2148b77],
9	(	CD	PERCENT	(	number	10	SENT_78	[p5l12t114r189b186],
10	25	CD	PERCENT	25	num	11	SENT_78	[p5l12t114r189b186],
11	%	NN	PERCENT	%	dep	8	SENT_78	[p5l12t114r189b186],
12	versus	CC	O	versus	_	0	SENT_78	[p5l219t130r436b171],
13	23	CD	PERCENT	23	num	14	SENT_78	[p5l471t115r641b184],
14	%	NN	PERCENT	%	appos	1	SENT_78	[p5l471t115r641b184],
15	,	,	O	,	_	0	SENT_78	[p5l471t115r641b184],
16	P	NN	O	p	appos	14	SENT_78	[p5l675t114r1002b185],
17	=	JJ	O	=	_	0	SENT_78	[p5l675t114r1002b185],
18	O.	NNP	O	O.	iobj	17	SENT_78	[p5l675t114r1002b185],
19	52	CD	NUMBER	52	num	20	SENT_78	[p5l675t114r1002b185],
20	)	CD	NUMBER	)	dobj	17	SENT_78	[p5l675t114r1002b185],
21	.	.	O	.	_	0	SENT_78	[p5l675t114r1002b185],

1	Results	NNS	O	result	nsubj	7	SENT_79	[p5l1040t113r1283b171],
2	for	IN	O	for	_	0	SENT_79	[p5l1317t113r1416b171],
3	codon	NN	O	codon	prep_for	1	SENT_79	[p5l1447t113r1667b171],
4	49	CD	NUMBER	49	num	3	SENT_79	[p5l1701t115r1782b171],
5	were	VBD	O	be	cop	7	SENT_79	[p5l1816t130r1979b171],
6	also	RB	O	also	advmod	7	SENT_79	[p5l2014t114r2148b171],
7	similar	JJ	O	similar	_	0	SENT_79	[p5l10t210r250b268],
8	when	WRB	O	when	advmod	9	SENT_79	[p5l289t211r486b268],
9	conducted	VBN	O	conduct	advcl	7	SENT_79	[p5l528t210r901b268],
10	only	RB	O	only	advmod	9	SENT_79	[p5l942t211r1102b286],
11	in	IN	O	in	_	0	SENT_79	[p5l1140t213r1211b267],
12	Caucasian	JJ	MISC	caucasian	amod	13	SENT_79	[p5l1253t212r1611b268],
13	subjects	NNS	O	subject	prep_in	9	SENT_79	[p5l1655t210r1930b286],
14	(	JJ	O	(	amod	15	SENT_79	[p5l1976t210r2149b283],
15	data	NNS	O	datum	npadvmod	16	SENT_79	[p5l1976t210r2149b283],
16	not	RB	O	not	neg	17	SENT_79	[p5l9t313r129b364],
17	shown	VBN	O	show	partmod	13	SENT_79	[p5l160t306r437b378],
18	)	NN	O	)	dobj	17	SENT_79	[p5l160t306r437b378],
19	.	.	O	.	_	0	SENT_79	[p5l160t306r437b378],

1	Discussion	NN	O	discussion	_	0	SENT_80	[p5l11t532r404b590],

1	Consistent	JJ	O	consistent	dobj	11	SENT_81	[p5l10t723r389b779],
2	with	IN	O	with	_	0	SENT_81	[p5l433t721r595b779],
3	most	JJS	O	most	amod	5	SENT_81	[p5l641t728r815b779],
4	other	JJ	O	other	amod	5	SENT_81	[p5l862t721r1050b779],
5	reports	NNS	O	report	prep_with	1	SENT_81	[p5l1095t728r1339b797],
6	in	IN	O	in	_	0	SENT_81	[p5l1386t724r1456b778],
7	the	DT	O	the	det	8	SENT_81	[p5l1503t721r1615b779],
8	literature	NN	O	literature	prep_in	11	SENT_81	[p5l1662t721r2003b791],
9	,	,	O	,	_	0	SENT_81	[p5l1662t721r2003b791],
10	we	PRP	O	we	nsubj	11	SENT_81	[p5l2052t738r2148b779],
11	found	VBD	O	find	dep	40	SENT_81	[p5l9t815r220b873],
12	no	DT	O	no	det	13	SENT_81	[p5l251t832r342b873],
13	association	NN	O	association	dobj	11	SENT_81	[p5l375t818r766b873],
14	between	IN	O	between	_	0	SENT_81	[p5l795t815r1092b873],
15	resting	VBG	O	rest	prepc_between	13	SENT_81	[p5l1124t818r1364b891],
16	or	CC	O	or	_	0	SENT_81	[p5l1395t832r1466b873],
17	exercise	NN	O	exercise	prepc_between	13	SENT_81	[p5l1497t818r1771b873],
18	heart	NN	O	heart	nn	19	SENT_81	[p5l1804t815r1986b873],
19	rate	NN	O	rate	dobj	17	SENT_81	[p5l2017t823r2148b873],
20	and	CC	O	and	_	0	SENT_81	[p5l9t909r140b967],
21	codon	NN	O	codon	nn	23	SENT_81	[p5l181t909r401b967],
22	389	CD	NUMBER	389	num	23	SENT_81	[p5l442t910r566b967],
23	genotype	NN	O	genotype	conj_and	19	SENT_81	[p5l607t902r1192b985],
24	.4	CD	NUMBER	.4	num	25	SENT_81	[p5l607t902r1192b985],
25	‘	NN	O	‘	dep	23	SENT_81	[p5l607t902r1192b985],
26	6	CD	NUMBER	6	dep	23	SENT_81	[p5l607t902r1192b985],
27	'	''	O	'	_	0	SENT_81	[p5l607t902r1192b985],
28	9	CD	NUMBER	9	num	29	SENT_81	[p5l607t902r1192b985],
29	‘“	NN	O	‘“	conj_and	19	SENT_81	[p5l607t902r1192b985],
30	Similarly	RB	O	similarly	rcmod	29	SENT_81	[p5l1236t909r1551b985],
31	consistent	JJ	O	consistent	dep	30	SENT_81	[p5l1589t912r1949b967],
32	with	IN	O	with	_	0	SENT_81	[p5l1987t909r2148b967],
33	other	JJ	O	other	amod	34	SENT_81	[p5l9t1004r198b1062],
34	reports	NNS	O	report	prep_with	31	SENT_81	[p5l245t1012r490b1080],
35	in	IN	O	in	_	0	SENT_81	[p5l539t1007r609b1061],
36	the	DT	O	the	det	37	SENT_81	[p5l657t1004r770b1062],
37	literature	NN	O	literature	prep_in	34	SENT_81	[p5l819t1004r1159b1075],
38	,	,	O	,	_	0	SENT_81	[p5l819t1004r1159b1075],
39	we	PRP	O	we	nsubj	40	SENT_81	[p5l1211t1021r1307b1062],
40	found	VBD	O	find	_	0	SENT_81	[p5l1357t1004r1568b1062],
41	no	DT	O	no	det	42	SENT_81	[p5l1617t1021r1707b1062],
42	association	NN	O	association	dobj	40	SENT_81	[p5l1758t1007r2148b1062],
43	between	IN	O	between	_	0	SENT_81	[p5l7t1100r304b1158],
44	heart	NN	O	heart	nn	46	SENT_81	[p5l375t1100r557b1158],
45	rate	NN	O	rate	nn	46	SENT_81	[p5l628t1107r758b1158],
46	response	NN	O	response	prep_between	42	SENT_81	[p5l831t1117r1136b1176],
47	to	TO	O	to	_	0	SENT_81	[p5l1208t1107r1278b1158],
48	[	CD	NUMBER	[	num	51	SENT_81	[p5l1350t1100r1788b1176],
49	3-adrenergic	JJ	O	3-adrenergic	amod	51	SENT_81	[p5l1350t1100r1788b1176],
50	receptor	NN	O	receptor	nn	51	SENT_81	[p5l1859t1107r2150b1176],
51	antagonists	NNS	O	antagonist	prep_to	40	SENT_81	[p5l9t1196r413b1269],
52	and	CC	O	and	_	0	SENT_81	[p5l444t1193r575b1251],
53	codon	NN	O	codon	conj_and	51	SENT_81	[p5l605t1193r825b1251],
54	389	CD	NUMBER	389	num	53	SENT_81	[p5l856t1195r980b1251],
55	genotype	NN	O	genotype	dep	53	SENT_81	[p5l1012t1186r1538b1269],
56	.4	CD	NUMBER	.4	num	55	SENT_81	[p5l1012t1186r1538b1269],
57	"	``	O	"	punct	55	SENT_81	[p5l1012t1186r1538b1269],
58	6	CD	NUMBER	6	num	59	SENT_81	[p5l1012t1186r1538b1269],
59	'12	CD	NUMBER	'12	dep	55	SENT_81	[p5l1012t1186r1538b1269],

1	With	IN	O	with	_	0	SENT_82	[p5l84t1289r263b1346],
2	regard	NN	O	regard	_	0	SENT_82	[p5l305t1289r526b1364],
3	to	TO	O	to	_	0	SENT_82	[p5l568t1296r638b1346],
4	associations	NNS	O	association	prep_with_regard_to	11	SENT_82	[p5l682t1292r1103b1346],
5	with	IN	O	with	_	0	SENT_82	[p5l1145t1289r1307b1346],
6	codon	NN	O	codon	prep_with	4	SENT_82	[p5l1350t1289r1570b1346],
7	49	CD	NUMBER	49	num	6	SENT_82	[p5l1614t1290r1714b1359],
8	,	,	O	,	_	0	SENT_82	[p5l1614t1290r1714b1359],
9	our	PRP$	O	we	poss	10	SENT_82	[p5l1762t1305r1881b1346],
10	results	NNS	O	result	nsubj	18	SENT_82	[p5l1923t1289r2148b1346],
11	agree	VBP	O	agree	_	0	SENT_82	[p5l9t1399r190b1458],
12	with	IN	O	with	_	0	SENT_82	[p5l219t1382r380b1440],
13	Ranade	NNP	O	Ranade	prep_with	11	SENT_82	[p5l410t1382r666b1440],
14	et	FW	O	et	nn	16	SENT_82	[p5l697t1388r757b1440],
15	al.	FW	O	al.	nn	16	SENT_82	[p5l781t1375r924b1440],
16	“	NN	O	“	dep	13	SENT_82	[p5l781t1375r924b1440],
17	and	CC	O	and	_	0	SENT_82	[p5l958t1382r1090b1440],
18	find	VB	O	find	conj_and	11	SENT_82	[p5l1119t1382r1261b1440],
19	a	DT	O	a	det	21	SENT_82	[p5l1291t1399r1326b1440],
20	significant	JJ	O	significant	amod	21	SENT_82	[p5l1357t1382r1728b1458],
21	association	NN	O	association	dobj	18	SENT_82	[p5l1758t1385r2149b1440],
22	between	IN	O	between	_	0	SENT_82	[p5l7t1478r304b1536],
23	untreated	JJ	O	untreated	amod	26	SENT_82	[p5l325t1478r669b1536],
24	resting	VBG	O	rest	amod	26	SENT_82	[p5l692t1481r933b1554],
25	heart	NN	O	heart	nn	26	SENT_82	[p5l955t1478r1138b1536],
26	rate	NN	O	rate	prep_between	21	SENT_82	[p5l1161t1485r1291b1536],
27	and	CC	O	and	_	0	SENT_82	[p5l1316t1478r1447b1536],
28	codon	NN	O	codon	nn	30	SENT_82	[p5l1471t1478r1691b1536],
29	49	CD	NUMBER	49	num	30	SENT_82	[p5l1715t1480r1796b1536],
30	genotype	NN	O	genotype	prep_between	21	SENT_82	[p5l1822t1485r2148b1554],
31	in	IN	O	in	_	0	SENT_82	[p5l9t1576r79b1630],
32	hypertensive	JJ	O	hypertensive	amod	33	SENT_82	[p5l124t1573r579b1649],
33	individuals	NNS	O	individual	prep_in	30	SENT_82	[p5l626t1573r1038b1631],
34	.	.	O	.	_	0	SENT_82	[p5l626t1573r1038b1631],

1	However	RB	O	however	advmod	6	SENT_83	[p5l1089t1575r1414b1643],
2	,	,	O	,	_	0	SENT_83	[p5l1089t1575r1414b1643],
3	other	JJ	O	other	amod	4	SENT_83	[p5l1465t1573r1654b1631],
4	investigators	NNS	O	investigator	nsubj	6	SENT_83	[p5l1699t1576r2148b1649],
5	have	VBP	O	have	aux	6	SENT_83	[p5l9t1666r173b1724],
6	failed	VBN	O	fail	_	0	SENT_83	[p5l211t1666r405b1724],
7	to	TO	O	to	aux	8	SENT_83	[p5l441t1674r510b1724],
8	find	VB	O	find	xcomp	6	SENT_83	[p5l547t1666r691b1724],
9	this	DT	O	this	det	11	SENT_83	[p5l726t1666r856b1724],
10	association	NN	O	association	nn	11	SENT_83	[p5l893t1659r1503b1724],
11	.7	NN	NUMBER	.7	iobj	8	SENT_83	[p5l893t1659r1503b1724],
12	'	''	DATE	'	_	0	SENT_83	[p5l893t1659r1503b1724],
13	13	CD	DATE	13	number	14	SENT_83	[p5l893t1659r1503b1724],
14	'14	CD	DATE	'14	dobj	8	SENT_83	[p5l893t1659r1503b1724],
15	One	CD	NUMBER	one	num	16	SENT_83	[p5l1542t1668r1686b1724],
16	explanation	NN	O	explanation	nsubj	22	SENT_83	[p5l1724t1666r2148b1742],
17	for	IN	O	for	_	0	SENT_83	[p5l9t1761r107b1819],
18	this	DT	O	this	det	19	SENT_83	[p5l152t1762r281b1819],
19	inconsistency	NN	O	inconsistency	prep_for	16	SENT_83	[p5l328t1764r817b1837],
20	may	MD	O	may	aux	22	SENT_83	[p5l860t1778r1013b1837],
21	be	VB	O	be	cop	22	SENT_83	[p5l1054t1761r1134b1819],
22	differences	NNS	O	difference	rcmod	14	SENT_83	[p5l1181t1761r1562b1819],
23	in	IN	O	in	_	0	SENT_83	[p5l1609t1764r1679b1818],
24	populations	NNS	O	population	prep_in	22	SENT_83	[p5l1724t1761r2148b1837],
25	studied	VBN	O	study	partmod	24	SENT_83	[p5l10t1857r267b1915],
26	(	CD	NUMBER	(	num	29	SENT_83	[p5l303t1857r426b1929],
27	i.e.	FW	O	i.e.	nn	29	SENT_83	[p5l303t1857r426b1929],
28	hypertensive	JJ	O	hypertensive	amod	29	SENT_83	[p5l464t1857r918b1933],
29	subjects	NNS	O	subject	dobj	25	SENT_83	[p5l955t1857r1231b1933],
30	versus	CC	O	versus	prep	29	SENT_83	[p5l1263t1874r1480b1915],
31	those	DT	O	those	det	40	SENT_83	[p5l1515t1857r1703b1915],
32	undergoing	VBG	O	undergo	dep	40	SENT_83	[p5l1737t1857r2150b1933],
33	dobutamine	NN	O	dobutamine	nn	35	SENT_83	[p5l9t1951r440b2009],
34	stress	NN	O	stress	nn	35	SENT_83	[p5l473t1959r657b2009],
35	echocardiogram	NN	O	echocardiogram	dobj	32	SENT_83	[p5l688t1951r1259b2027],
36	or	CC	O	or	_	0	SENT_83	[p5l1291t1968r1362b2009],
37	with	IN	O	with	dep	40	SENT_83	[p5l1391t1952r1553b2009],
38	heart	NN	O	heart	nn	39	SENT_83	[p5l1583t1952r1765b2009],
39	failure	NN	O	failure	pobj	37	SENT_83	[p5l1796t1951r2065b2024],
40	)	NN	O	)	dep	30	SENT_83	[p5l1796t1951r2065b2024],
41	.	.	O	.	_	0	SENT_83	[p5l1796t1951r2065b2024],

1	A	DT	DURATION	a	det	3	SENT_84	[p5l2099t1953r2149b2008],
2	second	JJ	DURATION	second	amod	3	SENT_84	[p5l10t2046r254b2104],
3	explanation	NN	O	explanation	nsubj	12	SENT_84	[p5l290t2046r714b2122],
4	for	IN	O	for	_	0	SENT_84	[p5l750t2046r849b2104],
5	these	DT	O	these	det	6	SENT_84	[p5l883t2047r1065b2104],
6	differences	NNS	O	difference	prep_for	3	SENT_84	[p5l1102t2046r1483b2104],
7	could	MD	O	could	aux	12	SENT_84	[p5l1520t2046r1716b2104],
8	be	VB	O	be	cop	12	SENT_84	[p5l1750t2047r1830b2104],
9	a	DT	O	a	det	12	SENT_84	[p5l1868t2063r1902b2104],
10	type	NN	O	type	nn	12	SENT_84	[p5l1938t2054r2089b2122],
11	I	CD	NUMBER	i	num	12	SENT_84	[p5l2126t2049r2148b2103],
12	error	NN	O	error	_	0	SENT_84	[p5l9t2159r191b2212],
13	,	,	O	,	_	0	SENT_84	[p5l9t2159r191b2212],
14	based	VBN	O	base	_	0	SENT_84	[p5l235t2142r433b2200],
15	on	IN	O	on	prepc_based_on	12	SENT_84	[p5l476t2159r567b2200],
16	the	DT	O	the	det	17	SENT_84	[p5l609t2142r721b2200],
17	number	NN	O	number	pobj	12	SENT_84	[p5l764t2142r1043b2200],
18	of	IN	O	of	_	0	SENT_84	[p5l1085t2142r1157b2200],
19	comparisons	NNS	O	comparison	prep_of	17	SENT_84	[p5l1195t2145r1641b2218],
20	made	VBN	O	make	partmod	19	SENT_84	[p5l1684t2142r1875b2200],
21	in	IN	O	in	_	0	SENT_84	[p5l1918t2145r1988b2199],
22	our	PRP$	O	we	poss	23	SENT_84	[p5l2031t2159r2150b2200],
23	study	NN	O	study	prep_in	20	SENT_84	[p5l10t2237r212b2312],
24	.	.	O	.	_	0	SENT_84	[p5l10t2237r212b2312],

1	Therefore	RB	O	therefore	advmod	15	SENT_85	[p5l263t2236r621b2307],
2	,	,	O	,	_	0	SENT_85	[p5l263t2236r621b2307],
3	our	PRP$	O	we	poss	4	SENT_85	[p5l675t2253r793b2294],
4	results	NNS	O	result	nsubjpass	15	SENT_85	[p5l839t2237r1065b2294],
5	with	IN	O	with	_	0	SENT_85	[p5l1111t2237r1273b2294],
6	resting	VBG	O	rest	prepc_with	4	SENT_85	[p5l1321t2240r1561b2312],
7	heart	NN	O	heart	nn	8	SENT_85	[p5l1608t2237r1790b2294],
8	rate	NN	O	rate	dobj	6	SENT_85	[p5l1837t2244r1968b2294],
9	and	CC	O	and	_	0	SENT_85	[p5l2018t2237r2149b2294],
10	codon	NN	O	codon	nn	12	SENT_85	[p5l9t2332r230b2390],
11	49	CD	NUMBER	49	num	12	SENT_85	[p5l260t2334r340b2390],
12	genotype	NN	O	genotype	dobj	6	SENT_85	[p5l372t2339r698b2408],
13	should	MD	O	should	aux	15	SENT_85	[p5l730t2332r969b2390],
14	be	VB	O	be	auxpass	15	SENT_85	[p5l996t2332r1076b2390],
15	interpreted	VBN	O	interpret	_	0	SENT_85	[p5l1107t2332r1501b2408],
16	with	IN	O	with	_	0	SENT_85	[p5l1528t2332r1689b2390],
17	caution	NN	O	caution	prep_with	15	SENT_85	[p5l1720t2335r2005b2390],
18	.	.	O	.	_	0	SENT_85	[p5l1720t2335r2005b2390],

1	Although	IN	O	although	mark	7	SENT_86	[p5l84t2427r421b2503],
2	untreated	JJ	O	untreated	csubj	7	SENT_86	[p5l465t2427r809b2485],
3	resting	VBG	O	rest	dep	2	SENT_86	[p5l854t2430r1095b2503],
4	heart	NN	O	heart	nn	5	SENT_86	[p5l1139t2427r1321b2485],
5	rate	NN	O	rate	dobj	3	SENT_86	[p5l1367t2434r1497b2485],
6	was	VBD	O	be	cop	7	SENT_86	[p5l1542t2444r1670b2485],
7	different	JJ	O	different	advcl	14	SENT_86	[p5l1717t2427r2020b2485],
8	by	IN	O	by	_	0	SENT_86	[p5l2064t2427r2151b2503],
9	codon	NN	O	codon	nn	11	SENT_86	[p5l9t2522r230b2580],
10	49	CD	NUMBER	49	num	11	SENT_86	[p5l267t2523r348b2579],
11	genotype	NN	O	genotype	prep_by	7	SENT_86	[p5l387t2529r731b2598],
12	,	,	O	,	_	0	SENT_86	[p5l387t2529r731b2598],
13	we	PRP	O	we	nsubj	14	SENT_86	[p5l771t2539r867b2580],
14	found	VBD	O	find	_	0	SENT_86	[p5l904t2522r1116b2580],
15	no	DT	O	no	det	16	SENT_86	[p5l1152t2539r1243b2580],
16	differences	NNS	O	difference	dobj	14	SENT_86	[p5l1281t2522r1662b2580],
17	in	IN	O	in	_	0	SENT_86	[p5l1699t2525r1770b2579],
18	untreated	JJ	O	untreated	amod	20	SENT_86	[p5l1805t2522r2149b2580],
19	exercise	NN	O	exercise	nn	20	SENT_86	[p5l9t2620r283b2675],
20	HR	NN	DURATION	hr	prep_in	14	SENT_86	[p5l312t2620r419b2674],
21	or	CC	O	or	_	0	SENT_86	[p5l445t2634r516b2675],
22	the	DT	O	the	conj_or	20	SENT_86	[p5l542t2617r654b2675],
23	resting	VBG	O	rest	amod	22	SENT_86	[p5l682t2620r922b2693],
24	or	CC	O	or	_	0	SENT_86	[p5l948t2634r1020b2675],
25	exercise	NN	O	exercise	nn	28	SENT_86	[p5l1045t2620r1320b2675],
26	heart	NN	O	heart	nn	28	SENT_86	[p5l1348t2617r1530b2675],
27	rate	NN	O	rate	nn	28	SENT_86	[p5l1556t2624r1687b2675],
28	responses	NNS	O	response	prep_in	14	SENT_86	[p5l1714t2634r2051b2693],
29	to	TO	O	to	_	0	SENT_86	[p5l2078t2624r2148b2675],
30	metoprolol	NN	O	metoprolol	prep_to	28	SENT_86	[p5l9t2711r404b2787],
31	corrected	VBN	O	correct	partmod	30	SENT_86	[p5l449t2711r776b2769],
32	for	IN	O	for	_	0	SENT_86	[p5l821t2711r919b2769],
33	plasma	NN	O	plasma	nn	35	SENT_86	[p5l962t2711r1211b2787],
34	drug	NN	O	drug	nn	35	SENT_86	[p5l1256t2711r1417b2787],
35	concentration	NN	O	concentration	prep_for	31	SENT_86	[p5l1461t2714r1979b2769],
36	.	.	O	.	_	0	SENT_86	[p5l1461t2714r1979b2769],

1	Additionally	RB	O	additionally	advmod	11	SENT_87	[p5l2027t2711r2148b2769, p5l9t2807r364b2883],
2	,	,	O	,	_	0	SENT_87	[p5l2027t2711r2148b2769, p5l9t2807r364b2883],
3	when	WRB	O	when	advmod	4	SENT_87	[p5l389t2807r587b2865],
4	analyzed	VBN	O	analyze	advcl	11	SENT_87	[p5l609t2807r920b2883],
5	by	IN	O	by	_	0	SENT_87	[p5l939t2807r1027b2883],
6	linear	JJ	O	linear	amod	8	SENT_87	[p5l1047t2807r1249b2865],
7	regression	NN	O	regression	nn	8	SENT_87	[p5l1269t2810r1624b2883],
8	analysis	NN	O	analysis	prep_by	4	SENT_87	[p5l1647t2807r1941b2883],
9	,	,	O	,	_	0	SENT_87	[p5l1647t2807r1941b2883],
10	there	EX	O	there	expl	11	SENT_87	[p5l1967t2807r2148b2865],
11	was	VBD	O	be	_	0	SENT_87	[p5l7t2918r135b2959],
12	also	RB	O	also	advmod	11	SENT_87	[p5l163t2901r297b2959],
13	no	DT	O	no	det	14	SENT_87	[p5l325t2918r416b2959],
14	difference	NN	O	difference	nsubj	11	SENT_87	[p5l444t2901r794b2959],
15	by	IN	O	by	_	0	SENT_87	[p5l819t2901r907b2977],
16	genotype	NN	O	genotype	prep_by	11	SENT_87	[p5l932t2909r1277b2977],
17	.	.	O	.	_	0	SENT_87	[p5l932t2909r1277b2977],

1	Given	VBN	O	give	dep	15	SENT_88	[p5l1309t2903r1520b2959],
2	that	IN	O	that	complm	8	SENT_88	[p5l1546t2901r1690b2959],
3	32	CD	NUMBER	32	num	4	SENT_88	[p5l1716t2922r1744b2974],
4	(	CD	NUMBER	(	nsubj	8	SENT_88	[p5l1777t2901r1912b2973],
5	the	DT	O	the	det	7	SENT_88	[p5l1777t2901r1912b2973],
6	slope	NN	O	slope	nn	7	SENT_88	[p5l1942t2901r2145b2977],
7	)	NN	O	)	dep	4	SENT_88	[p5l1942t2901r2145b2977],
8	represents	VBZ	O	represent	pcomp	1	SENT_88	[p5l9t3004r365b3072],
9	the	DT	O	the	det	10	SENT_88	[p5l388t2996r500b3054],
10	quotient	NN	O	quotient	dobj	8	SENT_88	[p5l525t2999r829b3072],
11	of	IN	O	of	_	0	SENT_88	[p5l852t2996r924b3054],
12	Emax/ECSO	NNP	O	Emax/ECSO	prep_of	10	SENT_88	[p5l943t2996r1372b3067],
13	,	,	O	,	_	0	SENT_88	[p5l943t2996r1372b3067],
14	this	DT	O	this	nsubj	15	SENT_88	[p5l1400t2996r1529b3054],
15	suggests	VBZ	O	suggest	_	0	SENT_88	[p5l1554t3004r1838b3072],
16	a	DT	O	a	det	17	SENT_88	[p5l1862t3013r1897b3054],
17	lack	NN	O	lack	dobj	15	SENT_88	[p5l1919t2996r2060b3054],
18	of	IN	O	of	_	0	SENT_88	[p5l2081t2996r2153b3054],
19	relevant	JJ	O	relevant	amod	21	SENT_88	[p5l9t3092r295b3150],
20	pharmacodynamic	JJ	O	pharmacodynamic	amod	21	SENT_88	[p5l330t3092r997b3168],
21	differences	NNS	O	difference	prep_of	17	SENT_88	[p5l1033t3092r1414b3150],
22	by	IN	O	by	_	0	SENT_88	[p5l1447t3092r1535b3168],
23	genotype	NN	O	genotype	prep_by	15	SENT_88	[p5l1568t3099r1894b3168],
24	in	IN	O	in	_	0	SENT_88	[p5l1930t3095r2000b3149],
25	the	DT	O	the	det	28	SENT_88	[p5l2035t3092r2148b3150],
26	negative	JJ	O	negative	amod	28	SENT_88	[p5l9t3190r306b3262],
27	chronotropic	JJ	O	chronotropic	amod	28	SENT_88	[p5l337t3187r802b3262],
28	response	NN	O	response	prep_in	23	SENT_88	[p5l832t3203r1137b3262],
29	to	TO	O	to	_	0	SENT_88	[p5l1167t3194r1237b3244],
30	metoprolol	NN	O	metoprolol	prep_to	28	SENT_88	[p5l1267t3187r1680b3262],
31	.	.	O	.	_	0	SENT_88	[p5l1267t3187r1680b3262],

1	Interestingly	RB	O	interestingly	advmod	14	SENT_89	[p5l86t3282r547b3357],
2	,	,	O	,	_	0	SENT_89	[p5l86t3282r547b3357],
3	when	WRB	O	when	advmod	8	SENT_89	[p5l575t3282r773b3339],
4	these	DT	O	these	det	5	SENT_89	[p5l797t3282r979b3339],
5	data	NNS	O	datum	nsubjpass	8	SENT_89	[p5l1006t3282r1155b3339],
6	were	VBD	O	be	auxpass	8	SENT_89	[p5l1178t3298r1342b3339],
7	not	RB	O	not	neg	8	SENT_89	[p5l1368t3289r1488b3339],
8	corrected	VBN	O	correct	advcl	14	SENT_89	[p5l1514t3282r1841b3339],
9	for	IN	O	for	_	0	SENT_89	[p5l1866t3281r1964b3339],
10	drug	NN	O	drug	nn	11	SENT_89	[p5l1989t3282r2150b3357],
11	exposure	NN	O	exposure	prep_for	8	SENT_89	[p5l9t3394r342b3453],
12	,	,	O	,	_	0	SENT_89	[p5l9t3394r342b3453],
13	there	EX	O	there	expl	14	SENT_89	[p5l408t3377r588b3435],
14	were	VBD	O	be	_	0	SENT_89	[p5l648t3394r811b3435],
15	trends	NNS	O	trend	nsubj	14	SENT_89	[p5l873t3377r1093b3435],
16	toward	IN	O	toward	_	0	SENT_89	[p5l1155t3377r1401b3435],
17	differences	NNS	O	difference	prep_toward	15	SENT_89	[p5l1462t3377r1842b3435],
18	in	IN	O	in	_	0	SENT_89	[p5l1904t3380r1975b3434],
19	the	DT	O	the	det	23	SENT_89	[p5l2035t3377r2148b3435],
20	exercise	NN	O	exercise	nn	23	SENT_89	[p5l9t3475r283b3530],
21	heart	NN	O	heart	nn	23	SENT_89	[p5l310t3472r492b3530],
22	rate	NN	O	rate	nn	23	SENT_89	[p5l517t3479r648b3530],
23	response	NN	O	response	prep_in	17	SENT_89	[p5l674t3489r980b3548],
24	at	IN	O	at	_	0	SENT_89	[p5l1007t3479r1070b3530],
25	the	DT	O	the	det	26	SENT_89	[p5l1095t3472r1207b3530],
26	time	NN	O	time	prep_at	14	SENT_89	[p5l1234t3475r1393b3530],
27	of	IN	O	of	_	0	SENT_89	[p5l1420t3472r1491b3530],
28	approximate	JJ	O	approximate	amod	31	SENT_89	[p5l1513t3475r1960b3548],
29	peak	NN	O	peak	nn	31	SENT_89	[p5l1986t3472r2151b3548],
30	drug	NN	O	drug	nn	31	SENT_89	[p5l9t3567r170b3643],
31	concentration	NN	O	concentration	prep_of	26	SENT_89	[p5l196t3570r714b3625],
32	.	.	O	.	_	0	SENT_89	[p5l196t3570r714b3625],

1	These	DT	O	these	det	2	SENT_90	[p5l744t3567r945b3625],
2	data	NNS	O	datum	nsubj	3	SENT_90	[p5l974t3567r1123b3625],
3	highlight	VBP	O	highlight	_	0	SENT_90	[p5l1149t3567r1480b3643],
4	the	DT	O	the	det	5	SENT_90	[p5l1506t3567r1618b3625],
5	importance	NN	O	importance	dobj	3	SENT_90	[p5l1647t3570r2053b3643],
6	of	IN	O	of	_	0	SENT_90	[p5l2081t3567r2153b3625],
7	inclusion	NN	O	inclusion	prep_of	5	SENT_90	[p5l9t3661r338b3719],
8	of	IN	O	of	_	0	SENT_90	[p5l374t3661r446b3719],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_90	[p5l475t3661r1077b3737],
10	analysis	NN	O	analysis	prep_of	7	SENT_90	[p5l1113t3661r1388b3737],
11	in	IN	O	in	_	0	SENT_90	[p5l1424t3664r1494b3718],
12	drug	NN	O	drug	nn	15	SENT_90	[p5l1530t3661r1691b3737],
13	target	NN	O	target	nn	15	SENT_90	[p5l1725t3669r1927b3737],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_90	[p5l1961t3662r2147b3737, p5l9t3760r458b3833],
15	studies	NNS	O	study	prep_in	10	SENT_90	[p5l488t3757r746b3827],
16	,	,	O	,	_	0	SENT_90	[p5l488t3757r746b3827],
17	to	TO	O	to	aux	18	SENT_90	[p5l779t3764r849b3815],
18	insure	VB	O	insure	xcomp	3	SENT_90	[p5l878t3760r1093b3815],
19	that	IN	O	that	complm	25	SENT_90	[p5l1123t3757r1266b3815],
20	observed	VBN	O	observe	amod	21	SENT_90	[p5l1295t3757r1607b3815],
21	differences	NNS	O	difference	nsubj	25	SENT_90	[p5l1635t3757r2016b3815],
22	are	VBP	O	be	cop	25	SENT_90	[p5l2046t3774r2147b3815],
23	not	RB	O	not	neg	25	SENT_90	[p6l9t32r129b82],
24	false	JJ	O	false	amod	25	SENT_90	[p6l162t24r316b82],
25	associations	NNS	O	association	ccomp	18	SENT_90	[p6l350t27r771b82],
26	that	WDT	O	that	nsubjpass	29	SENT_90	[p6l805t24r949b82],
27	are	VBP	O	be	aux	29	SENT_90	[p6l982t41r1083b82],
28	being	VBG	O	be	auxpass	29	SENT_90	[p6l1115t24r1313b100],
29	inﬂuenced	VBN	O	inﬂuenced	rcmod	25	SENT_90	[p6l1345t24r1723b82],
30	by	IN	O	by	_	0	SENT_90	[p6l1754t24r1842b100],
31	variable	JJ	O	variable	amod	32	SENT_90	[p6l1869t24r2147b82],
32	pharmacokinetics	NNS	O	pharmacokinetic	agent	29	SENT_90	[p6l8t119r658b195],
33	.	.	O	.	_	0	SENT_90	[p6l8t119r658b195],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nsubj	4	SENT_91	[p6l86t215r727b291],
2	has	VBZ	O	have	aux	4	SENT_91	[p6l759t215r875b273],
3	historically	RB	O	historically	advmod	4	SENT_91	[p6l908t215r1306b291],
4	focused	VBN	O	focus	_	0	SENT_91	[p6l1335t215r1604b273],
5	on	IN	O	on	_	0	SENT_91	[p6l1635t232r1727b273],
6	drugmetabolizing	VBG	O	drugmetabolize	prepc_on	4	SENT_91	[p6l1759t215r2147b291, p6l7t310r295b385],
7	enzymes	NNS	O	enzyme	dobj	6	SENT_91	[p6l336t326r639b385],
8	where	WRB	O	where	advmod	15	SENT_91	[p6l680t310r894b367],
9	measurement	NN	O	measurement	nsubj	15	SENT_91	[p6l936t317r1418b367],
10	of	IN	O	of	_	0	SENT_91	[p6l1460t309r1531b367],
11	drug	NN	O	drug	nn	12	SENT_91	[p6l1569t310r1730b385],
12	concentration	NN	O	concentration	prep_of	9	SENT_91	[p6l1771t317r2147b367, p6l8t408r153b462],
13	is	VBZ	O	be	cop	15	SENT_91	[p6l185t408r235b462],
14	the	DT	O	the	det	15	SENT_91	[p6l267t405r380b462],
15	norm	NN	O	norm	rcmod	7	SENT_91	[p6l413t421r624b462],
16	.	.	O	.	_	0	SENT_91	[p6l413t421r624b462],

1	However	RB	O	however	advmod	7	SENT_92	[p6l662t407r987b475],
2	,	,	O	,	_	0	SENT_92	[p6l662t407r987b475],
3	relatively	RB	O	relatively	advmod	6	SENT_92	[p6l1023t405r1352b480],
4	few	JJ	O	few	amod	6	SENT_92	[p6l1381t404r1505b462],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_92	[p6l1534t405r2149b480],
6	studies	NNS	O	study	nsubj	7	SENT_92	[p6l10t500r250b558],
7	focused	VBD	O	focus	dep	11	SENT_92	[p6l276t500r545b558],
8	on	IN	O	on	_	0	SENT_92	[p6l571t517r662b558],
9	drug	NN	O	drug	nn	10	SENT_92	[p6l688t500r849b576],
10	targets	NNS	O	target	prep_on	7	SENT_92	[p6l873t507r1106b576],
11	include	VBP	O	include	_	0	SENT_92	[p6l1131t500r1394b558],
12	pharmacokinetics	NNS	O	pharmacokinetic	dobj	11	SENT_92	[p6l1420t500r2051b576],
13	or	CC	O	or	_	0	SENT_92	[p6l2078t517r2149b558],
14	drug	NN	O	drug	nn	15	SENT_92	[p6l9t593r170b669],
15	exposure	NN	O	exposure	conj_or	12	SENT_92	[p6l200t610r514b669],
16	in	IN	O	in	_	0	SENT_92	[p6l546t596r616b650],
17	their	PRP$	O	they	poss	18	SENT_92	[p6l646t593r814b651],
18	analysis	NN	O	analysis	prep_in	11	SENT_92	[p6l844t585r1301b669],
19	.15	CD	NUMBER	.15	number	20	SENT_92	[p6l844t585r1301b669],
20	‘	CD	NUMBER	‘	num	21	SENT_92	[p6l844t585r1301b669],
21	19	CD	NUMBER	19	dep	11	SENT_92	[p6l844t585r1301b669],
22	This	DT	O	this	det	23	SENT_92	[p6l1331t593r1481b651],
23	failure	NN	O	failure	nsubj	11	SENT_92	[p6l1512t593r1735b651],
24	to	TO	O	to	aux	25	SENT_92	[p6l1766t600r1836b651],
25	account	VB	O	account	infmod	23	SENT_92	[p6l1868t600r2149b651],
26	for	IN	O	for	mark	28	SENT_92	[p6l9t689r107b747],
27	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	28	SENT_92	[p6l149t689r780b765],
28	occurs	VBZ	O	occur	advcl	25	SENT_92	[p6l826t706r1048b747],
29	despite	IN	O	despite	_	0	SENT_92	[p6l1094t689r1341b765],
30	the	DT	O	the	det	31	SENT_92	[p6l1386t689r1498b747],
31	fact	NN	O	fact	prep_despite	28	SENT_92	[p6l1543t689r1671b747],
32	that	IN	O	that	complm	38	SENT_92	[p6l1714t689r1858b747],
33	a	DT	O	a	det	35	SENT_92	[p6l1902t706r1937b747],
34	large	JJ	O	large	amod	35	SENT_92	[p6l1980t689r2147b765],
35	percentage	NN	O	percentage	nsubj	38	SENT_92	[p6l8t791r390b859],
36	of	IN	O	of	_	0	SENT_92	[p6l433t783r505b841],
37	drugs	NNS	O	drug	prep_of	35	SENT_92	[p6l543t783r733b859],
38	have	VBP	O	have	ccomp	28	SENT_92	[p6l775t783r940b841],
39	variability	NN	O	variability	dobj	38	SENT_92	[p6l980t783r1342b859],
40	in	IN	O	in	_	0	SENT_92	[p6l1381t786r1452b840],
41	their	PRP$	O	they	poss	42	SENT_92	[p6l1493t783r1661b841],
42	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	39	SENT_92	[p6l1701t783r2148b859, p6l9t882r232b937],
43	.	.	O	.	_	0	SENT_92	[p6l1701t783r2148b859, p6l9t882r232b937],

1	Our	PRP$	O	we	poss	2	SENT_93	[p6l289t881r424b937],
2	data	NNS	O	datum	nsubj	3	SENT_93	[p6l474t879r623b937],
3	suggest	VBP	O	suggest	_	0	SENT_93	[p6l676t886r930b955],
4	that	IN	O	that	complm	10	SENT_93	[p6l980t879r1124b937],
5	such	PDT	O	such	predet	7	SENT_93	[p6l1176t879r1336b937],
6	an	DT	O	a	det	7	SENT_93	[p6l1389t896r1474b937],
7	omission	NN	O	omission	nsubj	10	SENT_93	[p6l1525t882r1845b937],
8	can	MD	O	can	aux	10	SENT_93	[p6l1896t896r2018b937],
9	be	VB	O	be	cop	10	SENT_93	[p6l2068t879r2148b937],
10	important	JJ	O	important	ccomp	3	SENT_93	[p6l9t976r386b1049],
11	,	,	O	,	_	0	SENT_93	[p6l9t976r386b1049],
12	potentially	RB	O	potentially	advmod	13	SENT_93	[p6l432t973r822b1049],
13	leading	VBG	O	lead	xcomp	3	SENT_93	[p6l861t973r1122b1049],
14	to	TO	O	to	_	0	SENT_93	[p6l1162t981r1232b1031],
15	spurious	JJ	O	spurious	amod	16	SENT_93	[p6l1276t976r1571b1049],
16	associations	NNS	O	association	prep_to	13	SENT_93	[p6l1614t976r2035b1031],
17	or	CC	O	or	_	0	SENT_93	[p6l2078t990r2149b1031],
18	difficulty	NN	O	difficulty	prep_to	13	SENT_93	[p6l9t1068r333b1144],
19	in	IN	O	in	_	0	SENT_93	[p6l388t1072r458b1126],
20	interpreting	VBG	O	interpret	prepc_in	13	SENT_93	[p6l516t1072r943b1144],
21	data	NNS	O	datum	dobj	20	SENT_93	[p6l1000t1069r1166b1126],
22	.	.	O	.	_	0	SENT_93	[p6l1000t1069r1166b1126],

1	Further	RB	O	further	advmod	7	SENT_94	[p6l1229t1069r1502b1139],
2	,	,	O	,	_	0	SENT_94	[p6l1229t1069r1502b1139],
3	it	PRP	O	it	nsubj	7	SENT_94	[p6l1565t1072r1614b1126],
4	is	VBZ	O	be	cop	7	SENT_94	[p6l1671t1072r1721b1126],
5	likely	JJ	O	likely	advmod	7	SENT_94	[p6l1780t1069r1973b1144],
6	not	RB	O	not	neg	7	SENT_94	[p6l2028t1076r2149b1126],
7	sufficient	JJ	O	sufficient	_	0	SENT_94	[p6l10t1164r338b1222],
8	to	TO	O	to	aux	10	SENT_94	[p6l377t1171r447b1222],
9	simply	RB	O	simply	advmod	10	SENT_94	[p6l488t1164r725b1240],
10	determine	VB	O	determine	xcomp	7	SENT_94	[p6l763t1164r1123b1222],
11	genotype	NN	O	genotype	dobj	10	SENT_94	[p6l1163t1171r1489b1240],
12	of	IN	O	of	_	0	SENT_94	[p6l1531t1164r1602b1222],
13	relevant	JJ	O	relevant	amod	15	SENT_94	[p6l1637t1164r1924b1222],
14	drugmetabolizing	VBG	O	drugmetabolize	amod	15	SENT_94	[p6l1963t1164r2148b1240, p6l9t1259r474b1334],
15	enzymes	NNS	O	enzyme	prep_of	11	SENT_94	[p6l520t1275r842b1334],
16	.	.	O	.	_	0	SENT_94	[p6l520t1275r842b1334],

1	In	IN	O	in	_	0	SENT_95	[p6l894t1261r966b1316],
2	this	DT	O	this	det	3	SENT_95	[p6l1013t1259r1143b1316],
3	population	NN	O	population	prep_in	8	SENT_95	[p6l1190t1259r1600b1334],
4	,	,	O	,	_	0	SENT_95	[p6l1190t1259r1600b1334],
5	we	PRP	O	we	nsubj	8	SENT_95	[p6l1650t1275r1746b1316],
6	had	VBD	O	have	aux	8	SENT_95	[p6l1794t1259r1926b1316],
7	separately	RB	O	separately	advmod	8	SENT_95	[p6l1974t1275r2148b1334, p6l9t1354r209b1429],
8	genotyped	VBN	O	genotype	_	0	SENT_95	[p6l246t1354r619b1429],
9	for	IN	O	for	_	0	SENT_95	[p6l659t1353r757b1411],
10	polymorphisms	NNS	O	polymorphism	prep_for	8	SENT_95	[p6l795t1354r1351b1429],
11	in	IN	O	in	_	0	SENT_95	[p6l1392t1357r1462b1411],
12	the	DT	O	the	det	15	SENT_95	[p6l1502t1354r1614b1411],
13	CYPZD6	NN	O	cypzd6	nn	15	SENT_95	[p6l1656t1355r1946b1411],
14	gene	NN	O	gene	nn	15	SENT_95	[p6l1985t1370r2148b1429],
15	(	NN	O	(	prep_in	10	SENT_95	[p6l12t1449r254b1521],
16	which	WDT	O	which	nsubj	17	SENT_95	[p6l12t1449r254b1521],
17	controls	VBZ	O	control	rcmod	15	SENT_95	[p6l315t1449r601b1507],
18	approximately	RB	O	approximately	quantmod	19	SENT_95	[p6l663t1449r1180b1525],
19	70-80	CD	PERCENT	70-80	num	20	SENT_95	[p6l1243t1451r1516b1507],
20	%	NN	PERCENT	%	dobj	17	SENT_95	[p6l1243t1451r1516b1507],
21	of	IN	O	of	_	0	SENT_95	[p6l1577t1449r1648b1507],
22	metoprolol	NN	O	metoprolol	poss	25	SENT_95	[p6l1704t1449r2148b1525],
23	’s	POS	O	’s	_	0	SENT_95	[p6l1704t1449r2148b1525],
24	metabolism	NN	O	metabolism	nn	25	SENT_95	[p6l12t1929r543b2008],
25	)	NN	O	)	prep_of	20	SENT_95	[p6l12t1929r543b2008],
26	?	.	O	?	_	0	SENT_95	[p6l12t1929r543b2008],

1	“	NN	O	“	nsubj	39	SENT_96	[p6l12t1929r543b2008],
2	We	PRP	O	we	nsubj	3	SENT_96	[p6l602t1939r712b1994],
3	found	VBD	O	find	rcmod	1	SENT_96	[p6l774t1936r985b1994],
4	that	IN	O	that	complm	21	SENT_96	[p6l1046t1936r1188b1994],
5	CYPZD6	NN	O	cypzd6	nn	6	SENT_96	[p6l1251t1938r1541b1994],
6	genotypes	NNS	O	genotype	nsubjpass	21	SENT_96	[p6l1600t1944r1957b2012],
7	and	CC	O	and	_	0	SENT_96	[p6l2019t1936r2150b1994],
8	activity	NN	O	activity	nn	9	SENT_96	[p6l13t2035r277b2108],
9	scores	NNS	O	score	nsubjpass	21	SENT_96	[p6l325t2049r531b2090],
10	between	IN	O	between	_	0	SENT_96	[p6l579t2032r876b2090],
11	codon	NN	O	codon	nn	14	SENT_96	[p6l925t2032r1145b2090],
12	49	CD	NUMBER	49	num	14	SENT_96	[p6l1194t2033r1275b2090],
13	genotype	NN	O	genotype	nn	14	SENT_96	[p6l1326t2039r1652b2108],
14	groups	NNS	O	group	prep_between	6	SENT_96	[p6l1702t2049r1937b2108],
15	were	VBD	O	be	auxpass	21	SENT_96	[p6l1985t2049r2148b2090],
16	nearly	RB	O	nearly	advmod	21	SENT_96	[p6l12t2126r234b2202],
17	identical	JJ	O	identical	amod	19	SENT_96	[p6l265t2126r572b2184],
18	(	NN	O	(	nn	19	SENT_96	[p6l611t2126r784b2199],
19	data	NNS	O	datum	pobj	16	SENT_96	[p6l611t2126r784b2199],
20	not	RB	O	not	neg	21	SENT_96	[p6l817t2134r937b2184],
21	shown	VBN	O	show	ccomp	3	SENT_96	[p6l973t2126r1249b2198],
22	)	NN	O	)	dobj	21	SENT_96	[p6l973t2126r1249b2198],
23	,	,	O	,	_	0	SENT_96	[p6l973t2126r1249b2198],
24	indicating	VBG	O	indicate	partmod	22	SENT_96	[p6l1288t2126r1650b2202],
25	that	IN	O	that	complm	35	SENT_96	[p6l1683t2126r1826b2184],
26	CYPZD6	NN	O	cypzd6	nn	28	SENT_96	[p6l1862t2128r2152b2184],
27	genotype	NN	O	genotype	nn	28	SENT_96	[p6l12t2229r338b2297],
28	data	NNS	O	datum	dep	35	SENT_96	[p6l379t2221r528b2279],
29	alone	RB	O	alone	advmod	35	SENT_96	[p6l568t2221r758b2279],
30	(	RB	O	(	amod	35	SENT_96	[p6l803t2221r1107b2293],
31	without	IN	O	without	_	0	SENT_96	[p6l803t2221r1107b2293],
32	plasma	NN	O	plasma	nn	34	SENT_96	[p6l1146t2221r1395b2297],
33	concentration	NN	O	concentration	nn	34	SENT_96	[p6l1434t2224r1934b2279],
34	data	NNS	O	datum	prep_without	30	SENT_96	[p6l1974t2221r2146b2293],
35	)	NN	O	)	dep	24	SENT_96	[p6l1974t2221r2146b2293],
36	would	MD	O	would	aux	39	SENT_96	[p6l11t2317r232b2375],
37	not	RB	O	not	neg	39	SENT_96	[p6l254t2324r375b2375],
38	have	VB	O	have	aux	39	SENT_96	[p6l397t2317r561b2375],
39	allowed	VBN	O	allow	_	0	SENT_96	[p6l586t2317r859b2375],
40	the	DT	O	the	det	42	SENT_96	[p6l881t2317r994b2375],
41	appropriate	JJ	O	appropriate	amod	42	SENT_96	[p6l1017t2320r1423b2393],
42	degree	NN	O	degree	dobj	39	SENT_96	[p6l1448t2317r1674b2393],
43	of	IN	O	of	_	0	SENT_96	[p6l1698t2317r1769b2375],
44	correction	NN	O	correction	prep_of	42	SENT_96	[p6l1788t2320r2149b2375],
45	for	IN	O	for	_	0	SENT_96	[p6l12t2411r111b2469],
46	drug	NN	O	drug	nn	47	SENT_96	[p6l134t2412r295b2487],
47	exposure	NN	O	exposure	prep_for	39	SENT_96	[p6l317t2428r650b2487],
48	.	.	O	.	_	0	SENT_96	[p6l317t2428r650b2487],

1	This	DT	O	this	nsubj	4	SENT_97	[p6l676t2412r825b2469],
2	is	VBZ	O	be	cop	4	SENT_97	[p6l849t2415r900b2469],
3	not	RB	O	not	neg	4	SENT_97	[p6l924t2419r1045b2469],
4	surprising	JJ	O	surprising	_	0	SENT_97	[p6l1069t2415r1418b2487],
5	given	VBN	O	give	prep	4	SENT_97	[p6l1441t2415r1633b2487],
6	that	IN	O	that	complm	9	SENT_97	[p6l1656t2412r1799b2469],
7	there	EX	O	there	expl	9	SENT_97	[p6l1822t2412r2002b2469],
8	can	MD	O	can	aux	9	SENT_97	[p6l2027t2428r2149b2469],
9	be	VB	O	be	pcomp	5	SENT_97	[p6l10t2507r90b2565],
10	up	RB	O	up	advmod	9	SENT_97	[p6l146t2524r236b2583],
11	to	TO	O	to	aux	13	SENT_97	[p6l293t2514r362b2565],
12	30-fold	RB	O	30-fold	advmod	13	SENT_97	[p6l421t2507r671b2565],
13	range	VB	O	range	dep	10	SENT_97	[p6l727t2524r921b2583],
14	in	IN	O	in	_	0	SENT_97	[p6l978t2510r1048b2564],
15	S-metoprolol	NN	O	s-metoprolol	nn	16	SENT_97	[p6l1103t2507r1562b2583],
16	concentrations	NNS	O	concentration	prep_in	13	SENT_97	[p6l1619t2510r2148b2565],
17	among	IN	O	among	_	0	SENT_97	[p6l13t2617r258b2676],
18	CYPZD6-extensive	JJ	O	cypzd6-extensive	amod	19	SENT_97	[p6l292t2602r942b2658],
19	metabolizers	NNS	O	metabolizer	prep_among	13	SENT_97	[p6l977t2593r1512b2658],
20	.2	NN	NUMBER	.2	nn	21	SENT_97	[p6l977t2593r1512b2658],
21	°	NN	O	°	dobj	13	SENT_97	[p6l977t2593r1512b2658],
22	Hence	RB	O	hence	advmod	36	SENT_97	[p6l1546t2603r1784b2670],
23	,	,	O	,	_	0	SENT_97	[p6l1546t2603r1784b2670],
24	failure	NN	O	failure	nsubj	36	SENT_97	[p6l1822t2600r2045b2658],
25	to	TO	O	to	aux	27	SENT_97	[p6l2079t2608r2149b2658],
26	have	VB	O	have	aux	27	SENT_97	[p6l12t2696r177b2753],
27	measured	VBN	O	measure	infmod	24	SENT_97	[p6l221t2696r559b2753],
28	plasma	NN	O	plasma	nn	30	SENT_97	[p6l601t2696r850b2771],
29	drug	NN	O	drug	nn	30	SENT_97	[p6l894t2696r1055b2771],
30	concentrations	NNS	O	concentration	dobj	27	SENT_97	[p6l1098t2699r1627b2753],
31	in	IN	O	in	_	0	SENT_97	[p6l1672t2699r1742b2753],
32	this	DT	O	this	det	33	SENT_97	[p6l1785t2696r1914b2753],
33	study	NN	O	study	prep_in	27	SENT_97	[p6l1960t2696r2152b2771],
34	may	MD	O	may	aux	36	SENT_97	[p6l12t2808r165b2867],
35	have	VB	O	have	aux	36	SENT_97	[p6l192t2791r356b2849],
36	resulted	VBN	O	result	rcmod	21	SENT_97	[p6l387t2791r666b2849],
37	in	IN	O	in	_	0	SENT_97	[p6l695t2794r765b2848],
38	spurious	JJ	O	spurious	amod	39	SENT_97	[p6l796t2794r1090b2867],
39	findings	NNS	O	finding	prep_in	36	SENT_97	[p6l1121t2791r1428b2867],
40	.	.	O	.	_	0	SENT_97	[p6l1121t2791r1428b2867],

1	The	DT	O	the	det	3	SENT_98	[p6l87t2885r219b2943],
2	second	JJ	ORDINAL	second	amod	3	SENT_98	[p6l246t2885r489b2943],
3	issue	NN	O	issue	nsubj	7	SENT_98	[p6l514t2888r680b2943],
4	our	PRP$	O	we	poss	5	SENT_98	[p6l706t2902r824b2943],
5	data	NNS	O	datum	nsubj	6	SENT_98	[p6l848t2885r997b2943],
6	raises	VBZ	O	raise	rcmod	3	SENT_98	[p6l1021t2888r1209b2943],
7	is	VBZ	O	be	_	0	SENT_98	[p6l1234t2888r1284b2943],
8	that	IN	O	that	complm	28	SENT_98	[p6l1309t2885r1452b2943],
9	a	DT	O	a	det	11	SENT_98	[p6l1478t2902r1512b2943],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_98	[p6l1536t2885r2150b2961],
11	association	NN	O	association	nsubj	28	SENT_98	[p6l13t2984r403b3039],
12	with	IN	O	with	_	0	SENT_98	[p6l425t2981r586b3039],
13	one	CD	NUMBER	one	num	14	SENT_98	[p6l611t2998r739b3039],
14	phenotype	NN	O	phenotype	prep_with	11	SENT_98	[p6l763t2981r1144b3057],
15	(	CD	NUMBER	(	num	16	SENT_98	[p6l1172t2981r1248b3053],
16	e.	NN	O	e.	nsubjpass	24	SENT_98	[p6l1172t2981r1248b3053],
17	g.	VBN	O	g.	partmod	16	SENT_98	[p6l1256t2998r1312b3057],
18	blood	NN	O	blood	nn	20	SENT_98	[p6l1338t2981r1542b3039],
19	pressure	NN	O	pressure	nn	20	SENT_98	[p6l1564t2981r1875b3057],
20	)	NN	O	)	dobj	17	SENT_98	[p6l1564t2981r1875b3057],
21	can	MD	O	can	aux	24	SENT_98	[p6l1903t2988r2150b3039],
22	not	RB	O	not	neg	24	SENT_98	[p6l1903t2988r2150b3039],
23	be	VB	O	be	auxpass	24	SENT_98	[p6l10t3075r90b3133],
24	extrapolated	VBN	O	extrapolate	rcmod	14	SENT_98	[p6l134t3075r576b3151],
25	across	IN	O	across	_	0	SENT_98	[p6l620t3092r827b3133],
26	other	JJ	O	other	amod	27	SENT_98	[p6l871t3075r1059b3133],
27	phenotypes	NNS	O	phenotype	prep_across	24	SENT_98	[p6l1100t3076r1512b3151],
28	(	VBP	O	(	ccomp	7	SENT_98	[p6l1558t3076r1698b3151],
29	e.g.	FW	O	e.g.	dobj	28	SENT_98	[p6l1558t3076r1698b3151],
30	heart	NN	O	heart	nn	31	SENT_98	[p6l1745t3075r1927b3133],
31	rate	NN	O	rate	dep	29	SENT_98	[p6l1969t3076r2144b3148],
32	)	RB	O	)	advmod	28	SENT_98	[p6l1969t3076r2144b3148],
33	,	,	O	,	_	0	SENT_98	[p6l1969t3076r2144b3148],
34	even	RB	O	even	advmod	41	SENT_98	[p6l13t3187r177b3228],
35	when	WRB	O	when	advmod	41	SENT_98	[p6l205t3170r402b3228],
36	the	DT	O	the	det	38	SENT_98	[p6l431t3170r543b3228],
37	same	JJ	O	same	amod	38	SENT_98	[p6l575t3187r749b3228],
38	drug	NN	O	drug	nsubjpass	41	SENT_98	[p6l780t3170r941b3246],
39	is	VBZ	O	be	aux	41	SENT_98	[p6l969t3173r1019b3228],
40	being	VBG	O	be	auxpass	41	SENT_98	[p6l1048t3170r1246b3246],
41	investigated	VBN	O	investigate	dep	28	SENT_98	[p6l1273t3171r1701b3246],
42	in	IN	O	in	_	0	SENT_98	[p6l1731t3173r1801b3227],
43	the	DT	O	the	det	45	SENT_98	[p6l1830t3170r1942b3228],
44	same	JJ	O	same	amod	45	SENT_98	[p6l1974t3187r2148b3228],
45	individuals	NNS	O	individual	prep_in	41	SENT_98	[p6l12t3266r424b3324],
46	.	.	O	.	_	0	SENT_98	[p6l12t3266r424b3324],

1	While	IN	O	while	mark	7	SENT_99	[p6l469t3266r682b3324],
2	we	PRP	O	we	nsubj	7	SENT_99	[p6l724t3283r820b3324],
3	and	CC	O	and	_	0	SENT_99	[p6l864t3266r996b3324],
4	others	NNS	O	other	conj_and	2	SENT_99	[p6l1038t3266r1256b3324],
5	have	VBP	O	have	aux	7	SENT_99	[p6l1299t3266r1464b3324],
6	previously	RB	DATE	previously	advmod	7	SENT_99	[p6l1507t3266r1876b3342],
7	shown	VBN	O	show	csubjpass	13	SENT_99	[p6l1917t3266r2149b3324],
8	ADRB1	NN	O	adrb1	nn	9	SENT_99	[p6l7t3363r251b3418],
9	codon	NN	O	codon	dobj	7	SENT_99	[p6l299t3361r519b3418],
10	389	CD	NUMBER	389	num	9	SENT_99	[p6l561t3362r684b3418],
11	is	VBZ	O	be	auxpass	13	SENT_99	[p6l727t3364r778b3418],
12	significantly	RB	O	significantly	advmod	13	SENT_99	[p6l820t3360r1259b3436],
13	associated	VBN	O	associate	_	0	SENT_99	[p6l1298t3361r1654b3418],
14	with	IN	O	with	_	0	SENT_99	[p6l1692t3361r1853b3418],
15	antihypertensive	JJ	O	antihypertensive	amod	18	SENT_99	[p6l1894t3361r2148b3436, p6l12t3457r374b3530],
16	and	CC	O	and	_	0	SENT_99	[p6l398t3454r528b3512],
17	other	JJ	O	other	amod	18	SENT_99	[p6l550t3454r739b3512],
18	responses	NNS	O	response	prep_with	13	SENT_99	[p6l760t3471r1096b3530],
19	to	TO	O	to	aux	20	SENT_99	[p6l1119t3461r1188b3512],
20	[	VB	O	[	xcomp	13	SENT_99	[p6l1211t3447r1683b3527],
21	3-blockade3	JJ	O	3-blockade3	amod	22	SENT_99	[p6l1211t3447r1683b3527],
22	‘	NN	O	‘	dobj	20	SENT_99	[p6l1211t3447r1683b3527],
23	5	CD	NUMBER	5	num	22	SENT_99	[p6l1211t3447r1683b3527],
24	we	PRP	O	we	nsubj	25	SENT_99	[p6l1706t3471r1802b3512],
25	found	VBD	O	find	rcmod	22	SENT_99	[p6l1825t3454r2036b3512],
26	no	DT	O	no	det	28	SENT_99	[p6l2058t3471r2149b3512],
27	such	JJ	O	such	amod	28	SENT_99	[p6l14t3550r174b3608],
28	association	NN	O	association	dobj	25	SENT_99	[p6l223t3553r613b3608],
29	with	IN	O	with	_	0	SENT_99	[p6l658t3550r820b3608],
30	negative	JJ	O	negative	amod	32	SENT_99	[p6l867t3553r1165b3626],
31	chronotropic	JJ	O	chronotropic	amod	32	SENT_99	[p6l1213t3550r1678b3626],
32	response	NN	O	response	prep_with	25	SENT_99	[p6l1726t3567r2030b3626],
33	to	TO	O	to	_	0	SENT_99	[p6l2079t3557r2149b3608],
34	metoprolol	NN	O	metoprolol	prep_to	25	SENT_99	[p6l12t3645r407b3721],
35	in	IN	O	in	_	0	SENT_99	[p6l449t3648r519b3702],
36	the	DT	O	the	det	38	SENT_99	[p6l560t3645r673b3703],
37	same	JJ	O	same	amod	38	SENT_99	[p6l717t3662r891b3703],
38	patients	NNS	O	patient	prep_in	34	SENT_99	[p6l933t3648r1233b3721],
39	.	.	O	.	_	0	SENT_99	[p6l933t3648r1233b3721],

1	This	DT	O	this	det	2	SENT_100	[p6l1277t3645r1426b3703],
2	lack	NN	O	lack	nsubjpass	12	SENT_100	[p6l1469t3645r1610b3703],
3	of	IN	O	of	_	0	SENT_100	[p6l1649t3645r1721b3703],
4	association	NN	O	association	prep_of	2	SENT_100	[p6l1759t3648r2149b3703],
5	with	IN	O	with	_	0	SENT_100	[p6l11t3740r172b3798],
6	heart	NN	O	heart	nn	8	SENT_100	[p6l223t3740r405b3798],
7	rate	NN	O	rate	nn	8	SENT_100	[p6l456t3747r587b3798],
8	response	NN	O	response	prep_with	4	SENT_100	[p6l639t3757r944b3816],
9	has	VBZ	O	have	aux	12	SENT_100	[p6l996t3740r1112b3798],
10	also	RB	O	also	advmod	12	SENT_100	[p6l1164t3740r1298b3798],
11	been	VBN	O	be	auxpass	12	SENT_100	[p6l1348t3740r1518b3798],
12	documented	VBN	O	document	_	0	SENT_100	[p6l1570t3740r2015b3798],
13	by	IN	O	by	_	0	SENT_100	[p6l2065t3740r2152b3816],
14	others	NNS	O	other	agent	12	SENT_100	[p7l13t11r430b75],
15	.4	CD	NUMBER	.4	number	16	SENT_100	[p7l13t11r430b75],
16	‘	CD	NUMBER	‘	num	18	SENT_100	[p7l13t11r430b75],
17	6	CD	NUMBER	6	number	18	SENT_100	[p7l13t11r430b75],
18	'12	CD	NUMBER	'12	dep	12	SENT_100	[p7l13t11r430b75],

1	We	PRP	O	we	nsubj	2	SENT_101	[p7l88t116r197b172],
2	believe	VBP	O	believe	_	0	SENT_101	[p7l223t114r470b172],
3	that	IN	O	that	complm	7	SENT_101	[p7l497t114r640b172],
4	this	DT	O	this	det	5	SENT_101	[p7l667t114r796b172],
5	finding	NN	O	finding	nsubjpass	7	SENT_101	[p7l824t114r1084b190],
6	is	VBZ	O	be	auxpass	7	SENT_101	[p7l1109t117r1160b172],
7	explained	VBN	O	explain	ccomp	2	SENT_101	[p7l1188t114r1534b190],
8	by	IN	O	by	_	0	SENT_101	[p7l1558t114r1646b190],
9	differences	NNS	O	difference	agent	7	SENT_101	[p7l1671t114r2051b172],
10	in	IN	O	in	_	0	SENT_101	[p7l2079t117r2149b171],
11	mechanisms	NNS	O	mechanism	prep_in	9	SENT_101	[p7l12t208r453b266],
12	of	IN	O	of	_	0	SENT_101	[p7l478t208r549b266],
13	metoprolol	NN	O	metoprolol	prep_of	11	SENT_101	[p7l567t208r961b284],
14	between	IN	O	between	_	0	SENT_101	[p7l982t208r1279b266],
15	phenotypes	NNS	O	phenotype	prep_between	13	SENT_101	[p7l1301t208r1713b284],
16	studied	VBN	O	study	partmod	15	SENT_101	[p7l1738t208r2012b266],
17	.	.	O	.	_	0	SENT_101	[p7l1738t208r2012b266],

1	For	IN	O	for	_	0	SENT_102	[p7l2039t211r2150b266],
2	instance	NN	O	instance	prep_for	10	SENT_102	[p7l12t306r324b374],
3	,	,	O	,	_	0	SENT_102	[p7l12t306r324b374],
4	the	DT	O	the	det	6	SENT_102	[p7l383t303r495b361],
5	antihypertensive	JJ	O	antihypertensive	amod	6	SENT_102	[p7l551t303r1145b379],
6	effects	NNS	O	effect	nsubjpass	10	SENT_102	[p7l1201t303r1422b361],
7	of	IN	O	of	_	0	SENT_102	[p7l1477t303r1548b361],
8	metoprolol	NN	O	metoprolol	prep_of	6	SENT_102	[p7l1598t303r1992b379],
9	are	VBP	O	be	auxpass	10	SENT_102	[p7l2048t320r2149b361],
10	thought	VBN	O	think	_	0	SENT_102	[p7l12t399r300b475],
11	to	TO	O	to	aux	14	SENT_102	[p7l359t406r428b457],
12	be	VB	O	be	cop	14	SENT_102	[p7l486t399r566b457],
13	largely	RB	O	largely	advmod	14	SENT_102	[p7l626t399r863b475],
14	due	JJ	O	due	xcomp	10	SENT_102	[p7l921t399r1046b457],
15	to	TO	O	to	_	0	SENT_102	[p7l1106t406r1176b457],
16	reduction	NN	O	reduction	prep_to	14	SENT_102	[p7l1236t399r1579b457],
17	in	IN	O	in	_	0	SENT_102	[p7l1638t402r1708b456],
18	[	CD	NUMBER	[	num	21	SENT_102	[p7l1767t401r2149b475, p7l12t493r342b551],
19	3receptormediated	JJ	O	3receptormediated	amod	21	SENT_102	[p7l1767t401r2149b475, p7l12t493r342b551],
20	renin	NN	O	renin	nn	21	SENT_102	[p7l378t496r566b551],
21	release	NN	O	release	prep_in	16	SENT_102	[p7l602t493r854b563],
22	,	,	O	,	_	0	SENT_102	[p7l602t493r854b563],
23	while	IN	O	while	mark	21	SENT_102	[p7l893t493r1087b551],
24	the	DT	O	the	det	25	SENT_102	[p7l1124t493r1236b551],
25	effects	NNS	O	effect	nsubj	21	SENT_102	[p7l1274t492r1495b551],
26	on	IN	O	on	_	0	SENT_102	[p7l1533t509r1624b550],
27	heart	NN	O	heart	nn	28	SENT_102	[p7l1661t493r1842b551],
28	rate	NN	O	rate	prep_on	25	SENT_102	[p7l1879t500r2009b551],
29	are	VBP	O	be	cop	21	SENT_102	[p7l2047t509r2149b551],
30	likely	JJ	O	likely	amod	21	SENT_102	[p7l12t589r205b664],
31	due	JJ	O	due	_	0	SENT_102	[p7l248t589r374b646],
32	to	TO	O	to	_	0	SENT_102	[p7l420t596r490b646],
33	direct	JJ	O	direct	amod	34	SENT_102	[p7l536t589r736b646],
34	inhibition	NN	O	inhibition	prep_due_to	21	SENT_102	[p7l781t589r1141b646],
35	of	IN	O	of	_	0	SENT_102	[p7l1187t588r1258b646],
36	myocardial	JJ	O	myocardial	amod	37	SENT_102	[p7l1299t589r1694b664],
37	ﬁ	NN	O	ﬁ	prep_of	34	SENT_102	[p7l1739t590r2144b664],
38	.	.	O	.	_	0	SENT_102	[p7l1739t590r2144b664],

1	—	NN	O	—	_	0	SENT_103	[p7l1739t590r2144b664],
2	.	.	O	.	_	0	SENT_103	[p7l1739t590r2144b664],

1	receptors	NNS	O	receptor	_	0	SENT_104	[p7l1739t590r2144b664],
2	,	,	O	,	_	0	SENT_104	[p7l1739t590r2144b664],
3	particularly	RB	O	particularly	advmod	4	SENT_104	[p7l12t684r421b760],
4	in	IN	O	in	dep	1	SENT_104	[p7l448t687r518b741],
5	the	DT	O	the	det	7	SENT_104	[p7l547t684r660b742],
6	sino-atrial	JJ	O	sino-atrial	amod	7	SENT_104	[p7l692t684r1046b742],
7	node	NN	O	node	pobj	4	SENT_104	[p7l1075t684r1270b742],
8	.	.	O	.	_	0	SENT_104	[p7l1075t684r1270b742],

1	In	IN	O	in	_	0	SENT_105	[p7l90t781r162b836],
2	summary	NN	O	summary	prep_in	32	SENT_105	[p7l212t796r554b855],
3	,	,	O	,	_	0	SENT_105	[p7l212t796r554b855],
4	our	PRP$	O	we	poss	5	SENT_105	[p7l607t796r726b837],
5	data	NNS	O	datum	nsubj	6	SENT_105	[p7l774t779r923b837],
6	suggest	VBP	O	suggest	parataxis	32	SENT_105	[p7l973t786r1226b855],
7	no	DT	O	no	det	8	SENT_105	[p7l1275t796r1365b837],
8	association	NN	O	association	dobj	6	SENT_105	[p7l1416t782r1806b837],
9	between	IN	O	between	_	0	SENT_105	[p7l1853t779r2150b837],
10	ADRB1	NN	O	adrb1	nn	11	SENT_105	[p7l7t876r251b931],
11	genotype	NN	O	genotype	prep_between	8	SENT_105	[p7l294t881r620b950],
12	and	CC	O	and	_	0	SENT_105	[p7l658t874r789b932],
13	heart	NN	O	heart	nn	15	SENT_105	[p7l825t874r1007b932],
14	rate	NN	O	rate	nn	15	SENT_105	[p7l1044t881r1174b932],
15	response	NN	O	response	conj_and	11	SENT_105	[p7l1211t891r1516b950],
16	to	TO	O	to	_	0	SENT_105	[p7l1553t881r1623b932],
17	metoprolol	NN	O	metoprolol	prep_to	11	SENT_105	[p7l1661t874r2073b950],
18	,	,	O	,	_	0	SENT_105	[p7l1661t874r2073b950],
19	a	DT	O	a	det	20	SENT_105	[p7l2115t891r2150b932],
20	finding	NN	O	finding	nsubjpass	32	SENT_105	[p7l12t968r272b1044],
21	that	WDT	O	that	nsubjpass	25	SENT_105	[p7l300t968r443b1026],
22	may	MD	O	may	aux	25	SENT_105	[p7l472t985r624b1044],
23	have	VB	O	have	aux	25	SENT_105	[p7l651t968r816b1026],
24	been	VBN	O	be	auxpass	25	SENT_105	[p7l844t968r1014b1026],
25	misinterpreted	VBN	O	misinterpret	rcmod	20	SENT_105	[p7l1043t968r1564b1044],
26	had	VBD	O	have	aux	32	SENT_105	[p7l1593t968r1725b1026],
27	metoprolol	NN	O	metoprolol	nn	29	SENT_105	[p7l1754t968r2149b1044],
28	plasma	NN	O	plasma	nn	29	SENT_105	[p7l12t1064r260b1140],
29	concentrations	NNS	O	concentration	dobj	32	SENT_105	[p7l294t1067r824b1122],
30	not	RB	O	not	neg	32	SENT_105	[p7l858t1071r979b1122],
31	been	VBN	O	be	auxpass	32	SENT_105	[p7l1010t1064r1180b1122],
32	measured	VBN	O	measure	_	0	SENT_105	[p7l1213t1064r1569b1122],
33	.	.	O	.	_	0	SENT_105	[p7l1213t1064r1569b1122],

1	This	DT	O	this	nsubj	2	SENT_106	[p7l1605t1064r1754b1122],
2	highlights	VBZ	O	highlight	_	0	SENT_106	[p7l1789t1064r2148b1140],
3	the	DT	O	the	det	4	SENT_106	[p7l12t1158r125b1216],
4	importance	NN	O	importance	dobj	2	SENT_106	[p7l153t1161r559b1234],
5	of	IN	O	of	_	0	SENT_106	[p7l589t1158r660b1216],
6	being	VBG	O	be	cop	7	SENT_106	[p7l682t1158r880b1234],
7	able	JJ	O	able	prepc_of	4	SENT_106	[p7l907t1158r1047b1216],
8	to	TO	O	to	aux	9	SENT_106	[p7l1076t1166r1145b1216],
9	control	VB	O	control	xcomp	7	SENT_106	[p7l1175t1158r1430b1216],
10	for	IN	O	for	_	0	SENT_106	[p7l1458t1158r1557b1216],
11	drug	NN	O	drug	nn	12	SENT_106	[p7l1584t1158r1745b1234],
12	concentration	NN	O	concentration	prep_for	9	SENT_106	[p7l1772t1166r2148b1216, p7l12t1256r157b1311],
13	in	IN	O	in	_	0	SENT_106	[p7l190t1256r260b1310],
14	drug	NN	O	drug	nn	17	SENT_106	[p7l293t1253r454b1329],
15	target	NN	O	target	nn	17	SENT_106	[p7l486t1261r688b1329],
16	pharmacogenetic	JJ	O	pharmacogenetic	amod	17	SENT_106	[p7l720t1254r1334b1329],
17	studies	NNS	O	study	prep_in	12	SENT_106	[p7l1368t1253r1627b1311],
18	.	.	O	.	_	0	SENT_106	[p7l1368t1253r1627b1311],

1	Our	PRP$	O	we	poss	2	SENT_107	[p7l1666t1255r1800b1311],
2	data	NNS	O	datum	nsubj	4	SENT_107	[p7l1833t1253r1981b1311],
3	also	RB	O	also	advmod	4	SENT_107	[p7l2015t1253r2149b1311],
4	highlight	VBP	O	highlight	_	0	SENT_107	[p7l12t1349r342b1425],
5	the	DT	O	the	det	6	SENT_107	[p7l386t1349r499b1407],
6	fact	NN	O	fact	dobj	4	SENT_107	[p7l544t1349r671b1407],
7	that	IN	O	that	dep	11	SENT_107	[p7l716t1349r859b1407],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	9	SENT_107	[p7l902t1349r1516b1425],
9	associations	NNS	O	association	nsubj	11	SENT_107	[p7l1561t1352r1982b1407],
10	can	MD	O	can	aux	11	SENT_107	[p7l2027t1366r2149b1407],
11	vary	VB	O	vary	dep	4	SENT_107	[p7l10t1462r165b1521],
12	across	IN	O	across	_	0	SENT_107	[p7l198t1462r406b1503],
13	phenotypes	NNS	O	phenotype	prep_across	11	SENT_107	[p7l441t1446r872b1521],
14	,	,	O	,	_	0	SENT_107	[p7l441t1446r872b1521],
15	even	RB	O	even	advmod	11	SENT_107	[p7l912t1462r1076b1503],
16	when	WRB	O	when	advmod	23	SENT_107	[p7l1109t1446r1307b1503],
17	the	DT	O	the	det	19	SENT_107	[p7l1341t1446r1453b1503],
18	same	JJ	O	same	amod	19	SENT_107	[p7l1491t1462r1665b1503],
19	patients	NNS	O	patient	nsubjpass	23	SENT_107	[p7l1700t1449r1982b1521],
20	and	CC	O	and	_	0	SENT_107	[p7l2019t1446r2150b1503],
21	drug	NN	O	drug	conj_and	19	SENT_107	[p7l13t1541r174b1616],
22	are	VBP	O	be	auxpass	23	SENT_107	[p7l203t1557r304b1598],
23	studied	VBN	O	study	dep	11	SENT_107	[p7l335t1541r609b1598],
24	.	.	O	.	_	0	SENT_107	[p7l335t1541r609b1598],

1	Materials	NNPS	O	Materials	_	0	SENT_108	[p7l15t1771r371b1828],
2	and	CC	O	and	_	0	SENT_108	[p7l402t1771r542b1828],
3	methods	NNS	O	method	conj_and	1	SENT_108	[p7l576t1771r910b1828],

1	Patients	NNS	O	patient	tmod	36	SENT_109	[p7l16t1958r267b2014],
2	The	DT	O	the	det	3	SENT_109	[p7l11t2052r143b2109],
3	population	NN	O	population	nsubjpass	7	SENT_109	[p7l181t2052r573b2127],
4	studied	VBN	O	study	partmod	3	SENT_109	[p7l614t2051r870b2109],
5	has	VBZ	O	have	aux	7	SENT_109	[p7l907t2051r1022b2109],
6	been	VBN	O	be	auxpass	7	SENT_109	[p7l1059t2051r1228b2109],
7	described	VBN	O	describe	rcmod	1	SENT_109	[p7l1267t2051r1598b2109],
8	elsewhere	RB	O	elsewhere	advmod	7	SENT_109	[p7l1637t2051r1979b2109],
9	and	CC	O	and	_	0	SENT_109	[p7l2019t2051r2150b2109],
10	the	DT	O	the	det	12	SENT_109	[p7l12t2146r125b2204],
11	pharmacogenetic	JJ	O	pharmacogenetic	amod	12	SENT_109	[p7l168t2146r782b2222],
12	association	NN	O	association	nsubjpass	30	SENT_109	[p7l826t2149r1216b2204],
13	with	IN	O	with	_	0	SENT_109	[p7l1257t2147r1419b2204],
14	the	DT	O	the	det	17	SENT_109	[p7l1462t2146r1574b2204],
15	blood	NN	O	blood	nn	17	SENT_109	[p7l1616t2146r1820b2204],
16	pressure	NN	O	pressure	nn	17	SENT_109	[p7l1862t2163r2148b2222],
17	response	NN	O	response	prep_with	12	SENT_109	[p7l12t2259r317b2318],
18	to	TO	O	to	_	0	SENT_109	[p7l350t2249r420b2300],
19	metoprolol	NN	O	metoprolol	prep_to	17	SENT_109	[p7l452t2242r847b2318],
20	in	IN	O	in	_	0	SENT_109	[p7l879t2245r950b2299],
21	the	DT	O	the	det	23	SENT_109	[p7l981t2242r1093b2300],
22	first	JJ	ORDINAL	first	amod	23	SENT_109	[p7l1126t2242r1262b2300],
23	40	CD	NUMBER	40	prep_in	19	SENT_109	[p7l1294t2244r1377b2300],
24	of	IN	O	of	_	0	SENT_109	[p7l1410t2242r1481b2300],
25	these	DT	O	these	det	26	SENT_109	[p7l1508t2242r1690b2300],
26	subjects	NNS	O	subject	prep_of	23	SENT_109	[p7l1725t2242r2001b2318],
27	has	VBZ	O	have	aux	30	SENT_109	[p7l2033t2242r2149b2300],
28	been	VBN	O	be	auxpass	30	SENT_109	[p7l10t2335r180b2392],
29	previously	RB	DATE	previously	advmod	30	SENT_109	[p7l245t2335r613b2410],
30	reported	VBN	O	report	rcmod	1	SENT_109	[p7l677t2327r1028b2410],
31	.3	NN	NUMBER	.3	nn	32	SENT_109	[p7l677t2327r1028b2410],
32	Brieﬂy	NN	O	brieﬂy	dobj	30	SENT_109	[p7l1096t2334r1334b2410],
33	,	,	O	,	_	0	SENT_109	[p7l1096t2334r1334b2410],
34	the	DT	O	the	det	35	SENT_109	[p7l1405t2335r1517b2392],
35	study	NN	O	study	nsubj	36	SENT_109	[p7l1585t2335r1778b2410],
36	included	VBD	O	include	_	0	SENT_109	[p7l1841t2335r2150b2392],
37	hypertensive	JJ	O	hypertensive	amod	38	SENT_109	[p7l12t2431r466b2506],
38	men	NNS	O	man	dobj	36	SENT_109	[p7l500t2447r657b2488],
39	and	CC	O	and	_	0	SENT_109	[p7l690t2431r822b2488],
40	women	NNS	O	woman	dobj	36	SENT_109	[p7l852t2447r1116b2488],
41	between	IN	O	between	_	0	SENT_109	[p7l1147t2431r1444b2488],
42	the	DT	O	the	det	43	SENT_109	[p7l1476t2431r1589b2488],
43	ages	NNS	O	age	prep_between	36	SENT_109	[p7l1623t2447r1767b2506],
44	of	IN	O	of	_	0	SENT_109	[p7l1802t2430r1873b2488],
45	35	CD	NUMBER	35	nn	48	SENT_109	[p7l1903t2432r1981b2488],
46	and	CC	O	and	_	0	SENT_109	[p7l2019t2431r2149b2488],
47	65	CD	DURATION	65	nn	48	SENT_109	[p7l15t2528r92b2584],
48	years	NNS	NUMBER	year	prep_of	43	SENT_109	[p7l127t2543r323b2602],
49	.	.	O	.	_	0	SENT_109	[p7l127t2543r323b2602],

1	Hypertension	NN	O	hypertension	nsubjpass	3	SENT_110	[p7l362t2529r842b2602],
2	was	VBD	O	be	auxpass	3	SENT_110	[p7l874t2543r1002b2584],
3	defined	VBN	O	define	_	0	SENT_110	[p7l1036t2526r1302b2584],
4	as	IN	O	as	_	0	SENT_110	[p7l1335t2543r1400b2584],
5	an	DT	O	a	det	7	SENT_110	[p7l1435t2543r1520b2584],
6	untreated	JJ	O	untreated	amod	7	SENT_110	[p7l1551t2526r1895b2584],
7	(	NN	O	(	prep_as	3	SENT_110	[p7l1931t2526r2053b2598],
8	for	IN	O	for	_	0	SENT_110	[p7l1931t2526r2053b2598],
9	at	IN	DURATION	at	quantmod	11	SENT_110	[p7l2086t2533r2150b2584],
10	least	JJS	DURATION	least	mwe	9	SENT_110	[p7l12t2621r170b2679],
11	2	CD	DURATION	2	num	12	SENT_110	[p7l211t2622r250b2678],
12	weeks	NNS	NUMBER	week	prep_for	7	SENT_110	[p7l288t2621r520b2693],
13	)	CD	NUMBER	)	num	14	SENT_110	[p7l288t2621r520b2693],
14	DBP	NN	ORGANIZATION	dbp	npadvmod	15	SENT_110	[p7l564t2623r710b2678],
15	>	JJR	O	>	amod	19	SENT_110	[p7l761t2622r905b2686],
16	95	CD	NUMBER	95	amod	19	SENT_110	[p7l761t2622r905b2686],
17	and	CC	O	and	_	0	SENT_110	[p7l949t2621r1081b2679],
18	<	JJR	O	<	conj_and	16	SENT_110	[p7l1132t2623r1584b2697],
19	115mmHg	NN	O	115mmhg	dep	12	SENT_110	[p7l1132t2623r1584b2697],
20	after	IN	O	after	_	0	SENT_110	[p7l1625t2621r1783b2679],
21	sitting	VBG	O	sit	prepc_after	3	SENT_110	[p7l1823t2624r2047b2697],
22	at	IN	DURATION	at	quantmod	24	SENT_110	[p7l2086t2628r2150b2679],
23	least	JJS	DURATION	least	mwe	22	SENT_110	[p7l12t2716r170b2774],
24	5	CD	DURATION	5	num	25	SENT_110	[p7l200t2719r234b2774],
25	min	NN	DURATION	min	dobj	21	SENT_110	[p7l255t2719r398b2773],
26	on	IN	O	on	_	0	SENT_110	[p7l428t2733r519b2774],
27	two	CD	NUMBER	two	num	29	SENT_110	[p7l548t2723r678b2774],
28	clinic	NN	O	clinic	nn	29	SENT_110	[p7l709t2716r902b2774],
29	visits	NNS	O	visit	prep_on	25	SENT_110	[p7l928t2719r1106b2774],
30	separated	VBN	O	separate	partmod	29	SENT_110	[p7l1139t2716r1470b2792],
31	by	IN	O	by	_	0	SENT_110	[p7l1497t2716r1584b2792],
32	at	IN	O	at	quantmod	34	SENT_110	[p7l1612t2723r1675b2774],
33	least	JJS	O	least	mwe	32	SENT_110	[p7l1704t2716r1861b2774],
34	3	CD	DURATION	3	num	35	SENT_110	[p7l1892t2718r1927b2774],
35	days	NNS	NUMBER	day	agent	30	SENT_110	[p7l1960t2716r2132b2792],
36	.	.	O	.	_	0	SENT_110	[p7l1960t2716r2132b2792],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_111	[p7l90t2813r367b2868],
2	were	VBD	O	be	auxpass	3	SENT_111	[p7l408t2827r571b2868],
3	excluded	VBN	O	exclude	_	0	SENT_111	[p7l614t2810r930b2868],
4	if	IN	O	if	mark	6	SENT_111	[p7l972t2810r1022b2867],
5	they	PRP	O	they	nsubj	17	SENT_111	[p7l1059t2810r1218b2886],
6	had	VBD	O	have	advcl	3	SENT_111	[p7l1256t2810r1388b2868],
7	concomitant	JJ	O	concomitant	amod	8	SENT_111	[p7l1430t2813r1884b2868],
8	conditions	NNS	O	condition	dobj	6	SENT_111	[p7l1926t2810r2149b2868, p7l12t2909r187b2964],
9	that	WDT	O	that	nsubjpass	12	SENT_111	[p7l214t2906r357b2964],
10	were	VBD	O	be	aux	12	SENT_111	[p7l381t2923r544b2964],
11	being	VBG	O	be	auxpass	12	SENT_111	[p7l569t2906r767b2982],
12	treated	VBN	O	treat	rcmod	8	SENT_111	[p7l792t2906r1037b2964],
13	with	IN	O	with	_	0	SENT_111	[p7l1061t2906r1222b2964],
14	antihypertensive	JJ	O	antihypertensive	amod	15	SENT_111	[p7l1249t2906r1844b2982],
15	medications	NNS	O	medication	prep_with	12	SENT_111	[p7l1871t2906r2149b2964, p7l12t3003r187b3058],
16	or	CC	O	or	_	0	SENT_111	[p7l214t3017r285b3058],
17	had	VBD	O	have	conj_or	6	SENT_111	[p7l310t3000r442b3058],
18	other	JJ	O	other	amod	19	SENT_111	[p7l467t3000r656b3058],
19	conditions	NNS	O	condition	dobj	17	SENT_111	[p7l680t3000r1057b3058],
20	that	WDT	O	that	nsubj	22	SENT_111	[p7l1083t3001r1226b3058],
21	would	MD	O	would	aux	22	SENT_111	[p7l1249t3000r1471b3058],
22	preclude	VB	O	preclude	rcmod	19	SENT_111	[p7l1496t3000r1798b3076],
23	/	:	O	/	punct	25	SENT_111	[p7l1824t3000r2150b3073],
24	3-blocker	NN	O	3-blocker	nn	25	SENT_111	[p7l1824t3000r2150b3073],
25	use	NN	O	use	dep	19	SENT_111	[p7l11t3087r209b3151],
26	.	.	O	.	_	0	SENT_111	[p7l11t3087r209b3151],

1	“	NN	O	“	nsubj	4	SENT_112	[p7l11t3087r209b3151],
2	All	DT	O	all	det	3	SENT_112	[p7l245t3094r342b3151],
3	subjects	NNS	O	subject	dep	1	SENT_112	[p7l377t3094r653b3169],
4	provided	VBD	O	provide	_	0	SENT_112	[p7l686t3094r1001b3169],
5	written	VBN	O	write	amod	7	SENT_112	[p7l1032t3097r1290b3151],
6	informed	VBN	O	inform	amod	7	SENT_112	[p7l1324t3093r1652b3151],
7	consent	NN	O	consent	dobj	4	SENT_112	[p7l1686t3101r1980b3151],
8	.	.	O	.	_	0	SENT_112	[p7l1686t3101r1980b3151],

1	The	DT	O	the	det	2	SENT_113	[p7l2016t3094r2148b3151],
2	protocol	NN	O	protocol	nsubjpass	4	SENT_113	[p7l12t3190r310b3266],
3	was	VBD	O	be	auxpass	4	SENT_113	[p7l340t3207r468b3248],
4	approved	VBN	O	approve	_	0	SENT_113	[p7l501t3190r829b3266],
5	by	IN	O	by	_	0	SENT_113	[p7l858t3190r946b3266],
6	the	DT	O	the	det	7	SENT_113	[p7l975t3190r1087b3248],
7	University	NNP	ORGANIZATION	University	agent	4	SENT_113	[p7l1119t3192r1488b3266],
8	of	IN	ORGANIZATION	of	_	0	SENT_113	[p7l1518t3190r1589b3248],
9	Florida	NNP	ORGANIZATION	Florida	nn	12	SENT_113	[p7l1617t3190r1860b3248],
10	Institutional	NNP	ORGANIZATION	Institutional	nn	12	SENT_113	[p7l1892t3192r2148b3248, p7l12t3285r219b3342],
11	Review	NNP	ORGANIZATION	Review	nn	12	SENT_113	[p7l272t3287r521b3342],
12	Board	NNP	ORGANIZATION	Board	prep_of	7	SENT_113	[p7l573t3285r793b3342],
13	.	.	O	.	_	0	SENT_113	[p7l573t3285r793b3342],

1	All	DT	O	all	det	3	SENT_114	[p7l848t3285r946b3342],
2	study	NN	O	study	nn	3	SENT_114	[p7l1000t3285r1192b3360],
3	visits	NNS	O	visit	nsubj	4	SENT_114	[p7l1239t3288r1417b3342],
4	took	VBD	O	take	_	0	SENT_114	[p7l1470t3285r1630b3342],
5	place	NN	O	place	dobj	4	SENT_114	[p7l1680t3285r1861b3360],
6	in	IN	O	in	_	0	SENT_114	[p7l1914t3288r1984b3342],
7	the	DT	O	the	det	8	SENT_114	[p7l2036t3285r2148b3342],
8	University	NNP	ORGANIZATION	University	prep_in	4	SENT_114	[p7l12t3382r381b3455],
9	of	IN	ORGANIZATION	of	_	0	SENT_114	[p7l440t3379r511b3437],
10	Florida	NNP	ORGANIZATION	Florida	nn	14	SENT_114	[p7l568t3380r811b3437],
11	General	NNP	ORGANIZATION	General	nn	14	SENT_114	[p7l873t3380r1147b3437],
12	Clinical	JJ	ORGANIZATION	clinical	amod	14	SENT_114	[p7l1209t3380r1482b3437],
13	Research	NNP	ORGANIZATION	Research	nn	14	SENT_114	[p7l1544t3380r1852b3437],
14	Center	NNP	ORGANIZATION	Center	prep_of	8	SENT_114	[p7l1913t3381r2150b3437],
15	(	CD	NUMBER	(	num	16	SENT_114	[p7l16t3474r303b3546],
16	GCRC	NNP	O	GCRC	dep	14	SENT_114	[p7l16t3474r303b3546],
17	)	CD	NUMBER	)	num	16	SENT_114	[p7l16t3474r303b3546],
18	.	.	O	.	_	0	SENT_114	[p7l16t3474r303b3546],

1	Study	NNP	O	Study	_	0	SENT_115	[p8l12t18r194b94],
2	protocol	NN	O	protocol	nn	4	SENT_115	[p8l214t18r480b94],
3	Baseline	NN	O	baseline	nn	4	SENT_115	[p8l12t113r267b171],
4	studies	NNS	O	study	dep	1	SENT_115	[p8l286t113r520b171],
5	.	.	O	.	_	0	SENT_115	[p8l286t113r520b171],

1	All	DT	O	all	det	2	SENT_116	[p8l603t114r700b171],
2	patients	NNS	O	patient	nsubj	3	SENT_116	[p8l722t117r1004b189],
3	underwent	VBD	O	undergo	_	0	SENT_116	[p8l1026t114r1414b171],
4	a	DT	O	a	det	6	SENT_116	[p8l1437t130r1472b171],
5	2-week	JJ	DURATION	2-week	amod	6	SENT_116	[p8l1494t114r1740b171],
6	washout	NN	O	washout	dobj	3	SENT_116	[p8l1758t114r2059b171],
7	of	IN	O	of	_	0	SENT_116	[p8l2081t113r2153b171],
8	all	DT	O	all	det	10	SENT_116	[p8l9t209r91b267],
9	antihypertensive	JJ	O	antihypertensive	amod	10	SENT_116	[p8l141t209r736b285],
10	medications	NNS	O	medication	prep_of	6	SENT_116	[p8l786t209r1218b267],
11	to	TO	O	to	aux	12	SENT_116	[p8l1267t216r1337b267],
12	determine	VB	O	determine	xcomp	3	SENT_116	[p8l1387t209r1747b267],
13	eligibility	NN	O	eligibility	dobj	12	SENT_116	[p8l1797t209r2144b285],
14	.	.	O	.	_	0	SENT_116	[p8l1797t209r2144b285],

1	Once	RB	DATE	once	advmod	4	SENT_117	[p8l10t305r192b361],
2	eligibility	NN	O	eligibility	nsubjpass	4	SENT_117	[p8l271t304r608b379],
3	was	VBD	O	be	auxpass	4	SENT_117	[p8l681t320r810b361],
4	determined	VBN	O	determine	dep	10	SENT_117	[p8l889t304r1314b374],
5	,	,	O	,	_	0	SENT_117	[p8l889t304r1314b374],
6	24-h	JJ	O	24-h	amod	8	SENT_117	[p8l1398t304r1556b361],
7	hemodynamic	JJ	O	hemodynamic	amod	8	SENT_117	[p8l1634t304r2148b379],
8	monitoring	NN	O	monitoring	nsubjpass	10	SENT_117	[p8l9t402r417b475],
9	was	VBD	O	be	auxpass	10	SENT_117	[p8l486t416r614b457],
10	conducted	VBN	O	conduct	_	0	SENT_117	[p8l686t399r1059b457],
11	using	VBG	O	use	xcomp	10	SENT_117	[p8l1129t402r1321b475],
12	an	DT	O	a	det	50	SENT_117	[p8l1392t416r1477b457],
13	Accutracker	NNP	O	Accutracker	nn	19	SENT_117	[p8l1547t399r1964b457],
14	DX	NNP	O	DX	nn	19	SENT_117	[p8l2035t401r2148b456],
15	(	NNP	O	(	nn	19	SENT_117	[p8l12t494r336b566],
16	SunTech	NNP	ORGANIZATION	SunTech	nn	19	SENT_117	[p8l12t494r336b566],
17	Medical	NNP	ORGANIZATION	Medical	nn	19	SENT_117	[p8l375t494r654b552],
18	Instruments	NNP	ORGANIZATION	Instruments	nn	19	SENT_117	[p8l696t497r1125b552],
19	Inc.	NNP	ORGANIZATION	Inc.	dep	50	SENT_117	[p8l1167t497r1317b564],
20	,	,	O	,	_	0	SENT_117	[p8l1167t497r1317b564],
21	Raleigh	NNP	LOCATION	Raleigh	nn	25	SENT_117	[p8l1363t494r1641b570],
22	,	,	O	,	_	0	SENT_117	[p8l1363t494r1641b570],
23	NC	NNP	O	NC	appos	25	SENT_117	[p8l1685t496r1817b564],
24	,	,	O	,	_	0	SENT_117	[p8l1685t496r1817b564],
25	USA	NNP	LOCATION	USA	dep	50	SENT_117	[p8l1863t494r2033b566],
26	)	CD	NUMBER	)	num	25	SENT_117	[p8l1863t494r2033b566],
27	or	CC	O	or	_	0	SENT_117	[p8l2078t511r2149b552],
28	SpaceLabs	NNP	O	SpaceLabs	dep	50	SENT_117	[p8l9t589r362b665],
29	90207	CD	NUMBER	90207	num	34	SENT_117	[p8l407t590r619b647],
30	oscillometric	JJ	O	oscillometric	amod	34	SENT_117	[p8l664t589r1121b647],
31	ambulatory	JJ	O	ambulatory	amod	34	SENT_117	[p8l1166t589r1575b665],
32	blood	NN	O	blood	nn	34	SENT_117	[p8l1614t589r1818b647],
33	pressure	NN	O	pressure	nn	34	SENT_117	[p8l1861t606r2148b665],
34	monitor	NN	O	monitor	dep	28	SENT_117	[p8l9t687r301b742],
35	(	CD	NUMBER	(	dep	28	SENT_117	[p8l334t684r711b760],
36	SpaceLabs	NNP	ORGANIZATION	SpaceLabs	nn	43	SENT_117	[p8l334t684r711b760],
37	Inc.	NNP	ORGANIZATION	Inc.	nn	43	SENT_117	[p8l743t686r892b754],
38	,	,	O	,	_	0	SENT_117	[p8l743t686r892b754],
39	Redmond	NNP	PERSON	Redmond	appos	43	SENT_117	[p8l928t684r1288b754],
40	,	,	O	,	_	0	SENT_117	[p8l928t684r1288b754],
41	WA	NNP	LOCATION	WA	appos	43	SENT_117	[p8l1322t685r1463b754],
42	,	,	O	,	_	0	SENT_117	[p8l1322t685r1463b754],
43	USA	NNP	LOCATION	USA	dep	35	SENT_117	[p8l1497t684r1667b756],
44	)	CD	NUMBER	)	num	43	SENT_117	[p8l1497t684r1667b756],
45	according	VBG	O	accord	_	0	SENT_117	[p8l1702t684r2050b760],
46	to	TO	O	to	prepc_according_to	19	SENT_117	[p8l2078t691r2148b742],
47	previously	RB	DATE	previously	advmod	48	SENT_117	[p8l8t776r377b852],
48	described	VBN	O	describe	amod	49	SENT_117	[p8l405t776r736b834],
49	methods	NNS	O	method	pobj	19	SENT_117	[p8l765t769r1127b834],
50	.3	NN	NUMBER	.3	dobj	11	SENT_117	[p8l765t769r1127b834],

1	Baseline	NN	O	baseline	nn	3	SENT_118	[p8l86t873r372b931],
2	treadmill	NN	O	treadmill	nn	3	SENT_118	[p8l434t873r756b931],
3	studies	NNS	O	study	nsubjpass	5	SENT_118	[p8l820t873r1060b931],
4	were	VBD	O	be	auxpass	5	SENT_118	[p8l1120t890r1283b931],
5	performed	VBN	O	perform	_	0	SENT_118	[p8l1345t873r1714b949],
6	on	IN	O	on	_	0	SENT_118	[p8l1776t890r1867b931],
7	a	DT	DURATION	a	det	8	SENT_118	[p8l1929t890r1964b931],
8	day	NN	DURATION	day	prep_on	5	SENT_118	[p8l2026t873r2151b949],
9	subsequent	JJ	O	subsequent	_	0	SENT_118	[p8l10t968r408b1043],
10	to	TO	O	to	_	0	SENT_118	[p8l461t975r530b1025],
11	ambulatory	JJ	O	ambulatory	amod	13	SENT_118	[p8l586t968r996b1043],
12	hemodynamic	JJ	O	hemodynamic	amod	13	SENT_118	[p8l1048t968r1563b1043],
13	monitoring	NN	O	monitoring	prep_subsequent_to	8	SENT_118	[p8l1616t971r2041b1043],
14	.	.	O	.	_	0	SENT_118	[p8l1616t971r2041b1043],

1	A	DT	O	a	nsubj	17	SENT_119	[p8l2099t969r2149b1025],
2	graded	VBN	O	grade	csubjpass	6	SENT_119	[p8l9t1063r246b1138],
3	treadmill	NN	O	treadmill	nn	4	SENT_119	[p8l284t1063r606b1120],
4	protocol	NN	O	protocol	dobj	2	SENT_119	[p8l645t1063r944b1138],
5	was	VBD	O	be	auxpass	6	SENT_119	[p8l981t1079r1109b1120],
6	designed	VBN	O	design	dep	1	SENT_119	[p8l1149t1063r1461b1138],
7	in	IN	O	in	_	0	SENT_119	[p8l1499t1066r1570b1120],
8	which	WDT	O	which	dobj	11	SENT_119	[p8l1607t1063r1827b1120],
9	patients	NNS	O	patient	nsubj	11	SENT_119	[p8l1866t1066r2148b1138],
10	gradually	RB	O	gradually	advmod	11	SENT_119	[p8l9t1158r340b1234],
11	reached	VBD	O	reach	prepc_in	6	SENT_119	[p8l370t1158r645b1216],
12	85	CD	PERCENT	85	num	13	SENT_119	[p8l680t1160r831b1216],
13	%	NN	PERCENT	%	dobj	11	SENT_119	[p8l680t1160r831b1216],
14	of	IN	O	of	_	0	SENT_119	[p8l865t1158r936b1216],
15	their	PRP$	O	they	poss	16	SENT_119	[p8l965t1158r1133b1216],
16	maximal	JJ	O	maximal	prep_of	13	SENT_119	[p8l1165t1158r1476b1216],
17	predicted	VBN	O	predict	_	0	SENT_119	[p8l1508t1158r1840b1234],
18	exercise	NN	O	exercise	nn	20	SENT_119	[p8l1873t1161r2147b1216],
19	heart	NN	O	heart	nn	20	SENT_119	[p8l9t1253r191b1310],
20	rate	NN	O	rate	dobj	17	SENT_119	[p8l229t1260r360b1310],
21	calculated	VBN	O	calculate	partmod	20	SENT_119	[p8l400t1253r757b1310],
22	as	IN	O	as	_	0	SENT_119	[p8l796t1269r861b1310],
23	(	NN	O	(	prep_as	21	SENT_119	[p8l904t1253r1073b1325],
24	0.85	CD	NUMBER	0.85	num	23	SENT_119	[p8l904t1253r1073b1325],
25	x	CC	O	x	_	0	SENT_119	[p8l1103t1271r1140b1309],
26	(	CD	NUMBER	(	number	27	SENT_119	[p8l1169t1253r1683b1328],
27	220	CD	NUMBER	220	num	28	SENT_119	[p8l1169t1253r1683b1328],
28	—	NN	O	—	conj_x	23	SENT_119	[p8l1169t1253r1683b1328],
29	patient	NN	O	patient	poss	33	SENT_119	[p8l1169t1253r1683b1328],
30	’s	POS	O	’s	_	0	SENT_119	[p8l1169t1253r1683b1328],
31	age	NN	O	age	nn	33	SENT_119	[p8l1723t1253r1909b1328],
32	)	CD	NUMBER	)	num	33	SENT_119	[p8l1723t1253r1909b1328],
33	)	NN	O	)	dep	28	SENT_119	[p8l1723t1253r1909b1328],
34	.	.	O	.	_	0	SENT_119	[p8l1723t1253r1909b1328],

1	A	DT	O	a	det	3	SENT_120	[p8l1951t1254r2002b1310],
2	12lead	JJ	O	12lead	amod	3	SENT_120	[p8l2045t1254r2148b1310, p8l9t1347r153b1405],
3	ECG	NN	O	ecg	nsubjpass	20	SENT_120	[p8l190t1348r347b1405],
4	(	CD	NUMBER	(	num	5	SENT_120	[p8l388t1342r656b1419],
5	CASE	NN	O	case	dep	3	SENT_120	[p8l388t1342r656b1419],
6	®	CD	NUMBER	®	num	7	SENT_120	[p8l388t1342r656b1419],
7	15	CD	NUMBER	15	dep	3	SENT_120	[p8l701t1349r796b1417],
8	,	,	O	,	_	0	SENT_120	[p8l701t1349r796b1417],
9	Marquette	NNP	ORGANIZATION	Marquette	nn	17	SENT_120	[p8l837t1349r1203b1423],
10	Electronics	NNP	ORGANIZATION	Electronics	nn	17	SENT_120	[p8l1243t1347r1627b1405],
11	Inc.	NNP	ORGANIZATION	Inc.	nn	17	SENT_120	[p8l1666t1349r1816b1417],
12	,	,	O	,	_	0	SENT_120	[p8l1666t1349r1816b1417],
13	Milwaukee	NNP	LOCATION	Milwaukee	appos	17	SENT_120	[p8l1858t1347r2148b1405, p8l9t1442r141b1513],
14	,	,	O	,	_	0	SENT_120	[p8l1858t1347r2148b1405, p8l9t1442r141b1513],
15	WI	NNP	O	WI	appos	17	SENT_120	[p8l205t1445r327b1512],
16	,	,	O	,	_	0	SENT_120	[p8l205t1445r327b1512],
17	USA	NNP	LOCATION	USA	appos	7	SENT_120	[p8l392t1442r562b1514],
18	)	CD	NUMBER	)	num	17	SENT_120	[p8l392t1442r562b1514],
19	was	VBD	O	be	auxpass	20	SENT_120	[p8l624t1459r752b1500],
20	placed	VBN	O	place	_	0	SENT_120	[p8l812t1442r1041b1518],
21	to	TO	O	to	aux	22	SENT_120	[p8l1100t1449r1170b1500],
22	monitor	VB	O	monitor	xcomp	20	SENT_120	[p8l1231t1445r1524b1500],
23	heart	NN	O	heart	nn	24	SENT_120	[p8l1583t1442r1765b1500],
24	rate	NN	O	rate	dobj	22	SENT_120	[p8l1825t1449r1956b1500],
25	and	CC	O	and	_	0	SENT_120	[p8l2018t1442r2149b1500],
26	conduction	NN	O	conduction	dobj	22	SENT_120	[p8l9t1537r417b1595],
27	during	IN	O	during	_	0	SENT_120	[p8l462t1537r697b1613],
28	the	DT	O	the	det	30	SENT_120	[p8l741t1537r853b1595],
29	treadmill	NN	O	treadmill	nn	30	SENT_120	[p8l898t1537r1221b1595],
30	exercise	NN	O	exercise	prep_during	22	SENT_120	[p8l1266t1540r1560b1595],
31	.	.	O	.	_	0	SENT_120	[p8l1266t1540r1560b1595],

1	Heart	NNP	O	Heart	nn	2	SENT_121	[p8l1609t1539r1801b1595],
2	rate	NN	O	rate	nsubjpass	4	SENT_121	[p8l1845t1544r1976b1595],
3	was	VBD	O	be	auxpass	4	SENT_121	[p8l2020t1554r2148b1595],
4	recorded	VBN	O	record	_	0	SENT_121	[p8l9t1632r316b1690],
5	for	IN	O	for	_	0	SENT_121	[p8l340t1632r439b1690],
6	each	DT	O	each	det	7	SENT_121	[p8l463t1632r624b1690],
7	patient	NN	O	patient	prep_for	4	SENT_121	[p8l647t1635r900b1708],
8	at	IN	O	at	_	0	SENT_121	[p8l925t1639r989b1690],
9	rest	NN	O	rest	nn	12	SENT_121	[p8l1013t1639r1137b1690],
10	(	CD	NUMBER	(	num	12	SENT_121	[p8l1165t1632r1466b1708],
11	supine	NN	O	supine	nn	12	SENT_121	[p8l1165t1632r1466b1708],
12	)	NN	O	)	prep_at	4	SENT_121	[p8l1165t1632r1466b1708],
13	,	,	O	,	_	0	SENT_121	[p8l1165t1632r1466b1708],
14	after	IN	O	after	_	0	SENT_121	[p8l1497t1632r1655b1690],
15	at	IN	DURATION	at	quantmod	17	SENT_121	[p8l1679t1639r1743b1690],
16	least	JJS	DURATION	least	mwe	15	SENT_121	[p8l1767t1632r1925b1690],
17	5	CD	DURATION	5	num	18	SENT_121	[p8l1951t1634r1985b1690],
18	min	NN	DURATION	min	prep_after	4	SENT_121	[p8l2006t1635r2149b1689],
19	in	IN	O	in	_	0	SENT_121	[p8l9t1729r79b1783],
20	the	DT	O	the	det	22	SENT_121	[p8l104t1726r217b1784],
21	supine	NN	O	supine	nn	22	SENT_121	[p8l246t1729r476b1802],
22	position	NN	O	position	prep_in	18	SENT_121	[p8l502t1729r812b1802],
23	.	.	O	.	_	0	SENT_121	[p8l502t1729r812b1802],

1	Treadmill	NN	O	treadmill	nn	2	SENT_122	[p8l840t1726r1179b1784],
2	exercise	NN	O	exercise	nsubjpass	5	SENT_122	[p8l1206t1729r1481b1784],
3	was	VBD	O	be	auxpass	5	SENT_122	[p8l1505t1743r1633b1784],
4	then	RB	O	then	advmod	5	SENT_122	[p8l1660t1726r1824b1784],
5	initiated	VBN	O	initiate	_	0	SENT_122	[p8l1849t1726r2149b1784],
6	at	IN	O	at	_	0	SENT_122	[p8l9t1829r73b1880],
7	3.3	CD	NUMBER	3.3	num	8	SENT_122	[p8l109t1824r211b1880],
8	mph	NN	O	mph	prep_at	5	SENT_122	[p8l231t1822r396b1898],
9	with	IN	O	with	_	0	SENT_122	[p8l429t1822r591b1880],
10	o	NN	PERCENT	o	nn	12	SENT_122	[p8l626t1824r736b1880],
11	%	NN	PERCENT	%	nn	12	SENT_122	[p8l626t1824r736b1880],
12	incline	NN	O	incline	prep_with	8	SENT_122	[p8l771t1822r1033b1880],
13	.	.	O	.	_	0	SENT_122	[p8l771t1822r1033b1880],

1	The	DT	O	the	det	2	SENT_123	[p8l1071t1822r1203b1880],
2	speed	NN	O	speed	nsubj	4	SENT_123	[p8l1242t1822r1437b1898],
3	remained	VBD	O	remain	cop	4	SENT_123	[p8l1472t1822r1806b1880],
4	constant	JJ	O	constant	_	0	SENT_123	[p8l1842t1829r2149b1880],
5	for	IN	O	for	_	0	SENT_123	[p8l9t1916r107b1974],
6	the	DT	O	the	det	7	SENT_123	[p8l141t1917r253b1974],
7	duration	NN	O	duration	prep_for	4	SENT_123	[p8l290t1917r596b1974],
8	of	IN	O	of	_	0	SENT_123	[p8l631t1916r703b1974],
9	the	DT	O	the	det	11	SENT_123	[p8l733t1917r846b1974],
10	exercise	NN	O	exercise	nn	11	SENT_123	[p8l883t1920r1157b1974],
11	test	NN	O	test	prep_of	7	SENT_123	[p8l1193t1924r1333b1987],
12	,	,	O	,	_	0	SENT_123	[p8l1193t1924r1333b1987],
13	with	IN	O	with	_	0	SENT_123	[p8l1371t1917r1532b1974],
14	the	DT	O	the	det	15	SENT_123	[p8l1568t1917r1680b1974],
15	slope	NN	O	slope	prep_with	4	SENT_123	[p8l1718t1917r1896b1992],
16	of	IN	O	of	_	0	SENT_123	[p8l1933t1916r2005b1974],
17	the	DT	O	the	det	18	SENT_123	[p8l2035t1917r2148b1974],
18	incline	NN	O	incline	prep_of	15	SENT_123	[p8l9t2012r252b2069],
19	increased	VBN	O	increase	partmod	18	SENT_123	[p8l277t2012r608b2069],
20	by	IN	O	by	_	0	SENT_123	[p8l629t2012r717b2087],
21	1	CD	PERCENT	1	num	22	SENT_123	[p8l744t2013r848b2069],
22	%	NN	PERCENT	%	agent	19	SENT_123	[p8l744t2013r848b2069],
23	every	DT	SET	every	det	24	SENT_123	[p8l873t2028r1062b2087],
24	minute	NN	SET	minute	dep	22	SENT_123	[p8l1083t2015r1339b2069],
25	up	IN	O	up	advmod	22	SENT_123	[p8l1364t2028r1454b2087],
26	to	TO	O	to	_	0	SENT_123	[p8l1478t2019r1548b2069],
27	the	DT	O	the	det	29	SENT_123	[p8l1573t2012r1685b2069],
28	7-min	JJ	DURATION	7-min	amod	29	SENT_123	[p8l1716t2014r1923b2069],
29	mark	NN	O	mark	prep_to	25	SENT_123	[p8l1947t2012r2144b2082],
30	,	,	O	,	_	0	SENT_123	[p8l1947t2012r2144b2082],
31	if	IN	O	if	mark	32	SENT_123	[p8l9t2107r59b2164],
32	necessary	JJ	O	necessary	dep	29	SENT_123	[p8l94t2124r441b2183],
33	.	.	O	.	_	0	SENT_123	[p8l94t2124r441b2183],

1	If	IN	O	if	mark	5	SENT_124	[p8l484t2107r537b2164],
2	patients	NNS	O	patient	nsubj	5	SENT_124	[p8l571t2110r853b2183],
3	did	VBD	O	do	aux	5	SENT_124	[p8l894t2107r1006b2165],
4	not	RB	O	not	neg	5	SENT_124	[p8l1045t2114r1165b2165],
5	reach	VB	O	reach	advcl	15	SENT_124	[p8l1204t2107r1395b2165],
6	target	NN	O	target	nn	8	SENT_124	[p8l1433t2114r1636b2183],
7	heart	NN	O	heart	nn	8	SENT_124	[p8l1674t2107r1856b2165],
8	rate	NN	O	rate	dobj	5	SENT_124	[p8l1895t2114r2026b2165],
9	by	IN	O	by	_	0	SENT_124	[p8l2064t2107r2151b2183],
10	7min	NN	O	7min	prep_by	5	SENT_124	[p8l14t2204r225b2272],
11	,	,	O	,	_	0	SENT_124	[p8l14t2204r225b2272],
12	the	DT	O	the	det	13	SENT_124	[p8l297t2202r409b2259],
13	slope	NN	O	slope	nsubjpass	15	SENT_124	[p8l477t2202r656b2277],
14	was	VBD	O	be	auxpass	15	SENT_124	[p8l721t2218r849b2259],
15	increased	VBN	O	increase	_	0	SENT_124	[p8l916t2202r1247b2259],
16	by	IN	O	by	_	0	SENT_124	[p8l1311t2202r1399b2277],
17	2	CD	PERCENT	2	num	18	SENT_124	[p8l1463t2203r1572b2259],
18	%	NN	PERCENT	%	agent	15	SENT_124	[p8l1463t2203r1572b2259],
19	every	DT	SET	every	det	20	SENT_124	[p8l1638t2218r1828b2277],
20	minute	NN	SET	minute	dep	18	SENT_124	[p8l1892t2205r2147b2259],
21	beginning	NN	O	beginning	dep	15	SENT_124	[p8l7t2297r370b2373],
22	at	IN	O	at	_	0	SENT_124	[p8l428t2304r491b2355],
23	the	DT	O	the	det	27	SENT_124	[p8l548t2297r661b2355],
24	8	CD	NUMBER	8	num	27	SENT_124	[p8l721t2298r932b2355],
25	—	NN	O	—	nn	27	SENT_124	[p8l721t2298r932b2355],
26	min	NN	DURATION	min	nn	27	SENT_124	[p8l721t2298r932b2355],
27	mark	NN	O	mark	prep_at	15	SENT_124	[p8l990t2297r1187b2355],
28	.	.	O	.	_	0	SENT_124	[p8l990t2297r1187b2355],

1	Patients	NNS	O	patient	nsubj	2	SENT_125	[p8l1250t2299r1528b2355],
2	completed	VBD	O	complete	_	0	SENT_125	[p8l1587t2297r1960b2373],
3	two	CD	NUMBER	two	num	5	SENT_125	[p8l2018t2304r2148b2355],
4	treadmill	NN	O	treadmill	nn	5	SENT_125	[p8l8t2392r330b2450],
5	studies	NNS	O	study	dobj	2	SENT_125	[p8l375t2392r616b2450],
6	on	IN	O	on	_	0	SENT_125	[p8l660t2409r751b2450],
7	the	DT	DATE	the	det	9	SENT_125	[p8l794t2392r906b2450],
8	same	JJ	DATE	same	amod	9	SENT_125	[p8l952t2409r1126b2450],
9	day	NN	DATE	day	prep_on	2	SENT_125	[p8l1171t2392r1306b2468],
10	,	,	O	,	_	0	SENT_125	[p8l1171t2392r1306b2468],
11	initiated	VBN	O	initiate	partmod	9	SENT_125	[p8l1353t2392r1653b2450],
12	at	IN	O	at	_	0	SENT_125	[p8l1696t2399r1760b2450],
13	1030	CD	DATE	1030	prep_at	11	SENT_125	[p8l1808t2394r1974b2450],
14	and	CC	DATE	and	_	0	SENT_125	[p8l2018t2392r2149b2450],
15	1430	CD	DATE	1430	conj_and	13	SENT_125	[p8l14t2488r197b2557],
16	,	,	O	,	_	0	SENT_125	[p8l14t2488r197b2557],
17	respectively	RB	O	respectively	advmod	11	SENT_125	[p8l266t2487r695b2563],
18	.	.	O	.	_	0	SENT_125	[p8l266t2487r695b2563],

1	These	DT	O	these	det	3	SENT_126	[p8l761t2487r963b2545],
2	study	NN	O	study	nn	3	SENT_126	[p8l1030t2487r1222b2563],
3	times	NNS	O	time	nsubjpass	5	SENT_126	[p8l1284t2490r1474b2545],
4	were	VBD	O	be	auxpass	5	SENT_126	[p8l1537t2504r1700b2545],
5	chosen	VBN	O	choose	_	0	SENT_126	[p8l1766t2487r2014b2545],
6	to	TO	O	to	aux	8	SENT_126	[p8l2078t2494r2148b2545],
7	approximately	RB	O	approximately	advmod	8	SENT_126	[p8l9t2582r526b2658],
8	coincide	VB	O	coincide	xcomp	5	SENT_126	[p8l550t2582r847b2640],
9	with	IN	O	with	_	0	SENT_126	[p8l871t2582r1033b2640],
10	the	DT	O	the	det	12	SENT_126	[p8l1057t2582r1170b2640],
11	expected	VBN	O	expect	amod	12	SENT_126	[p8l1197t2582r1510b2658],
12	maximum	NN	O	maximum	prep_with	8	SENT_126	[p8l1534t2585r1901b2640],
13	(	CD	NUMBER	(	num	14	SENT_126	[p8l1931t2582r2145b2654],
14	Cmax	NN	O	cmax	npadvmod	12	SENT_126	[p8l1931t2582r2145b2654],
15	)	NN	O	)	dep	23	SENT_126	[p8l1931t2582r2145b2654],
16	and	CC	O	and	_	0	SENT_126	[p8l9t2676r141b2733],
17	half-maximum	NN	O	half-maximum	conj_and	15	SENT_126	[p8l169t2675r701b2733],
18	(	CD	PERCENT	(	num	19	SENT_126	[p8l734t2667r975b2758],
19	%	NN	PERCENT	%	dep	15	SENT_126	[p8l734t2667r975b2758],
20	CmaX	NN	O	cmax	dep	23	SENT_126	[p8l734t2667r975b2758],
21	)	CD	NUMBER	)	num	20	SENT_126	[p8l734t2667r975b2758],
22	plasma	NN	O	plasma	nn	23	SENT_126	[p8l1007t2676r1256b2751],
23	concentrations	NNS	O	concentration	dep	14	SENT_126	[p8l1285t2679r1815b2733],
24	of	IN	O	of	_	0	SENT_126	[p8l1846t2675r1918b2733],
25	metoprolol	NN	O	metoprolol	prep_of	23	SENT_126	[p8l1942t2683r2148b2733, p8l8t2771r219b2847],
26	during	IN	O	during	_	0	SENT_126	[p8l249t2771r484b2847],
27	the	DT	O	the	det	29	SENT_126	[p8l512t2771r625b2829],
28	treatment	NN	O	treatment	nn	29	SENT_126	[p8l655t2778r1006b2829],
29	phase	NN	O	phase	prep_during	12	SENT_126	[p8l1035t2771r1254b2847],
30	.	.	O	.	_	0	SENT_126	[p8l1035t2771r1254b2847],

1	Metoprolol	NN	O	metoprolol	_	0	SENT_127	[p8l12t3001r360b3077],
2	therapy	NN	O	therapy	dep	1	SENT_127	[p8l398t3001r654b3077],
3	.	.	O	.	_	0	SENT_127	[p8l398t3001r654b3077],

1	Metoprolol	NN	O	metoprolol	nn	2	SENT_128	[p8l738t3001r1135b3077],
2	therapy	NN	O	therapy	nsubjpass	4	SENT_128	[p8l1175t3001r1448b3077],
3	was	VBD	O	be	auxpass	4	SENT_128	[p8l1484t3018r1611b3059],
4	initiated	VBN	O	initiate	_	0	SENT_128	[p8l1652t3001r1951b3059],
5	after	IN	O	after	mark	9	SENT_128	[p8l1992t3001r2150b3059],
6	baseline	NN	O	baseline	nn	7	SENT_128	[p8l7t3097r293b3155],
7	studies	NNS	O	study	nsubjpass	9	SENT_128	[p8l332t3097r572b3155],
8	were	VBD	O	be	auxpass	9	SENT_128	[p8l608t3114r772b3155],
9	completed	VBN	O	complete	advcl	4	SENT_128	[p8l810t3097r1201b3173],
10	.	.	O	.	_	0	SENT_128	[p8l810t3097r1201b3173],

1	Patients	NNS	O	patient	nsubjpass	16	SENT_129	[p8l1243t3099r1521b3155],
2	took	VBD	O	take	_	0	SENT_129	[p8l1558t3097r1719b3155],
3	metoprolol	NN	O	metoprolol	iobj	2	SENT_129	[p8l1753t3097r2148b3173],
4	tartrate	JJ	O	tartrate	amod	6	SENT_129	[p8l8t3200r265b3250],
5	50	CD	NUMBER	50	tmod	4	SENT_129	[p8l294t3194r376b3250],
6	mg	NN	O	mg	dobj	2	SENT_129	[p8l393t3209r504b3268],
7	every	DT	O	every	det	8	SENT_129	[p8l530t3209r719b3268],
8	12h	NN	O	12h	dep	6	SENT_129	[p8l749t3192r890b3249],
9	(	CD	NUMBER	(	number	10	SENT_129	[p8l919t3193r1114b3264],
10	0830	CD	DATE	0830	num	8	SENT_129	[p8l919t3193r1114b3264],
11	and	CC	DATE	and	_	0	SENT_129	[p8l1142t3193r1273b3250],
12	2230	CD	DATE	2230	num	13	SENT_129	[p8l1300t3193r1493b3264],
13	)	NN	O	)	dobj	2	SENT_129	[p8l1300t3193r1493b3264],
14	and	CC	O	and	_	0	SENT_129	[p8l1525t3192r1656b3250],
15	were	VBD	O	be	auxpass	16	SENT_129	[p8l1680t3209r1844b3250],
16	seen	VBN	O	see	conj_and	2	SENT_129	[p8l1873t3209r2025b3250],
17	for	IN	O	for	_	0	SENT_129	[p8l2051t3192r2150b3250],
18	weekly	JJ	SET	weekly	amod	19	SENT_129	[p8l7t3289r253b3365],
19	titration	NN	O	titration	prep_for	16	SENT_129	[p8l280t3292r575b3347],
20	to	TO	O	to	_	0	SENT_129	[p8l604t3296r674b3347],
21	100	CD	NUMBER	100	prep_to	16	SENT_129	[p8l711t3291r832b3347],
22	and	CC	O	and	_	0	SENT_129	[p8l863t3289r994b3347],
23	200	CD	NUMBER	200	num	24	SENT_129	[p8l1025t3291r1152b3347],
24	mg	NN	O	mg	dep	26	SENT_129	[p8l1168t3306r1280b3365],
25	every	DT	O	every	det	26	SENT_129	[p8l1309t3306r1498b3365],
26	12h	NN	O	12h	conj_and	2	SENT_129	[p8l1531t3289r1673b3346],
27	if	IN	O	if	mark	34	SENT_129	[p8l1703t3289r1753b3346],
28	clinic	NN	O	clinic	nn	29	SENT_129	[p8l1779t3289r1972b3347],
29	DBP	NN	O	dbp	nsubj	34	SENT_129	[p8l2002t3291r2149b3346],
30	was	VBD	O	be	cop	34	SENT_129	[p8l7t3402r135b3443],
31	greater	JJR	O	greater	mwe	32	SENT_129	[p8l202t3392r444b3461],
32	than	IN	O	than	quantmod	33	SENT_129	[p8l510t3385r674b3443],
33	90	CD	NUMBER	90	num	34	SENT_129	[p8l742t3387r825b3443],
34	mmHg	NN	O	mmhg	dep	2	SENT_129	[p8l841t3387r1087b3461],
35	and	CC	O	and	_	0	SENT_129	[p8l1153t3385r1284b3443],
36	the	DT	O	the	det	37	SENT_129	[p8l1350t3385r1463b3443],
37	patient	NN	O	patient	nsubj	40	SENT_129	[p8l1530t3388r1782b3461],
38	did	VBD	O	do	aux	40	SENT_129	[p8l1850t3385r1962b3443],
39	not	RB	O	not	neg	40	SENT_129	[p8l2028t3392r2149b3443],
40	experience	VB	O	experience	conj_and	2	SENT_129	[p8l9t3484r388b3556],
41	intolerable	JJ	O	intolerable	amod	43	SENT_129	[p8l431t3481r812b3538],
42	side	JJ	O	side	amod	43	SENT_129	[p8l857t3481r990b3538],
43	effects	NNS	O	effect	dobj	40	SENT_129	[p8l1034t3480r1274b3538],
44	.	.	O	.	_	0	SENT_129	[p8l1034t3480r1274b3538],

1	Patients	NNS	O	patient	nsubjpass	16	SENT_130	[p8l1321t3483r1600b3538],
2	who	WP	O	who	nsubj	3	SENT_130	[p8l1640t3481r1794b3538],
3	achieved	VBD	O	achieve	rcmod	1	SENT_130	[p8l1838t3481r2149b3538],
4	target	NN	O	target	nn	5	SENT_130	[p9l8t24r211b93],
5	DBP	NN	O	dbp	dobj	3	SENT_130	[p9l239t19r385b74],
6	continued	VBD	O	continue	_	0	SENT_130	[p9l414t17r777b75],
7	therapy	NN	O	therapy	dobj	6	SENT_130	[p9l804t17r1078b93],
8	for	IN	O	for	_	0	SENT_130	[p9l1103t17r1201b75],
9	at	IN	O	at	quantmod	11	SENT_130	[p9l1229t24r1292b75],
10	least	JJS	O	least	mwe	9	SENT_130	[p9l1320t17r1477b75],
11	4	CD	NUMBER	4	num	13	SENT_130	[p9l1505t19r1543b74],
12	more	JJR	O	more	quantmod	11	SENT_130	[p9l1573t34r1753b75],
13	weeks	NNS	DURATION	week	prep_for	6	SENT_130	[p9l1781t17r1988b75],
14	and	CC	O	and	_	0	SENT_130	[p9l2018t17r2149b75],
15	were	VBD	O	be	auxpass	16	SENT_130	[p9l7t130r170b171],
16	seen	VBN	O	see	conj_and	6	SENT_130	[p9l202t130r354b171],
17	biweekly	RB	SET	biweekly	advmod	16	SENT_130	[p9l380t113r695b189],
18	for	IN	O	for	_	0	SENT_130	[p9l721t113r819b171],
19	clinic	NN	O	clinic	nn	22	SENT_130	[p9l846t113r1039b171],
20	blood	NN	O	blood	nn	22	SENT_130	[p9l1065t113r1270b171],
21	pressure	NN	O	pressure	nn	22	SENT_130	[p9l1297t130r1584b189],
22	measurements	NNS	O	measurement	prep_for	16	SENT_130	[p9l1614t120r2144b171],
23	.	.	O	.	_	0	SENT_130	[p9l1614t120r2144b171],

1	Those	DT	O	those	nsubjpass	24	SENT_131	[p9l7t209r216b266],
2	who	WP	O	who	nsubj	15	SENT_131	[p9l266t209r420b266],
3	failed	VBD	O	fail	rcmod	1	SENT_131	[p9l472t208r666b266],
4	to	TO	O	to	aux	5	SENT_131	[p9l717t216r787b266],
5	reach	VB	O	reach	xcomp	3	SENT_131	[p9l839t209r1030b266],
6	target	NN	O	target	nn	7	SENT_131	[p9l1081t216r1283b284],
7	BP	NN	O	bp	dobj	5	SENT_131	[p9l1335t211r1422b266],
8	on	IN	O	on	_	0	SENT_131	[p9l1473t225r1565b266],
9	the	DT	O	the	det	12	SENT_131	[p9l1616t209r1728b266],
10	maximum	NN	O	maximum	nn	12	SENT_131	[p9l1781t212r2148b266],
11	metoprolol	NN	O	metoprolol	nn	12	SENT_131	[p9l9t305r404b381],
12	dose	NN	O	dose	prep_on	5	SENT_131	[p9l434t305r608b376],
13	,	,	O	,	_	0	SENT_131	[p9l434t305r608b376],
14	but	CC	O	but	_	0	SENT_131	[p9l640t305r759b363],
15	had	VBD	O	have	conj_but	3	SENT_131	[p9l789t305r920b363],
16	a	DT	O	a	det	18	SENT_131	[p9l951t322r985b363],
17	DBP	NN	O	dbp	nn	18	SENT_131	[p9l1015t308r1161b362],
18	reduction	NN	O	reduction	dobj	15	SENT_131	[p9l1190t305r1533b363],
19	2	CD	PERCENT	2	number	21	SENT_131	[p9l1575t315r1623b370],
20	10	CD	PERCENT	10	number	21	SENT_131	[p9l1644t307r1791b363],
21	%	NN	PERCENT	%	amod	18	SENT_131	[p9l1644t307r1791b363],
22	were	VBD	O	be	auxpass	24	SENT_131	[p9l1819t322r1983b363],
23	also	RB	O	also	advmod	24	SENT_131	[p9l2014t305r2148b363],
24	treated	VBN	O	treat	_	0	SENT_131	[p9l8t400r254b457],
25	for	IN	O	for	_	0	SENT_131	[p9l281t400r379b457],
26	4	CD	NUMBER	4	num	28	SENT_131	[p9l406t403r444b456],
27	more	JJR	O	more	amod	28	SENT_131	[p9l472t417r653b457],
28	weeks	NNS	DURATION	week	prep_for	24	SENT_131	[p9l679t400r906b457],
29	.	.	O	.	_	0	SENT_131	[p9l679t400r906b457],

1	Patients	NNS	O	patient	nsubj	11	SENT_132	[p9l938t403r1216b457],
2	who	WP	O	who	nsubj	3	SENT_132	[p9l1243t400r1396b457],
3	failed	VBD	O	fail	rcmod	1	SENT_132	[p9l1424t400r1618b457],
4	to	TO	O	to	aux	5	SENT_132	[p9l1645t407r1714b457],
5	meet	VB	O	meet	xcomp	3	SENT_132	[p9l1742t407r1917b457],
6	either	DT	O	either	dobj	5	SENT_132	[p9l1945t400r2150b457],
7	of	IN	O	of	_	0	SENT_132	[p9l9t496r81b554],
8	these	DT	O	these	det	10	SENT_132	[p9l121t496r303b554],
9	response	NN	O	response	nn	10	SENT_132	[p9l348t513r653b572],
10	criteria	NNS	O	criterion	prep_of	6	SENT_132	[p9l700t499r946b554],
11	proceeded	VBD	O	proceed	_	0	SENT_132	[p9l989t496r1352b572],
12	to	TO	O	to	_	0	SENT_132	[p9l1397t503r1466b554],
13	the	DT	O	the	det	14	SENT_132	[p9l1511t496r1624b554],
14	end	NN	O	end	prep_to	11	SENT_132	[p9l1670t496r1801b554],
15	of	IN	O	of	_	0	SENT_132	[p9l1845t496r1917b554],
16	study	NN	O	study	nn	17	SENT_132	[p9l1959t496r2151b572],
17	evaluation	NN	O	evaluation	prep_of	14	SENT_132	[p9l9t591r401b647],
18	.	.	O	.	_	0	SENT_132	[p9l9t591r401b647],

1	Treatment	NN	O	treatment	nn	2	SENT_133	[p9l16t804r344b859],
2	studies	NNS	O	study	_	0	SENT_133	[p9l389t801r622b859],
3	.	.	O	.	_	0	SENT_133	[p9l389t801r622b859],

1	Ambulatory	JJ	O	ambulatory	amod	3	SENT_134	[p9l706t802r1132b877],
2	hemodynamic	JJ	O	hemodynamic	amod	3	SENT_134	[p9l1178t802r1693b877],
3	monitoring	NN	O	monitoring	nsubjpass	8	SENT_134	[p9l1741t805r2150b877],
4	and	CC	O	and	_	0	SENT_134	[p9l9t897r141b955],
5	treadmill	NN	O	treadmill	nn	6	SENT_134	[p9l169t897r491b955],
6	studies	NNS	O	study	conj_and	3	SENT_134	[p9l522t897r762b955],
7	were	VBD	O	be	auxpass	8	SENT_134	[p9l789t914r953b955],
8	repeated	VBN	O	repeat	_	0	SENT_134	[p9l982t897r1283b973],
9	after	IN	O	after	_	0	SENT_134	[p9l1313t897r1471b955],
10	at	IN	DURATION	at	quantmod	12	SENT_134	[p9l1499t904r1563b955],
11	least	JJS	DURATION	least	mwe	10	SENT_134	[p9l1591t897r1748b955],
12	4	CD	DURATION	4	num	13	SENT_134	[p9l1778t900r1816b954],
13	weeks	NNS	NUMBER	week	prep_after	8	SENT_134	[p9l1843t897r2052b955],
14	of	IN	O	of	_	0	SENT_134	[p9l2081t897r2153b955],
15	stable	JJ	O	stable	amod	17	SENT_134	[p9l10t992r209b1050],
16	dose	NN	O	dose	nn	17	SENT_134	[p9l251t992r406b1050],
17	metoprolol	NN	O	metoprolol	prep_of	13	SENT_134	[p9l446t992r859b1068],
18	.	.	O	.	_	0	SENT_134	[p9l446t992r859b1068],

1	Subjects	NNS	O	subject	nsubjpass	36	SENT_135	[p9l904t992r1188b1068],
2	exercised	VBN	O	exercise	dep	1	SENT_135	[p9l1229t992r1551b1050],
3	using	VBG	O	use	ccomp	2	SENT_135	[p9l1588t995r1781b1068],
4	the	DT	O	the	det	7	SENT_135	[p9l1819t992r1931b1050],
5	same	JJ	O	same	amod	7	SENT_135	[p9l1973t1009r2147b1050],
6	treadmill	NN	O	treadmill	nn	7	SENT_135	[p9l8t1087r330b1145],
7	protocol	NN	O	protocol	dobj	3	SENT_135	[p9l355t1087r654b1163],
8	(	CD	NUMBER	(	dep	7	SENT_135	[p9l684t1087r828b1159],
9	i.e.	FW	O	i.e.	dep	7	SENT_135	[p9l684t1087r828b1159],
10	,	,	O	,	_	0	SENT_135	[p9l684t1087r828b1159],
11	grade	NN	O	grade	dobj	3	SENT_135	[p9l858t1087r1048b1163],
12	and	CC	O	and	_	0	SENT_135	[p9l1076t1087r1207b1145],
13	duration	NN	O	duration	conj_and	7	SENT_135	[p9l1233t1087r1562b1159],
14	)	RB	O	)	advmod	11	SENT_135	[p9l1233t1087r1562b1159],
15	as	IN	O	as	_	0	SENT_135	[p9l1592t1104r1657b1145],
16	baseline	NN	O	baseline	prep_as	11	SENT_135	[p9l1681t1087r1986b1157],
17	,	,	O	,	_	0	SENT_135	[p9l1681t1087r1986b1157],
18	and	CC	O	and	_	0	SENT_135	[p9l2018t1087r2149b1145],
19	metoprolol-treated	JJ	O	metoprolol-treated	amod	23	SENT_135	[p9l9t1181r679b1257],
20	24h	JJ	O	24h	amod	23	SENT_135	[p9l714t1181r860b1238],
21	ambulatory	JJ	O	ambulatory	amod	23	SENT_135	[p9l895t1181r1306b1257],
22	heart	NN	O	heart	nn	23	SENT_135	[p9l1338t1181r1520b1239],
23	rate	NN	O	rate	dobj	3	SENT_135	[p9l1555t1189r1704b1252],
24	,	,	O	,	_	0	SENT_135	[p9l1555t1189r1704b1252],
25	and	CC	O	and	_	0	SENT_135	[p9l1744t1181r1875b1239],
26	resting	VBG	O	rest	ccomp	2	SENT_135	[p9l1909t1184r2150b1257],
27	and	CC	O	and	_	0	SENT_135	[p9l9t1276r141b1333],
28	exercise	NN	O	exercise	conj_and	2	SENT_135	[p9l169t1279r444b1333],
29	heart	NN	O	heart	nn	30	SENT_135	[p9l473t1276r655b1333],
30	rates	NNS	O	rate	dobj	28	SENT_135	[p9l683t1283r845b1333],
31	at	IN	O	at	_	0	SENT_135	[p9l875t1283r939b1333],
32	1030	CD	DATE	1030	prep_at	28	SENT_135	[p9l972t1277r1138b1333],
33	and	CC	DATE	and	_	0	SENT_135	[p9l1168t1276r1299b1333],
34	1430	CD	DATE	1430	conj_and	32	SENT_135	[p9l1333t1277r1498b1333],
35	were	VBD	O	be	auxpass	36	SENT_135	[p9l1525t1292r1689b1333],
36	determined	VBN	O	determine	_	0	SENT_135	[p9l1718t1276r2144b1333],
37	.	.	O	.	_	0	SENT_135	[p9l1718t1276r2144b1333],

1	In	IN	O	in	_	0	SENT_136	[p9l9t1373r82b1427],
2	addition	NN	O	addition	prep_in	6	SENT_136	[p9l132t1370r449b1441],
3	,	,	O	,	_	0	SENT_136	[p9l132t1370r449b1441],
4	subjects	NNS	O	subject	nsubjpass	6	SENT_136	[p9l506t1370r782b1446],
5	were	VBD	O	be	auxpass	6	SENT_136	[p9l830t1387r994b1428],
6	admitted	VBN	O	admit	_	0	SENT_136	[p9l1045t1370r1365b1428],
7	to	TO	O	to	_	0	SENT_136	[p9l1414t1378r1484b1428],
8	the	DT	O	the	det	9	SENT_136	[p9l1535t1370r1647b1428],
9	GCRC	NNP	ORGANIZATION	GCRC	prep_to	6	SENT_136	[p9l1699t1372r1916b1428],
10	for	IN	O	for	_	0	SENT_136	[p9l1966t1370r2064b1428],
11	a	DT	O	a	det	14	SENT_136	[p9l2114t1387r2149b1428],
12	steady-state	JJ	O	steady-state	amod	14	SENT_136	[p9l10t1465r421b1541],
13	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_136	[p9l492t1465r1093b1541],
14	study	NN	O	study	prep_for	6	SENT_136	[p9l1166t1466r1369b1541],
15	.	.	O	.	_	0	SENT_136	[p9l1166t1466r1369b1541],

1	Indwelling	VBG	MISC	indwell	amod	3	SENT_137	[p9l1445t1465r1828b1541],
2	venous	JJ	O	venous	amod	3	SENT_137	[p9l1896t1482r2147b1523],
3	catheters	NNS	O	catheter	nsubjpass	5	SENT_137	[p9l9t1561r325b1619],
4	were	VBD	O	be	auxpass	5	SENT_137	[p9l383t1578r546b1619],
5	placed	VBN	O	place	_	0	SENT_137	[p9l606t1561r852b1637],
6	,	,	O	,	_	0	SENT_137	[p9l606t1561r852b1637],
7	and	CC	O	and	_	0	SENT_137	[p9l916t1561r1047b1619],
8	blood	NN	O	blood	nn	9	SENT_137	[p9l1104t1561r1308b1619],
9	samples	NNS	O	sample	nsubjpass	11	SENT_137	[p9l1369t1561r1645b1637],
10	were	VBD	O	be	auxpass	11	SENT_137	[p9l1703t1578r1867b1619],
11	drawn	VBN	O	draw	conj_and	5	SENT_137	[p9l1927t1561r2149b1619],
12	immediately	RB	O	immediately	advmod	11	SENT_137	[p9l9t1656r457b1731],
13	before	RB	O	before	advmod	11	SENT_137	[p9l504t1655r742b1726],
14	,	,	O	,	_	0	SENT_137	[p9l504t1655r742b1726],
15	and	CC	O	and	_	0	SENT_137	[p9l800t1656r931b1713],
16	at	IN	O	at	conj_and	5	SENT_137	[p9l984t1663r1047b1713],
17	2	CD	NUMBER	2	pobj	16	SENT_137	[p9l1100t1657r1157b1726],
18	,	,	O	,	_	0	SENT_137	[p9l1100t1657r1157b1726],
19	4	CD	NUMBER	4	conj_and	17	SENT_137	[p9l1214t1658r1271b1726],
20	,	,	O	,	_	0	SENT_137	[p9l1214t1658r1271b1726],
21	8	CD	NUMBER	8	conj_and	17	SENT_137	[p9l1329t1657r1385b1726],
22	,	,	O	,	_	0	SENT_137	[p9l1329t1657r1385b1726],
23	and	CC	O	and	_	0	SENT_137	[p9l1444t1656r1575b1713],
24	12h	NN	O	12h	conj_and	17	SENT_137	[p9l1632t1656r1773b1713],
25	after	IN	O	after	_	0	SENT_137	[p9l1826t1655r1984b1713],
26	the	DT	O	the	det	28	SENT_137	[p9l2035t1656r2148b1713],
27	metoprolol	NN	O	metoprolol	nn	28	SENT_137	[p9l9t1751r404b1826],
28	dose	NN	O	dose	prep_after	16	SENT_137	[p9l453t1751r608b1808],
29	for	IN	O	for	_	0	SENT_137	[p9l656t1750r754b1808],
30	pharmacokinetic	JJ	O	pharmacokinetic	amod	31	SENT_137	[p9l800t1751r1401b1826],
31	analysis	NN	O	analysis	prep_for	28	SENT_137	[p9l1449t1751r1743b1826],
32	.	.	O	.	_	0	SENT_137	[p9l1449t1751r1743b1826],

1	R	NN	O	r	_	0	SENT_138	[p9l1792t1753r1863b1808],
2	-	:	O	-	_	0	SENT_138	[p9l1792t1753r1863b1808],
3	and	CC	O	and	cc	8	SENT_138	[p9l1912t1751r2043b1808],
4	Smetoprolol	NNP	O	Smetoprolol	nn	6	SENT_138	[p9l2089t1752r2148b1808, p9l9t1846r404b1922],
5	plasma	NN	O	plasma	nn	6	SENT_138	[p9l466t1846r714b1922],
6	concentrations	NNS	O	concentration	nsubjpass	8	SENT_138	[p9l777t1849r1308b1904],
7	were	VBD	O	be	auxpass	8	SENT_138	[p9l1368t1863r1532b1904],
8	determined	VBN	O	determine	dep	1	SENT_138	[p9l1596t1846r2004b1904],
9	by	IN	O	by	prep	8	SENT_138	[p9l2063t1846r2151b1922],

1	B-blocker	JJ	O	b-blocker	amod	4	SENT_139	[p9l9t2087r233b2144],
2	drug	NN	O	drug	nn	4	SENT_139	[p9l249t2087r361b2146],
3	target	NN	O	target	nn	4	SENT_139	[p9l380t2092r532b2146],
4	pharmacogenetics	NNS	O	pharmacogenetic	nsubj	17	SENT_139	[p9l551t2087r993b2146],
5	@	IN	O	@	_	0	SENT_139	[p9l2026t2075r2152b2199],
6	AL	NNP	O	AL	nn	7	SENT_139	[p9l7t2160r58b2199],
7	Beitelshees	NNP	O	Beitelshees	prep_@	4	SENT_139	[p9l78t2158r298b2200],
8	et	FW	O	et	nn	11	SENT_139	[p9l318t2163r354b2200],
9	al	FW	O	al	nn	11	SENT_139	[p9l371t2158r407b2200],
10	chiral	JJ	O	chiral	amod	11	SENT_139	[p9l10t2446r209b2504],
11	HPLC	NN	O	hplc	dep	7	SENT_139	[p9l272t2448r473b2504],
12	with	IN	O	with	_	0	SENT_139	[p9l534t2446r695b2504],
13	ﬂuorescence	NN	O	ﬂuorescence	nn	14	SENT_139	[p9l757t2446r1196b2504],
14	detection	NN	O	detection	prep_with	11	SENT_139	[p9l1260t2446r1593b2504],
15	as	IN	O	as	prep	14	SENT_139	[p9l1656t2463r1721b2504],
16	previously	RB	DATE	previously	pcomp	15	SENT_139	[p9l1783t2446r2152b2522],
17	described	VBN	O	describe	_	0	SENT_139	[p9l10t2534r430b2599],
18	.	.	O	.	_	0	SENT_139	[p9l10t2534r430b2599],

1	”	NN	O	”	_	0	SENT_140	[p9l10t2534r430b2599],

1	Genotyping	VBG	O	genotype	amod	3	SENT_141	[p9l15t2687r382b2762],
2	Blood	NN	O	blood	nn	3	SENT_141	[p9l10t2781r214b2838],
3	samples	NNS	O	sample	nsubjpass	5	SENT_141	[p9l243t2781r519b2856],
4	were	VBD	O	be	auxpass	5	SENT_141	[p9l546t2797r709b2838],
5	obtained	VBN	O	obtain	_	0	SENT_141	[p9l739t2781r1051b2838],
6	for	IN	O	for	_	0	SENT_141	[p9l1078t2780r1177b2838],
7	genotyping	VBG	O	genotype	prepc_for	5	SENT_141	[p9l1204t2784r1609b2856],
8	at	IN	O	at	_	0	SENT_141	[p9l1637t2788r1700b2838],
9	study	NN	O	study	nn	10	SENT_141	[p9l1729t2781r1922b2856],
10	entry	NN	O	entry	prep_at	7	SENT_141	[p9l1948t2788r2145b2856],
11	.	.	O	.	_	0	SENT_141	[p9l1948t2788r2145b2856],

1	Genomic	JJ	O	genomic	amod	2	SENT_142	[p9l11t2877r334b2934],
2	DNA	NN	O	dna	nsubjpass	4	SENT_142	[p9l389t2877r558b2933],
3	was	VBD	O	be	auxpass	4	SENT_142	[p9l609t2893r737b2934],
4	isolated	VBN	O	isolate	_	0	SENT_142	[p9l792t2876r1065b2934],
5	from	IN	O	from	_	0	SENT_142	[p9l1120t2876r1289b2934],
6	whole	JJ	O	whole	amod	7	SENT_142	[p9l1342t2876r1558b2934],
7	blood	NN	O	blood	prep_from	4	SENT_142	[p9l1611t2876r1815b2934],
8	using	VBG	O	use	partmod	7	SENT_142	[p9l1869t2879r2061b2952],
9	a	DT	O	a	det	14	SENT_142	[p9l2115t2893r2150b2934],
10	commercial	JJ	O	commercial	amod	14	SENT_142	[p9l10t2970r424b3028],
11	kit	NN	O	kit	nn	14	SENT_142	[p9l471t2970r563b3028],
12	(	NN	O	(	nn	14	SENT_142	[p9l613t2965r996b3046],
13	Purgene	NN	O	purgene	nn	14	SENT_142	[p9l613t2965r996b3046],
14	®	NN	O	®	dobj	8	SENT_142	[p9l613t2965r996b3046],
15	,	,	O	,	_	0	SENT_142	[p9l613t2965r996b3046],
16	Gentra	NNP	ORGANIZATION	Gentra	nn	17	SENT_142	[p9l1050t2972r1291b3028],
17	Systems	NNPS	ORGANIZATION	Systems	appos	14	SENT_142	[p9l1338t2972r1633b3046],
18	,	,	O	,	_	0	SENT_142	[p9l1338t2972r1633b3046],
19	Minneapolis	NNP	LOCATION	Minneapolis	appos	14	SENT_142	[p9l1684t2970r2144b3046],
20	,	,	O	,	_	0	SENT_142	[p9l1684t2970r2144b3046],
21	MN	NN	O	mn	appos	14	SENT_142	[p9l8t3067r157b3135],
22	,	,	O	,	_	0	SENT_142	[p9l8t3067r157b3135],
23	USA	NNP	LOCATION	USA	appos	14	SENT_142	[p9l230t3065r422b3137],
24	)	CD	NUMBER	)	num	23	SENT_142	[p9l230t3065r422b3137],
25	.	.	O	.	_	0	SENT_142	[p9l230t3065r422b3137],

1	Genotypes	NNS	O	genotype	nsubjpass	3	SENT_143	[p9l498t3066r872b3141],
2	were	VBD	O	be	auxpass	3	SENT_143	[p9l940t3082r1104b3123],
3	determined	VBN	O	determine	_	0	SENT_143	[p9l1175t3065r1583b3123],
4	by	IN	O	by	_	0	SENT_143	[p9l1650t3065r1737b3141],
5	PCR	NN	O	pcr	agent	3	SENT_143	[p9l1804t3066r1950b3123],
6	and	CC	O	and	_	0	SENT_143	[p9l2019t3065r2149b3123],
7	subsequent	JJ	O	subsequent	amod	8	SENT_143	[p9l11t3160r408b3236],
8	RFLP	NN	O	rflp	agent	3	SENT_143	[p9l441t3162r613b3217],
9	with	IN	O	with	_	0	SENT_143	[p9l643t3160r805b3218],
10	Sau96I	NN	O	sau96us	nsubj	14	SENT_143	[p9l836t3161r1067b3218],
11	for	IN	O	for	_	0	SENT_143	[p9l1100t3160r1198b3218],
12	codon	NN	O	codon	prep_for	10	SENT_143	[p9l1230t3160r1450b3218],
13	49	CD	NUMBER	49	num	12	SENT_143	[p9l1483t3161r1564b3218],
14	using	VBG	O	use	prepc_with	3	SENT_143	[p9l1596t3163r1789b3236],
15	protocols	NNS	O	protocol	dobj	14	SENT_143	[p9l1820t3160r2149b3236],
16	modified	VBN	O	modify	partmod	15	SENT_143	[p9l9t3252r329b3310],
17	from	IN	O	from	_	0	SENT_143	[p9l395t3252r565b3310],
18	previously	RB	DATE	previously	advmod	19	SENT_143	[p9l631t3252r1000b3328],
19	described	VBN	O	describe	amod	20	SENT_143	[p9l1066t3252r1397b3310],
20	methods	NNS	O	method	prep_from	16	SENT_143	[p9l1464t3245r1908b3310],
21	.1	CD	NUMBER	.1	number	22	SENT_143	[p9l1464t3245r1908b3310],
22	'23	CD	NUMBER	'23	dep	15	SENT_143	[p9l1464t3245r1908b3310],
23	RFLP	NN	O	rflp	dep	22	SENT_143	[p9l1978t3255r2150b3309],

1	genotypes	NNS	O	genotype	nsubjpass	3	SENT_144	[p10l9t24r367b93],
2	were	VBD	O	be	auxpass	3	SENT_144	[p10l396t34r559b75],
3	scored	VBN	O	score	_	0	SENT_144	[p10l592t17r815b75],
4	by	IN	O	by	_	0	SENT_144	[p10l842t17r930b93],
5	at	IN	O	at	quantmod	7	SENT_144	[p10l959t24r1022b75],
6	least	JJS	O	least	mwe	5	SENT_144	[p10l1051t17r1209b75],
7	two	CD	NUMBER	two	num	9	SENT_144	[p10l1239t24r1369b75],
8	blinded	JJ	O	blinded	amod	9	SENT_144	[p10l1398t17r1670b75],
9	investigators	NNS	O	investigator	agent	3	SENT_144	[p10l1700t20r2148b93],
10	who	WP	O	who	nsubj	12	SENT_144	[p10l8t112r161b170],
11	were	VBD	O	be	cop	12	SENT_144	[p10l193t129r357b170],
12	unaware	JJ	O	unaware	rcmod	9	SENT_144	[p10l390t129r690b170],
13	of	IN	O	of	_	0	SENT_144	[p10l725t112r797b170],
14	the	DT	O	the	det	15	SENT_144	[p10l826t112r939b170],
15	subjects	NNS	O	subject	prep_of	12	SENT_144	[p10l974t112r1270b188],
16	’	JJ	O	’	amod	19	SENT_144	[p10l974t112r1270b188],
17	clinical	JJ	O	clinical	amod	19	SENT_144	[p10l1307t112r1562b170],
18	drug	NN	O	drug	nn	19	SENT_144	[p10l1596t112r1758b188],
19	responses	NNS	O	response	dep	15	SENT_144	[p10l1789t129r2145b188],
20	.	.	O	.	_	0	SENT_144	[p10l1789t129r2145b188],

1	PCR	NN	O	pcr	nsubj	2	SENT_145	[p10l10t208r156b264],
2	followed	VBN	O	follow	_	0	SENT_145	[p10l181t206r487b264],
3	by	IN	O	by	_	0	SENT_145	[p10l511t207r598b282],
4	Pyrosequencing	VBG	O	pyrosequence	prepc_by	2	SENT_145	[p10l623t209r1185b282],
5	(	NN	O	(	nn	7	SENT_145	[p10l1213t207r1384b279],
6	PSQ	NN	O	psq	nn	7	SENT_145	[p10l1213t207r1384b279],
7	HS	NN	O	h	dobj	4	SENT_145	[p10l1404t208r1498b264],
8	96A	CD	NUMBER	96a	num	9	SENT_145	[p10l1526t207r1685b279],
9	)	NN	O	)	nsubjpass	11	SENT_145	[p10l1526t207r1685b279],
10	was	VBD	O	be	auxpass	11	SENT_145	[p10l1712t223r1841b264],
11	used	VBN	O	use	rcmod	7	SENT_145	[p10l1866t207r2026b264],
12	for	IN	O	for	_	0	SENT_145	[p10l2052t206r2150b264],
13	genotyping	VBG	O	genotype	prepc_for	11	SENT_145	[p10l9t305r415b378],
14	codon	NN	O	codon	dobj	13	SENT_145	[p10l474t302r694b360],
15	389	CD	NUMBER	389	num	14	SENT_145	[p10l754t304r898b372],
16	,	,	O	,	_	0	SENT_145	[p10l754t304r898b372],
17	with	IN	O	with	_	0	SENT_145	[p10l961t302r1122b360],
18	genotypes	NNS	O	genotype	prep_with	2	SENT_145	[p10l1181t309r1539b378],
19	determined	VBN	O	determine	partmod	18	SENT_145	[p10l1599t302r2008b360],
20	by	IN	O	by	_	0	SENT_145	[p10l2064t302r2152b378],
21	Pyrosequencing	VBG	PERSON	pyrosequence	agent	19	SENT_145	[p10l10t401r572b474],
22	software	NN	O	software	dobj	21	SENT_145	[p10l623t398r934b456],
23	.	.	O	.	_	0	SENT_145	[p10l623t398r934b456],

1	Five	CD	NUMBER	five	num	2	SENT_146	[p10l991t401r1129b456],
2	samples	NNS	O	sample	nsubjpass	7	SENT_146	[p10l1183t398r1458b474],
3	were	VBD	O	be	cop	4	SENT_146	[p10l1508t415r1672b456],
4	problematic	JJ	O	problematic	_	0	SENT_146	[p10l1723t398r2150b474],
5	and	CC	O	and	_	0	SENT_146	[p10l10t493r141b551],
6	were	VBD	O	be	auxpass	7	SENT_146	[p10l165t510r329b551],
7	sent	VBN	O	send	conj_and	4	SENT_146	[p10l358t500r501b551],
8	for	IN	O	for	_	0	SENT_146	[p10l527t493r625b551],
9	direct	JJ	O	direct	amod	10	SENT_146	[p10l651t493r851b551],
10	sequencing	NN	O	sequencing	prep_for	7	SENT_146	[p10l878t496r1278b569],
11	(	CD	NUMBER	(	num	14	SENT_146	[p10l1307t493r1730b565],
12	Amersham	NNP	ORGANIZATION	Amersham	nn	14	SENT_146	[p10l1307t493r1730b565],
13	,	,	O	,	_	0	SENT_146	[p10l1307t493r1730b565],
14	MegaBACE	NNP	O	MegaBACE	tmod	7	SENT_146	[p10l1760t494r2150b569],
15	1000	CD	DATE	1000	num	16	SENT_146	[p10l15t588r204b660],
16	)	CD	NUMBER	)	dep	14	SENT_146	[p10l15t588r204b660],
17	to	TO	O	to	aux	18	SENT_146	[p10l237t595r307b646],
18	ensure	VB	O	ensure	xcomp	7	SENT_146	[p10l338t605r567b646],
19	correct	JJ	O	correct	amod	21	SENT_146	[p10l598t595r840b646],
20	genotype	NN	O	genotype	nn	21	SENT_146	[p10l869t595r1195b664],
21	assignment	NN	O	assignment	dobj	18	SENT_146	[p10l1226t591r1646b664],
22	.	.	O	.	_	0	SENT_146	[p10l1226t591r1646b664],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_147	[p10l12t758r324b816],
2	analysis	NN	O	analysis	nsubjpass	9	SENT_147	[p10l350t758r600b833],
3	Resting	VBG	O	rest	amod	2	SENT_147	[p10l10t855r269b928],
4	and	CC	O	and	_	0	SENT_147	[p10l322t853r454b910],
5	exercise	NN	O	exercise	nn	7	SENT_147	[p10l508t856r782b910],
6	heart	NN	O	heart	nn	7	SENT_147	[p10l837t853r1019b910],
7	rates	NNS	O	rate	nsubjpass	9	SENT_147	[p10l1072t860r1234b910],
8	were	VBD	O	be	auxpass	9	SENT_147	[p10l1287t869r1450b910],
9	calculated	VBN	O	calculate	_	0	SENT_147	[p10l1505t853r1862b910],
10	as	IN	O	as	_	0	SENT_147	[p10l1917t869r1981b910],
11	the	DT	O	the	det	12	SENT_147	[p10l2036t853r2148b910],
12	average	NN	O	average	prep_as	9	SENT_147	[p10l10t965r272b1024],
13	of	IN	O	of	_	0	SENT_147	[p10l302t948r374b1006],
14	6	CD	NUMBER	6	num	16	SENT_147	[p10l401t950r438b1006],
15	R-R	NN	O	r-r	nn	16	SENT_147	[p10l468t951r587b1005],
16	intervals	NNS	O	interval	prep_of	12	SENT_147	[p10l614t948r936b1006],
17	.	.	O	.	_	0	SENT_147	[p10l614t948r936b1006],

1	In	IN	O	in	_	0	SENT_148	[p10l970t951r1043b1005],
2	the	DT	O	the	det	3	SENT_148	[p10l1072t948r1184b1006],
3	case	NN	O	case	prep_in	11	SENT_148	[p10l1214t965r1354b1006],
4	of	IN	O	of	_	0	SENT_148	[p10l1384t948r1456b1006],
5	exercise	NN	O	exercise	nn	7	SENT_148	[p10l1481t951r1756b1006],
6	heart	NN	O	heart	nn	7	SENT_148	[p10l1785t948r1967b1006],
7	rate	NN	O	rate	prep_of	3	SENT_148	[p10l1995t955r2144b1018],
8	,	,	O	,	_	0	SENT_148	[p10l1995t955r2144b1018],
9	this	DT	O	this	nsubjpass	11	SENT_148	[p10l9t1043r138b1101],
10	was	VBD	O	be	auxpass	11	SENT_148	[p10l176t1060r304b1101],
11	based	VBN	O	base	_	0	SENT_148	[p10l342t1043r540b1101],
12	on	IN	O	on	_	0	SENT_148	[p10l579t1060r670b1101],
13	the	DT	O	the	det	15	SENT_148	[p10l709t1043r821b1101],
14	ECG	NN	O	ecg	nn	15	SENT_148	[p10l862t1045r1019b1101],
15	recording	NN	O	recording	prep_on	11	SENT_148	[p10l1057t1043r1396b1119],
16	in	IN	O	in	_	0	SENT_148	[p10l1434t1046r1504b1100],
17	the	DT	DATE	the	det	18	SENT_148	[p10l1543t1043r1656b1101],
18	minute	NN	DATE	minute	prep_in	15	SENT_148	[p10l1696t1046r1951b1101],
19	after	IN	O	after	mark	21	SENT_148	[p10l1992t1043r2150b1101],
20	subjects	NNS	O	subject	nsubj	21	SENT_148	[p10l11t1138r287b1214],
21	achieved	VBD	O	achieve	advcl	11	SENT_148	[p10l318t1138r629b1196],
22	their	PRP$	O	they	poss	25	SENT_148	[p10l659t1138r826b1196],
23	target	NN	O	target	nn	25	SENT_148	[p10l854t1145r1057b1214],
24	heart	NN	O	heart	nn	25	SENT_148	[p10l1086t1138r1268b1196],
25	rate	NN	O	rate	dobj	21	SENT_148	[p10l1297t1145r1447b1196],
26	.	.	O	.	_	0	SENT_148	[p10l1297t1145r1447b1196],

1	Because	IN	O	because	_	0	SENT_149	[p10l87t1235r359b1290],
2	of	IN	O	of	prepc_because_of	16	SENT_149	[p10l395t1232r467b1290],
3	the	DT	O	the	det	6	SENT_149	[p10l497t1232r610b1290],
4	relatively	RB	O	relatively	advmod	5	SENT_149	[p10l645t1232r974b1308],
5	infrequent	JJ	O	infrequent	amod	6	SENT_149	[p10l1006t1232r1381b1308],
6	occurrence	NN	O	occurrence	pobj	16	SENT_149	[p10l1416t1249r1801b1290],
7	of	IN	O	of	_	0	SENT_149	[p10l1837t1232r1909b1290],
8	Gly49	NN	O	gly49	nn	9	SENT_149	[p10l1940t1232r2147b1308],
9	homozygotes	NNS	O	homozygote	prep_of	6	SENT_149	[p10l9t1328r481b1404],
10	and	CC	O	and	_	0	SENT_149	[p10l539t1328r670b1386],
11	Gly389	NN	O	gly389	nn	12	SENT_149	[p10l728t1328r979b1404],
12	homozygotes	NNS	O	homozygote	conj_and	9	SENT_149	[p10l1037t1328r1527b1404],
13	,	,	O	,	_	0	SENT_149	[p10l1037t1328r1527b1404],
14	it	PRP	O	it	nsubjpass	16	SENT_149	[p10l1589t1331r1638b1386],
15	was	VBD	O	be	auxpass	16	SENT_149	[p10l1692t1345r1820b1386],
16	decided	VBN	O	decide	_	0	SENT_149	[p10l1877t1328r2150b1386],
17	a	DT	O	a	det	18	SENT_149	[p10l10t1442r46b1482],
18	priori	FW	O	priori	nsubj	26	SENT_149	[p10l90t1425r272b1500],
19	to	TO	O	to	aux	20	SENT_149	[p10l322t1431r392b1482],
20	pool	VB	O	pool	xcomp	16	SENT_149	[p10l443t1424r601b1500],
21	heterozygotes	NNS	O	heterozygote	dobj	20	SENT_149	[p10l652t1424r1141b1500],
22	and	CC	O	and	_	0	SENT_149	[p10l1194t1424r1325b1482],
23	Variant	JJ	O	variant	amod	24	SENT_149	[p10l1374t1427r1625b1482],
24	homozygotes	NNS	O	homozygote	conj_and	21	SENT_149	[p10l1676t1424r2148b1500],
25	and	CC	O	and	_	0	SENT_149	[p10l10t1518r141b1576],
26	classify	VB	O	classify	xcomp	16	SENT_149	[p10l188t1518r442b1594],
27	them	PRP	O	they	dobj	26	SENT_149	[p10l486t1518r672b1576],
28	as	IN	O	as	_	0	SENT_149	[p10l720t1535r785b1576],
29	G1y49	NN	O	g1y49	nn	30	SENT_149	[p10l834t1518r1041b1594],
30	carriers	NNS	O	carrier	prep_as	26	SENT_149	[p10l1091t1521r1344b1576],
31	and	CC	O	and	_	0	SENT_149	[p10l1393t1518r1524b1576],
32	Gly389	NN	O	gly389	nn	33	SENT_149	[p10l1573t1518r1823b1594],
33	carriers	NNS	O	carrier	conj_and	30	SENT_149	[p10l1873t1521r2145b1576],
34	.	.	O	.	_	0	SENT_149	[p10l1873t1521r2145b1576],

1	Given	VBN	O	give	prep	16	SENT_150	[p10l11t1616r221b1672],
2	the	DT	O	the	det	4	SENT_150	[p10l251t1614r364b1672],
3	allele	NN	O	allele	nn	4	SENT_150	[p10l396t1614r578b1672],
4	frequencies	NNS	O	frequency	dep	1	SENT_150	[p10l610t1614r1012b1690],
5	for	IN	O	for	_	0	SENT_150	[p10l1044t1614r1142b1672],
6	the	DT	O	the	det	8	SENT_150	[p10l1172t1614r1284b1672],
7	ADRB1	NN	O	adrb1	nn	8	SENT_150	[p10l1311t1616r1555b1671],
8	polymorphisms	NNS	O	polymorphism	prep_for	4	SENT_150	[p10l1592t1614r2148b1690],
9	among	IN	O	among	_	0	SENT_150	[p10l10t1726r255b1785],
10	the	DT	O	the	det	12	SENT_150	[p10l280t1709r392b1767],
11	54	CD	NUMBER	54	num	12	SENT_150	[p10l420t1711r501b1767],
12	patients	NNS	O	patient	prep_among	8	SENT_150	[p10l527t1712r810b1785],
13	studied	VBN	O	study	partmod	12	SENT_150	[p10l838t1709r1111b1779],
14	,	,	O	,	_	0	SENT_150	[p10l838t1709r1111b1779],
15	we	PRP	O	we	nsubj	16	SENT_150	[p10l1140t1726r1236b1767],
16	had	VBD	O	have	_	0	SENT_150	[p10l1262t1709r1394b1767],
17	80	CD	PERCENT	80	number	18	SENT_150	[p10l1421t1711r1572b1767],
18	%	NN	PERCENT	%	amod	19	SENT_150	[p10l1421t1711r1572b1767],
19	power	NN	O	power	dobj	16	SENT_150	[p10l1597t1726r1815b1785],
20	to	TO	O	to	aux	21	SENT_150	[p10l1840t1716r1909b1767],
21	detect	VB	O	detect	xcomp	16	SENT_150	[p10l1937t1709r2150b1767],
22	at	IN	O	at	advmod	27	SENT_150	[p10l10t1810r74b1860],
23	least	JJS	O	least	pobj	22	SENT_150	[p10l102t1803r259b1860],
24	a	DT	O	a	det	27	SENT_150	[p10l288t1819r323b1860],
25	7.4	CD	PERCENT	7.4	number	26	SENT_150	[p10l356t1804r526b1860],
26	%	NN	PERCENT	%	amod	27	SENT_150	[p10l356t1804r526b1860],
27	difference	NN	O	difference	dobj	21	SENT_150	[p10l556t1802r905b1860],
28	in	IN	O	in	_	0	SENT_150	[p10l934t1806r1004b1859],
29	reduction	NN	O	reduction	prep_in	21	SENT_150	[p10l1033t1803r1376b1860],
30	in	IN	O	in	_	0	SENT_150	[p10l1404t1806r1475b1859],
31	exercise	NN	O	exercise	nn	33	SENT_150	[p10l1504t1806r1779b1860],
32	heart	NN	O	heart	nn	33	SENT_150	[p10l1807t1803r1990b1860],
33	rate	NN	O	rate	prep_in	21	SENT_150	[p10l2018t1810r2148b1860],
34	between	IN	O	between	_	0	SENT_150	[p10l7t1898r304b1956],
35	genotype	NN	O	genotype	nn	36	SENT_150	[p10l334t1905r660b1974],
36	groups	NNS	O	group	prep_between	33	SENT_150	[p10l690t1915r945b1974],
37	.	.	O	.	_	0	SENT_150	[p10l690t1915r945b1974],

1	Baseline	NN	O	baseline	nn	2	SENT_151	[p10l87t1993r373b2051],
2	characteristics	NNS	O	characteristic	nsubj	3	SENT_151	[p10l428t1993r928b2051],
3	were	VBD	O	be	_	0	SENT_151	[p10l980t2010r1144b2051],
4	compared	VBN	O	compare	prep	3	SENT_151	[p10l1200t1993r1550b2069],
5	between	IN	O	between	pcomp	4	SENT_151	[p10l1601t1993r1899b2051],
6	genotypes	NNS	O	genotype	pobj	5	SENT_151	[p10l1952t2010r2148b2069, p10l9t2093r191b2162],
7	using	VBG	O	use	partmod	6	SENT_151	[p10l224t2089r417b2162],
8	x2	NN	O	x2	dobj	7	SENT_151	[p10l449t2079r534b2158],
9	,	,	O	,	_	0	SENT_151	[p10l449t2079r534b2158],
10	Fisher	NNP	PERSON	Fisher	poss	13	SENT_151	[p10l573t2086r829b2144],
11	's	POS	O	's	_	0	SENT_151	[p10l573t2086r829b2144],
12	exact	JJ	O	exact	amod	13	SENT_151	[p10l865t2093r1048b2144],
13	tests	NNS	O	test	pobj	5	SENT_151	[p10l1081t2093r1253b2156],
14	,	,	O	,	_	0	SENT_151	[p10l1081t2093r1253b2156],
15	or	CC	O	or	_	0	SENT_151	[p10l1292t2103r1364b2144],
16	Student	NN	O	student	poss	19	SENT_151	[p10l1397t2086r1717b2144],
17	's	POS	O	's	_	0	SENT_151	[p10l1397t2086r1717b2144],
18	unpaired	JJ	O	unpaired	amod	19	SENT_151	[p10l1750t2086r2069b2162],
19	ttest	NN	O	ttest	conj_or	6	SENT_151	[p10l2105t2092r2149b2144, p10l9t2189r150b2252],
20	,	,	O	,	_	0	SENT_151	[p10l2105t2092r2149b2144, p10l9t2189r150b2252],
21	as	IN	O	as	_	0	SENT_151	[p10l191t2198r255b2239],
22	appropriate	JJ	O	appropriate	prep_as	3	SENT_151	[p10l293t2184r718b2257],
23	.	.	O	.	_	0	SENT_151	[p10l293t2184r718b2257],

1	To	TO	O	to	aux	2	SENT_152	[p10l755t2184r841b2239],
2	investigate	VB	O	investigate	csubjpass	22	SENT_152	[p10l877t2184r1258b2257],
3	pharmacodynamic	JJ	O	pharmacodynamic	amod	4	SENT_152	[p10l1294t2181r1962b2257],
4	relationships	NNS	O	relationship	dobj	2	SENT_152	[p10l1997t2181r2148b2239, p10l9t2276r354b2352],
5	,	,	O	,	_	0	SENT_152	[p10l1997t2181r2148b2239, p10l9t2276r354b2352],
6	S-metoprolol	NN	O	s-metoprolol	nn	8	SENT_152	[p10l392t2277r851b2352],
7	plasma	NN	O	plasma	nn	8	SENT_152	[p10l886t2276r1135b2352],
8	concentration	NN	O	concentration	conj_and	4	SENT_152	[p10l1171t2279r1671b2334],
9	and	CC	O	and	_	0	SENT_152	[p10l1707t2276r1839b2334],
10	exercise	NN	O	exercise	nn	13	SENT_152	[p10l1874t2279r2149b2334],
11	heart	NN	O	heart	nn	13	SENT_152	[p10l9t2372r192b2430],
12	rate	NN	O	rate	nn	13	SENT_152	[p10l231t2379r362b2430],
13	response	NN	O	response	conj_and	4	SENT_152	[p10l404t2389r709b2448],
14	to	TO	O	to	_	0	SENT_152	[p10l751t2379r821b2430],
15	metoprolol	NN	O	metoprolol	prep_to	2	SENT_152	[p10l861t2372r1257b2448],
16	at	IN	O	at	_	0	SENT_152	[p10l1298t2379r1362b2430],
17	the	DT	O	the	det	20	SENT_152	[p10l1402t2372r1515b2430],
18	two	CD	NUMBER	two	num	20	SENT_152	[p10l1556t2379r1686b2430],
19	time	NN	O	time	nn	20	SENT_152	[p10l1728t2375r1886b2430],
20	points	NNS	O	point	prep_at	2	SENT_152	[p10l1927t2375r2148b2448],
21	were	VBD	O	be	auxpass	22	SENT_152	[p10l8t2483r171b2524],
22	plotted	VBN	O	plot	_	0	SENT_152	[p10l213t2467r467b2542],
23	by	IN	O	by	_	0	SENT_152	[p10l507t2467r594b2542],
24	genotype	NN	O	genotype	nn	25	SENT_152	[p10l634t2474r960b2542],
25	group	NN	O	group	agent	22	SENT_152	[p10l1002t2483r1207b2542],
26	(	CD	NUMBER	(	num	27	SENT_152	[p10l1253t2467r1526b2542],
27	Arg389	NN	O	arg389	nsubj	36	SENT_152	[p10l1253t2467r1526b2542],
28	or	CC	O	or	_	0	SENT_152	[p10l1571t2483r1642b2524],
29	Ser49	NN	O	ser49	nn	30	SENT_152	[p10l1683t2468r1870b2524],
30	homozygotes	NNS	O	homozygote	conj_or	27	SENT_152	[p10l1914t2467r2148b2524, p10l9t2569r268b2638],
31	and	CC	O	and	_	0	SENT_152	[p10l303t2562r435b2620],
32	Gly389	NN	O	gly389	nn	35	SENT_152	[p10l470t2562r720b2638],
33	or	CC	O	or	_	0	SENT_152	[p10l758t2579r829b2620],
34	Gly49	NN	O	gly49	conj_or	32	SENT_152	[p10l863t2562r1070b2638],
35	carriers	NNS	O	carrier	conj_and	27	SENT_152	[p10l1107t2562r1406b2634],
36	)	VBP	O	)	rcmod	25	SENT_152	[p10l1107t2562r1406b2634],
37	.	.	O	.	_	0	SENT_152	[p10l1107t2562r1406b2634],

1	The	DT	O	the	det	3	SENT_153	[p10l1442t2562r1575b2620],
2	concentrationresponse	NN	O	concentrationresponse	nn	3	SENT_153	[p10l1611t2565r2152b2620, p10l9t2674r315b2733],
3	curves	NNS	O	curve	nsubjpass	12	SENT_153	[p10l346t2674r567b2715],
4	revealed	VBD	O	reveal	_	0	SENT_153	[p10l596t2657r888b2715],
5	little	JJ	O	little	amod	6	SENT_153	[p10l917t2657r1079b2715],
6	evidence	NN	O	evidence	dobj	4	SENT_153	[p10l1111t2657r1420b2715],
7	of	IN	O	of	_	0	SENT_153	[p10l1451t2657r1522b2715],
8	nonlinearity	NN	O	nonlinearity	prep_of	6	SENT_153	[p10l1547t2657r1991b2733],
9	and	CC	O	and	_	0	SENT_153	[p10l2019t2657r2150b2715],
10	so	RB	O	so	advmod	12	SENT_153	[p10l11t2768r81b2809],
11	were	VBD	O	be	auxpass	12	SENT_153	[p10l121t2768r285b2809],
12	modeled	VBN	O	model	conj_and	4	SENT_153	[p10l328t2752r635b2809],
13	with	IN	O	with	_	0	SENT_153	[p10l674t2752r835b2809],
14	a	DT	O	a	det	17	SENT_153	[p10l878t2768r912b2809],
15	linear	JJ	O	linear	amod	17	SENT_153	[p10l954t2752r1155b2809],
16	pharmacodynamic	JJ	O	pharmacodynamic	amod	17	SENT_153	[p10l1195t2752r1863b2827],
17	model	NN	O	model	prep_with	12	SENT_153	[p10l1904t2752r2144b2822],
18	,	,	O	,	_	0	SENT_153	[p10l1904t2752r2144b2822],
19	where	WRB	O	where	advmod	21	SENT_153	[p10l8t2846r221b2904],
20	E	NN	O	e	nsubj	21	SENT_153	[p10l254t2846r739b2916],
21	=	JJ	O	=	rcmod	17	SENT_153	[p10l254t2846r739b2916],
22	EmaX/EC50	NN	O	emax/ec50	nn	24	SENT_153	[p10l254t2846r739b2916],
23	x	NN	O	x	nn	24	SENT_153	[p10l765t2865r802b2902],
24	C	NN	O	c	dobj	21	SENT_153	[p10l830t2848r895b2917],
25	,	,	O	,	_	0	SENT_153	[p10l830t2848r895b2917],
26	when	WRB	O	when	advmod	30	SENT_153	[p10l934t2846r1131b2904],
27	concentration	NN	O	concentration	nsubj	30	SENT_153	[p10l1168t2849r1668b2904],
28	is	VBZ	O	be	cop	30	SENT_153	[p10l1703t2849r1754b2904],
29	much	RB	O	much	advmod	30	SENT_153	[p10l1790t2846r1993b2904],
30	less	JJR	O	less	dep	24	SENT_153	[p10l2029t2846r2148b2904],
31	than	IN	O	than	_	0	SENT_153	[p10l9t2942r174b3000],
32	EC50	NN	O	ec50	prep_than	21	SENT_153	[p10l229t2944r408b3013],
33	.	.	O	.	_	0	SENT_153	[p10l229t2944r408b3013],

1	Simplified	VBN	O	simplify	partmod	8	SENT_154	[p10l468t2942r844b3018],
2	,	,	O	,	_	0	SENT_154	[p10l468t2942r844b3018],
3	this	DT	O	this	det	4	SENT_154	[p10l904t2942r1033b3000],
4	equation	NN	O	equation	nsubj	8	SENT_154	[p10l1089t2945r1403b3018],
5	is	VBZ	O	be	cop	8	SENT_154	[p10l1457t2945r1508b3000],
6	E	NN	O	e	nn	8	SENT_154	[p10l1559t2945r1720b3015],
7	=	JJ	O	=	amod	8	SENT_154	[p10l1559t2945r1720b3015],
8	y	NN	O	y	_	0	SENT_154	[p10l1559t2945r1720b3015],
9	x	NN	O	x	dep	10	SENT_154	[p10l1747t2961r1784b2998],
10	C	NN	O	c	amod	8	SENT_154	[p10l1811t2944r1877b3013],
11	,	,	O	,	_	0	SENT_154	[p10l1811t2944r1877b3013],
12	where	WRB	O	where	advmod	20	SENT_154	[p10l1934t2942r2148b3000],
13	32	CD	NUMBER	32	num	15	SENT_154	[p10l9t3060r38b3111],
14	=	JJ	O	=	amod	15	SENT_154	[p10l57t3067r109b3085],
15	slope	NN	O	slope	nsubj	20	SENT_154	[p10l129t3039r307b3115],
16	and	CC	O	and	advmod	20	SENT_154	[p10l336t3039r467b3097],
17	is	VBZ	O	be	cop	20	SENT_154	[p10l494t3042r544b3097],
18	the	DT	O	the	det	20	SENT_154	[p10l571t3039r684b3097],
19	pharmacodynamic	JJ	O	pharmacodynamic	amod	20	SENT_154	[p10l711t3039r1379b3115],
20	parameter	NN	O	parameter	advcl	8	SENT_154	[p10l1405t3046r1764b3115],
21	of	IN	O	of	_	0	SENT_154	[p10l1791t3039r1862b3097],
22	interest	NN	O	interest	prep_of	20	SENT_154	[p10l1884t3042r2150b3097],
23	that	WDT	O	that	nsubjpass	25	SENT_154	[p10l9t3133r153b3191],
24	was	VBD	O	be	auxpass	25	SENT_154	[p10l178t3150r306b3191],
25	compared	VBN	O	compare	rcmod	20	SENT_154	[p10l335t3133r685b3209],
26	by	IN	O	by	_	0	SENT_154	[p10l711t3133r798b3209],
27	genotype	NN	O	genotype	agent	25	SENT_154	[p10l823t3141r1168b3209],
28	.	.	O	.	_	0	SENT_154	[p10l823t3141r1168b3209],

1	Heart	NNP	O	Heart	nn	4	SENT_155	[p10l1201t3136r1394b3191],
2	rate	NN	O	rate	nn	4	SENT_155	[p10l1421t3141r1552b3191],
3	treatment	NN	O	treatment	nn	4	SENT_155	[p10l1580t3141r1931b3191],
4	effect	NN	O	effect	nsubjpass	10	SENT_155	[p10l1959t3133r2150b3191],
5	by	IN	O	by	_	0	SENT_155	[p10l7t3228r95b3304],
6	genotype	NN	O	genotype	nn	7	SENT_155	[p10l120t3236r446b3304],
7	group	NN	O	group	prep_by	4	SENT_155	[p10l474t3245r679b3304],
8	was	VBD	O	be	auxpass	10	SENT_155	[p10l705t3245r833b3286],
9	then	RB	O	then	advmod	10	SENT_155	[p10l861t3228r1025b3286],
10	analyzed	VBN	O	analyze	_	0	SENT_155	[p10l1053t3228r1364b3304],
11	using	VBG	O	use	xcomp	10	SENT_155	[p10l1389t3231r1582b3304],
12	the	DT	O	the	nsubj	13	SENT_155	[p10l1607t3228r1720b3286],
13	generalized	VBN	O	generalize	dep	11	SENT_155	[p10l1748t3228r2150b3304],
14	linear	JJ	O	linear	amod	16	SENT_155	[p10l9t3324r211b3382],
15	model	NN	O	model	nn	16	SENT_155	[p10l243t3324r465b3382],
16	procedure	NN	O	procedure	dobj	13	SENT_155	[p10l498t3324r851b3400],
17	with	IN	O	with	_	0	SENT_155	[p10l883t3324r1045b3382],
18	race	NN	O	race	prep_with	13	SENT_155	[p10l1078t3341r1217b3382],
19	as	IN	O	as	_	0	SENT_155	[p10l1251t3341r1316b3382],
20	a	DT	O	a	det	21	SENT_155	[p10l1350t3341r1385b3382],
21	covariate	NN	O	covariate	prep_as	13	SENT_155	[p10l1418t3327r1755b3382],
22	.	.	O	.	_	0	SENT_155	[p10l1418t3327r1755b3382],

1	Given	VBN	O	give	prep	24	SENT_156	[p10l1793t3326r2004b3382],
2	the	DT	O	the	det	3	SENT_156	[p10l2036t3324r2148b3382],
3	inﬂuence	NN	O	inﬂuence	dep	1	SENT_156	[p10l9t3418r340b3476],
4	of	IN	O	of	_	0	SENT_156	[p10l409t3418r481b3476],
5	plasma	NN	O	plasma	nn	6	SENT_156	[p10l543t3419r792b3494],
6	concentration	NN	O	concentration	prep_of	3	SENT_156	[p10l860t3422r1360b3476],
7	on	IN	O	on	_	0	SENT_156	[p10l1429t3435r1520b3476],
8	the	DT	O	the	det	11	SENT_156	[p10l1587t3419r1700b3476],
9	heart	NN	O	heart	nn	11	SENT_156	[p10l1768t3419r1950b3476],
10	rate	NN	O	rate	nn	11	SENT_156	[p10l2018t3426r2148b3476],
11	response	NN	O	response	prep_on	6	SENT_156	[p10l9t3530r333b3589],
12	,	,	O	,	_	0	SENT_156	[p10l9t3530r333b3589],
13	the	DT	O	the	det	14	SENT_156	[p10l385t3514r498b3571],
14	heart	NN	O	heart	nsubjpass	24	SENT_156	[p10l546t3514r729b3571],
15	rate	NN	O	rate	nn	16	SENT_156	[p10l776t3521r906b3571],
16	responses	NNS	O	response	dep	14	SENT_156	[p10l955t3530r1292b3589],
17	(	JJ	PERCENT	(	amod	19	SENT_156	[p10l1344t3514r1632b3589],
18	percent	NN	PERCENT	percent	nn	19	SENT_156	[p10l1344t3514r1632b3589],
19	change	NN	O	change	dep	14	SENT_156	[p10l1680t3514r1931b3589],
20	from	IN	O	from	_	0	SENT_156	[p10l1980t3513r2149b3571],
21	baseline	NN	O	baseline	nn	22	SENT_156	[p10l7t3609r318b3681],
22	)	NN	O	)	prep_from	19	SENT_156	[p10l7t3609r318b3681],
23	were	VBD	O	be	auxpass	24	SENT_156	[p10l365t3626r528b3667],
24	corrected	VBN	O	correct	_	0	SENT_156	[p10l575t3609r902b3667],
25	for	IN	O	for	_	0	SENT_156	[p10l946t3609r1044b3667],
26	plasma	NN	O	plasma	nn	27	SENT_156	[p10l1088t3609r1337b3685],
27	concentration	NN	O	concentration	prep_for	24	SENT_156	[p10l1382t3612r1882b3667],
28	at	IN	O	at	_	0	SENT_156	[p10l1928t3616r1992b3667],
29	the	DT	O	the	det	30	SENT_156	[p10l2036t3609r2148b3667],
30	time	NN	O	time	prep_at	24	SENT_156	[p10l9t3707r168b3761],
31	of	IN	O	of	_	0	SENT_156	[p10l199t3703r270b3761],
32	treadmill	NN	O	treadmill	nn	33	SENT_156	[p10l295t3704r617b3761],
33	study	NN	O	study	prep_of	30	SENT_156	[p10l649t3704r841b3779],
34	prior	RB	O	prior	_	0	SENT_156	[p10l868t3707r1040b3779],
35	to	TO	O	to	_	0	SENT_156	[p10l1068t3711r1138b3761],
36	such	JJ	O	such	amod	37	SENT_156	[p10l1170t3704r1330b3761],
37	analyses	NNS	O	analysis	prep_prior_to	24	SENT_156	[p10l1361t3704r1669b3779],
38	.	.	O	.	_	0	SENT_156	[p10l1361t3704r1669b3779],

1	All	DT	O	all	det	3	SENT_157	[p11l85t17r182b74],
2	statistical	JJ	O	statistical	amod	3	SENT_157	[p11l211t17r540b75],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_157	[p11l568t17r858b93],
4	were	VBD	O	be	auxpass	5	SENT_157	[p11l882t34r1046b75],
5	performed	VBN	O	perform	_	0	SENT_157	[p11l1073t17r1442b93],
6	using	VBG	O	use	xcomp	5	SENT_157	[p11l1467t20r1659b93],
7	SPSS	NNP	ORGANIZATION	SPSS	dobj	6	SENT_157	[p11l1685t19r1839b75],
8	(	CD	NUMBER	(	num	7	SENT_157	[p11l1869t17r2150b89],
9	version	NN	O	version	dep	24	SENT_157	[p11l1869t17r2150b89],
10	11.0	CD	NUMBER	11.0	num	9	SENT_157	[p11l15t114r176b183],
11	,	,	O	,	_	0	SENT_157	[p11l15t114r176b183],
12	SPSS	NNP	ORGANIZATION	SPSS	nn	13	SENT_157	[p11l223t114r377b170],
13	Inc.	NNP	ORGANIZATION	Inc.	conj_or	9	SENT_157	[p11l420t115r570b182],
14	,	,	O	,	_	0	SENT_157	[p11l420t115r570b182],
15	Chicago	NNP	LOCATION	Chicago	conj_or	9	SENT_157	[p11l617t112r923b188],
16	,	,	O	,	_	0	SENT_157	[p11l617t112r923b188],
17	IL	NN	LOCATION	il	conj_or	9	SENT_157	[p11l970t115r1054b183],
18	,	,	O	,	_	0	SENT_157	[p11l970t115r1054b183],
19	USA	NNP	LOCATION	USA	conj_or	9	SENT_157	[p11l1100t112r1271b184],
20	)	CD	NUMBER	)	num	19	SENT_157	[p11l1100t112r1271b184],
21	or	CC	O	or	_	0	SENT_157	[p11l1317t129r1388b170],
22	SAS	NNP	O	SAS	conj_or	9	SENT_157	[p11l1429t114r1553b170],
23	(	CD	NUMBER	(	dep	24	SENT_157	[p11l1598t112r1879b184],
24	Version	NNP	O	Version	dep	6	SENT_157	[p11l1598t112r1879b184],
25	8	CD	NUMBER	8	num	24	SENT_157	[p11l1922t114r1978b182],
26	,	,	O	,	_	0	SENT_157	[p11l1922t114r1978b182],
27	SAS	NNP	ORGANIZATION	SAS	nn	29	SENT_157	[p11l2025t114r2148b170],
28	Institute	NNP	ORGANIZATION	Institute	nn	29	SENT_157	[p11l10t209r308b265],
29	Inc.	NNP	ORGANIZATION	Inc.	appos	24	SENT_157	[p11l346t209r496b277],
30	,	,	O	,	_	0	SENT_157	[p11l346t209r496b277],
31	Cary	NNP	PERSON	Cary	appos	24	SENT_157	[p11l539t208r714b283],
32	,	,	O	,	_	0	SENT_157	[p11l539t208r714b283],
33	NC	NNP	O	NC	appos	24	SENT_157	[p11l753t208r886b277],
34	,	,	O	,	_	0	SENT_157	[p11l753t208r886b277],
35	USA	NNP	LOCATION	USA	appos	24	SENT_157	[p11l927t207r1119b279],
36	)	CD	NUMBER	)	num	35	SENT_157	[p11l927t207r1119b279],
37	.	.	O	.	_	0	SENT_157	[p11l927t207r1119b279],

1	A	DT	O	a	det	4	SENT_158	[p11l1159t208r1209b264],
2	P	NN	O	p	nn	4	SENT_158	[p11l1241t207r1500b265],
3	—	NN	O	—	nn	4	SENT_158	[p11l1241t207r1500b265],
4	value	NN	O	value	nsubjpass	10	SENT_158	[p11l1241t207r1500b265],
5	of	IN	O	of	_	0	SENT_158	[p11l1538t207r1610b265],
6	less	JJR	O	less	mwe	7	SENT_158	[p11l1642t207r1762b265],
7	than	IN	O	than	quantmod	8	SENT_158	[p11l1798t207r1963b265],
8	0.05	CD	NUMBER	0.05	prep_of	4	SENT_158	[p11l1999t208r2145b265],
9	was	VBD	O	be	auxpass	10	SENT_158	[p11l8t318r135b359],
10	considered	VBN	O	consider	_	0	SENT_158	[p11l167t301r549b359],
11	statistically	RB	O	statistically	advmod	12	SENT_158	[p11l580t301r978b377],
12	significant	JJ	O	significant	acomp	10	SENT_158	[p11l1007t301r1396b377],
13	.	.	O	.	_	0	SENT_158	[p11l1007t301r1396b377],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_159	[p11l8t488r729b564],

1	We	PRP	O	we	nsubj	3	SENT_160	[p11l8t674r105b724],
2	would	MD	O	would	aux	3	SENT_160	[p11l126t672r323b724],
3	like	VB	O	like	_	0	SENT_160	[p11l344t672r453b724],
4	to	TO	O	to	aux	6	SENT_160	[p11l475t679r537b724],
5	gratefully	RB	O	gratefully	advmod	6	SENT_160	[p11l559t672r861b740],
6	acknowledge	VB	O	acknowledge	xcomp	3	SENT_160	[p11l880t672r1286b740],
7	Kathy	NNP	PERSON	Kathy	nn	8	SENT_160	[p11l1308t672r1495b740],
8	Eberst	NNP	PERSON	Eberst	dobj	6	SENT_160	[p11l1514t672r1702b724],
9	for	IN	O	for	_	0	SENT_160	[p11l1723t672r1811b724],
10	her	PRP$	O	she	poss	12	SENT_160	[p11l1831t672r1933b724],
11	expert	NN	O	expert	nn	12	SENT_160	[p11l1954t679r2151b740],
12	HPLC	NN	O	hplc	prep_for	8	SENT_160	[p11l10t759r188b809],
13	analytic	JJ	O	analytic	amod	14	SENT_160	[p11l245t757r493b825],
14	assistance	NN	O	assistance	dep	27	SENT_160	[p11l550t760r856b809],
15	and	CC	O	and	_	0	SENT_160	[p11l913t757r1030b809],
16	Dr	NN	O	dr	dep	27	SENT_160	[p11l1086t760r1162b808],
17	Hartmut	NNP	PERSON	Hartmut	nn	18	SENT_160	[p11l1218t760r1487b809],
18	Derendorf	NNP	PERSON	Derendorf	dep	14	SENT_160	[p11l1542t757r1865b809],
19	for	IN	O	for	_	0	SENT_160	[p11l1917t757r2005b809],
20	his	PRP$	O	he	poss	23	SENT_160	[p11l2059t757r2149b809],
21	mg	NN	O	mg	nn	23	SENT_160	[p11l8t1178r135b1302],
22	ﬂ-blocker	NN	O	ﬂ-blocker	nn	23	SENT_160	[p11l1164t1190r1389b1247],
23	drug	NN	O	drug	prep_for	18	SENT_160	[p11l1404t1190r1517b1249],
24	target	NN	O	target	nn	25	SENT_160	[p11l1536t1195r1687b1249],
25	pharmacogenetics	NNS	O	pharmacogenetic	dep	27	SENT_160	[p11l1707t1190r2149b1249],
26	AL	NNP	MISC	AL	nn	27	SENT_160	[p11l1753t1263r1805b1302],
27	Beitelshees	NNP	MISC	Beitelshees	dep	8	SENT_160	[p11l1825t1261r2045b1303],
28	et	FW	O	et	nn	29	SENT_160	[p11l2065t1266r2101b1303],
29	al	FW	O	al	dep	27	SENT_160	[p11l2117t1261r2153b1303],
30	insightful	JJ	O	insightful	amod	31	SENT_160	[p11l8t1549r312b1617],
31	comments	NNS	O	comment	dep	29	SENT_160	[p11l358t1555r688b1601],
32	regarding	VBG	O	regard	_	0	SENT_160	[p11l734t1549r1033b1617],
33	the	DT	O	the	det	34	SENT_160	[p11l1076t1549r1176b1601],
34	manuscript	NN	O	manuscript	prep_regarding	8	SENT_160	[p11l1223t1552r1595b1617],
35	.	.	O	.	_	0	SENT_160	[p11l1223t1552r1595b1617],

1	This	DT	O	this	det	2	SENT_161	[p11l1643t1549r1776b1600],
2	study	NN	O	study	nsubjpass	4	SENT_161	[p11l1823t1549r1993b1617],
3	was	VBD	O	be	auxpass	4	SENT_161	[p11l2035t1564r2149b1600],
4	supported	VBN	O	support	_	0	SENT_161	[p11l10t1634r324b1702],
5	by	IN	O	by	_	0	SENT_161	[p11l343t1634r420b1702],
6	NIH	NNP	ORGANIZATION	NIH	nn	8	SENT_161	[p11l438t1636r568b1685],
7	Grants	NNPS	O	Grants	nn	8	SENT_161	[p11l590t1636r797b1686],
8	HL64691	NN	O	hl64691	agent	4	SENT_161	[p11l820t1636r1119b1697],
9	,	,	O	,	_	0	SENT_161	[p11l820t1636r1119b1697],
10	HL68834	NN	O	hl68834	appos	8	SENT_161	[p11l1145t1636r1444b1697],
11	,	,	O	,	_	0	SENT_161	[p11l1145t1636r1444b1697],
12	and	CC	O	and	_	0	SENT_161	[p11l1470t1634r1587b1686],
13	by	IN	O	by	_	0	SENT_161	[p11l1606t1634r1684b1702],
14	the	DT	O	the	det	20	SENT_161	[p11l1702t1634r1802b1686],
15	University	NNP	ORGANIZATION	University	dep	20	SENT_161	[p11l1824t1636r2151b1702],
16	of	IN	ORGANIZATION	of	_	0	SENT_161	[p11l9t1718r73b1769],
17	Florida	NNP	ORGANIZATION	Florida	nn	19	SENT_161	[p11l95t1718r312b1769],
18	GCRC	NNP	ORGANIZATION	GCRC	nn	19	SENT_161	[p11l338t1720r531b1769],
19	Grant	NNP	ORGANIZATION	Grant	prep_of	15	SENT_161	[p11l558t1720r739b1769],
20	RROOO82	NN	O	rrooo82	conj_and	8	SENT_161	[p11l765t1720r1058b1769],
21	.	.	O	.	_	0	SENT_161	[p11l765t1720r1058b1769],

1	Duality	NN	O	duality	_	0	SENT_162	[p11l11t1915r286b1991],
2	of	IN	O	of	_	0	SENT_162	[p11l314t1915r395b1973],
3	Interest	NN	O	interest	prep_of	1	SENT_162	[p11l423t1918r721b1973],

1	The	DT	O	the	det	3	SENT_163	[p11l7t2094r130b2152],
2	study	NN	O	study	nn	3	SENT_163	[p11l167t2094r348b2170],
3	sponsor	NN	O	sponsor	nsubj	4	SENT_163	[p11l384t2111r646b2170],
4	had	VBD	O	have	_	0	SENT_163	[p11l683t2094r801b2152],
5	no	DT	O	no	det	6	SENT_163	[p11l845t2111r925b2152],
6	involvement	NN	O	involvement	dobj	4	SENT_163	[p11l965t2094r1379b2152],
7	in	IN	O	in	_	0	SENT_163	[p11l1417t2095r1470b2151],
8	study	NN	O	study	nn	9	SENT_163	[p11l1510t2094r1691b2170],
9	design	NN	O	design	prep_in	6	SENT_163	[p11l1727t2094r1962b2170],
10	,	,	O	,	_	0	SENT_163	[p11l1727t2094r1962b2170],
11	data	NNS	O	datum	appos	9	SENT_163	[p11l2005t2094r2147b2152],
12	collection	NN	O	collection	nn	14	SENT_163	[p11l9t2177r348b2248],
13	,	,	O	,	_	0	SENT_163	[p11l9t2177r348b2248],
14	analysis	NN	O	analysis	dep	11	SENT_163	[p11l390t2177r658b2253],
15	,	,	O	,	_	0	SENT_163	[p11l390t2177r658b2253],
16	or	CC	O	or	_	0	SENT_163	[p11l700t2194r769b2235],
17	interpretation	NN	O	interpretation	conj_or	14	SENT_163	[p11l805t2179r1279b2253],
18	,	,	O	,	_	0	SENT_163	[p11l805t2179r1279b2253],
19	writing	VBG	O	write	partmod	6	SENT_163	[p11l1319t2179r1552b2253],
20	of	IN	O	of	_	0	SENT_163	[p11l1592t2177r1657b2235],
21	the	DT	O	the	det	22	SENT_163	[p11l1690t2177r1796b2235],
22	paper	NN	O	paper	prep_of	6	SENT_163	[p11l1836t2194r2041b2253],
23	,	,	O	,	_	0	SENT_163	[p11l1836t2194r2041b2253],
24	or	CC	O	or	_	0	SENT_163	[p11l2083t2194r2151b2235],
25	the	DT	O	the	det	26	SENT_163	[p11l8t2262r114b2320],
26	decision	NN	O	decision	conj_or	6	SENT_163	[p11l145t2262r413b2320],
27	to	TO	O	to	aux	28	SENT_163	[p11l445t2268r511b2320],
28	submit	VB	O	submit	infmod	26	SENT_163	[p11l541t2262r771b2320],
29	the	DT	O	the	det	30	SENT_163	[p11l798t2262r904b2320],
30	paper	NN	O	paper	dobj	28	SENT_163	[p11l938t2279r1128b2338],
31	for	IN	O	for	_	0	SENT_163	[p11l1153t2262r1246b2320],
32	publication	NN	O	publication	prep_for	30	SENT_163	[p11l1276t2262r1666b2338],
33	.	.	O	.	_	0	SENT_163	[p11l1276t2262r1666b2338],

1	References	NNS	O	reference	_	0	SENT_164	[p11l11t2448r424b2506],

1	1	CD	NUMBER	1	num	3	SENT_165	[p11l44t2628r61b2674],
2	Mason	NNP	ORGANIZATION	Mason	nn	3	SENT_165	[p11l144t2629r324b2675],
3	DA	NNP	ORGANIZATION	DA	_	0	SENT_165	[p11l378t2629r472b2685],
4	,	,	O	,	_	0	SENT_165	[p11l378t2629r472b2685],
5	Moore	NNP	PERSON	Moore	nn	6	SENT_165	[p11l528t2629r708b2675],
6	JD	NNP	O	JD	appos	3	SENT_165	[p11l756t2629r832b2686],
7	,	,	O	,	_	0	SENT_165	[p11l756t2629r832b2686],
8	Green	NNP	ORGANIZATION	Green	nn	9	SENT_165	[p11l886t2628r1050b2675],
9	SA	NNP	ORGANIZATION	SA	appos	3	SENT_165	[p11l1103t2628r1185b2685],
10	,	,	O	,	_	0	SENT_165	[p11l1103t2628r1185b2685],
11	Liggett	NNP	ORGANIZATION	Liggett	nn	12	SENT_165	[p11l1241t2628r1433b2690],
12	SB	NN	O	sb	appos	3	SENT_165	[p11l1482t2628r1562b2675],
13	.	.	O	.	_	0	SENT_165	[p11l1482t2628r1562b2675],

1	A	DT	O	a	det	3	SENT_166	[p11l1612t2629r1651b2674],
2	gain	NN	O	gain	nn	3	SENT_166	[p11l1698t2626r2146b2690],
3	—	NN	O	—	_	0	SENT_166	[p11l1698t2626r2146b2690],
4	of	IN	O	of	_	0	SENT_166	[p11l1698t2626r2146b2690],
5	—	CD	NUMBER	—	num	7	SENT_166	[p11l1698t2626r2146b2690],
6	function	NN	O	function	nn	7	SENT_166	[p11l1698t2626r2146b2690],
7	polymorphism	NN	O	polymorphism	prep_of	3	SENT_166	[p11l143t2703r544b2767],
8	in	IN	O	in	_	0	SENT_166	[p11l580t2704r625b2751],
9	a	DT	O	a	det	12	SENT_166	[p11l660t2717r686b2752],
10	G-protein	NN	MISC	g-protein	nn	12	SENT_166	[p11l720t2704r985b2767],
11	coupling	NN	O	coupling	nn	12	SENT_166	[p11l1019t2703r1261b2767],
12	domain	NN	O	domain	prep_in	7	SENT_166	[p11l1295t2703r1505b2752],
13	of	IN	O	of	_	0	SENT_166	[p11l1540t2703r1593b2752],
14	the	DT	O	the	det	17	SENT_166	[p11l1622t2703r1710b2752],
15	human	JJ	O	human	amod	17	SENT_166	[p11l1744t2703r1936b2752],
16	beta1adrenergic	JJ	O	beta1adrenergic	amod	17	SENT_166	[p11l1972t2703r2149b2752, p11l141t2779r437b2843],
17	receptor	NN	O	receptor	prep_of	3	SENT_166	[p11l465t2785r709b2843],
18	.	.	O	.	_	0	SENT_166	[p11l465t2785r709b2843],

1	/	:	O	/	punct	3	SENT_167	[p11l734t2781r755b2839],
2	Biol	NNP	O	Biol	nn	3	SENT_167	[p11l780t2779r874b2828],
3	Chem	NNP	O	Chem	_	0	SENT_167	[p11l898t2779r1048b2828],
4	1999	CD	DATE	1999	dep	3	SENT_167	[p11l1075t2781r1229b2838],
5	;	:	O	;	_	0	SENT_167	[p11l1075t2781r1229b2838],
6	274	CD	NUMBER	274	dep	3	SENT_167	[p11l1258t2781r1379b2828],
7	:	:	O	:	_	0	SENT_167	[p11l1258t2781r1379b2828],
8	12670-12674	CD	NUMBER	12670-12674	dep	6	SENT_167	[p11l1411t2781r1817b2828],
9	.	.	O	.	_	0	SENT_167	[p11l1411t2781r1817b2828],

1	2	CD	NUMBER	2	num	3	SENT_168	[p11l41t2856r72b2903],
2	Rathz	NNP	ORGANIZATION	Rathz	nn	3	SENT_168	[p11l144t2855r293b2903],
3	DA	NNP	ORGANIZATION	DA	_	0	SENT_168	[p11l349t2857r444b2914],
4	,	,	O	,	_	0	SENT_168	[p11l349t2857r444b2914],
5	Brown	NNP	PERSON	Brown	nn	6	SENT_168	[p11l504t2857r677b2903],
6	KM	NNP	O	KM	appos	3	SENT_168	[p11l737t2857r841b2914],
7	,	,	O	,	_	0	SENT_168	[p11l737t2857r841b2914],
8	Kramer	NNP	ORGANIZATION	Kramer	nn	9	SENT_168	[p11l902t2857r1101b2903],
9	LA	NNP	ORGANIZATION	LA	appos	3	SENT_168	[p11l1156t2857r1234b2914],
10	,	,	O	,	_	0	SENT_168	[p11l1156t2857r1234b2914],
11	Liggett	NNP	ORGANIZATION	Liggett	nn	12	SENT_168	[p11l1294t2856r1487b2918],
12	SB	NN	O	sb	appos	3	SENT_168	[p11l1541t2856r1621b2903],
13	.	.	O	.	_	0	SENT_168	[p11l1541t2856r1621b2903],

1	Amino	NN	O	amino	nn	4	SENT_169	[p11l1676t2856r1859b2903],
2	acid	NN	O	acid	nn	4	SENT_169	[p11l1914t2855r2023b2903],
3	49	CD	NUMBER	49	num	4	SENT_169	[p11l2078t2856r2147b2903],
4	polymorphisms	NNS	O	polymorphism	nsubj	10	SENT_169	[p11l143t2931r572b2995],
5	of	IN	O	of	_	0	SENT_169	[p11l608t2931r662b2980],
6	the	DT	O	the	det	9	SENT_169	[p11l695t2931r784b2980],
7	human	JJ	O	human	amod	9	SENT_169	[p11l823t2931r1014b2980],
8	beta1-adrenergic	JJ	O	beta1-adrenergic	amod	9	SENT_169	[p11l1056t2931r1532b2995],
9	receptor	NN	O	receptor	prep_of	4	SENT_169	[p11l1571t2937r1804b2995],
10	affect	VB	O	affect	_	0	SENT_169	[p11l1838t2931r1990b2980],
11	agonist-promoted	JJ	O	agonist-promoted	amod	12	SENT_169	[p11l2025t2946r2148b2995, p11l143t3007r538b3071],
12	trafficking	NN	O	trafficking	dobj	10	SENT_169	[p11l565t3007r856b3071],
13	.	.	O	.	_	0	SENT_169	[p11l565t3007r856b3071],

1	/	:	O	/	punct	3	SENT_170	[p11l882t3009r902b3067],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_170	[p11l928t3007r1218b3056],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_170	[p11l1241t3007r1527b3056],
4	2002	CD	DATE	2002	dep	3	SENT_170	[p11l1547t3008r1704b3066],
5	;	:	O	;	_	0	SENT_170	[p11l1547t3008r1704b3066],
6	39	CD	NUMBER	39	dep	3	SENT_170	[p11l1734t3008r1818b3056],
7	:	:	O	:	_	0	SENT_170	[p11l1734t3008r1818b3056],
8	155-160	CD	NUMBER	155-160	dep	6	SENT_170	[p11l1849t3008r2109b3056],
9	.	.	O	.	_	0	SENT_170	[p11l1849t3008r2109b3056],

1	3	CD	NUMBER	3	_	0	SENT_171	[p11l44t3084r71b3131],
2	Johnson	NNP	O	Johnson	nn	3	SENT_171	[p11l140t3083r361b3143],
3	JA	NNP	O	JA	dep	1	SENT_171	[p11l393t3085r462b3143],
4	,	,	O	,	_	0	SENT_171	[p11l393t3085r462b3143],
5	Zineh	NNP	O	Zineh	nn	6	SENT_171	[p11l496t3083r651b3131],
6	I	NNP	O	I	appos	3	SENT_171	[p11l687t3085r711b3142],
7	,	,	O	,	_	0	SENT_171	[p11l687t3085r711b3142],
8	Puckett	NNP	PERSON	Puckett	nn	10	SENT_171	[p11l749t3083r953b3131],
9	B	NNP	O	B	nn	10	SENT_171	[p11l984t3085r1046b3143],
10	]	NN	O	]	appos	3	SENT_171	[p11l984t3085r1046b3143],
11	,	,	O	,	_	0	SENT_171	[p11l984t3085r1046b3143],
12	McGorray	NN	O	mcgorray	nn	13	SENT_171	[p11l1084t3084r1359b3147],
13	SP	NN	O	sp	appos	3	SENT_171	[p11l1390t3084r1467b3142],
14	,	,	O	,	_	0	SENT_171	[p11l1390t3084r1467b3142],
15	Yarandi	NNP	O	Yarandi	nn	16	SENT_171	[p11l1499t3083r1706b3131],
16	HN	NNP	O	HN	appos	3	SENT_171	[p11l1742t3085r1845b3141],
17	,	,	O	,	_	0	SENT_171	[p11l1742t3085r1845b3141],
18	Pauly	NNP	O	Pauly	nn	19	SENT_171	[p11l1882t3083r2026b3147],
19	DF	NNP	O	DF	appos	3	SENT_171	[p11l2059t3085r2145b3131],
20	.	.	O	.	_	0	SENT_171	[p11l2059t3085r2145b3131],

1	Beta	NN	O	beta	_	0	SENT_172	[p11l144t3162r258b3208],
2	1	CD	NUMBER	1	number	3	SENT_172	[p11l303t3159r654b3223],
3	—	CD	NUMBER	—	num	6	SENT_172	[p11l303t3159r654b3223],
4	adrenergic	JJ	O	adrenergic	amod	6	SENT_172	[p11l303t3159r654b3223],
5	receptor	NN	O	receptor	nn	6	SENT_172	[p11l695t3165r928b3223],
6	polymorphisms	NNS	O	polymorphism	dep	1	SENT_172	[p11l967t3159r1395b3223],
7	and	CC	O	and	_	0	SENT_172	[p11l1435t3159r1536b3208],
8	antihypertensive	JJ	O	antihypertensive	amod	9	SENT_172	[p11l1578t3159r2036b3223],
9	response	NN	O	response	dep	1	SENT_172	[p11l2079t3174r2148b3208, p11l140t3249r330b3299],
10	to	TO	O	to	_	0	SENT_172	[p11l355t3241r410b3284],
11	metoprolol	NN	O	metoprolol	prep_to	9	SENT_172	[p11l438t3235r758b3299],
12	.	.	O	.	_	0	SENT_172	[p11l438t3235r758b3299],

1	Clin	NNP	O	Clin	nn	3	SENT_173	[p11l792t3235r889b3284],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_173	[p11l915t3235r1200b3284],
3	Ther	NNP	O	Ther	_	0	SENT_173	[p11l1227t3235r1344b3284],
4	2003	CD	DATE	2003	num	3	SENT_173	[p11l1363t3236r1520b3294],
5	;	:	O	;	_	0	SENT_173	[p11l1363t3236r1520b3294],
6	74	CD	NUMBER	74	num	8	SENT_173	[p11l1551t3237r1633b3284],
7	:	:	O	:	_	0	SENT_173	[p11l1551t3237r1633b3284],
8	44-52	CD	NUMBER	44-52	dep	3	SENT_173	[p11l1661t3237r1852b3284],
9	.	.	O	.	_	0	SENT_173	[p11l1661t3237r1852b3284],

1	4	CD	NUMBER	4	num	3	SENT_174	[p11l40t3313r72b3359],
2	Liu	NNP	PERSON	Liu	nn	3	SENT_174	[p11l144t3312r217b3360],
3	J	NNP	PERSON	J	_	0	SENT_174	[p11l250t3313r280b3371],
4	,	,	O	,	_	0	SENT_174	[p11l250t3313r280b3371],
5	Liu	NNP	PERSON	Liu	nn	6	SENT_174	[p11l318t3312r391b3360],
6	ZQ	NNP	O	ZQ	appos	3	SENT_174	[p11l426t3313r527b3370],
7	,	,	O	,	_	0	SENT_174	[p11l426t3313r527b3370],
8	Tan	NNP	O	Tan	nn	9	SENT_174	[p11l560t3313r661b3360],
9	ZR	NNP	O	ZR	appos	3	SENT_174	[p11l695t3313r780b3370],
10	,	,	O	,	_	0	SENT_174	[p11l695t3313r780b3370],
11	Chen	NNP	PERSON	Chen	nn	12	SENT_174	[p11l816t3311r960b3360],
12	XP	NN	O	xp	appos	3	SENT_174	[p11l995t3313r1082b3370],
13	,	,	O	,	_	0	SENT_174	[p11l995t3313r1082b3370],
14	Wang	NNP	PERSON	Wang	nn	15	SENT_174	[p11l1115t3313r1278b3375],
15	LS	NN	O	l	appos	3	SENT_174	[p11l1315t3313r1387b3370],
16	,	,	O	,	_	0	SENT_174	[p11l1315t3313r1387b3370],
17	Zhou	NNP	O	Zhou	nn	18	SENT_174	[p11l1422t3311r1565b3360],
18	G	NNP	O	G	appos	3	SENT_174	[p11l1601t3313r1641b3360],
19	et	FW	O	et	nn	20	SENT_174	[p11l1677t3317r1726b3360],
20	al.	FW	O	al.	dep	18	SENT_174	[p11l1756t3311r1814b3360],
21	.	.	O	.	_	0	SENT_174	[p11l1756t3311r1814b3360],

1	G	NN	O	g	nn	4	SENT_175	[p11l1850t3311r2146b3375],
2	|	NNS	O	|	nn	4	SENT_175	[p11l1850t3311r2146b3375],
3	y389Arg	NN	O	y389arg	nn	4	SENT_175	[p11l1850t3311r2146b3375],
4	polymorphism	NN	O	polymorphism	nsubjpass	9	SENT_175	[p11l143t3387r544b3451],
5	of	IN	O	of	_	0	SENT_175	[p11l591t3387r645b3435],
6	beta1-adrenergic	JJ	O	beta1-adrenergic	amod	7	SENT_175	[p11l689t3387r1166b3450],
7	receptor	NN	O	receptor	prep_of	4	SENT_175	[p11l1212t3392r1444b3451],
8	is	VBZ	O	be	auxpass	9	SENT_175	[p11l1489t3388r1523b3435],
9	associated	VBN	O	associate	_	0	SENT_175	[p11l1568t3387r1849b3435],
10	with	IN	O	with	_	0	SENT_175	[p11l1894t3387r2014b3435],
11	the	DT	O	the	det	13	SENT_175	[p11l2060t3387r2148b3435],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_175	[p11l141t3462r538b3511],
13	response	NN	O	response	prep_with	9	SENT_175	[p11l568t3477r809b3526],
14	to	TO	O	to	_	0	SENT_175	[p11l839t3468r894b3511],
15	metoprolol	NN	O	metoprolol	prep_to	9	SENT_175	[p11l926t3462r1247b3526],
16	.	.	O	.	_	0	SENT_175	[p11l926t3462r1247b3526],

1	Clin	NNP	O	Clin	nn	3	SENT_176	[p11l1285t3462r1382b3511],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_176	[p11l1413t3462r1698b3511],
3	Ther	NNP	O	Ther	_	0	SENT_176	[p11l1730t3462r1847b3511],
4	2003	CD	DATE	2003	num	3	SENT_176	[p11l1870t3464r2027b3521],
5	;	:	O	;	_	0	SENT_176	[p11l1870t3464r2027b3521],
6	74	CD	NUMBER	74	num	8	SENT_176	[p11l2063t3465r2146b3511],
7	:	:	O	:	_	0	SENT_176	[p11l2063t3465r2146b3511],
8	372-379	CD	NUMBER	372-379	dep	3	SENT_176	[p11l144t3540r404b3587],
9	.	.	O	.	_	0	SENT_176	[p11l144t3540r404b3587],

1	Sofowora	NNP	O	Sofowora	nn	2	SENT_177	[p12l142t21r402b69],
2	CG	NNP	O	CG	_	0	SENT_177	[p12l430t22r534b79],
3	,	,	O	,	_	0	SENT_177	[p12l430t22r534b79],
4	Dishy	NNP	O	Dishy	nn	5	SENT_177	[p12l567t21r718b84],
5	V	NNP	O	V	appos	2	SENT_177	[p12l741t22r792b79],
6	,	,	O	,	_	0	SENT_177	[p12l741t22r792b79],
7	Muszkat	NNP	PERSON	Muszkat	nn	8	SENT_177	[p12l826t21r1054b69],
8	M	NNP	PERSON	M	appos	2	SENT_177	[p12l1082t23r1149b79],
9	,	,	O	,	_	0	SENT_177	[p12l1082t23r1149b79],
10	Xie	NNP	O	Xie	nn	11	SENT_177	[p12l1179t22r1264b69],
11	HG	NNP	O	HG	appos	2	SENT_177	[p12l1294t22r1394b79],
12	,	,	O	,	_	0	SENT_177	[p12l1294t22r1394b79],
13	Kim	NNP	PERSON	Kim	nn	14	SENT_177	[p12l1427t22r1528b69],
14	RB	NN	O	rb	appos	2	SENT_177	[p12l1560t23r1640b79],
15	,	,	O	,	_	0	SENT_177	[p12l1560t23r1640b79],
16	Harris	NNP	PERSON	Harris	nn	17	SENT_177	[p12l1673t22r1827b69],
17	PA	NN	O	pa	appos	2	SENT_177	[p12l1857t23r1926b69],
18	et	FW	O	et	nn	19	SENT_177	[p12l1953t26r2002b69],
19	al.	FW	O	al.	dep	17	SENT_177	[p12l2026t21r2083b69],
20	.	.	O	.	_	0	SENT_177	[p12l2026t21r2083b69],

1	A	DT	O	a	det	4	SENT_178	[p12l2111t23r2151b69],
2	common	JJ	O	common	amod	4	SENT_178	[p12l141t111r389b145],
3	beta1	NN	O	beta1	nn	4	SENT_178	[p12l419t96r895b160],
4	—	NN	O	—	nsubj	13	SENT_178	[p12l419t96r895b160],
5	adrenergic	JJ	O	adrenergic	amod	9	SENT_178	[p12l419t96r895b160],
6	receptor	NN	O	receptor	nn	9	SENT_178	[p12l921t102r1153b160],
7	polymorphism	NN	O	polymorphism	nn	9	SENT_178	[p12l1177t96r1578b160],
8	(	NN	O	(	nn	9	SENT_178	[p12l1606t96r1948b160],
9	Arg389G	NN	O	arg389g	dep	4	SENT_178	[p12l1606t96r1948b160],
10	|	CD	NUMBER	|	num	11	SENT_178	[p12l1606t96r1948b160],
11	y	NN	O	y	dep	4	SENT_178	[p12l1606t96r1948b160],
12	)	CD	NUMBER	)	dep	11	SENT_178	[p12l1606t96r1948b160],
13	affects	VBZ	O	affect	_	0	SENT_178	[p12l1973t96r2148b145],
14	blood	NN	O	blood	nn	16	SENT_178	[p12l143t172r298b221],
15	pressure	NN	O	pressure	nn	16	SENT_178	[p12l335t187r560b236],
16	response	NN	O	response	dobj	13	SENT_178	[p12l594t187r835b236],
17	to	TO	O	to	_	0	SENT_178	[p12l866t178r921b221],
18	beta	NN	O	beta	nn	22	SENT_178	[p12l954t172r1363b221],
19	—	CD	NUMBER	—	num	22	SENT_178	[p12l954t172r1363b221],
20	b	NN	O	b	nn	22	SENT_178	[p12l954t172r1363b221],
21	|	NN	O	|	nn	22	SENT_178	[p12l954t172r1363b221],
22	ockade	NN	O	ockade	prep_to	16	SENT_178	[p12l954t172r1363b221],
23	.	.	O	.	_	0	SENT_178	[p12l954t172r1363b221],

1	Clin	NNP	O	Clin	nn	3	SENT_179	[p12l1400t172r1497b221],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_179	[p12l1530t172r1815b221],
3	Ther	NNP	O	Ther	_	0	SENT_179	[p12l1846t172r1964b221],
4	2003	CD	DATE	2003	num	3	SENT_179	[p12l1988t174r2145b231],
5	;	:	O	;	_	0	SENT_179	[p12l1988t174r2145b231],
6	73	CD	NUMBER	73	num	8	SENT_179	[p12l143t250r225b297],
7	:	:	O	:	_	0	SENT_179	[p12l143t250r225b297],
8	366-371	CD	NUMBER	366-371	dep	3	SENT_179	[p12l257t250r516b297],
9	.	.	O	.	_	0	SENT_179	[p12l257t250r516b297],

1	La	NNP	PERSON	La	nn	3	SENT_180	[p12l144t327r198b373],
2	Rosee	NNP	PERSON	Rosee	nn	3	SENT_180	[p12l230t327r384b373],
3	K	NNP	PERSON	K	nsubj	23	SENT_180	[p12l415t327r461b384],
4	,	,	O	,	_	0	SENT_180	[p12l415t327r461b384],
5	Huntgeburth	NNP	O	Huntgeburth	nn	6	SENT_180	[p12l495t325r853b388],
6	M	NNP	O	M	appos	3	SENT_180	[p12l886t327r953b384],
7	,	,	O	,	_	0	SENT_180	[p12l886t327r953b384],
8	Rosenkranz	NNP	PERSON	Rosenkranz	nn	9	SENT_180	[p12l987t325r1297b373],
9	S	NNP	O	S	appos	3	SENT_180	[p12l1325t326r1368b384],
10	,	,	O	,	_	0	SENT_180	[p12l1325t326r1368b384],
11	Bohm	NNP	PERSON	Bohm	nn	12	SENT_180	[p12l1402t325r1560b373],
12	M	NNP	O	M	appos	3	SENT_180	[p12l1593t327r1660b384],
13	,	,	O	,	_	0	SENT_180	[p12l1593t327r1660b384],
14	Schnabel	NNP	PERSON	Schnabel	nn	22	SENT_180	[p12l1693t325r1941b373],
15	P.	NNP	O	P.	nn	22	SENT_180	[p12l1974t327r2017b373],
16	The	NNP	O	The	nn	22	SENT_180	[p12l2045t325r2148b373],
17	Arg389G	NN	O	arg389g	nn	22	SENT_180	[p12l139t400r441b464],
18	|	NN	O	|	nn	22	SENT_180	[p12l139t400r441b464],
19	y	NN	O	y	nn	22	SENT_180	[p12l139t400r441b464],
20	beta1-adrenoceptor	NN	O	beta1-adrenoceptor	nn	22	SENT_180	[p12l517t400r1075b464],
21	gene	NN	O	gene	nn	22	SENT_180	[p12l1148t415r1283b464],
22	polymorphism	NN	O	polymorphism	appos	3	SENT_180	[p12l1360t400r1762b464],
23	determines	VBZ	O	determine	_	0	SENT_180	[p12l1838t400r2149b449],
24	contractile	NN	O	contractile	nn	25	SENT_180	[p12l141t477r432b526],
25	response	NN	O	response	dobj	23	SENT_180	[p12l474t491r715b541],
26	to	TO	O	to	_	0	SENT_180	[p12l754t483r809b526],
27	catecholamines	NNS	O	catecholamine	prep_to	23	SENT_180	[p12l848t477r1295b526],
28	.	.	O	.	_	0	SENT_180	[p12l848t477r1295b526],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_181	[p12l1340t477r1825b541],
2	2004	CD	DATE	2004	num	1	SENT_181	[p12l1862t478r2019b536],
3	;	:	O	;	_	0	SENT_181	[p12l1862t478r2019b536],
4	14	CD	NUMBER	14	num	6	SENT_181	[p12l2065t478r2146b526],
5	:	:	O	:	_	0	SENT_181	[p12l2065t478r2146b526],
6	711-716	CD	NUMBER	711-716	dep	1	SENT_181	[p12l144t556r404b602],
7	.	.	O	.	_	0	SENT_181	[p12l144t556r404b602],

1	Terra	NNP	LOCATION	Terra	nn	2	SENT_182	[p12l139t631r279b677],
2	SG	NNP	LOCATION	SG	_	0	SENT_182	[p12l306t630r396b687],
3	,	,	O	,	_	0	SENT_182	[p12l306t630r396b687],
4	Pauly	NNP	O	Pauly	nn	5	SENT_182	[p12l427t628r572b692],
5	DF	NNP	O	DF	appos	2	SENT_182	[p12l597t631r683b687],
6	,	,	O	,	_	0	SENT_182	[p12l597t631r683b687],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_182	[p12l714t631r803b677],
8	CR	NN	O	cr	appos	2	SENT_182	[p12l828t630r917b687],
9	,	,	O	,	_	0	SENT_182	[p12l828t630r917b687],
10	Patterson	NNP	PERSON	Patterson	nn	11	SENT_182	[p12l948t631r1202b677],
11	JH	NNP	O	JH	appos	2	SENT_182	[p12l1227t631r1302b688],
12	,	,	O	,	_	0	SENT_182	[p12l1227t631r1302b688],
13	Adams	NNP	PERSON	Adams	nn	14	SENT_182	[p12l1328t628r1517b677],
14	KF	NNP	O	KF	appos	2	SENT_182	[p12l1544t630r1620b687],
15	,	,	O	,	_	0	SENT_182	[p12l1544t630r1620b687],
16	Schofield	NNP	PERSON	Schofield	nn	17	SENT_182	[p12l1650t628r1899b677],
17	RS	NN	O	r	appos	2	SENT_182	[p12l1929t630r1989b677],
18	et	FW	O	et	nn	20	SENT_182	[p12l2017t634r2065b677],
19	al.	FW	O	al.	nn	20	SENT_182	[p12l2087t628r2145b677],
20	beta	NN	O	beta	dep	17	SENT_182	[p12l143t704r590b768],
21	.	.	O	.	_	0	SENT_182	[p12l143t704r590b768],

1	—	NN	O	—	_	0	SENT_183	[p12l143t704r590b768],
2	.	.	O	.	_	0	SENT_183	[p12l143t704r590b768],

1	Adrenergic	JJ	O	adrenergic	amod	3	SENT_184	[p12l143t704r590b768],
2	receptor	NN	O	receptor	nn	3	SENT_184	[p12l612t710r845b768],
3	polymorphisms	NNS	O	polymorphism	nsubj	10	SENT_184	[p12l865t704r1293b768],
4	and	CC	O	and	_	0	SENT_184	[p12l1313t704r1414b753],
5	responses	NNS	O	response	nsubj	10	SENT_184	[p12l1439t719r1705b768],
6	during	IN	O	during	_	0	SENT_184	[p12l1725t704r1905b768],
7	titration	NN	O	titration	prep_during	3	SENT_184	[p12l1927t706r2146b753],
8	of	IN	O	of	_	0	SENT_184	[p12l141t781r195b830],
9	metoprolol	NN	O	metoprolol	prep_of	7	SENT_184	[p12l223t781r525b845],
10	controlled	JJ	O	controlled	_	0	SENT_184	[p12l556t781r836b830],
11	release/extended	JJ	O	release/extended	amod	12	SENT_184	[p12l869t781r1341b836],
12	release	NN	O	release	dobj	10	SENT_184	[p12l1374t781r1559b830],
13	in	IN	O	in	_	0	SENT_184	[p12l1589t782r1634b829],
14	heart	NN	O	heart	nn	15	SENT_184	[p12l1667t781r1808b830],
15	failure	NN	O	failure	prep_in	12	SENT_184	[p12l1831t781r2017b830],
16	.	.	O	.	_	0	SENT_184	[p12l1831t781r2017b830],

1	Clin	NNP	O	Clin	nn	3	SENT_185	[p12l2053t781r2150b830],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_185	[p12l143t856r429b904],
3	Ther	NNP	O	Ther	_	0	SENT_185	[p12l455t856r572b904],
4	2005	CD	DATE	2005	num	3	SENT_185	[p12l591t857r748b914],
5	;	:	O	;	_	0	SENT_185	[p12l591t857r748b914],
6	77	CD	NUMBER	77	num	8	SENT_185	[p12l780t858r862b904],
7	:	:	O	:	_	0	SENT_185	[p12l780t858r862b904],
8	127-137	CD	NUMBER	127-137	dep	3	SENT_185	[p12l893t857r1153b904],
9	.	.	O	.	_	0	SENT_185	[p12l893t857r1153b904],

1	Terra	NNP	LOCATION	Terra	nn	2	SENT_186	[p12l139t934r279b980],
2	SG	NNP	LOCATION	SG	_	0	SENT_186	[p12l305t933r395b990],
3	,	,	O	,	_	0	SENT_186	[p12l305t933r395b990],
4	Hamilton	NNP	ORGANIZATION	Hamilton	nn	5	SENT_186	[p12l426t931r676b980],
5	KK	NNP	ORGANIZATION	KK	appos	2	SENT_186	[p12l706t933r789b990],
6	,	,	O	,	_	0	SENT_186	[p12l706t933r789b990],
7	Pauly	NNP	O	Pauly	nn	8	SENT_186	[p12l819t931r963b995],
8	DF	NNP	O	DF	appos	2	SENT_186	[p12l989t934r1075b990],
9	,	,	O	,	_	0	SENT_186	[p12l989t934r1075b990],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_186	[p12l1105t934r1193b980],
11	CR	NN	O	cr	appos	2	SENT_186	[p12l1218t933r1307b990],
12	,	,	O	,	_	0	SENT_186	[p12l1218t933r1307b990],
13	Patterson	NNP	PERSON	Patterson	nn	14	SENT_186	[p12l1337t934r1591b980],
14	JH	NNP	O	JH	appos	2	SENT_186	[p12l1616t934r1691b991],
15	,	,	O	,	_	0	SENT_186	[p12l1616t934r1691b991],
16	Adams	NNP	PERSON	Adams	nn	17	SENT_186	[p12l1715t931r1904b980],
17	KF	NNP	O	KF	appos	2	SENT_186	[p12l1931t933r1991b980],
18	et	FW	O	et	nn	19	SENT_186	[p12l2018t937r2066b980],
19	al.	FW	O	al.	dep	17	SENT_186	[p12l2087t931r2145b980],
20	.	.	O	.	_	0	SENT_186	[p12l2087t931r2145b980],

1	Beta1-adrenergic	JJ	O	beta1-adrenergic	amod	3	SENT_187	[p12l144t1008r618b1072],
2	receptor	NN	O	receptor	nn	3	SENT_187	[p12l643t1014r875b1072],
3	polymorphisms	NNS	O	polymorphism	nsubj	5	SENT_187	[p12l898t1008r1325b1072],
4	and	CC	O	and	advmod	5	SENT_187	[p12l1349t1008r1449b1057],
5	left	VBD	O	leave	_	0	SENT_187	[p12l1477t1008r1561b1057],
6	ventricular	JJ	O	ventricular	amod	8	SENT_187	[p12l1580t1008r1876b1057],
7	remodeling	NN	O	remodeling	nn	8	SENT_187	[p12l1899t1008r2147b1057, p12l142t1085r225b1147],
8	changes	NNS	O	change	dobj	5	SENT_187	[p12l277t1084r505b1147],
9	in	IN	O	in	_	0	SENT_187	[p12l557t1085r602b1132],
10	response	NN	O	response	prep_in	5	SENT_187	[p12l657t1098r898b1147],
11	to	TO	O	to	_	0	SENT_187	[p12l948t1089r1002b1132],
12	beta-blocker	NN	O	beta-blocker	nn	13	SENT_187	[p12l1055t1084r1403b1132],
13	therapy	NN	O	therapy	prep_to	5	SENT_187	[p12l1450t1084r1677b1147],
14	.	.	O	.	_	0	SENT_187	[p12l1450t1084r1677b1147],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_188	[p12l1734t1084r2152b1147],
2	Genomics	NNP	O	Genomics	_	0	SENT_188	[p12l145t1160r401b1207],
3	2005	CD	DATE	2005	num	2	SENT_188	[p12l425t1160r582b1217],
4	;	:	O	;	_	0	SENT_188	[p12l425t1160r582b1217],
5	15	CD	NUMBER	15	num	7	SENT_188	[p12l614t1160r695b1207],
6	:	:	O	:	_	0	SENT_188	[p12l614t1160r695b1207],
7	227-234	CD	NUMBER	227-234	dep	2	SENT_188	[p12l724t1160r986b1207],
8	.	.	O	.	_	0	SENT_188	[p12l724t1160r986b1207],

1	Xie	NNP	O	Xie	nn	2	SENT_189	[p12l141t1236r225b1283],
2	HG	NNP	O	HG	_	0	SENT_189	[p12l264t1236r365b1293],
3	,	,	O	,	_	0	SENT_189	[p12l264t1236r365b1293],
4	Dishy	NNP	O	Dishy	nn	5	SENT_189	[p12l407t1234r558b1298],
5	V	NNP	O	V	appos	2	SENT_189	[p12l589t1236r640b1293],
6	,	,	O	,	_	0	SENT_189	[p12l589t1236r640b1293],
7	Sofowora	NNP	O	Sofowora	nn	8	SENT_189	[p12l681t1234r940b1283],
8	C	NNP	O	C	appos	2	SENT_189	[p12l977t1236r1035b1293],
9	,	,	O	,	_	0	SENT_189	[p12l977t1236r1035b1293],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_189	[p12l1077t1236r1178b1283],
11	RB	NN	O	rb	appos	2	SENT_189	[p12l1219t1237r1298b1293],
12	,	,	O	,	_	0	SENT_189	[p12l1219t1237r1298b1293],
13	Landau	NNP	PERSON	Landau	nn	14	SENT_189	[p12l1341t1234r1537b1283],
14	R	NNP	PERSON	R	appos	2	SENT_189	[p12l1578t1237r1621b1293],
15	,	,	O	,	_	0	SENT_189	[p12l1578t1237r1621b1293],
16	Smiley	NNP	PERSON	Smiley	nn	17	SENT_189	[p12l1662t1234r1843b1298],
17	RM	NN	O	rm	appos	2	SENT_189	[p12l1880t1237r1965b1283],
18	et	FW	O	et	nn	19	SENT_189	[p12l2005t1240r2054b1283],
19	al.	FW	O	al.	dep	17	SENT_189	[p12l2087t1234r2145b1283],
20	.	.	O	.	_	0	SENT_189	[p12l2087t1234r2145b1283],

1	Arg389G	NN	O	arg389g	nn	4	SENT_190	[p12l139t1311r441b1375],
2	|	CD	NUMBER	|	num	4	SENT_190	[p12l139t1311r441b1375],
3	y	NN	O	y	nn	4	SENT_190	[p12l139t1311r441b1375],
4	beta	NN	O	beta	nsubj	17	SENT_190	[p12l487t1311r604b1360],
5	1-adrenoceptor	JJ	O	1-adrenoceptor	amod	6	SENT_190	[p12l654t1311r1087b1375],
6	polymorphism	NN	O	polymorphism	dep	4	SENT_190	[p12l1132t1311r1532b1375],
7	varies	VBZ	O	vary	_	0	SENT_190	[p12l1579t1312r1734b1360],
8	in	IN	O	in	_	0	SENT_190	[p12l1780t1312r1825b1359],
9	frequency	NN	O	frequency	prep_in	7	SENT_190	[p12l1870t1311r2150b1375],
10	among	IN	O	among	_	0	SENT_190	[p12l141t1401r335b1450],
11	different	JJ	O	different	amod	13	SENT_190	[p12l375t1387r610b1435],
12	ethnic	JJ	O	ethnic	amod	13	SENT_190	[p12l645t1387r817b1435],
13	groups	NNS	O	group	prep_among	9	SENT_190	[p12l854t1401r1045b1450],
14	but	CC	O	but	_	0	SENT_190	[p12l1084t1387r1176b1435],
15	does	VBZ	O	do	aux	17	SENT_190	[p12l1212t1387r1339b1435],
16	not	RB	O	not	neg	17	SENT_190	[p12l1379t1392r1471b1435],
17	alter	VB	O	alter	conj_but	7	SENT_190	[p12l1506t1387r1628b1435],
18	response	NN	O	response	dobj	17	SENT_190	[p12l1665t1401r1906b1450],
19	in	FW	O	in	prep	18	SENT_190	[p12l1946t1388r1992b1435],
20	vivo	FW	O	vivo	pobj	19	SENT_190	[p12l2031t1388r2146b1435],
21	.	.	O	.	_	0	SENT_190	[p12l2031t1388r2146b1435],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_191	[p12l143t1462r628b1526],
2	2001	CD	DATE	2001	num	1	SENT_191	[p12l651t1464r808b1521],
3	;	:	O	;	_	0	SENT_191	[p12l651t1464r808b1521],
4	11	CD	NUMBER	11	num	6	SENT_191	[p12l841t1464r922b1511],
5	:	:	O	:	_	0	SENT_191	[p12l841t1464r922b1511],
6	191-197	CD	NUMBER	191-197	dep	1	SENT_191	[p12l953t1464r1213b1511],
7	.	.	O	.	_	0	SENT_191	[p12l953t1464r1213b1511],

1	Buscher	NNP	PERSON	Buscher	nn	2	SENT_192	[p12l149t1539r364b1588],
2	R	NNP	PERSON	R	_	0	SENT_192	[p12l385t1541r428b1598],
3	,	,	O	,	_	0	SENT_192	[p12l385t1541r428b1598],
4	Belger	NNP	PERSON	Belger	nn	5	SENT_192	[p12l455t1539r627b1603],
5	H	NNP	PERSON	H	appos	2	SENT_192	[p12l648t1541r701b1598],
6	,	,	O	,	_	0	SENT_192	[p12l648t1541r701b1598],
7	Eilmes	NNP	O	Eilmes	nn	9	SENT_192	[p12l728t1539r898b1588],
8	K	NNP	O	K	nn	9	SENT_192	[p12l921t1541r984b1599],
9	]	NNP	O	]	appos	2	SENT_192	[p12l921t1541r984b1599],
10	,	,	O	,	_	0	SENT_192	[p12l921t1541r984b1599],
11	Tellkamp	NNP	PERSON	Tellkamp	nn	12	SENT_192	[p12l1006t1539r1260b1603],
12	R	NNP	PERSON	R	appos	2	SENT_192	[p12l1284t1541r1327b1598],
13	,	,	O	,	_	0	SENT_192	[p12l1284t1541r1327b1598],
14	Radke	NNP	PERSON	Radke	nn	15	SENT_192	[p12l1353t1539r1515b1588],
15	J	NNP	PERSON	J	appos	2	SENT_192	[p12l1534t1541r1564b1599],
16	,	,	O	,	_	0	SENT_192	[p12l1534t1541r1564b1599],
17	Dhein	NNP	O	Dhein	nn	18	SENT_192	[p12l1590t1539r1750b1588],
18	S	NNP	O	S	appos	2	SENT_192	[p12l1774t1541r1801b1588],
19	et	FW	O	et	nn	20	SENT_192	[p12l1824t1545r1873b1588],
20	al.	FW	O	al.	dep	18	SENT_192	[p12l1891t1539r1948b1588],
21	.	.	O	.	_	0	SENT_192	[p12l1891t1539r1948b1588],

1	In-vivo	JJ	O	in-vivo	amod	2	SENT_193	[p12l1975t1540r2151b1588],
2	studies	NNS	O	study	nsubj	5	SENT_193	[p12l145t1615r335b1663],
3	do	VBP	O	do	aux	5	SENT_193	[p12l355t1615r425b1663],
4	not	RB	O	not	neg	5	SENT_193	[p12l447t1620r538b1663],
5	support	VB	O	support	_	0	SENT_193	[p12l556t1620r772b1678],
6	a	DT	O	a	det	9	SENT_193	[p12l790t1629r817b1663],
7	major	JJ	O	major	amod	9	SENT_193	[p12l840t1616r999b1678],
8	functional	JJ	O	functional	amod	9	SENT_193	[p12l1014t1615r1291b1663],
9	role	NN	O	role	dobj	5	SENT_193	[p12l1315t1615r1415b1663],
10	for	IN	O	for	_	0	SENT_193	[p12l1433t1615r1512b1663],
11	the	DT	O	the	det	12	SENT_193	[p12l1527t1615r1615b1663],
12	C	NN	O	c	prep_for	5	SENT_193	[p12l1636t1615r1933b1678],
13	-	:	O	-	_	0	SENT_193	[p12l1636t1615r1933b1678],
14	|	NN	O	|	nn	17	SENT_193	[p12l1636t1615r1933b1678],
15	y389Arg	NN	O	y389arg	nn	17	SENT_193	[p12l1636t1615r1933b1678],
16	beta	NN	O	beta	nn	17	SENT_193	[p12l1957t1615r2074b1663],
17	1adrenoceptor	NN	O	1adrenoceptor	dep	5	SENT_193	[p12l2098t1616r2148b1663, p12l143t1943r521b2007],

1	polymorphism	NN	O	polymorphism	_	0	SENT_194	[p12l555t1943r955b2007],
2	in	IN	O	in	_	0	SENT_194	[p12l993t1945r1038b1991],
3	humans	NNS	O	human	prep_in	1	SENT_194	[p12l1076t1943r1310b1992],
4	.	.	O	.	_	0	SENT_194	[p12l1076t1943r1310b1992],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_195	[p12l1349t1943r1833b2007],
2	2001	CD	DATE	2001	num	1	SENT_195	[p12l1865t1945r2022b2002],
3	;	:	O	;	_	0	SENT_195	[p12l1865t1945r2022b2002],
4	11	CD	NUMBER	11	num	6	SENT_195	[p12l2063t1945r2143b1992],
5	:	:	O	:	_	0	SENT_195	[p12l2063t1945r2143b1992],
6	199-205	CD	NUMBER	199-205	dep	1	SENT_195	[p12l146t2021r407b2068],
7	.	.	O	.	_	0	SENT_195	[p12l146t2021r407b2068],

1	Ranade	NN	O	ranade	nn	2	SENT_196	[p12l146t2096r345b2144],
2	K	NN	O	k	_	0	SENT_196	[p12l373t2098r419b2154],
3	,	,	O	,	_	0	SENT_196	[p12l373t2098r419b2154],
4	Jorgenson	NNP	PERSON	Jorgenson	nn	5	SENT_196	[p12l445t2098r722b2159],
5	E	NNP	O	E	appos	2	SENT_196	[p12l751t2098r790b2154],
6	,	,	O	,	_	0	SENT_196	[p12l751t2098r790b2154],
7	Sheu	NNP	PERSON	Sheu	nn	8	SENT_196	[p12l819t2096r951b2144],
8	WH	NNP	PERSON	WH	appos	2	SENT_196	[p12l975t2097r1092b2155],
9	,	,	O	,	_	0	SENT_196	[p12l975t2097r1092b2155],
10	Pei	NNP	PERSON	Pei	nn	11	SENT_196	[p12l1123t2097r1196b2144],
11	D	NNP	O	D	appos	2	SENT_196	[p12l1225t2098r1280b2154],
12	,	,	O	,	_	0	SENT_196	[p12l1225t2098r1280b2154],
13	Hsiung	NNP	PERSON	Hsiung	nn	14	SENT_196	[p12l1311t2097r1498b2159],
14	CA	NNP	O	CA	appos	2	SENT_196	[p12l1525t2097r1618b2155],
15	,	,	O	,	_	0	SENT_196	[p12l1525t2097r1618b2155],
16	Chiang	NNP	PERSON	Chiang	nn	17	SENT_196	[p12l1647t2096r1843b2159],
17	FT	NNP	O	FT	appos	2	SENT_196	[p12l1872t2098r1933b2144],
18	et	FW	O	et	nn	19	SENT_196	[p12l1956t2101r2005b2144],
19	al.	FW	O	al.	dep	17	SENT_196	[p12l2026t2096r2084b2144],
20	.	.	O	.	_	0	SENT_196	[p12l2026t2096r2084b2144],

1	A	DT	O	a	det	2	SENT_197	[p12l2109t2098r2148b2144],
2	polymorphism	NN	O	polymorphism	nsubjpass	9	SENT_197	[p12l146t2172r546b2236],
3	in	IN	O	in	_	0	SENT_197	[p12l593t2173r637b2220],
4	the	DT	O	the	det	7	SENT_197	[p12l681t2172r769b2221],
5	beta1	NN	O	beta1	nn	7	SENT_197	[p12l813t2172r956b2221],
6	adrenergic	JJ	O	adrenergic	amod	7	SENT_197	[p12l1010t2172r1307b2236],
7	receptor	NN	O	receptor	prep_in	2	SENT_197	[p12l1350t2178r1583b2236],
8	is	VBZ	O	be	auxpass	9	SENT_197	[p12l1624t2173r1658b2221],
9	associated	VBN	O	associate	_	0	SENT_197	[p12l1700t2172r1981b2221],
10	with	IN	O	with	_	0	SENT_197	[p12l2024t2172r2144b2221],
11	resting	VBG	O	rest	prepc_with	9	SENT_197	[p12l146t2249r328b2311],
12	heart	NN	O	heart	nn	13	SENT_197	[p12l358t2247r500b2296],
13	rate	NN	O	rate	dobj	11	SENT_197	[p12l526t2253r643b2296],
14	.	.	O	.	_	0	SENT_197	[p12l526t2253r643b2296],

1	Am	VBP	O	be	_	0	SENT_198	[p12l670t2250r758b2295],
2	/	:	O	/	punct	3	SENT_198	[p12l778t2250r799b2307],
3	Hum	NNP	O	Hum	nsubj	5	SENT_198	[p12l824t2250r948b2296],
4	Genet	NNP	O	Genet	dep	5	SENT_198	[p12l975t2249r1132b2296],
5	2002	CD	DATE	2002	ccomp	1	SENT_198	[p12l1154t2249r1311b2306],
6	;	:	O	;	_	0	SENT_198	[p12l1154t2249r1311b2306],
7	70	CD	NUMBER	70	dobj	1	SENT_198	[p12l1342t2249r1424b2296],
8	:	:	O	:	_	0	SENT_198	[p12l1342t2249r1424b2296],
9	935-942	CD	NUMBER	935-942	dep	7	SENT_198	[p12l1453t2249r1716b2296],
10	.	.	O	.	_	0	SENT_198	[p12l1453t2249r1716b2296],

1	O’Shaughnessy	NNP	O	O’Shaughnessy	nn	2	SENT_199	[p12l144t2324r574b2388],
2	KM	NNP	O	KM	_	0	SENT_199	[p12l610t2326r714b2383],
3	,	,	O	,	_	0	SENT_199	[p12l610t2326r714b2383],
4	Fu	NNP	O	Fu	nn	5	SENT_199	[p12l755t2326r813b2373],
5	B	NNP	O	B	appos	2	SENT_199	[p12l852t2326r896b2383],
6	,	,	O	,	_	0	SENT_199	[p12l852t2326r896b2383],
7	Dickerson	NNP	PERSON	Dickerson	nn	8	SENT_199	[p12l936t2324r1204b2373],
8	C	NNP	O	C	appos	2	SENT_199	[p12l1241t2326r1295b2383],
9	,	,	O	,	_	0	SENT_199	[p12l1241t2326r1295b2383],
10	Thurston	NNP	PERSON	Thurston	nn	11	SENT_199	[p12l1330t2324r1577b2373],
11	D	NNP	O	D	appos	2	SENT_199	[p12l1616t2326r1672b2383],
12	,	,	O	,	_	0	SENT_199	[p12l1616t2326r1672b2383],
13	Brown	NNP	PERSON	Brown	nn	14	SENT_199	[p12l1711t2326r1885b2373],
14	M	NNP	O	M	appos	2	SENT_199	[p12l1924t2326r2009b2384],
15	]	NN	O	]	dep	14	SENT_199	[p12l1924t2326r2009b2384],
16	.	.	O	.	_	0	SENT_199	[p12l1924t2326r2009b2384],

1	The	DT	O	the	det	4	SENT_200	[p12l2043t2324r2146b2373],
2	gain-of-function	NN	O	gain-of-function	nn	4	SENT_200	[p12l143t2400r591b2463],
3	G389R	NN	O	g389r	nn	4	SENT_200	[p12l632t2401r820b2448],
4	variant	NN	O	variant	nsubj	10	SENT_200	[p12l855t2401r1046b2448],
5	of	IN	O	of	_	0	SENT_200	[p12l1081t2400r1135b2448],
6	the	DT	O	the	det	7	SENT_200	[p12l1169t2400r1257b2448],
7	beta1-adrenoceptor	NN	O	beta1-adrenoceptor	prep_of	4	SENT_200	[p12l1296t2400r1855b2463],
8	does	VBZ	O	do	aux	10	SENT_200	[p12l1890t2400r2018b2448],
9	not	RB	O	not	neg	10	SENT_200	[p12l2057t2405r2148b2448],
10	influence	VB	O	influence	_	0	SENT_200	[p12l145t2475r395b2524],
11	blood	NN	O	blood	nn	12	SENT_200	[p12l433t2475r588b2524],
12	pressure	NN	O	pressure	dobj	10	SENT_200	[p12l629t2490r855b2539],
13	or	CC	O	or	_	0	SENT_200	[p12l891t2490r948b2524],
14	heart	NN	O	heart	nn	16	SENT_200	[p12l983t2475r1124b2524],
15	rate	NN	O	rate	nn	16	SENT_200	[p12l1160t2481r1262b2524],
16	response	NN	O	response	conj_or	12	SENT_200	[p12l1300t2490r1542b2539],
17	to	TO	O	to	_	0	SENT_200	[p12l1577t2481r1632b2524],
18	beta	NN	O	beta	nn	22	SENT_200	[p12l1669t2475r2062b2524],
19	—	CD	NUMBER	—	num	22	SENT_200	[p12l1669t2475r2062b2524],
20	b	NN	O	b	nn	22	SENT_200	[p12l1669t2475r2062b2524],
21	|	NN	O	|	nn	22	SENT_200	[p12l1669t2475r2062b2524],
22	ockade	NN	O	ockade	prep_to	12	SENT_200	[p12l1669t2475r2062b2524],
23	in	IN	O	in	_	0	SENT_200	[p12l2100t2477r2144b2523],
24	hypertensive	JJ	O	hypertensive	amod	25	SENT_200	[p12l145t2552r496b2616],
25	subjects	NNS	O	subject	prep_in	10	SENT_200	[p12l521t2552r757b2616],
26	.	.	O	.	_	0	SENT_200	[p12l521t2552r757b2616],

1	Clin	NNP	PERSON	Clin	nn	4	SENT_201	[p12l790t2552r888b2601],
2	Sci	NNP	PERSON	Sci	nn	4	SENT_201	[p12l913t2553r986b2601],
3	(	NNP	O	(	nn	4	SENT_201	[p12l1009t2552r1249b2613],
4	London	NNP	LOCATION	London	_	0	SENT_201	[p12l1009t2552r1249b2613],
5	)	CD	NUMBER	)	num	6	SENT_201	[p12l1009t2552r1249b2613],
6	2000	CD	DATE	2000	dep	4	SENT_201	[p12l1273t2553r1430b2611],
7	;	:	O	;	_	0	SENT_201	[p12l1273t2553r1430b2611],
8	99	CD	NUMBER	99	num	10	SENT_201	[p12l1459t2554r1544b2601],
9	:	:	O	:	_	0	SENT_201	[p12l1459t2554r1544b2601],
10	233-238	CD	NUMBER	233-238	dep	4	SENT_201	[p12l1573t2553r1835b2601],
11	.	.	O	.	_	0	SENT_201	[p12l1573t2553r1835b2601],

1	Humma	NNP	PERSON	Humma	nn	2	SENT_202	[p12l146t2630r366b2676],
2	LM	NNP	O	LM	_	0	SENT_202	[p12l395t2630r493b2686],
3	,	,	O	,	_	0	SENT_202	[p12l395t2630r493b2686],
4	Puckett	NNP	PERSON	Puckett	nn	6	SENT_202	[p12l525t2628r728b2676],
5	B	NNP	O	B	nn	6	SENT_202	[p12l755t2630r817b2687],
6	]	NN	O	]	appos	2	SENT_202	[p12l755t2630r817b2687],
7	,	,	O	,	_	0	SENT_202	[p12l755t2630r817b2687],
8	Richardson	NNP	PERSON	Richardson	nn	12	SENT_202	[p12l848t2628r1147b2676],
9	HE	PRP	O	he	dep	12	SENT_202	[p12l1177t2630r1263b2686],
10	,	,	O	,	_	0	SENT_202	[p12l1177t2630r1263b2686],
11	Terra	NNP	ORGANIZATION	Terra	dep	12	SENT_202	[p12l1290t2630r1430b2676],
12	SG	NNP	ORGANIZATION	SG	appos	2	SENT_202	[p12l1458t2629r1548b2686],
13	,	,	O	,	_	0	SENT_202	[p12l1458t2629r1548b2686],
14	Andrisin	NNP	LOCATION	Andrisin	nn	15	SENT_202	[p12l1574t2628r1798b2676],
15	TE	NNP	LOCATION	TE	appos	2	SENT_202	[p12l1824t2630r1904b2686],
16	,	,	O	,	_	0	SENT_202	[p12l1824t2630r1904b2686],
17	Lejeune	NNP	PERSON	Lejeune	nn	18	SENT_202	[p12l1936t2629r2146b2691],
18	BL	NN	O	bl	appos	2	SENT_202	[p12l146t2706r208b2752],
19	et	FW	O	et	nn	20	SENT_202	[p12l251t2709r300b2752],
20	al.	FW	O	al.	dep	18	SENT_202	[p12l340t2704r398b2752],
21	.	.	O	.	_	0	SENT_202	[p12l340t2704r398b2752],

1	Effects	NNS	O	effect	_	0	SENT_203	[p12l447t2704r619b2752],
2	of	IN	O	of	_	0	SENT_203	[p12l662t2704r716b2752],
3	beta1-adrenoceptor	JJ	O	beta1-adrenoceptor	amod	5	SENT_203	[p12l758t2704r1316b2768],
4	genetic	JJ	O	genetic	amod	5	SENT_203	[p12l1357t2705r1561b2767],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_203	[p12l1606t2704r2033b2768],
6	on	IN	O	on	_	0	SENT_203	[p12l2077t2718r2144b2752],
7	resting	VBG	O	rest	prepc_on	5	SENT_203	[p12l146t2781r328b2843],
8	hemodynamics	NNS	O	hemodynamic	dobj	7	SENT_203	[p12l368t2779r793b2843],
9	in	IN	O	in	_	0	SENT_203	[p12l830t2781r874b2827],
10	patients	NNS	O	patient	prep_in	7	SENT_203	[p12l915t2781r1131b2843],
11	undergoing	VBG	O	undergo	partmod	10	SENT_203	[p12l1169t2779r1491b2843],
12	diagnostic	JJ	O	diagnostic	amod	13	SENT_203	[p12l1530t2779r1815b2843],
13	testing	NN	O	testing	dobj	11	SENT_203	[p12l1849t2781r2035b2843],
14	for	IN	O	for	_	0	SENT_203	[p12l2071t2779r2149b2828],
15	ischemia	NN	O	ischemia	prep_for	11	SENT_203	[p12l145t2855r399b2903],
16	.	.	O	.	_	0	SENT_203	[p12l145t2855r399b2903],

1	Am	VBP	O	be	dep	3	SENT_204	[p12l426t2857r555b2914],
2	]	CD	NUMBER	]	num	3	SENT_204	[p12l426t2857r555b2914],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_204	[p12l581t2855r770b2903],
4	2001	CD	DATE	2001	num	3	SENT_204	[p12l791t2856r948b2913],
5	;	:	O	;	_	0	SENT_204	[p12l791t2856r948b2913],
6	88	CD	NUMBER	88	dep	3	SENT_204	[p12l976t2856r1062b2903],
7	:	:	O	:	_	0	SENT_204	[p12l976t2856r1062b2903],
8	1034-1037	CD	DATE	1034-1037	dep	6	SENT_204	[p12l1093t2856r1426b2903],
9	.	.	O	.	_	0	SENT_204	[p12l1093t2856r1426b2903],

1	de	IN	O	de	dep	6	SENT_205	[p12l143t2931r209b2979],
2	Groote	NNP	O	Groote	nn	3	SENT_205	[p12l248t2932r439b2979],
3	P	NN	O	p	pobj	1	SENT_205	[p12l480t2933r523b2989],
4	,	,	O	,	_	0	SENT_205	[p12l480t2933r523b2989],
5	Helbecque	JJ	ORGANIZATION	helbecque	amod	6	SENT_205	[p12l566t2931r861b2994],
6	N	NN	ORGANIZATION	n	_	0	SENT_205	[p12l902t2933r959b2989],
7	,	,	O	,	_	0	SENT_205	[p12l902t2933r959b2989],
8	Lamblin	NN	LOCATION	lamblin	nn	9	SENT_205	[p12l1003t2931r1219b2979],
9	N	NN	LOCATION	n	appos	6	SENT_205	[p12l1262t2933r1320b2989],
10	,	,	O	,	_	0	SENT_205	[p12l1262t2933r1320b2989],
11	Hermant	JJ	O	hermant	amod	12	SENT_205	[p12l1364t2933r1607b2979],
12	X	NN	O	x	appos	6	SENT_205	[p12l1642t2932r1695b2989],
13	,	,	O	,	_	0	SENT_205	[p12l1642t2932r1695b2989],
14	Mc	NN	PERSON	mc	nn	16	SENT_205	[p12l1738t2933r1822b2979],
15	Fadden	NN	PERSON	fadden	nn	16	SENT_205	[p12l1861t2931r2060b2979],
16	E	NN	O	e	appos	6	SENT_205	[p12l2103t2933r2143b2989],
17	,	,	O	,	_	0	SENT_205	[p12l2103t2933r2143b2989],
18	Foucher-Hossein	NN	O	foucher-hossein	nn	19	SENT_205	[p12l146t3007r600b3055],
19	C	NN	O	c	appos	6	SENT_205	[p12l651t3009r690b3055],
20	et	FW	O	et	nn	21	SENT_205	[p12l741t3013r790b3055],
21	al.	FW	O	al.	dep	19	SENT_205	[p12l835t3007r893b3055],
22	.	.	O	.	_	0	SENT_205	[p12l835t3007r893b3055],

1	Association	NNP	O	Association	_	0	SENT_206	[p12l942t3008r1251b3055],
2	between	IN	O	between	_	0	SENT_206	[p12l1304t3007r1540b3055],
3	beta-1	NN	O	beta-1	prep_between	1	SENT_206	[p12l1593t3007r1757b3055],
4	and	CC	O	and	_	0	SENT_206	[p12l1817t3007r1918b3055],
5	beta-2	NN	O	beta-2	conj_and	3	SENT_206	[p12l1970t3007r2145b3055],
6	adrenergic	JJ	O	adrenergic	amod	9	SENT_206	[p12l143t3083r440b3147],
7	receptor	NN	O	receptor	nn	9	SENT_206	[p12l476t3089r708b3147],
8	gene	NN	O	gene	nn	9	SENT_206	[p12l741t3097r877b3147],
9	polymorphisms	NNS	O	polymorphism	dep	3	SENT_206	[p12l914t3083r1342b3147],
10	and	CC	O	and	_	0	SENT_206	[p12l1377t3083r1477b3132],
11	the	DT	O	the	det	12	SENT_206	[p12l1513t3083r1602b3132],
12	response	NN	O	response	conj_and	3	SENT_206	[p12l1639t3097r1880b3147],
13	to	TO	O	to	aux	14	SENT_206	[p12l1914t3089r1970b3132],
14	betablockade	VB	O	betablockade	infmod	12	SENT_206	[p12l2006t3083r2145b3132, p12l145t3159r392b3207],
15	in	IN	O	in	_	0	SENT_206	[p12l415t3160r459b3207],
16	patients	NNS	O	patient	prep_in	14	SENT_206	[p12l484t3160r701b3222],
17	with	IN	O	with	_	0	SENT_206	[p12l719t3159r839b3207],
18	stable	JJ	O	stable	amod	21	SENT_206	[p12l862t3159r1022b3207],
19	congestive	JJ	O	congestive	amod	21	SENT_206	[p12l1043t3160r1339b3222],
20	heart	NN	O	heart	nn	21	SENT_206	[p12l1362t3159r1503b3207],
21	failure	NN	O	failure	prep_with	16	SENT_206	[p12l1519t3159r1705b3207],
22	.	.	O	.	_	0	SENT_206	[p12l1519t3159r1705b3207],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_207	[p12l1731t3159r2151b3222],
2	Genomics	NNP	O	Genomics	_	0	SENT_207	[p12l147t3235r404b3282],
3	2005	CD	DATE	2005	num	2	SENT_207	[p12l427t3235r584b3292],
4	;	:	O	;	_	0	SENT_207	[p12l427t3235r584b3292],
5	15	CD	NUMBER	15	num	7	SENT_207	[p12l617t3235r698b3282],
6	:	:	O	:	_	0	SENT_207	[p12l617t3235r698b3282],
7	137-142	CD	NUMBER	137-142	dep	2	SENT_207	[p12l729t3235r989b3282],
8	.	.	O	.	_	0	SENT_207	[p12l729t3235r989b3282],

1	Masui	NNP	PERSON	Masui	nn	2	SENT_208	[p12l146t3311r305b3358],
2	T	NN	PERSON	t	_	0	SENT_208	[p12l328t3312r376b3368],
3	,	,	O	,	_	0	SENT_208	[p12l328t3312r376b3368],
4	Hashimoto	NN	PERSON	hashimoto	nn	5	SENT_208	[p12l405t3309r704b3358],
5	R	NN	PERSON	r	appos	2	SENT_208	[p12l731t3312r774b3368],
6	,	,	O	,	_	0	SENT_208	[p12l731t3312r774b3368],
7	Kusumi	NNP	PERSON	Kusumi	nn	11	SENT_208	[p12l803t3311r1002b3358],
8	I	PRP	O	I	dep	11	SENT_208	[p12l1030t3312r1055b3368],
9	,	,	O	,	_	0	SENT_208	[p12l1030t3312r1055b3368],
10	Suzuki	NNP	PERSON	Suzuki	dep	11	SENT_208	[p12l1083t3309r1256b3358],
11	K	NNP	PERSON	K	appos	2	SENT_208	[p12l1284t3311r1330b3368],
12	,	,	O	,	_	0	SENT_208	[p12l1284t3311r1330b3368],
13	Tanaka	NNP	ORGANIZATION	Tanaka	nn	14	SENT_208	[p12l1354t3309r1550b3358],
14	T	NN	ORGANIZATION	t	appos	2	SENT_208	[p12l1572t3312r1620b3368],
15	,	,	O	,	_	0	SENT_208	[p12l1572t3312r1620b3368],
16	Nakagawa	NNP	PERSON	Nakagawa	nn	17	SENT_208	[p12l1650t3309r1938b3373],
17	S	NNP	O	S	appos	2	SENT_208	[p12l1963t3311r1990b3358],
18	et	FW	O	et	nn	19	SENT_208	[p12l2016t3315r2065b3358],
19	al.	FW	O	al.	dep	17	SENT_208	[p12l2085t3309r2143b3358],
20	.	.	O	.	_	0	SENT_208	[p12l2085t3309r2143b3358],

1	A	DT	O	a	det	3	SENT_209	[p12l141t3388r180b3434],
2	possible	JJ	O	possible	amod	3	SENT_209	[p12l241t3386r459b3450],
3	association	NN	O	association	_	0	SENT_209	[p12l519t3387r820b3435],
4	between	IN	O	between	_	0	SENT_209	[p12l885t3386r1121b3435],
5	the	DT	O	the	det	7	SENT_209	[p12l1182t3386r1271b3435],
6	-116	CD	NUMBER	-116	num	7	SENT_209	[p12l1332t3386r1571b3441],
7	C/G	NN	O	c/g	prep_between	3	SENT_209	[p12l1332t3386r1571b3441],
8	single	JJ	O	single	amod	10	SENT_209	[p12l1634t3386r1793b3450],
9	nucleotide	NN	O	nucleotide	nn	10	SENT_209	[p12l1856t3386r2146b3435],
10	polymorphism	NN	O	polymorphism	dep	3	SENT_209	[p12l145t3462r546b3525],
11	of	IN	O	of	_	0	SENT_209	[p12l585t3462r638b3510],
12	the	DT	O	the	det	14	SENT_209	[p12l670t3462r758b3510],
13	XBP1	NN	O	xbp1	nn	14	SENT_209	[p12l794t3463r926b3510],
14	gene	NN	O	gene	prep_of	10	SENT_209	[p12l974t3476r1110b3525],
15	and	CC	O	and	_	0	SENT_209	[p12l1146t3462r1247b3510],
16	lithium	NN	O	lithium	nn	17	SENT_209	[p12l1286t3462r1476b3510],
17	prophylaxis	NN	O	prophylaxis	prep_of	10	SENT_209	[p12l1516t3462r1834b3525],
18	in	IN	O	in	_	0	SENT_209	[p12l1871t3463r1915b3510],
19	bipolar	JJ	O	bipolar	amod	20	SENT_209	[p12l1956t3462r2149b3525],
20	disorder	NN	O	disorder	prep_in	14	SENT_209	[p12l143t3538r383b3587],
21	.	.	O	.	_	0	SENT_209	[p12l143t3538r383b3587],

1	Int	NN	O	int	_	0	SENT_210	[p12l411t3540r517b3598],
2	]	CD	NUMBER	]	num	1	SENT_210	[p12l411t3540r517b3598],
3	Neuropsychopharmacol	NNP	O	Neuropsychopharmacol	dep	1	SENT_210	[p12l536t3538r1173b3602],
4	2005	CD	DATE	2005	num	3	SENT_210	[p12l1190t3540r1347b3587],
5	:	:	O	:	_	0	SENT_210	[p12l1190t3540r1347b3587],
6	1-6	CD	NUMBER	1-6	dep	1	SENT_210	[p12l1375t3540r1488b3597],
7	,	,	O	,	_	0	SENT_210	[p12l1375t3540r1488b3597],
8	[	CD	NUMBER	[	num	9	SENT_210	[p12l1516t3538r1693b3598],
9	E	NN	O	e	appos	6	SENT_210	[p12l1516t3538r1693b3598],
10	.	.	O	.	_	0	SENT_210	[p12l1516t3538r1693b3598],

1	—	NN	O	—	_	0	SENT_211	[p12l1516t3538r1693b3598],
2	.	.	O	.	_	0	SENT_211	[p12l1516t3538r1693b3598],

1	Pub	NN	O	pub	_	0	SENT_212	[p12l1516t3538r1693b3598],
2	ahead	RB	O	ahead	_	0	SENT_212	[p12l1714t3538r1880b3587],
3	of	IN	O	of	_	0	SENT_212	[p12l1904t3538r1957b3587],
4	print	NN	O	print	nn	5	SENT_212	[p12l1978t3538r2143b3602],
5	]	NN	O	]	prep_ahead_of	1	SENT_212	[p12l1978t3538r2143b3602],
6	.	.	O	.	_	0	SENT_212	[p12l1978t3538r2143b3602],

1	Monteleone	NNP	PERSON	Monteleone	nn	2	SENT_213	[p12l146t3613r481b3661],
2	P	NN	PERSON	p	_	0	SENT_213	[p12l521t3615r564b3671],
3	,	,	O	,	_	0	SENT_213	[p12l521t3615r564b3671],
4	Santonastaso	NNP	PERSON	Santonastaso	nn	5	SENT_213	[p12l605t3614r968b3661],
5	P	NN	PERSON	p	appos	2	SENT_213	[p12l1009t3615r1052b3671],
6	,	,	O	,	_	0	SENT_213	[p12l1009t3615r1052b3671],
7	Tortorella	NNP	PERSON	Tortorella	nn	8	SENT_213	[p12l1090t3613r1356b3661],
8	A	NNP	O	A	appos	2	SENT_213	[p12l1391t3615r1444b3671],
9	,	,	O	,	_	0	SENT_213	[p12l1391t3615r1444b3671],
10	Favaro	NNP	PERSON	Favaro	nn	11	SENT_213	[p12l1488t3615r1664b3661],
11	A	NNP	O	A	appos	2	SENT_213	[p12l1699t3615r1751b3671],
12	,	,	O	,	_	0	SENT_213	[p12l1699t3615r1751b3671],
13	Fabrazzo	NNP	O	Fabrazzo	nn	14	SENT_213	[p12l1795t3613r2035b3661],
14	M	NNP	O	M	appos	2	SENT_213	[p12l2076t3615r2143b3671],
15	,	,	O	,	_	0	SENT_213	[p12l2076t3615r2143b3671],
16	Castaldo	NNP	PERSON	Castaldo	nn	17	SENT_213	[p12l144t3689r383b3738],
17	E	NNP	O	E	appos	2	SENT_213	[p12l423t3691r449b3737],
18	et	FW	O	et	nn	19	SENT_213	[p12l487t3695r536b3738],
19	al.	FW	O	al.	dep	17	SENT_213	[p12l570t3689r628b3738],
20	.	.	O	.	_	0	SENT_213	[p12l570t3689r628b3738],

1	Serotonin	NN	MISC	serotonin	nn	3	SENT_214	[p12l670t3690r934b3738],
2	transporter	NN	O	transporter	nn	3	SENT_214	[p12l973t3695r1282b3753],
3	polymorphism	NN	O	polymorphism	_	0	SENT_214	[p12l1319t3689r1720b3753],
4	and	CC	O	and	_	0	SENT_214	[p12l1760t3689r1860b3738],
5	potential	JJ	O	potential	amod	6	SENT_214	[p12l1902t3689r2144b3753],
6	response	NN	O	response	conj_and	3	SENT_214	[p12l146t3779r386b3828],
7	to	TO	O	to	_	0	SENT_214	[p12l409t3770r464b3813],
8	SSR	NNP	O	SSR	nn	10	SENT_214	[p12l489t3766r626b3813],
9	|	CD	NUMBER	|	num	10	SENT_214	[p12l489t3766r626b3813],
10	s	NNS	O	s	prep_to	3	SENT_214	[p12l489t3766r626b3813],
11	in	IN	O	in	_	0	SENT_214	[p12l651t3766r696b3813],
12	bulimia	NN	O	bulimium	nn	13	SENT_214	[p12l723t3765r925b3813],
13	nervosa	NN	O	nervosa	prep_in	3	SENT_214	[p12l952t3779r1177b3813],
14	.	.	O	.	_	0	SENT_214	[p12l952t3779r1177b3813],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_215	[p12l1205t3765r1308b3813],
2	Psychiatr	NNP	O	Psychiatr	_	0	SENT_215	[p12l1328t3765r1570b3828],
3	2005	CD	DATE	2005	num	2	SENT_215	[p12l1586t3766r1743b3823],
4	;	:	O	;	_	0	SENT_215	[p12l1586t3766r1743b3823],
5	10	CD	NUMBER	10	num	7	SENT_215	[p12l1774t3766r1854b3813],
6	:	:	O	:	_	0	SENT_215	[p12l1774t3766r1854b3813],
7	716-718	CD	NUMBER	716-718	dep	2	SENT_215	[p12l1883t3766r2143b3813],
8	.	.	O	.	_	0	SENT_215	[p12l1883t3766r2143b3813],

1	Yang	NNP	PERSON	Yang	nn	2	SENT_216	[p13l141t18r279b80],
2	L	NNP	PERSON	L	_	0	SENT_216	[p13l325t19r364b75],
3	,	,	O	,	_	0	SENT_216	[p13l325t19r364b75],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_216	[p13l406t18r568b80],
5	YF	NNP	O	YF	appos	2	SENT_216	[p13l609t18r687b75],
6	,	,	O	,	_	0	SENT_216	[p13l609t18r687b75],
7	Li	NNP	PERSON	Li	nn	8	SENT_216	[p13l734t18r772b64],
8	J	NNP	PERSON	J	appos	2	SENT_216	[p13l813t19r842b76],
9	,	,	O	,	_	0	SENT_216	[p13l813t19r842b76],
10	Faraone	NNP	PERSON	Faraone	nn	11	SENT_216	[p13l890t19r1106b65],
11	SV	NNP	O	SV	appos	2	SENT_216	[p13l1148t18r1229b65],
12	.	.	O	.	_	0	SENT_216	[p13l1148t18r1229b65],

1	Association	NNP	O	Association	_	0	SENT_217	[p13l1271t18r1581b65],
2	of	IN	O	of	_	0	SENT_217	[p13l1625t16r1678b65],
3	norepinephrine	NN	O	norepinephrine	nn	5	SENT_217	[p13l1718t16r2146b80],
4	transporter	NN	O	transporter	nn	5	SENT_217	[p13l142t99r452b157],
5	gene	NN	O	gene	prep_of	1	SENT_217	[p13l493t107r628b157],
6	with	IN	O	with	_	0	SENT_217	[p13l669t93r789b142],
7	methylphenidate	NN	O	methylphenidate	nn	8	SENT_217	[p13l836t93r1310b157],
8	response	NN	O	response	prep_with	1	SENT_217	[p13l1355t107r1612b157],
9	.	.	O	.	_	0	SENT_217	[p13l1355t107r1612b157],

1	/	:	O	/	punct	6	SENT_218	[p13l1654t95r1675b153],
2	Am	VBP	O	be	cop	6	SENT_218	[p13l1712t95r1800b141],
3	Acad	NNP	O	Acad	nn	6	SENT_218	[p13l1839t93r1975b142],
4	Child	NNP	O	Child	nn	6	SENT_218	[p13l2016t93r2152b142],
5	Adolesc	NNP	O	Adolesc	nn	6	SENT_218	[p13l142t169r344b217],
6	Psychiatr	NNP	O	Psychiatr	_	0	SENT_218	[p13l368t169r609b232],
7	2004	CD	DATE	2004	num	6	SENT_218	[p13l628t170r785b227],
8	;	:	O	;	_	0	SENT_218	[p13l628t170r785b227],
9	43	CD	NUMBER	43	num	11	SENT_218	[p13l813t170r898b217],
10	:	:	O	:	_	0	SENT_218	[p13l813t170r898b217],
11	1154-1158	CD	DATE	1154-1158	dep	6	SENT_218	[p13l930t170r1263b217],
12	.	.	O	.	_	0	SENT_218	[p13l930t170r1263b217],

1	Yu	NNP	PERSON	Yu	nn	2	SENT_219	[p13l141t247r208b294],
2	YW	NNP	PERSON	YW	_	0	SENT_219	[p13l240t247r347b304],
3	,	,	O	,	_	0	SENT_219	[p13l240t247r347b304],
4	Tsai	NNP	PERSON	Tsai	nn	6	SENT_219	[p13l381t246r485b294],
5	S	NNP	O	S	nn	6	SENT_219	[p13l520t247r580b305],
6	]	NN	O	]	appos	2	SENT_219	[p13l520t247r580b305],
7	,	,	O	,	_	0	SENT_219	[p13l520t247r580b305],
8	Hong	NNP	LOCATION	Hong	nn	10	SENT_219	[p13l619t247r766b309],
9	C	NNP	LOCATION	C	nn	10	SENT_219	[p13l801t247r873b305],
10	]	NN	O	]	appos	6	SENT_219	[p13l801t247r873b305],
11	,	,	O	,	_	0	SENT_219	[p13l801t247r873b305],
12	Chen	NNP	PERSON	Chen	nn	14	SENT_219	[p13l910t245r1053b294],
13	T	NN	O	t	nn	14	SENT_219	[p13l1086t247r1151b305],
14	]	NN	O	]	appos	6	SENT_219	[p13l1086t247r1151b305],
15	,	,	O	,	_	0	SENT_219	[p13l1086t247r1151b305],
16	Chen	NNP	PERSON	Chen	nn	17	SENT_219	[p13l1188t245r1332b294],
17	MC	NNP	PERSON	MC	appos	6	SENT_219	[p13l1370t247r1481b304],
18	,	,	O	,	_	0	SENT_219	[p13l1370t247r1481b304],
19	Yang	NNP	ORGANIZATION	Yang	nn	20	SENT_219	[p13l1514t247r1652b309],
20	CW	NNP	ORGANIZATION	CW	appos	6	SENT_219	[p13l1687t247r1801b294],
21	.	.	O	.	_	0	SENT_219	[p13l1687t247r1801b294],

1	Association	NNP	O	Association	_	0	SENT_220	[p13l1834t246r2144b294],
2	study	NN	O	study	dep	1	SENT_220	[p13l143t321r293b385],
3	of	IN	O	of	_	0	SENT_220	[p13l323t321r377b370],
4	a	DT	O	a	det	6	SENT_220	[p13l405t336r431b370],
5	monoamine	NN	O	monoamine	nn	6	SENT_220	[p13l466t323r800b370],
6	oxidase	NN	O	oxidase	prep_of	2	SENT_220	[p13l832t321r1039b370],
7	a	DT	O	a	det	10	SENT_220	[p13l1071t336r1097b370],
8	gene	NN	O	gene	nn	10	SENT_220	[p13l1129t336r1265b385],
9	promoter	NN	O	promoter	nn	10	SENT_220	[p13l1298t327r1561b385],
10	polymorphism	NN	O	polymorphism	dep	1	SENT_220	[p13l1592t321r1992b385],
11	with	IN	O	with	_	0	SENT_220	[p13l2024t321r2144b370],
12	major	JJ	O	major	amod	14	SENT_220	[p13l146t398r305b461],
13	depressive	JJ	O	depressive	amod	14	SENT_220	[p13l335t397r621b461],
14	disorder	NN	O	disorder	prep_with	10	SENT_220	[p13l654t397r881b446],
15	and	CC	O	and	_	0	SENT_220	[p13l911t397r1012b446],
16	antidepressant	JJ	O	antidepressant	amod	17	SENT_220	[p13l1046t397r1453b461],
17	response	NN	O	response	prep_with	10	SENT_220	[p13l1486t411r1744b461],
18	.	.	O	.	_	0	SENT_220	[p13l1486t411r1744b461],

1	Neuropsychopharmacology	NNP	O	Neuropsychopharmacology	_	0	SENT_221	[p13l1781t397r2147b461, p13l141t473r530b536],
2	2005	CD	DATE	2005	num	1	SENT_221	[p13l550t474r707b531],
3	;	:	O	;	_	0	SENT_221	[p13l550t474r707b531],
4	30	CD	NUMBER	30	num	6	SENT_221	[p13l737t474r821b521],
5	:	:	O	:	_	0	SENT_221	[p13l737t474r821b521],
6	1719-1723	CD	DATE	1719-1723	dep	1	SENT_221	[p13l852t474r1186b521],
7	.	.	O	.	_	0	SENT_221	[p13l852t474r1186b521],

1	Ziegler	NNP	PERSON	Ziegler	nn	2	SENT_222	[p13l143t549r336b613],
2	S	NNP	O	S	_	0	SENT_222	[p13l360t551r403b608],
3	,	,	O	,	_	0	SENT_222	[p13l360t551r403b608],
4	Schillinger	NNP	PERSON	Schillinger	nn	5	SENT_222	[p13l433t549r722b613],
5	M	NNP	O	M	appos	2	SENT_222	[p13l748t551r815b608],
6	,	,	O	,	_	0	SENT_222	[p13l748t551r815b608],
7	Funk	NNP	O	Funk	nn	8	SENT_222	[p13l846t549r976b598],
8	M	NNP	O	M	appos	2	SENT_222	[p13l1002t551r1070b608],
9	,	,	O	,	_	0	SENT_222	[p13l1002t551r1070b608],
10	Felber	NNP	PERSON	Felber	nn	11	SENT_222	[p13l1101t549r1268b598],
11	K	NNP	PERSON	K	appos	2	SENT_222	[p13l1293t551r1338b608],
12	,	,	O	,	_	0	SENT_222	[p13l1293t551r1338b608],
13	Exner	NNP	PERSON	Exner	nn	14	SENT_222	[p13l1370t551r1523b598],
14	M	NNP	O	M	appos	2	SENT_222	[p13l1548t551r1615b608],
15	,	,	O	,	_	0	SENT_222	[p13l1548t551r1615b608],
16	Mlekusch	NNP	O	Mlekusch	nn	17	SENT_222	[p13l1647t549r1904b598],
17	W	NNP	O	W	appos	2	SENT_222	[p13l1929t551r1989b597],
18	et	FW	O	et	nn	19	SENT_222	[p13l2014t555r2063b598],
19	al.	FW	O	al.	dep	17	SENT_222	[p13l2085t549r2143b598],
20	.	.	O	.	_	0	SENT_222	[p13l2085t549r2143b598],

1	Association	NNP	O	Association	_	0	SENT_223	[p13l141t626r450b674],
2	of	IN	O	of	_	0	SENT_223	[p13l522t625r576b674],
3	a	DT	O	a	det	5	SENT_223	[p13l642t639r668b674],
4	functional	JJ	O	functional	amod	5	SENT_223	[p13l736t625r1013b674],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_223	[p13l1086t625r1487b689],
6	in	IN	O	in	_	0	SENT_223	[p13l1560t626r1605b673],
7	the	DT	O	the	det	11	SENT_223	[p13l1675t625r1763b674],
8	clopidogrel	NN	O	clopidogrel	nn	11	SENT_223	[p13l1832t625r2143b689],
9	target	NN	O	target	nn	11	SENT_223	[p13l142t706r309b764],
10	receptor	NN	O	receptor	nn	11	SENT_223	[p13l336t706r568b764],
11	gene	NN	O	gene	prep_in	5	SENT_223	[p13l591t715r742b764],
12	,	,	O	,	_	0	SENT_223	[p13l591t715r742b764],
13	P2Y12	NN	O	p2y12	prep_in	5	SENT_223	[p13l775t702r962b759],
14	,	,	O	,	_	0	SENT_223	[p13l775t702r962b759],
15	and	CC	O	and	_	0	SENT_223	[p13l991t701r1092b749],
16	the	DT	O	the	det	17	SENT_223	[p13l1119t701r1207b749],
17	risk	NN	O	risk	prep_in	5	SENT_223	[p13l1236t701r1323b749],
18	for	IN	O	for	_	0	SENT_223	[p13l1345t701r1424b749],
19	ischemic	JJ	O	ischemic	amod	21	SENT_223	[p13l1448t701r1686b749],
20	cerebrovascular	JJ	O	cerebrovascular	amod	21	SENT_223	[p13l1712t701r2148b749],
21	events	NNS	O	event	prep_for	1	SENT_223	[p13l143t783r320b826],
22	in	IN	O	in	_	0	SENT_223	[p13l363t778r407b825],
23	patients	NNS	O	patient	prep_in	1	SENT_223	[p13l454t778r670b841],
24	with	IN	O	with	_	0	SENT_223	[p13l710t777r830b826],
25	peripheral	JJ	O	peripheral	amod	27	SENT_223	[p13l877t777r1152b841],
26	artery	NN	O	artery	nn	27	SENT_223	[p13l1197t783r1356b841],
27	disease	NN	O	disease	prep_with	23	SENT_223	[p13l1397t777r1607b826],
28	.	.	O	.	_	0	SENT_223	[p13l1397t777r1607b826],

1	Stroke	NNP	O	Stroke	_	0	SENT_224	[p13l1654t777r1818b826],
2	2005	CD	DATE	2005	num	1	SENT_224	[p13l1856t779r2013b836],
3	;	:	O	;	_	0	SENT_224	[p13l1856t779r2013b836],
4	36	CD	NUMBER	36	num	6	SENT_224	[p13l2060t779r2143b826],
5	:	:	O	:	_	0	SENT_224	[p13l2060t779r2143b826],
6	1394-1399	CD	DATE	1394-1399	dep	1	SENT_224	[p13l146t855r480b901],
7	.	.	O	.	_	0	SENT_224	[p13l146t855r480b901],

1	Zineh	NNP	O	Zineh	nn	2	SENT_225	[p13l143t929r298b978],
2	I	NNP	O	I	_	0	SENT_225	[p13l330t931r355b988],
3	,	,	O	,	_	0	SENT_225	[p13l330t931r355b988],
4	Beitelshees	NNP	O	Beitelshees	nn	5	SENT_225	[p13l387t929r687b978],
5	AL	NNP	O	AL	appos	2	SENT_225	[p13l711t931r793b988],
6	,	,	O	,	_	0	SENT_225	[p13l711t931r793b988],
7	Gaedigk	NNP	O	Gaedigk	nn	8	SENT_225	[p13l824t929r1054b993],
8	A	NNP	O	A	appos	2	SENT_225	[p13l1077t931r1129b988],
9	,	,	O	,	_	0	SENT_225	[p13l1077t931r1129b988],
10	Walker	NNP	PERSON	Walker	nn	11	SENT_225	[p13l1157t929r1349b978],
11	JR	NNP	O	JR	appos	2	SENT_225	[p13l1371t931r1436b989],
12	,	,	O	,	_	0	SENT_225	[p13l1371t931r1436b989],
13	Pauly	NNP	O	Pauly	nn	14	SENT_225	[p13l1469t929r1613b993],
14	DF	NNP	O	DF	appos	2	SENT_225	[p13l1641t931r1727b988],
15	,	,	O	,	_	0	SENT_225	[p13l1641t931r1727b988],
16	Eberst	NNP	O	Eberst	nn	17	SENT_225	[p13l1760t929r1926b978],
17	K	NNP	O	K	appos	2	SENT_225	[p13l1953t931r1985b977],
18	et	FW	O	et	nn	19	SENT_225	[p13l2012t935r2061b978],
19	al.	FW	O	al.	dep	17	SENT_225	[p13l2085t929r2143b978],
20	.	.	O	.	_	0	SENT_225	[p13l2085t929r2143b978],

1	Pharmacokinetics	NNS	O	pharmacokinetic	nsubj	7	SENT_226	[p13l146t1005r630b1053],
2	and	CC	O	and	_	0	SENT_226	[p13l663t1005r763b1053],
3	CYP2D6	NN	O	cyp2d6	nn	4	SENT_226	[p13l799t1006r1027b1053],
4	genotypes	NNS	O	genotype	conj_and	1	SENT_226	[p13l1061t1010r1350b1068],
5	do	VBP	O	do	aux	7	SENT_226	[p13l1383t1005r1453b1053],
6	not	RB	O	not	neg	7	SENT_226	[p13l1489t1010r1580b1053],
7	predict	VB	O	predict	_	0	SENT_226	[p13l1614t1005r1807b1068],
8	metoprolol	NN	O	metoprolol	nn	10	SENT_226	[p13l1841t1005r2143b1068],
9	adverse	JJ	O	adverse	amod	10	SENT_226	[p13l143t1081r352b1130],
10	events	NNS	O	event	dobj	7	SENT_226	[p13l382t1087r558b1130],
11	or	CC	O	or	_	0	SENT_226	[p13l588t1095r645b1130],
12	efficacy	NN	O	efficacy	conj_or	10	SENT_226	[p13l672t1081r879b1145],
13	in	IN	O	in	_	0	SENT_226	[p13l910t1082r954b1129],
14	hypertension	NN	O	hypertension	prep_in	7	SENT_226	[p13l988t1081r1364b1145],
15	.	.	O	.	_	0	SENT_226	[p13l988t1081r1364b1145],

1	Clin	NNP	O	Clin	nn	3	SENT_227	[p13l1401t1081r1499b1130],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_227	[p13l1530t1081r1815b1130],
3	Ther	NNP	O	Ther	_	0	SENT_227	[p13l1846t1081r1963b1130],
4	2004	CD	DATE	2004	num	6	SENT_227	[p13l1986t1083r2143b1140],
5	;	:	O	;	_	0	SENT_227	[p13l1986t1083r2143b1140],
6	76	CD	NUMBER	76	dep	3	SENT_227	[p13l146t1159r228b1205],
7	:	:	O	:	_	0	SENT_227	[p13l146t1159r228b1205],
8	536	CD	NUMBER	536	num	9	SENT_227	[p13l257t1159r519b1205],
9	—	NN	O	—	dep	3	SENT_227	[p13l257t1159r519b1205],
10	544	CD	NUMBER	544	dep	9	SENT_227	[p13l257t1159r519b1205],
11	.	.	O	.	_	0	SENT_227	[p13l257t1159r519b1205],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_228	[p13l142t1233r363b1292],
2	JA	NNP	O	JA	_	0	SENT_228	[p13l391t1235r459b1292],
3	,	,	O	,	_	0	SENT_228	[p13l391t1235r459b1292],
4	Akers	NNP	PERSON	Akers	nn	5	SENT_228	[p13l487t1233r634b1281],
5	WS	NNP	O	WS	appos	2	SENT_228	[p13l658t1234r764b1291],
6	,	,	O	,	_	0	SENT_228	[p13l658t1234r764b1291],
7	Miller	NNP	PERSON	Miller	nn	11	SENT_228	[p13l797t1233r952b1281],
8	ST	JJ	O	st	amod	11	SENT_228	[p13l977t1234r1055b1291],
9	,	,	O	,	_	0	SENT_228	[p13l977t1234r1055b1291],
10	Applegate	NNP	O	Applegate	dep	11	SENT_228	[p13l1082t1233r1367b1296],
11	WB	NNP	O	WB	appos	5	SENT_228	[p13l1392t1234r1501b1281],
12	.	.	O	.	_	0	SENT_228	[p13l1392t1234r1501b1281],

1	Metoprolol	NNP	O	Metoprolol	nsubj	2	SENT_229	[p13l1534t1233r1838b1296],
2	minimizes	VBZ	O	minimize	_	0	SENT_229	[p13l1869t1234r2146b1281],
3	nighttime	JJ	TIME	nighttime	amod	6	SENT_229	[p13l146t1309r415b1372],
4	blood	NN	O	blood	nn	6	SENT_229	[p13l466t1309r622b1357],
5	pressure	NN	O	pressure	nn	6	SENT_229	[p13l675t1323r902b1372],
6	dip	NN	O	dip	dobj	2	SENT_229	[p13l951t1309r1037b1372],
7	in	IN	O	in	_	0	SENT_229	[p13l1088t1310r1132b1357],
8	hypertensive	JJ	O	hypertensive	amod	10	SENT_229	[p13l1185t1309r1535b1372],
9	black	JJ	O	black	amod	10	SENT_229	[p13l1586t1309r1728b1357],
10	males	NNS	O	male	prep_in	6	SENT_229	[p13l1777t1309r1948b1357],
11	.	.	O	.	_	0	SENT_229	[p13l1777t1309r1948b1357],

1	Am	VBP	O	be	_	0	SENT_230	[p13l1998t1311r2086b1357],
2	/	:	O	/	punct	1	SENT_230	[p13l2129t1311r2150b1368],
3	Hypertens	NNS	O	hyperten	dep	1	SENT_230	[p13l146t1386r409b1446],
4	1995	CD	DATE	1995	dep	3	SENT_230	[p13l435t1385r589b1441],
5	;	:	O	;	_	0	SENT_230	[p13l435t1385r589b1441],
6	8	CD	NUMBER	8	dep	3	SENT_230	[p13l617t1385r666b1431],
7	:	:	O	:	_	0	SENT_230	[p13l617t1385r666b1431],
8	254-259	CD	NUMBER	254-259	dep	6	SENT_230	[p13l695t1385r958b1431],
9	.	.	O	.	_	0	SENT_230	[p13l695t1385r958b1431],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_231	[p13l142t1460r364b1520],
2	JA	NNP	O	JA	_	0	SENT_231	[p13l421t1462r490b1520],
3	,	,	O	,	_	0	SENT_231	[p13l421t1462r490b1520],
4	Burlew	NNP	O	Burlew	nn	5	SENT_231	[p13l552t1460r739b1509],
5	BS	NNP	O	BS	appos	2	SENT_231	[p13l797t1462r875b1509],
6	.	.	O	.	_	0	SENT_231	[p13l797t1462r875b1509],

1	Metoprolol	NNP	O	Metoprolol	nn	2	SENT_232	[p13l937t1460r1242b1524],
2	metabolism	NN	O	metabolism	_	0	SENT_232	[p13l1302t1460r1624b1509],
3	via	IN	O	via	_	0	SENT_232	[p13l1681t1461r1756b1509],
4	cytochrome	NN	O	cytochrome	nn	5	SENT_232	[p13l1813t1460r2146b1524],
5	P4502D6	NN	O	p4502d6	prep_via	2	SENT_232	[p13l146t1537r403b1584],
6	in	IN	O	in	_	0	SENT_232	[p13l426t1537r471b1584],
7	ethnic	JJ	O	ethnic	amod	8	SENT_232	[p13l494t1536r665b1584],
8	populations	NNS	O	population	prep_in	2	SENT_232	[p13l688t1536r1028b1599],
9	.	.	O	.	_	0	SENT_232	[p13l688t1536r1028b1599],

1	Drug	NN	O	drug	nn	3	SENT_233	[p13l1055t1538r1186b1599],
2	Metab	NNP	O	Metab	nn	3	SENT_233	[p13l1207t1536r1379b1584],
3	Dispos	NNP	O	Dispos	_	0	SENT_233	[p13l1400t1537r1572b1599],
4	1996	CD	DATE	1996	num	3	SENT_233	[p13l1593t1537r1747b1594],
5	;	:	O	;	_	0	SENT_233	[p13l1593t1537r1747b1594],
6	24	CD	NUMBER	24	num	8	SENT_233	[p13l1772t1537r1857b1584],
7	:	:	O	:	_	0	SENT_233	[p13l1772t1537r1857b1584],
8	350-355	CD	NUMBER	350-355	dep	3	SENT_233	[p13l1883t1537r2143b1584],
9	.	.	O	.	_	0	SENT_233	[p13l1883t1537r2143b1584],

1	Maqbool	NNP	PERSON	Maqbool	nn	2	SENT_234	[p13l146t1612r392b1676],
2	A	NNP	O	A	_	0	SENT_234	[p13l415t1614r467b1671],
3	,	,	O	,	_	0	SENT_234	[p13l415t1614r467b1671],
4	Hall	NNP	O	Hall	nn	5	SENT_234	[p13l497t1612r595b1661],
5	AS	NNP	O	AS	appos	2	SENT_234	[p13l618t1614r704b1671],
6	,	,	O	,	_	0	SENT_234	[p13l618t1614r704b1671],
7	Ball	NNP	ORGANIZATION	Ball	nn	8	SENT_234	[p13l733t1612r822b1661],
8	SG	NNP	ORGANIZATION	SG	appos	2	SENT_234	[p13l849t1614r939b1671],
9	,	,	O	,	_	0	SENT_234	[p13l849t1614r939b1671],
10	Balmforth	NNP	LOCATION	Balmforth	nn	11	SENT_234	[p13l968t1612r1236b1661],
11	A	NNP	O	A	appos	2	SENT_234	[p13l1259t1614r1329b1672],
12	]	NN	O	]	dep	11	SENT_234	[p13l1259t1614r1329b1672],
13	.	.	O	.	_	0	SENT_234	[p13l1259t1614r1329b1672],

1	Common	JJ	O	common	amod	2	SENT_235	[p13l1356t1614r1617b1661],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_235	[p13l1645t1612r2072b1676],
3	of	IN	O	of	_	0	SENT_235	[p13l2095t1612r2149b1661],
4	beta1-adrenoceptor	NN	O	beta1-adrenoceptor	prep_of	2	SENT_235	[p13l145t1688r716b1752],
5	:	:	O	:	_	0	SENT_235	[p13l145t1688r716b1752],
6	identification	NN	O	identification	dep	2	SENT_235	[p13l758t1688r1118b1736],
7	and	CC	O	and	_	0	SENT_235	[p13l1158t1688r1259b1736],
8	rapid	JJ	O	rapid	amod	10	SENT_235	[p13l1299t1688r1436b1752],
9	screening	NN	O	screening	nn	10	SENT_235	[p13l1474t1689r1738b1751],
10	assay	NN	O	assay	conj_and	6	SENT_235	[p13l1778t1702r1934b1752],
11	.	.	O	.	_	0	SENT_235	[p13l1778t1702r1934b1752],

1	Lancet	NNP	O	Lancet	_	0	SENT_236	[p13l1977t1690r2150b1736],
2	1999	CD	DATE	1999	num	1	SENT_236	[p13l146t1765r301b1821],
3	;	:	O	;	_	0	SENT_236	[p13l146t1765r301b1821],
4	353	CD	NUMBER	353	num	6	SENT_236	[p13l331t1765r451b1811],
5	:	:	O	:	_	0	SENT_236	[p13l331t1765r451b1811],
6	897	CD	NUMBER	897	dep	1	SENT_236	[p13l480t1765r600b1811],
7	.	.	O	.	_	0	SENT_236	[p13l480t1765r600b1811],

